ENSG00000167323,STIM1,calcium signaling pathway,store-operated calcium entry (soce),immune cell modulation,cell migration and invasion,tumor progression,therapeutic target
ENSG00000144935,TRPC1,calcium influx,cell proliferation,mutations associated,store-operated calcium entry (soce),apoptosis resistance,angiogenesis promotion
ENSG00000089250,NOS1,nitric oxide production,cell migration,tumor microenvironment modulation,pi3k/akt pathway interaction,angiogenesis promotion,immune evasion enhancement
ENSG00000058668,ATP2B4,calcium regulation,cell proliferation,protein-protein interaction,epithelial-to-mesenchymal transition,oncogenic signaling pathway,biomarker candidate
ENSG00000069431,ABCC9,cellular proliferation,regulation of energy metabolism,apoptosis regulation,tumor suppressor or oncogene,atp-binding cassette transporter function,cardiac potassium channel regulation
ENSG00000187486,KCNJ11,potassium channel regulation,cell growth modulation,insulin secretion regulation,tumorigenesis promotion,signaling pathway disruption,atp-sensitive potassium channels dysfunction
ENSG00000084754,HADHA,mitochondrial beta-oxidation,lipid metabolism,altered energy production,glycolytic shift,tumorigenesis,prognostic biomarker
ENSG00000138029,HADHB,mitochondrial dysfunction,altered metabolic pathways,dysregulation of energy production,tumor cell proliferation,increased ros production,therapeutic target for cancer treatment
ENSG00000197265,GTF2E2,transcriptional regulation,gene overexpression,cell proliferation regulation,apoptosis suppression,dna damage response modulation,tumor suppressor regulation
ENSG00000153767,GTF2E1,rna polymerase ii-mediated transcription,tumor promoter,overexpression,transcriptional coactivator,mutations in cancer,cell cycle regulation
ENSG00000140307,GTF2A2,transcription regulation,oncogenic gene expression,chromatin remodeling,epigenetic modification,cell cycle progression,dna repair mechanisms
ENSG00000165417,GTF2A1,transcriptional regulation,proliferation and survival,overexpression,oncogenesis,cellular interaction,antisense transcription
ENSG00000162738,VANGL2,planar cell polarity signaling,cell migration and invasion,oncogene activation,wnt/β-catenin pathway interaction,tumor progression regulation,protein-protein interaction
ENSG00000274287,SCRIB,wnt/pcp pathway inhibition,cellular polarity regulation,tumor suppressor function,pcd signaling modulation,cell migration promotion,prognostic biomarker potential
ENSG00000004975,DVL2,wnt signaling pathway activation,co-activator function for ?-catenin,cell proliferation regulation,survival mechanisms,prognostic marker,tumor progression facilitation
ENSG00000102981,PARD6A,tumor progression,loss of polarity,cell migration,epithelial-to-mesenchymal transition,tight junction regulation,therapeutic target
ENSG00000177885,GRB2,oncogenic signaling,cell proliferation,signal transduction,tumor progression,prognostic marker,adaptor protein function
ENSG00000109458,GAB1,gab1/pi3k interaction,cell proliferation enhancement,apoptosis inhibition,oncogenic behavior promotion,tumor progression facilitation,signaling pathway activation
ENSG00000146648,EGFR,ras/mapk signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic profiling
ENSG00000138798,EGF,autocrine growth factor,cell proliferation,egf/egfr pathway,growth factor signaling,tumor aggressiveness,tumorigenesis
ENSG00000121879,PIK3CA,pi3k/akt/mtor pathway,constitutive activation,gain of function mutations,oncogenic signaling,therapeutic target,tumor progression
ENSG00000145675,PIK3R1,constitutive activation,gain of function mutations,regulatory subunit function,tumor progression,insulin signaling pathway,therapeutic target
ENSG00000197122,SRC,cellular proliferation,signaling pathway activation,oncogenic transformation,tumor progression,gene amplification,protein kinase activity
ENSG00000089159,PXN,fak signaling pathway,cell adhesion and migration,metastasis promotion,tumor progression,cellular invasion,integrin-mediated attachment
ENSG00000137392,CLPS,clps expression,pi3k/akt signaling pathway,promotion of cell proliferation,metastasis and invasion,interaction with mmps,apoptosis inhibition
ENSG00000175535,PNLIP,lipid metabolism alteration,tumor progression facilitation,energy supply enhancement,poor prognosis association,immune evasion mechanism,oncogenic pathway activation
ENSG00000078369,GNB1,overexpression,signaling pathway modulation,cell proliferation regulation,biomarker potential,apoptosis evasion,prognostic marker
ENSG00000127928,GNGT1,constitutive activation,guanine nucleotide-binding protein subunit t1,ras/raf/mapk pathway,tumor progression,cellular proliferation,gene overexpression
ENSG00000198515,CNGA1,regulation of cell proliferation,non-selective cation channel function,elevated expression in tumor tissues,cancer-related signaling pathways,tumor progression modulation,intracellular ion regulation
ENSG00000070729,CNGB1,calcium-dependent signaling,ion channel function,cellular proliferation,apoptosis regulation,calmodulin interaction,calcium homeostasis
ENSG00000257365,FNTB,lipid biosynthesis pathway,overexpression,metabolic reprogramming,tumor progression,oncogenic signaling,lipid metabolism alteration
ENSG00000168522,FNTA,lipid metabolic regulation,cell proliferation,cell survival,tumor progression,protein-protein interaction,therapeutic target
ENSG00000113522,RAD50,dna damage response,genomic stability maintenance,homologous recombination,oncogenic mutations,genomic instability induction,tumor suppressor function
ENSG00000020922,MRE11,dna damage response,genomic stability maintenance,tumor suppressor function,chromosomal instability prevention,dna repair machinery component,cancer progression association
ENSG00000182481,KPNA2,nuclear localization signal,cell proliferation,transcription factor transport,genomic instability,epigenetic regulation,apoptosis suppression
ENSG00000104320,NBN,genomic instability,tumor progression,genetic instability,dna damage response,scaffold protein function,checkpoint activation
ENSG00000172977,KAT5,tumor growth regulation,chromatin remodeling,cell cycle progression,apoptosis regulation,dna repair facilitation,tumor suppressor interaction
ENSG00000149311,ATM,genomic instability,dna damage response,oncogenesis driver,tumor suppressor function,cell cycle regulation,protein kinase activation
ENSG00000009954,BAZ1B,chromatin remodeling activity,epigenetic modifications,oncogene overexpression,cell cycle progression,transcriptional regulation disruption,swi/snf complex subunit
ENSG00000153147,SMARCA5,genomic instability,epigenetic regulation,cellular proliferation,dna damage response,chromatin remodeling,tumor suppression
ENSG00000103275,UBE2I,ubiquitin-conjugating enzyme function,dna repair pathway interaction,apoptosis evasion mechanism,tumor growth promotion,genetic mutation accumulation,cell proliferation regulation
ENSG00000116030,SUMO1,genomic instability,protein modification,cell cycle regulation,tumor progression,chromosomal alteration,transcriptional regulation
ENSG00000169139,UBE2V2,ubiquitination pathway,cell cycle regulation,dna repair,transcriptional control,tumor aggressiveness,oncogenesis
ENSG00000177889,UBE2N,ubiquitination pathway,genomic instability,tumor progression,cell proliferation,protein degradation,overexpression
ENSG00000138376,BARD1,genetic instability,homologous recombination,tumor suppressor function,apoptosis regulation,cell cycle control,protein-protein interaction
ENSG00000012048,BRCA1,homologous recombination,genomic stability,cell cycle regulation,tumor suppressor function,biomarker for chemotherapy response,chromosomal instability
ENSG00000188612,SUMO2,protein modification,epigenetic regulation,tumor growth,chemotherapy resistance,cell proliferation,apoptosis suppression
ENSG00000225589,MDC1,dna repair pathway,genomic stability maintenance,tumor growth promotion,therapeutic target,biomarker potential,cell survival enhancement
ENSG00000128731,HERC2,ubiquitin ligase activity,protein stability modulation,tumor progression,cell cycle regulation,anti-apoptotic function,pi3k/akt interaction
ENSG00000164053,ATRIP,cell cycle regulation,genetic instability,dna damage response,apoptosis resistance,atm/atr pathway,tumor progression
ENSG00000175054,ATR,dna damage response pathway,genomic instability,cell cycle checkpoint activation,oncogenic mutations,tumor suppressor function,dna replication fidelity
ENSG00000111602,TIMELESS,dna damage response regulation,chromosome instability driver,cell cycle progression modulation,g2/m checkpoint dysregulation,atr-chk1 pathway interaction,therapeutic target for chemotherapy resistance
ENSG00000075131,TIPIN,genomic instability,tumor suppressor,replication regulation,dna repair,helicase interaction,cell cycle regulation
ENSG00000163605,PPP4R2,genome instability,chromatin remodeling,cell cycle regulation,oncogenic function,tumor suppressor dysregulation,phosphatase activity modulation
ENSG00000149923,PPP4C,aberrant signaling pathway,cell cycle regulation,oncogenesis,apoptosis suppression,transcriptional modulation,tumor progression
ENSG00000108384,RAD51C,genomic instability,tumor suppressor function,dna repair pathway,homologous recombination,cell cycle regulation,checkpoint signaling
ENSG00000126215,XRCC3,genomic instability,homologous recombination,dna repair pathway,interstrand crosslink damage,chemotherapy resistance,genomic maintenance
ENSG00000197774,EME2,genomic stability,cell cycle regulation,dna repair pathway,tumor suppressor,cancer progression,ubiquitin-conjugating enzyme
ENSG00000172732,MUS81,genomic instability,homologous recombination repair,interstrand crosslink repair,double-strand break resolution,holliday junction processing,dna replication fidelity
ENSG00000154920,EME1,genomic instability,dna damage response,homologous recombination repair,tumor progression,onco-protein activation,cancer cell survival
ENSG00000139618,BRCA2,genetic instability,tumor suppressor function,homologous recombination repair (hrr),dna double-strand breaks,chromosomal aberrations,genomic instability
ENSG00000051180,RAD51,homologous recombination repair (hrr),dna damage response,genome instability,oncogenic transformation,cell cycle regulation,apoptosis evasion
ENSG00000175595,ERCC4,genomic instability,dna repair mechanism,nucleotide excision repair,cancer susceptibility,tumor suppressor function,base excision repair interaction
ENSG00000012061,ERCC1,genomic instability,dna repair mechanism,nucleotide excision repair,sensitivity to platinum-based chemotherapy,increased cell death,therapeutic response modulation
ENSG00000073050,XRCC1,dna repair mechanism,base excision repair pathway,genomic stability maintenance,oncogenic mutations risk factor,tumor cell sensitivity modulator,rna-protein interactions
ENSG00000005156,LIG3,genomic instability,dna repair deficiency,cell cycle regulation,apoptosis modulation,tumor suppressor function,homologous recombination repair
ENSG00000196419,XRCC6,genomic instability,dna repair deficiency,oncogenesis,apoptosis regulation,biomarker potential,poor prognosis
ENSG00000079246,XRCC5,dna repair mechanism,genomic instability,tumor growth promotion,oncogenic mutation facilitation,cancer cell survival,prognostic marker
ENSG00000152422,XRCC4,genomic instability,dna repair pathway,oncogenic mutations,tumor suppression,epigenetic regulation,therapeutic target
ENSG00000174405,LIG4,genomic instability,dna repair pathway,non-homologous end joining (nhej),chromosomal rearrangement,mutational burden,tumor progression
ENSG00000049860,HEXB,lysosomal dysfunction,glycosphingolipid metabolism,cell survival regulation,metabolic reprogramming,tumor progression facilitation,genetic disorder association
ENSG00000213614,HEXA,lysosomal regulation,autophagy dysregulation,cellular homeostasis disruption,apoptosis modulation,protein degradation pathway,lipid metabolism regulation
ENSG00000151348,EXT2,genomic instability,tumor suppressor role,mismatch repair pathway,dna damage response,mutational signature,oncogenic mutations
ENSG00000182197,EXT1,genomic instability,dna repair pathway,mutation hotspots,tumor suppressor function,genetic heterogeneity,epigenetic regulation
ENSG00000115904,SOS1,constitutive activation,oncogenic signaling pathway,ras activation,tumor progression,gef activity,cell proliferation
ENSG00000170312,CDK1,cell cycle progression,proliferation driver,genomic instability,mitotic entry,apoptosis resistance,chromosomal abnormalities
ENSG00000134057,CCNB1,mitotic regulation,cyclin overexpression,cell cycle progression,oncogenic potential,tumor growth promotion,therapeutic target
ENSG00000165494,PCF11,chromatin remodeling,oncogene activation,genomic instability,transcriptional regulation,cell proliferation,chromatin modification
ENSG00000172409,CLP1,ribosome biogenesis,mutation/alteration,cell growth/proliferation,aberrant rrna processing,tumor progression,anti-tumor target
ENSG00000187079,TEAD1,transcription factor activity,cell proliferation,overexpressed in cancer,emt regulation,metastasis promotion,yap/taz interaction
ENSG00000137693,YAP1,hippo pathway dysregulation,constitutive activation,gain of function mutations,tumor progression,therapeutic target,hippo signaling
ENSG00000074219,TEAD2,hippo-yap signaling,transcriptional regulation,constitutive activation,cell proliferation enhancement,tumor progression facilitation,poor prognostic marker
ENSG00000007866,TEAD3,transcriptional regulation,oncogenic function,tumor progression,epithelial-to-mesenchymal transition,prognostic biomarker,therapeutic target
ENSG00000197905,TEAD4,oncogene activity,gain of function mutations,transcriptional regulation,cell cycle progression,apoptosis inhibition,hippo pathway interaction
ENSG00000132964,CDK8,transcription regulation,tumor progression,cancer driver gene,metabolic adaptation,cell proliferation,protein-protein interaction
ENSG00000112237,CCNC,transcriptional regulator,cell cycle progression,constitutive activation,oncogenic potential,regulatory subunit,mrna processing
ENSG00000101665,SMAD7,constitutive activation,cell growth regulation,epithelial-to-mesenchymal transition suppression,inhibitory smad function,oncogene downregulation,smad family member interaction
ENSG00000157450,RNF111,tumor suppressor regulation,cell cycle modulation,dna damage response,protein degradation dysregulation,gene amplification,ring-type ubiquitin ligase
ENSG00000284792,PTEN,pi3k/akt signaling inhibition,tumor suppressor function,genomic instability prevention,cell growth regulation,protein phosphatase activity,molecular weight regulation
ENSG00000141510,TP53,dna damage response,cell cycle regulation,apoptosis induction,genomic instability,oncogenic pathway activation,tumor suppressor function
ENSG00000165699,TSC1,mtor signaling pathway,tumor suppressor function,loss of function mutations,cell growth regulation,cell proliferation enhancement,rapamycin sensitivity
ENSG00000103197,TSC2,mtor signaling pathway,constitutive activation,loss-of-function mutations,tumor progression,therapeutic target,genomic instability
ENSG00000284194,SCO2,electron transport chain disruption,mitochondrial dysfunction,succinate dehydrogenase complex regulation,metabolic reprogramming,tumor growth promotion,genomic instability
ENSG00000048392,RRM2B,dna synthesis regulation,mitochondrial localization,nucleotide metabolism,ribonucleotide reductase activation,tumor cell proliferation support,upregulated expression in cancer cells
ENSG00000135423,GLS2,increased glutamine metabolism,oncogenic potential,redox state regulation,tumor growth inhibition,antitumor effects,therapeutic target
ENSG00000146674,IGFBP3,igf system regulation,anti-apoptotic activity,tumor suppression,angiogenesis modulation,binding protein function,cellular response regulation
ENSG00000141682,PMAIP1,apoptosis regulation,cell cycle progression,dna damage response,mdm2 degradation,oncoprotein suppression,therapeutic target
ENSG00000015475,BID,apoptosis dysregulation,pro-apoptotic protein function,tumor suppressor activity,p53-mdm2 interaction,cell survival regulation,mitochondrial outer membrane permeabilization
ENSG00000120471,TP53AIP1,p53 pathway regulation,gene amplification,loss of tumor suppressor function,tumor cell survival inhibition,apoptosis induction,dna damage response
ENSG00000197050,ZNF420,tumor aggressiveness,biomarker potential,co-regulatory complexes,apoptosis evasion,cell proliferation enhancement,oncogene function
ENSG00000115107,STEAP3,iron regulation,metalloreductase activity,cell growth promotion,prognostic marker,tumor aggressiveness,iron metabolism regulation
ENSG00000104765,BNIP3L,mitochondrial dynamics,apoptosis regulation,tumor suppression,gene silencing,cellular stress response,pro-apoptotic function
ENSG00000170855,TRIAP1,genomic instability,tumor suppressor function,dna damage response,genetic mutations,protein-protein interactions,cell cycle regulation
ENSG00000042286,AIFM2,mitochondrial function,apoptosis inhibition,cell growth promotion,oxidative stress modulation,dna damage response regulation,protein-protein interaction
ENSG00000164938,TP53INP1,cell cycle regulation,tp53 interaction,apoptosis modulation,oncogenic properties,genomic instability,tumor suppression
ENSG00000120868,APAF1,apoptotic pathway regulation,dna damage response,tumor suppressor function,caspase activation,genomic instability,therapeutic target
ENSG00000177595,PIDD1,apoptosis regulation,tumor suppression,caspase activation,p53 interaction,programmed cell death regulation,gene expression modulation
ENSG00000169372,CRADD,apoptosis inhibition,necroptosis modulation,tumor progression,programmed cell death regulation,cell survival enhancement,ripk1 interaction
ENSG00000091106,NLRC4,inflammasome regulation,tumor immune microenvironment,bacterial recognition,pro-inflammatory signaling,immune response modulation,cancer-associated inflammation
ENSG00000138794,CASP6,apoptosis induction,pro-apoptotic activity,caspase cascade activation,tumor cell survival modulation,therapeutic target,programmed cell death regulation
ENSG00000003400,CASP10,apoptosis regulation,cancer suppression,genomic instability,inflammation modulation,programmed cell death,tumor progression
ENSG00000104419,NDRG1,tumor suppressor,downregulation,apoptosis induction,metastasis inhibition,cell differentiation,pi3k/akt pathway interaction
ENSG00000281449,BCL2L14,bcl-2 family interaction,anti-apoptotic function,tumor progression,therapeutic target,pro-survival signaling pathways,cell survival
ENSG00000089685,BIRC5,apoptosis inhibition,overexpression associated with poor prognosis,tumor progression,therapeutic target,cell cycle regulation,dna repair regulation
ENSG00000113916,BCL6,epigenetic regulation,transcriptional repression,oncogenic transcription factor,cell proliferation driver,apoptosis suppressor,epigenetic reprogramming
ENSG00000161642,ZNF385A,dna-binding protein,tumor suppressor function,loss-of-function mutations,cell cycle regulation,transcriptional repression,genomic instability
ENSG00000116017,ARID3A,**
arid family proteins,chromatin remodeling,tumor suppressor gene regulation,epithelial-to-mesenchymal transition,cell growth and differentiation,oncogene activation
ENSG00000165891,E2F7,tumor suppressor,cell cycle regulation,transcriptional regulation,epigenetic modification,dna methylation,histone modification
ENSG00000129173,E2F8,cell cycle regulation,transcriptional activation,oncogenic function,cell proliferation,apoptosis inhibition,chromatin remodeling
ENSG00000116717,GADD45A,tumor suppressor,cell cycle regulation,apoptosis regulation,dna repair,protein-protein interaction,cancer prognosis
ENSG00000087586,AURKA,cell cycle regulation,kinase activity,chromosomal instability,tumor progression,therapeutic target,mitotic progression
ENSG00000132646,PCNA,genomic instability,cell proliferation marker,dna replication facilitation,resistance to chemotherapy,apoptosis regulation,cell cycle progression
ENSG00000087088,BAX,apoptosis inhibition,genomic instability,tumor suppression,mitochondrial permeabilization,cell survival promotion,pro-apoptotic function
ENSG00000175793,SFN,cholesterol biosynthesis pathway,steroid hormone production,dysregulated lipid metabolism,cell proliferation regulation,potential therapeutic target,genetic mutations impact
ENSG00000145632,PLK2,cell cycle regulation,dysregulated mitosis,proliferation enhancement,apoptosis inhibition,genomic instability,oncogenic kinase activity
ENSG00000173846,PLK3,cell cycle progression,dna damage response,apoptosis regulation,cancer driver,tumor progression,protein-protein interactions
ENSG00000102760,RGCC,chromatin remodeling,oncogene activation,genomic instability,cell cycle regulation,dna repair mechanism,protein phosphorylation
ENSG00000118495,PLAGL1,oncogene,transcription factor regulation,apoptosis suppression,cell proliferation promotion,dna repair modulation,stem cell maintenance
ENSG00000115966,ATF2,transcription regulation,constitutive activation,genomic instability,apoptosis resistance,cell cycle progression,therapeutic target
ENSG00000177606,JUN,transcriptional regulation,cancer cell transformation,oncogenic activation,apoptosis resistance,proliferation enhancement,tumor progression
ENSG00000170345,FOS,transcription factor regulation,oncogene activation,cell proliferation enhancement,apoptosis inhibition,tumor progression facilitation,genetic amplification
ENSG00000122512,PMS2,dna mismatch repair,tumor suppressor function,loss of heterozygosity,genomic instability,oncogenesis,ploidy alteration
ENSG00000076242,MLH1,msi microsatellite instability,loss of function mutations,tumor suppressor function,genomic integrity maintenance,mismatch repair system,epigenetic silencing
ENSG00000158169,FANCC,genomic instability,dna repair deficiency,oncogenic mutations,telomere maintenance,meiotic recombination,therapeutic target
ENSG00000134574,DDB2,genomic instability,nucleotide excision repair pathway,dna damage response,cell cycle checkpoint regulation,apoptosis regulation,tumor progression
ENSG00000057657,PRDM1,tumor suppressor,epigenetic silencing,apoptosis regulation,cell cycle arrest,genomic instability,cancer therapy target
ENSG00000135679,MDM2,mdm2 protein degradation,p53 inhibition,tumor suppression loss,apoptosis evasion,genomic instability,post-translational regulation
ENSG00000198625,MDM4,p53 tumor suppressor inhibition,apoptosis suppression,cell survival enhancement,oncogenic regulation,protein stability modulation,tumor progression promotion
ENSG00000113328,CCNG1,cell cycle regulation,inhibitor of cdk activity,tumor suppressor function,cancer progression,genetic downregulation,proliferation control
ENSG00000064393,HIPK2,apoptosis regulation,tumor suppressor function,cell death pathway disruption,dna damage response,programmed cell death promotion,cellular stress response
ENSG00000127445,PIN1,proline isomerization,kinase activation,cell cycle progression,oncogenic transformation,akt signaling pathway,transcriptional regulation
ENSG00000163349,HIPK1,apoptosis regulation,cell cycle progression,microrna regulation,oncogene activation,tumor suppressor inhibition,cell proliferation enhancement
ENSG00000149136,SSRP1,transcription regulation,genome stability maintenance,oncogenic gene expression,tumor suppressor suppression,overexpression in tumors,biomarker potential
ENSG00000092201,SUPT16H,chromatin remodeling,genomic instability,dna repair pathway,transcriptional regulation,cellular response modulation,double-strand break repair
ENSG00000101266,CSNK2A1,ck2 signaling pathway,cell cycle regulation,gain of function mutations,protein kinase activation,tumor progression,chemotherapy resistance
ENSG00000070770,CSNK2A2,ck2 pathway,overexpression,tumor progression,cell proliferation,signal transduction,oncogenic transformation
ENSG00000088325,TPX2,genomic instability,aurora kinase a activation,mitotic spindle assembly disruption,cell cycle dysregulation,microtubule-associated protein function,oncogenic process promotion
ENSG00000188976,NOC2L,nuclear regulation,cell cycle progression,chromatin modulation,tumor suppressor regulation,protein degradation,poor prognosis predictor
ENSG00000176749,CDK5R1,cell proliferation,apoptosis inhibition,cell cycle regulation,dna repair regulation,tumor progression,therapeutic target
ENSG00000164885,CDK5,genomic instability,cellular proliferation,tumor progression,apoptosis inhibition,pi3k/akt pathway activation,oncogenic mechanism
ENSG00000152192,POU4F1,transcription factor,cell proliferation,constitutive expression,tumor progression,poor prognosis,dna replication regulation
ENSG00000151615,POU4F2,tumor suppression,cellular proliferation,transcriptional regulation,apoptosis regulation,downregulation in cancer,pi3k/akt pathway interaction
ENSG00000172530,BANP,cell cycle regulation,transcription factor activity,apoptosis inhibition,tumor aggressiveness,cell proliferation enhancement,prognostic biomarker
ENSG00000025293,PHF20,tumor promoter,constitutive expression,transcriptional regulation,oncogenic driver,genomic instability,histone modification
ENSG00000185513,L3MBTL1,histone modification,epigenetic regulation,tumor suppression,genome stability,chromatin remodeling,dna damage response
ENSG00000238134,EHMT2,histone modification,chromatin compaction,epigenetic regulation,genomic instability,tumor progression,prognostic biomarker
ENSG00000181090,EHMT1,histone methylation,tumor progression,methylation-dependent epigenetic regulation,transcriptional regulation,cell proliferation,genomic stability
ENSG00000137203,TFAP2A,oncogenic transformation,cell proliferation,transcriptional regulation,dysregulated expression,tumor progression,metastasis
ENSG00000124795,DEK,chromatin regulation,apoptosis resistance,oncogene interaction,tumor suppressor modulation,genomic instability,prognostic marker
ENSG00000087510,TFAP2C,transcription regulation,tumor progression,oncogenesis,epigenetic modification,protein-protein interaction,cell cycle regulation
ENSG00000186153,WWOX,ww domain interactions,tumor suppression,oxidoreductase activity,cell growth regulation,dna damage response,protein-protein interactions
ENSG00000008196,TFAP2B,transcriptional regulation,cancer progression,epithelial-to-mesenchymal transition (emt),cell metabolism modification,gene expression modulation,tumor aggressiveness
ENSG00000127337,YEATS4,histone regulation,tumorigenesis,chromatin remodeling,transcriptional dysregulation,histone recognition,dna repair dysfunction
ENSG00000091831,ESR1,ligand-independent activation,estrogen signaling pathways,cell proliferation,therapeutic target,transcription factor,gene regulation
ENSG00000156802,ATAD2,chromatin remodeling,cell proliferation,oncogenic transcription,cell migration,chromatin modification,gene expression regulation
ENSG00000112715,VEGFA,vegf signaling,angiogenesis promotion,oncogenic driver,prognostic biomarker,therapeutic target,genomic amplification
ENSG00000163235,TGFA,erk/mapk pathway activation,growth factor signaling,oncogenic driver,tumor progression promoter,cell proliferation enhancer,adhesion molecule regulator
ENSG00000124762,CDKN1A,cell cycle regulation,tumor suppressor,genomic instability,cyclin-dependent kinase inhibition,cell proliferation regulation,dna damage response
ENSG00000159216,RUNX1,oncogenic transcription,tumor suppressor regulation,cell cycle progression,apoptosis inhibition,angiogenesis promotion,therapeutic target
ENSG00000078900,TP73,cell cycle regulation,apoptosis modulation,transcription factor function,tumor suppressor role,angiogenesis promotion,emt regulation
ENSG00000179588,ZFPM1,transcriptional regulation,cell differentiation,gene expression modulation,tumor suppression,therapeutic target,proliferation inhibition
ENSG00000102145,GATA1,gata1 overexpression,transcriptional regulation,hematopoietic cell development disruption,cell proliferation enhancement,tumor initiation and progression,epigenetic modification alterations
ENSG00000143387,CTSK,tumor progression,metastasis promoter,cellular invasion,ecm remodeling,proteolytic activity,therapeutic target
ENSG00000197641,SERPINB13,apoptosis regulation,cellular morphology changes,chymotrypsin inhibition,oncogenic process promotion,poor prognosis association,proteolytic regulation disruption
ENSG00000110092,CCND1,g1-s phase transition acceleration,constitutive activation,cell proliferation enhancement,cyclin-cdk complex formation,signaling pathway modulation,oncogenic driver gene
ENSG00000135446,CDK4,cell cycle regulation,oncogene activation,overexpression driven tumorigenesis,cell proliferation enhancement,retinoblastoma protein inactivation,constitutive phosphorylation pathway
ENSG00000173153,ESRRA,cell proliferation,genetic amplification,transcriptional regulation,tumor progression,oncogenic cooperation,nuclear receptor activity
ENSG00000109819,PPARGC1A,energy metabolism regulation,glycolysis modulation,glucose homeostasis regulation,tumor growth promotion,metabolic adaptation,coactivator function
ENSG00000122691,TWIST1,pi3k/akt signaling,epithelial-to-mesenchymal transition (emt),gain of function mutations,tumor progression,chromatin remodeling,rna transcription regulation
ENSG00000124813,RUNX2,transcription factor regulation,oncogenic driver,cell proliferation enhancement,chromatin remodeling,protein-protein interactions,apoptosis suppression
ENSG00000109705,NKX3-2,tumor suppressor function,downregulated expression,embryonic development regulation,cell differentiation control,wnt/β-catenin pathway modulation,pi3k/akt signaling interference
ENSG00000120149,MSX2,pi3k/akt signaling,homeobox transcription factor,tumor progression,cellular differentiation,therapeutic target,resistance to therapy
ENSG00000141646,SMAD4,tumor suppressor function,loss of function mutations,disrupted tgf-β signaling,enhanced cell growth and proliferation,contributes to tumorigenesis,poor prognosis
ENSG00000170365,SMAD1,tgf-β signaling pathway,epithelial-to-mesenchymal transition (emt) process,genomic profiling alterations,tumor suppressor function,cell growth regulation,apoptosis promotion
ENSG00000020633,RUNX3,tumor suppressor function,epigenetic silencing,cell proliferation regulation,apoptosis promotion,signaling pathway modulation,genomic instability
ENSG00000166949,SMAD3,cell proliferation enhancement,tgf-β signaling disruption,smad protein complex formation,apoptosis inhibition,transcriptional regulation alteration,genomic instability promotion
ENSG00000198176,TFDP1,cell cycle regulation,transcription factor activity,oncogene activation,apoptosis inhibition,tumor suppressor downregulation,genomic instability
ENSG00000169016,E2F6,cell cycle regulation,tumor suppressor function,gene expression repression,cell proliferation inhibition,oncogenesis disruption,epigenetic regulation
ENSG00000114126,TFDP2,aberrant transcription regulation,angiogenic factor activation,cell cycle progression,dna repair pathway dysregulation,e2f/dp complex interaction,oncogene overexpression
ENSG00000174197,MGA,tumor suppressor,transcriptional regulation,estrogen receptor interaction,cell proliferation,survival promotion,aggressive phenotype
ENSG00000125952,MAX,myc/max heterodimer,transcriptional regulation,cell cycle progression,proliferation inhibition,tumor suppression,genomic instability
ENSG00000213246,SUPT4H1,transcription regulation,gain of function mutations,tumor progression,poor prognosis,cell proliferation,chromatin remodeling
ENSG00000196235,SUPT5H,cancer driver gene,oncogene potential,rna processing regulation,genomic instability induction,apoptosis inhibition,cell cycle progression promotion
ENSG00000103363,ELOB,translation elongation,oncogenic role,cell proliferation,rna binding,apoptosis resistance,tumor growth enhancement
ENSG00000154582,ELOC,elongin complex,protein degradation regulation,tumor growth enhancement,oncogene regulation,epigenetic modification,chromatin remodeling
ENSG00000125651,GTF2F1,genomic instability,aneuploidy,oncogene,transcriptional regulation,dna damage response,genome integrity
ENSG00000188342,GTF2F2,dna repair pathway dysregulation,transcription factor activity enhancement,epigenetic modifications,oncogene overexpression,tumor suppressor gene silencing,genomic instability promotion
ENSG00000114503,NCBP2,epigenetic regulation,chromatin remodeling,prognostic marker,transcriptional regulator,tumor progression,cancer cell proliferation
ENSG00000136937,NCBP1,exportin-5 complex,snrna transport,cell proliferation,ribosome biogenesis,angiogenesis,tumor progression
ENSG00000224748,TAP1,impaired antigen presentation,mhc class i pathway disruption,cancer progression,metastasis facilitation,immune evasion mechanism,cellular peptide loading
ENSG00000223481,TAP2,antigen processing,immune evasion,impaired antigen presentation,tumor progression,angiogenesis,mhc class i loading
ENSG00000166126,AMN,pi3k/akt signaling pathway,cell proliferation,genomic upregulation,protein-protein interactions,apoptosis regulation,cancer metastasis
ENSG00000107611,CUBN,vitamin b12 reabsorption,transmembrane receptor,tumor suppressor function,cellular uptake regulation,receptor-ligand interaction,intestinal absorption
ENSG00000146085,MMUT,genomic instability,tumor suppression,microsatellite instability,dna repair mechanism,oncogenesis,cancer progression
ENSG00000151611,MMAA,mitochondrial monoamine oxidase a,neurotransmitter regulation,cellular redox balance,tumor progression,rapid cell proliferation,warburg effect
ENSG00000117560,FASLG,tumor promotion,anti-apoptotic function,angiogenesis regulation,apoptosis evasion,tumor microenvironment modulation,fas receptor interaction
ENSG00000026103,FAS,apoptosis regulation,downregulated expression,loss of function mutations,tumor growth,therapeutic target,cancer prognosis
ENSG00000156735,BAG4,bag4 overexpression,apoptosis inhibition,cell survival promotion,metastasis facilitation,co-chaperone function,protein folding regulation
ENSG00000067182,TNFRSF1A,tnf-alpha signaling pathway,anti-apoptotic function,inflammation regulation,tumor progression,cancer cell survival,genomic instability
ENSG00000230108,TNF,chronic inflammation,tumor progression,cell death regulation,anti-tumor effects,pro-inflammatory signaling,epithelial-to-mesenchymal transition
ENSG00000106052,TAX1BP1,nf-κb pathway inhibition,tumor suppressor function,apoptosis regulation,cell cycle progression inhibition,pi3k/akt pathway modulation,mdm2 interaction
ENSG00000118503,TNFAIP3,nf-κb signaling pathway,constitutive activation,loss of function mutations,tumor progression,therapeutic target,genome instability
ENSG00000104689,TNFRSF10A,apoptosis regulation,tumor necrosis factor receptor superfamily,cell death pathway,immune modulation,treatment resistance,programmed cell death
ENSG00000173530,TNFRSF10D,apoptosis regulation,tumor microenvironment modulation,immune cell interaction,inflammation modulation,cell survival alteration,therapeutic target
ENSG00000120889,TNFRSF10B,apoptosis regulation,trail binding,cell death pathway,tumor progression,cancer therapy target,receptor overexpression
ENSG00000134259,NGF,ngf mediated signal transduction,tumor progression,cell survival and proliferation,apoptosis suppression,therapeutic target,pro-tumorigenic microenvironment
ENSG00000064300,NGFR,cell signaling,tumor progression,immune evasion,oncogenic processes,pi3k/akt pathway interaction,cell proliferation
ENSG00000184216,IRAK1,nf-κb signaling pathway,constitutive activation,tumor progression,immunomodulation,therapeutic target,genomic amplification
ENSG00000172936,MYD88,constitutive activation,gain of function mutations,tumor progression,nf-kb pathway,innate immunity evasion,cytokine signaling
ENSG00000109320,NFKB1,nf-κb activation,constitutive activation,gain of function mutations,tumor progression,inflammation promotion,apoptosis suppression
ENSG00000173039,RELA,nf-kb signaling pathway,aberrant nuclear localization,chromosomal amplifications,apoptosis evasion,tumor progression,transcriptional regulation
ENSG00000119048,UBE2B,p53 degradation,ubiquitin-conjugating enzyme family,cellular regulation,tumor progression,proliferation promotion,survival enhancement
ENSG00000070950,RAD18,genomic instability,homologous recombination,dna damage repair,cell cycle regulation,antitumor therapy target,translesion synthesis
ENSG00000114742,WDR48,e3 ubiquitin ligase activity,oncogenic signaling,cell cycle regulation,apoptosis modulation,chemotherapy resistance,poor prognosis marker
ENSG00000162607,USP1,deubiquitinase activity,genomic instability,cell proliferation,stabilization of pcna,tumor progression,signaling pathway regulation
ENSG00000009413,REV3L,dna damage response,genetic instability,tumor suppressor mutation,genome maintenance,checkpoint activation,oncogenic potential
ENSG00000116670,MAD2L2,cell cycle regulation,gain of function mutations,constitutive activation,tumor progression,oncogenic driver,apoptosis inhibition
ENSG00000163743,RCHY1,cell cycle regulation,chromatin remodeling,transcriptional modulation,oncogenic overexpression,genomic instability,microrna regulation
ENSG00000170734,POLH,nucleotide excision repair,genomic instability,error-prone translesion synthesis,apoptosis regulation,tumor suppressor gene mutation,oncogene activation
ENSG00000121060,TRIM25,e3 ubiquitin ligase activity,protein stability regulation,autophagy modulation,cell growth influence,apoptosis regulation,antiviral defense
ENSG00000156587,UBE2L6,dna repair,ubiquitination pathway,oncogene potential,cell cycle regulation,protein stability modulation,genomic instability
ENSG00000182179,UBA7,ubiquitination pathway,protein degradation,oncogene regulation,cell cycle progression,dna repair mechanism,therapeutic target
ENSG00000187608,ISG15,oncogenic regulation,tumor suppressor function,cellular stress response,ubiquitin-like protein,immune system modulation,therapeutic target
ENSG00000184900,SUMO3,sumoylation,post-translational modification,protein stabilization,oncogenic transformation,cell proliferation regulation,tumor suppressor inhibition
ENSG00000131944,FAAP24,genomic instability,tumor suppressor function,dna interstrand crosslink repair,chromosomal alterations,oncogenic mutations,cell cycle regulation
ENSG00000187790,FANCM,genomic instability,dna helicase activity,homologous recombination repair (hrr),synaptic interactions,oncogenic mutation rates,therapeutic target
ENSG00000169689,CENPX,kinetochore formation,chromosome segregation,genomic integrity,mitotic spindle assembly,chromosomal instability,aneuploidy
ENSG00000175279,CENPS,chromosomal instability,kinetochore assembly,mitotic stability,oncogenic process,spindle checkpoint resistance,tumor progression
ENSG00000140525,FANCI,genomic instability,genetic alterations,interstrand dna crosslinks,genome stability,dna repair pathways,oncogenic drivers
ENSG00000144554,FANCD2,fanconi anemia pathway,genomic instability,interstrand dna crosslinks,tumor suppressor,genetic stability,homologous recombination
ENSG00000175198,PCCA,tumor promotion,cell proliferation,oncogenesis,tumor metastasis,poor prognosis,overexpression
ENSG00000114054,PCCB,lipid metabolism,cell proliferation,pi3k/akt signaling,cellular stress responses,apoptosis regulation,membrane transfer protein
ENSG00000275300,MCCC2,mitochondrial function,tumor progression,genomic alterations,cellular metabolism regulation,energy production disruption,metabolic pathway alteration
ENSG00000078070,MCCC1,metabolic regulation,cellular stress,leucine catabolism,oncogenic processes,tumor progression,therapeutic target
ENSG00000175505,CLCF1,wnt signaling pathway,oncogenic potential,cell proliferation,apoptosis suppression,therapeutic target,cytokine activity
ENSG00000006016,CRLF1,cell growth regulation,immune evasion mechanisms,angiogenesis promotion,prognostic marker,tumor microenvironment modulation,oncogene activation
ENSG00000130175,PRKCSH,er calcium homeostasis disruption,tumor suppressor gene,cell proliferation enhancement,genomic instability driver,oncogenic signaling pathway activation,protein kinase c regulation
ENSG00000089597,GANAB,n-glycosylation impairment,tumor progression,apoptosis suppression,cell growth regulation,glycoprotein dysfunction,protein trafficking disruption
ENSG00000179218,CALR,jak-stat pathway activation,cellular signaling modulation,cancer driver mutations,protein folding regulation,molecular chaperone function,calcium homeostasis regulation
ENSG00000283777,CANX,cellular homeostasis,er-resident molecular chaperone,tumor progression,apoptosis resistance,cell proliferation,signaling pathway regulation
ENSG00000182185,RAD51B,genomic instability,homologous recombination,dna damage response,chromosomal integrity,tumor suppressor function,genetic instability
ENSG00000243678,NME2,**,therapeutic target,apoptosis inhibition,tumor progression,cell proliferation enhancement,dna repair modulation
ENSG00000239672,NME1,nucleoside diphosphate kinase activity,cell proliferation promotion,metastasis facilitation,energy metabolism regulation,signaling pathway interaction,tumor growth promotion
ENSG00000157500,APPL1,oncogenic signaling,cellular signaling regulation,protein-protein interaction,regulation of pi3k/akt pathway,tumor progression facilitation,cell proliferation promotion
ENSG00000187323,DCC,tumor suppressor,cell adhesion regulation,neuronal guidance pathway,cell detachment facilitation,cancer progression,molecular interaction disruption
ENSG00000179222,MAGED1,cell cycle regulation,epithelial-to-mesenchymal transition (emt),oncogenic signaling pathway,angiogenesis promotion,poor prognosis marker,metastasis driver
ENSG00000113763,UNC5A,tumor suppressor,cell migration inhibition,apoptosis promotion,epithelial-to-mesenchymal transition inhibition,wnt/β-catenin pathway regulation,smad4 and p53 interaction
ENSG00000221823,PPP3R1,pp2b regulation,cell cycle dysregulation,apoptosis evasion,signaling pathway modulation,protein phosphatase activity,tumorigenesis
ENSG00000120910,PPP3CC,calcium/calmodulin-dependent regulation,calcineurin-nfat signaling,cell cycle progression,apoptosis regulation failure,transcription factor activation,protein phosphatase activity
ENSG00000171791,BCL2,apoptosis regulation,oncogenic function,anti-apoptotic activity,tumor growth promotion,therapeutic target,genomic amplification
ENSG00000002330,BAD,apoptosis regulation,pro-apoptotic protein function,bcl-2 interaction,cell survival inhibition,chemotherapy resistance,tumorigenesis promotion
ENSG00000030110,BAK1,apoptosis induction,tumor suppressor function,mitochondrial outer membrane regulation,cell death regulation,pro-survival pathway modulation,downregulation in cancer
ENSG00000172115,CYCS,apoptosis regulation,mitochondrial protein function,cellular metabolism modulation,tumorigenesis promotion,apoptotic pathway disruption,therapeutic target identification
ENSG00000101966,XIAP,apoptosis inhibition,anti-apoptotic function,overexpression,tumorigenesis,cell cycle regulation,chemotherapy resistance
ENSG00000164305,CASP3,apoptosis regulation,pro-apoptotic function,tumor cell survival,resistance to apoptosis,therapeutic target,genomic instability
ENSG00000165806,CASP7,apoptosis regulation,cell death induction,chromatin remodeling,tumor suppression,promoter binding,genetic instability
ENSG00000132906,CASP9,apoptosis dysregulation,genetic instability,dna repair mechanism disruption,tumor progression facilitation,therapeutic resistance enhancement,proteolytic cascade initiation
ENSG00000184047,DIABLO,apoptosis inhibition,cancer cell survival,cellular proliferation,genotoxic stress response,oncogenic promotion,tumor progression
ENSG00000169598,DFFB,apoptosis regulation,tumor suppression,cellular fragmentation,programmed cell death,dna cleavage,molecular maintenance
ENSG00000160049,DFFA,dna fragmentation regulation,genomic instability contribution,apoptotic signaling modulation,cell survival promotion,tumor progression marker,prognostic relevance
ENSG00000114030,KPNA1,nuclear localization signals recognition,gene expression regulation,cell proliferation promotion,tumor growth contribution,poor prognosis biomarker,nuclear transport facilitation
ENSG00000108424,KPNB1,nuclear transport regulation,transcription factor regulation,chromatin remodeling,oncogenic driver,poor prognosis marker,tumor aggressiveness promoter
ENSG00000180370,PAK2,cell migration,signaling pathway,cell survival,constitutive activation,cytoplasmic localization,protein interaction
ENSG00000071205,ARHGAP10,rhogtpase-activating protein,tumor suppressor,cell growth regulation,metastasis inhibition,pi3k/akt pathway interaction,rhoa/rock signaling regulation
ENSG00000137275,RIPK1,necroptosis,apoptotic suppression,tumor suppressor function,pro-inflammatory signaling,immune evasion,programmed cell death
ENSG00000129465,RIPK3,necroptotic pathway,tumor progression,cell survival,apoptosis inhibition,chemoresistance,signaling pathway regulation
ENSG00000131979,GCH1,bh4-dependent monoamine oxidation,tumor cell proliferation,pi3k/akt signaling activation,apoptosis suppression,oxidative stress induction,prognostic marker potential
ENSG00000137880,GCHFR,genomic instability,dna repair mechanism,oncogenic driver,tumor suppressor function,redox balance regulation,apoptosis evasion
ENSG00000244687,UBE2V1,protein regulation,ubiquitination pathway,genomic instability,tumor suppressor degradation,oncogene accumulation,dna repair mechanism disruption
ENSG00000175104,TRAF6,tumor progression,pro-inflammatory signaling,cancer cell proliferation,immune evasion,tumor angiogenesis,emt regulation
ENSG00000134070,IRAK2,chronic inflammation,immune response modulation,nf-κb activation,pro-inflammatory cytokine production,tumor-promoting activity,signaling pathway component
ENSG00000113070,HBEGF,cell proliferation,enhanced migration,angiogenesis promoter,tumor progression driver,growth factor signaling,proteolytic processing
ENSG00000198898,CAPZA2,actin filament regulation,cytoplasmic trafficking,cancer cell motility,cell invasion enhancement,rho gtpase pathway interaction,metastasis promotion
ENSG00000077549,CAPZB,actin filament regulation,cancer progression,mitotic regulation,motility and adhesion control,cell signaling modulation,cytoplasmic protein interaction
ENSG00000177938,CAPZA3,cell motility,cytoskeletal remodeling,tumor progression,oncogenic properties,protein-protein interactions,epithelial-to-mesenchymal transition
ENSG00000116489,CAPZA1,cell migration,cytoskeletal dynamics,arp2/3 complex regulation,oncogenic pathway interaction,tumor aggressiveness,therapeutic target
ENSG00000114745,GORASP1,vesicle transport,cell growth regulation,metastasis promotion,endocytic trafficking modulation,tumor aggressiveness enhancement,oncogene overexpression
ENSG00000167110,GOLGA2,golgi apparatus dysfunction,tumor progression,metastasis,protein trafficking regulation,emt facilitation,signaling pathway modulation
ENSG00000106799,TGFBR1,tgf-β signaling pathway,constitutive activation,loss of inhibitory function,cell cycle regulation,apoptosis dysregulation,immunosuppression
ENSG00000088832,FKBP1A,immunophilin regulation,apoptosis inhibition,tumor growth promotion,metastasis facilitation,transcription modulation,p53 interaction disruption
ENSG00000113319,RASGRF2,ras pathway activation,gef function,oncogenic potential,cell proliferation enhancement,metastasis promotion,signaling network modulation
ENSG00000058335,RASGRF1,gef activity,ras protein activation,oncogenic signaling,tumor growth promotion,cellular proliferation enhancement,gtpase regulation
ENSG00000120251,GRIA2,amplification of gria2,constitutive activation,cell proliferation regulation,epithelial-to-mesenchymal transition modulation,synaptic plasticity disruption,pi3k/akt pathway interaction
ENSG00000155511,GRIA1,oncogenic signaling pathway,glutamate receptor activation,cell proliferation enhancement,tumor progression facilitation,poor prognosis indicator,genetic dysregulation marker
ENSG00000105397,TYK2,oncogenic signaling,tumor progression,cell proliferation,apoptosis inhibition,cytokine signaling,immune evasion
ENSG00000142166,IFNAR1,ifn-α signaling pathway,interferon-mediated antiviral response,tumor immunomodulation,dysregulated cell survival,oncogenesis,tissue-specific expression regulation
ENSG00000162851,TFB2M,regulation of gene expression,transcription initiation complex,cell proliferation,apoptosis regulation,transcription factor interaction,chromatin remodeling
ENSG00000099821,POLRMT,mitochondrial transcription,oncogene upregulation,enhanced proliferation,poor prognosis,dna replication repair,mitochondrial dysfunction
ENSG00000128191,DGCR8,mirna biogenesis,microprocessor complex,post-transcriptional regulation,tumor progression,oncogenic pathways,rna processing
ENSG00000113360,DROSHA,microrna biogenesis,oncogenic micrornas,ribonuclease iii activity,tumor suppressor regulation,gene expression modulation,cancer-related overexpression
ENSG00000116918,TSNAX,genomic instability,wnt signaling regulation,tumor suppression,dna repair mechanisms,cell cycle regulation,protein-protein interaction
ENSG00000211460,TSN,genomic instability,dna repair mechanism,cell proliferation regulator,microrna regulation,pi3k/akt pathway interaction,rna-dna hybrid recognition
ENSG00000076108,BAZ2A,chromatin remodeling,epigenetic regulation,genomic instability,oncogenic signaling,cell proliferation,transcriptional control
ENSG00000119772,DNMT3A,genomic instability,epigenetic regulation,tumor progression,methylation patterns,chromatin remodeling,epigenetic silencing
ENSG00000142182,DNMT3L,genomic instability,dna methylation,tumor suppressor silencing,oncogenic potential,therapeutic target,epigenetic regulation
ENSG00000088305,DNMT3B,dna methylation,tumor suppressor silencing,genomic imprinting disruption,epigenetic regulation,gene expression modulation,cancer progression facilitation
ENSG00000055130,CUL1,oncoprotein regulation,gain of function mutations,cell cycle regulation,ubiquitination pathway,protein degradation,tumor progression
ENSG00000111530,CAND1,cell cycle regulation,oncogene upregulation,ubiquitin-proteasome pathway regulation,protein degradation inhibition,tumor growth promotion,cancer-related protein interaction
ENSG00000072274,TFRC,cell surface receptor,iron uptake regulation,cancer cell proliferation,oncogenic pathway activation,tumor microenvironment modulation,therapeutic target
ENSG00000010704,HFE,iron regulation,oxidative stress response,inflammation modulation,tumor microenvironment modification,iron overload,cell cycle progression
ENSG00000091513,TF,transcription factor activity,oncogenic activation,tumor progression,cell proliferation,gene amplification,poor prognosis
ENSG00000225312,HSD17B8,steroid hormone regulation,tumor progression,cell proliferation,androgen/estrogen imbalance,prognostic biomarker,signaling pathway interaction
ENSG00000145439,CBR4,cell differentiation,cell survival,oncogenic processes,carotenoid metabolism,enzymatic activity,altered expression
ENSG00000157456,CCNB2,cell cycle regulation,cyclin overexpression,oncogenic driver,cell proliferation enhancement,tumor growth promotion,genomic instability induction
ENSG00000100241,SBF1,chromatin remodeling,oncogene activation,tumor microenvironment modulation,transcriptional regulation disruption,cell survival enhancement,gene regulatory mechanism alteration
ENSG00000087053,MTMR2,dephosphorylation of 3-phosphoinositides,cellular growth regulation,tumor progression,phosphatase activity dysregulation,cell migration modulation,therapeutic target
ENSG00000003987,MTMR7,regulation of autophagy,mitophagy regulation,cellular stress response,metabolic adaptation,oncogenic function,pi3k/akt pathway interaction
ENSG00000104643,MTMR9,cellular regulation,tumor progression,pi3k/akt pathway modulation,potential tumor suppressor,phosphatase activity loss,cell survival and growth regulation
ENSG00000051382,PIK3CB,pi3k/akt/mtor signaling pathway,constitutive activation,cellular growth,cell proliferation,akt activation,oncogenic processes
ENSG00000105647,PIK3R2,pi3k/akt pathway,constitutive activation,regulatory subunit function,tumor progression,cell survival enhancement,genomic instability
ENSG00000171608,PIK3CD,tumor growth promotion,constitutive activation of signaling pathway,oncogenic driver mutation,cell survival enhancement,metabolic regulation alteration,tumor progression facilitation
ENSG00000117461,PIK3R3,negative regulator,constitutive activation,dysregulation of akt/mtor pathway,oncogenic processes,cell survival and proliferation,genomic instability
ENSG00000141506,PIK3R5,pi3k/akt signaling pathway,mutation leading to overexpression,constitutive activation driving oncogenesis,tumor progression and metastasis,therapeutic target for cancer treatment,cellular response modulation via protein interactions
ENSG00000105851,PIK3CG,g-protein coupled receptor activation,co-amplification with her2,immune response regulation,cell migration enhancement,cell survival promotion,signaling pathway activation
ENSG00000169499,PLEKHA2,cell membrane trafficking,overexpression,enhanced cell survival,signaling pathway modulation,metastasis promotion,tumor progression marker
ENSG00000163629,PTPN13,dephosphorylation of akt,negative regulation of pi3k/akt pathway,inhibition of cell proliferation,regulation of protein stability,interactions with src kinase,deubiquitinating enzyme (dub) activity
ENSG00000107679,PLEKHA1,cell proliferation,cell membrane organization,signaling pathway interaction,oncogenic processes,gene expression regulation,tumor progression
ENSG00000139505,MTMR6,pi3k/akt signaling,oncogene activation,overexpression,poor prognosis,therapeutic target,cell survival regulation
ENSG00000133812,SBF2,genomic instability,dna repair mechanism,genome maintenance,epigenetic regulation,tumor progression,genetic mutations
ENSG00000171100,MTM1,reduced expression,constitutive activation,loss-of-function mutations,akt pathway regulation,cellular proliferation,tumor progression
ENSG00000150712,MTMR12,tumor suppressor regulation,lkb1/ampk signaling,cell cycle regulation,phosphatase activity,energy homeostasis regulation,oxidative stress suppression
ENSG00000033327,GAB2,gab2 overexpression,pi3k/akt pathway activation,cell proliferation enhancement,tumor progression promotion,wnt/β-catenin pathway interaction,malignant transformation facilitation
ENSG00000150995,ITPR1,calcium channel regulation,aberrant signaling,tumor aggressiveness,poor prognosis,cell survival enhancement,oncogenic pathway activation
,MRVI1,microtubule stabilization,cell cycle regulation,apoptosis inhibition,tumor progression,metastasis promotion,kinase activation
ENSG00000111679,PTPN6,tumor suppressor function,constitutive activation of signaling pathways,dysregulation and overexpression in cancer,aberrant interaction with other proteins and receptors,resistance to chemotherapy and targeted therapies,cell proliferation and survival promotion
ENSG00000261371,PECAM1,angiogenesis,cell adhesion,immune response modulation,tumor invasion,metastasis promotion,vascular stabilization
ENSG00000179295,PTPN11,genomic instability,oncogenic signaling,cell proliferation,tumor growth promotion,tyrosine phosphatase activation,signaling pathway dysregulation
ENSG00000160712,IL6R,aberrant expression,cell proliferation,immune evasion,oncogenic potential,pro-inflammatory response,stat3 activation
ENSG00000136244,IL6,**
il-6 signaling pathway,tumor microenvironment modulation,oncogenic transcriptional regulation,pro-inflammatory cytokine expression,metastasis promotion,poor prognosis biomarker
ENSG00000115415,STAT1,stat1 mediated immune modulation,tumor microenvironment remodeling,ifn-gamma signaling pathway,genetic alterations in cancer,transcriptional regulation,cellular differentiation blockade
ENSG00000168610,STAT3,constitutive activation,phosphorylation regulation,transcription factor function,oncogenic signaling pathway,tumor cell proliferation,immune evasion mechanism
ENSG00000128052,KDR,vegf signaling pathway,angiogenesis promotion,receptor tyrosine kinase activity,cell proliferation enhancement,tumor progression facilitation,therapeutic target
ENSG00000113905,HRG,angiogenesis promotion,cell proliferation,epithelial-to-mesenchymal transition,heparin-binding growth factor family,immune response modulation,tumor progression enhancement
ENSG00000122194,PLG,tumor progression,angiogenesis,proteolytic activity,extracellular matrix degradation,growth factor release,metastasis
ENSG00000182718,ANXA2,oncogenic signaling,cell migration,invasion and metastasis,biomarker for prognosis,apoptosis inhibition,calcium-dependent binding
ENSG00000197747,S100A10,cellular migration,calcium homeostasis disruption,cytoskeletal regulation,tumor progression facilitation,metastasis promotion,inflammation modulation
ENSG00000276838,SERPINF2,angiogenic factor,tumor aggressiveness,cell proliferation regulation,metastasis promoter,poor prognostic marker,apoptosis inhibitor
ENSG00000122861,PLAU,upa/plasminogen activation,cell migration,epithelial-to-mesenchymal transition,metastasis progression,extracellular matrix degradation,prognostic marker
ENSG00000011422,PLAUR,tumor progression,cell migration,angiogenesis promotion,proteolysis facilitation,biomarker candidate,therapeutic target
ENSG00000165240,ATP7A,copper transport,cellular homeostasis,oncogenic driver,apoptosis modulation,redox regulation,chemotherapy resistance
ENSG00000120509,PDZD11,overexpression,cytoplasmic localization,cell adhesion disruption,tumor progression,metastasis facilitation,poor prognosis biomarker
ENSG00000103249,CLCN7,enhanced chloride channel activity,cell migration and invasion,tumor progression,dysregulated expression,pi3k/akt pathway interaction,calcium signaling modulation
ENSG00000081087,OSTM1,epithelial-to-mesenchymal transition,overexpression,cell adhesion,cell migration,tumor progression,prognostic marker
ENSG00000136810,TXN,oxidative stress,apoptosis inhibition,cell growth promotion,protein reduction activity,p53 interaction,redox regulation
ENSG00000265972,TXNIP,redox regulation,oxidative stress,glucose metabolism,apoptosis resistance,glycolytic shift,protein-protein interaction
ENSG00000162711,NLRP3,inflammasome activation,constitutive expression,oncogenic role,immune evasion,inflammation regulation,cell signaling modulation
ENSG00000103313,MEFV,inflammasome regulation,pro-inflammatory microenvironment,autoinflammatory disorder,innate immune response,pyroptosis induction,immune modulation
ENSG00000140368,PSTPIP1,cellular adhesion modulation,gene mutation driving oncogenesis,cytoskeleton dynamics regulation,tumor progression,protein interaction alteration,genomic instability
ENSG00000103490,PYCARD,inflammasome activation,pro-inflammatory cytokines,immune response regulation,cell survival promotion,tumor progression,therapeutic target
ENSG00000135346,CGA,immunoglobulin superfamily member,epithelial surface expression,adhesion molecule function,metastasis promoter,tumor biomarker,cell-to-cell adhesion mediator
ENSG00000104826,LHB,hormone regulation,tumor growth promotion,cell survival modulation,pituitary hormone expression,genomic upregulation,metastasis facilitation
ENSG00000126895,AVPR2,vasopressin receptor signaling,upregulation in cancer,cell proliferation,pi3k/akt pathway activation,epithelial-to-mesenchymal transition,tumor progression
ENSG00000101200,AVP,vasopressin overexpression,receptor activation,cell proliferation enhancement,migratory pathway modulation,poor prognosis marker,apoptosis evasion
ENSG00000115263,GCG,digestion regulation,appetite modulation,cell proliferation regulation,metabolic regulation,gut hormone secretion,none
ENSG00000215644,GCGR,glp-1 receptor signaling pathway,activation of pka/pkb pathway,dysregulation of glucose metabolism,promotion of cell proliferation,role in tumorigenesis,interaction with other signaling pathways
ENSG00000122679,RAMP3,tumor suppressor,cell proliferation,signaling regulation,g-protein coupled receptor interaction,mapk/erk pathway dysregulation,downregulation in cancer tissues
ENSG00000004948,CALCR,cell proliferation,pi3k/akt pathway activation,signaling pathway regulation,tumor progression,calcium homeostasis disruption,bone remodeling modulation
ENSG00000132329,RAMP1,camp/pka signaling pathway,receptor activity-modifying protein,cell proliferation enhancement,tumor progression factor,potential therapeutic target,signaling pathway regulation
ENSG00000134200,TSHB,**,cell proliferation,thyroid-stimulating hormone regulation,growth factor signaling,protein overexpression,oncogenic mutations
ENSG00000179600,GPHB5,wnt/β-catenin signaling pathway,overexpression,tumor progression,cell migration,glycosaminoglycan binding,prognostic marker
ENSG00000149735,GPHA2,cell proliferation,g protein signaling,tumor progression,metastasis,oncogenesis,biomarker
ENSG00000064989,CALCRL,pi3k/akt pathway,cancer cell metabolism,nf-κb activation,tumor progression,cell proliferation,g protein-coupled receptor
ENSG00000131477,RAMP2,calcium sensing receptor regulation,tumor progression,cell migration and invasion,epithelial-to-mesenchymal transition,angiogenesis promotion,protein interaction modulation
ENSG00000065325,GLP2R,glp-1 signaling pathway,oncogenic role,g protein-coupled receptor activation,cell proliferation enhancement,tumor progression promotion,pi3k/akt pathway interaction
ENSG00000131808,FSHB,fsh signaling pathway,oncogene activation,cell proliferation,tumor progression,hormone regulation,gene expression
ENSG00000138448,ITGAV,integrin signaling,cell adhesion molecule,metastasis promoting,epithelial-to-mesenchymal transition,tumor aggressiveness,glycoprotein binding
ENSG00000082781,ITGB5,focal adhesion,cell migration,signaling pathway activation,tumor progression,prognostic marker,cancer metastasis
ENSG00000103496,STX4,membrane trafficking,regulation of apoptosis,cell proliferation,oncogenic function,snare-protein interaction,rab gtpase activation
ENSG00000265808,SEC22B,er stress response,unfolded protein response,genomic instability,chromosomal rearrangements,oncogene activation,cell survival regulation
ENSG00000106571,GLI3,hedgehog signaling pathway,transcriptional regulation,aberrant activation,tumor progression,therapeutic target,genomic instability
ENSG00000185920,PTCH1,hedgehog signaling pathway,constitutive activation,loss-of-function mutations,tumor suppressor function,cell proliferation regulation,oncogenic transformation
ENSG00000111087,GLI1,hedgehog signaling pathway,transcriptional activation,cell proliferation,tumor progression,therapeutic resistance,genomic amplification
ENSG00000074047,GLI2,constitutive activation,transcription factor activity,oncogene,hedgehog signaling pathway,cell proliferation regulation,tumor progression
ENSG00000107882,SUFU,hedgehog signaling pathway,tumor suppressor function,negative regulation,oncogenic processes,aberrant activation,protein-protein interaction
ENSG00000133961,NUMB,notch signaling regulation,tumor suppressor function,cell cycle inhibition,ubiquitin-proteasome pathway interaction,apoptosis induction,protein degradation mechanism
ENSG00000078747,ITCH,protein degradation regulation,tumor suppressor,oncogenic signaling modulation,cell proliferation regulation,invasion and metastasis promotion,e3 ubiquitin ligase activity
ENSG00000011198,ABHD5,tumor suppressor function,lipid metabolism regulation,cancer driver mutation,cellular lipolysis dysregulation,cell cycle modulation,protein-protein interaction
ENSG00000166819,PLIN1,lipid storage regulation,tumor progression,oncogene activation,cell proliferation enhancement,chemoresistance promotion,lipid metabolism dysregulation
ENSG00000079435,LIPE,lipid metabolism,oncogenic process,tumor progression,aggressive tumor behavior,cellular energy homeostasis,hormone-sensitive lipase
ENSG00000170323,FABP4,fatty acid metabolism regulation,constitutive activation,oncogenic function,lipid accumulation,metabolic reprogramming,immune evasion
ENSG00000153822,KCNJ16,potassium channel regulation,cell proliferation promotion,tumor progression facilitation,oncogene potential,signaling pathway interaction,metabolic regulation alteration
ENSG00000157551,KCNJ15,driver gene mutation,potassium channel regulation,tumor growth promotion,apoptosis resistance,cellular ph regulation,oncogenic transformation
ENSG00000177807,KCNJ10,oncogene,cellular proliferation,apoptosis resistance,tumor progression,biomarker,therapeutic target
ENSG00000161921,CXCL16,angiogenesis promotion,emt regulation,metastasis facilitation,chemokine activity,cell proliferation enhancement,therapeutic target
ENSG00000172215,CXCR6,chemokine receptor activation,g-protein coupled signaling,immune evasion,tumor progression,angiogenesis,signaling pathway dysregulation
ENSG00000197405,C5AR1,immune cell activation,inflammation promotion,tumor progression,immunosuppressive environment,pi3k/akt pathway interaction,g-protein coupled receptor function
ENSG00000106804,C5,cancer-promoting immune evasion,tumor microenvironment modulation,angiogenesis enhancement,cell survival promotion,signaling pathway regulation,protease-activated receptor activation
ENSG00000006210,CX3CL1,angiogenesis promotion,immune evasion,cell adhesion molecule,tumor progression,metastasis facilitation,cell migration pathway modulation
ENSG00000168329,CX3CR1,tumor microenvironment modulation,immune cell infiltration,angiogenesis facilitation,metastasis promotion,apoptosis resistance,cell migration regulation
ENSG00000179002,TAS1R2,taste receptor signaling pathway,constitutive activation,gain of function mutations,cell proliferation,oncogenesis,therapeutic target
ENSG00000169962,TAS1R3,dysregulated gene expression,altered signaling pathways,metastasis regulation,tumor growth promotion,cellular proliferation enhancement,gpcr activation
ENSG00000173662,TAS1R1,immune evasion,cell proliferation,tumor progression,glucose metabolism,signaling pathway activation,molecular targeting
ENSG00000136928,GABBR2,gabaergic inhibition,cell proliferation,signaling pathway dysregulation,neurotransmitter receptor interaction,adenylate cyclase regulation,cancer cell survival
ENSG00000204681,GABBR1,g protein-coupled receptor regulation,cell proliferation inhibition,receptor dimerization,gpcr signaling,neurotransmitter regulation,tumor suppression
ENSG00000243646,IL10RB,tumor progression,inflammation regulation,immune evasion,therapeutic target,anti-inflammatory response,signaling pathway alteration
ENSG00000104064,GABPB1,gabp complex formation,oncogenic transcription,epithelial-to-mesenchymal transition,pi3k/akt signaling activation,cell proliferation regulation,metastasis promotion
ENSG00000154727,GABPA,oncogenic pathway activation,epithelial-to-mesenchymal transition,cell proliferation regulation,transcription factor interaction,gc-rich motif binding,cancer prognosis association
ENSG00000083312,TNPO1,transportin 1 overexpression,protein nuclear import,transcriptional regulation,cell cycle dysregulation,antitumor activity disruption,nuclear localization signal interaction
ENSG00000117245,KIF17,cell cycle regulation,tumor progression,oncogenic processes,epithelial-to-mesenchymal transition,mitosis regulation,apoptosis suppression
ENSG00000243955,GSTA1,gst regulation,antioxidant defense,dna damage response,cell survival modulation,therapeutic target,metabolic reprogramming
ENSG00000244067,GSTA2,genomic instability,chemoresistance,radioresistance,cell proliferation,dna repair,oncogenic transformation
ENSG00000001084,GCLC,glutathione synthesis,oxidative stress,dna damage,antioxidant response,cell signaling pathways,apoptosis regulation
ENSG00000023909,GCLM,glutathione synthesis,oxidative stress protection,chemoresistance,oncogenic pathway activation,cell survival enhancement,metabolic adaptation
ENSG00000254647,INS,insulin signaling,oncogenesis,enhanced glycolysis,pi3k/akt pathway,constitutive activation,cell survival and proliferation
ENSG00000171105,INSR,aberrant signaling,cell proliferation,glucose metabolism,insulin resistance,mutations leading to activation,tumor progression
ENSG00000173208,ABCD2,multidrug resistance,chemosensitivity modulation,cellular stress responses,apoptosis regulation,tumor progression,biomarker potential
ENSG00000101986,ABCD1,lipid metabolism regulation,peroxisomal transport,cellular homeostasis maintenance,cancer biology involvement,transcriptional regulation potential,tumor progression contribution
ENSG00000117528,ABCD3,**
cellular metabolism,chemoresistance,efflux pump activity,lipid transport,oncogenesis,tumor progression 
**
ENSG00000138075,ABCG5,cholesterol efflux,lipid metabolism regulation,cellular response modulation,tumor growth promotion,dietary sterol interaction,cancer susceptibility marker
ENSG00000143921,ABCG8,tumor growth regulation,cholesterol metabolism modulation,oncogenic processes involvement,cancer progression influence,tumor microenvironment regulation,apolipoprotein a1 interaction
ENSG00000160716,CHRNB2,constitutive activation,oncogenic role,aberrant expression,cell proliferation,apoptosis regulation,pi3k/akt pathway interaction
ENSG00000101204,CHRNA4,nicotinic acetylcholine receptor subunit,cell proliferation,apoptosis regulation,tumor growth modulation,anti-apoptotic protein interaction,cancer progression promotion
ENSG00000080644,CHRNA3,nicotinic acetylcholine receptor activation,cell proliferation enhancement,downstream signaling pathway modulation,tumor growth promotion,tumor progression facilitation,aberrant cell cycle regulation
ENSG00000117971,CHRNB4,nachr signaling pathway,antagonism of apoptosis,dysregulated receptor function,tumor cell proliferation,neurotransmission regulation,ligand binding affinity
ENSG00000111206,FOXM1,cell cycle regulation,transcriptional activation,g2/m phase transition,mitotic entry,proliferation enhancement,cancer cell survival
ENSG00000166851,PLK1,cell cycle regulation,oncogenic driver,tumor progression,cell proliferation,apoptosis resistance,kinase activation
ENSG00000117724,CENPF,kinase activity,genomic instability,mitotic errors,chromosomal alterations,cell division regulation,dna damage response
ENSG00000115353,TACR1,tumor progression,cell proliferation,signaling pathway activation,protein kinase c activation,phospholipase c regulation,growth factor binding
ENSG00000006128,TAC1,neurotransmitter regulation,tumor growth promotion,oncogene activation,angiogenesis,immune evasion,therapeutic target
ENSG00000075073,TACR2,tumor progression,cell proliferation,signal transduction,overexpression,protein interaction,metastasis
ENSG00000180914,OXTR,oxtr signaling pathway,oncogenic driver,cell migration enhancement,tumor progression facilitation,receptor-ligand interaction,g protein-coupled receptor function
ENSG00000101405,OXT,tumor progression,cell proliferation,oncogenic signaling,biomarker expression,mapk/erk pathway activation,stress regulation
ENSG00000147571,CRH,crh signaling,inflammation modulation,tumor growth promotion,cell proliferation enhancement,therapeutic target exploration,resistance mechanism interaction
ENSG00000145708,CRHBP,crh-binding,inflammation regulation,tumor microenvironment,metastasis promotion,angiogenesis enhancement,immune evasion
ENSG00000123146,ADGRE5,cell surface signaling,overexpression in cancer,g protein-coupled receptor domain,metastasis promotion,epithelial cell polarity disruption,therapeutic target
ENSG00000196352,CD55,tumor progression,complement regulation,immune evasion,oncogenesis,cell survival,metastasis
ENSG00000100211,CBY1,cytohesin activation,cell migration promotion,pi3k/akt signaling involvement,tumor progression facilitation,oncogenic overexpression,protein-protein interaction modulation
ENSG00000168036,CTNNB1,wnt pathway dysregulation,gain of function mutations,oncogenic protein expression,cell proliferation enhancement,therapeutic target resistance,gene regulatory network disruption
ENSG00000178585,CTNNBIP1,wnt/β-catenin pathway,constitutive β-catenin activation,loss of function mutations,oncogenic transformation,cell proliferation regulation,tumor suppressor dysfunction
ENSG00000100888,CHD8,**

chd8 expression,oncogene activation,chromatin remodeling,wnt/β-catenin pathway dysregulation,pi3k/akt/mtor signaling alteration,poor prognosis marker
**
ENSG00000180398,MCFD2,overexpression,vitamin k-dependent pathway disruption,cell proliferation promotion,angiogenesis facilitation,microenvironment modulation,tissue factor regulation
ENSG00000074695,LMAN1,glycoprotein processing,dysregulation of m6p pathway,poor prognosis,cellular signaling pathways,stress response,golgi apparatus dysfunction
ENSG00000170348,TMED10,protein targeting,onco-protein regulation,tumor suppressor interaction,cell cycle progression,cancer signaling pathway modulation,proliferation enhancement
ENSG00000086598,TMED2,wnt/β-catenin pathway regulation,mutations in tumor progression,aberrant protein trafficking,cell proliferation promotion,oncogene activation,potential biomarker
ENSG00000010610,CD4,immune system modulation,tumor immune evasion,cell adhesion molecule,t-cell activation,signal transduction pathway,mhc class ii interaction
ENSG00000182866,LCK,cell migration,pi3k/akt pathway,oncogenic processes,tumor proliferation,immune evasion,therapeutic target
ENSG00000115839,RAB3GAP1,tumor suppressor function,regulation of cell growth,loss-of-function mutations,protein synthesis regulation,cell adhesion modulation,akt/mtor pathway activation
ENSG00000118873,RAB3GAP2,tumor suppressor function,cell growth regulation,rab gtpase activation,oncogenic pathway activation,metastasis promotion,dna damage response modulation
ENSG00000148053,NTRK2,mapk/erk pathway activation,ntrk2 fusion genes,chromosomal rearrangements,targeted therapy resistance,protein kinase activity,oncogenic driver
ENSG00000176697,BDNF,trkb signaling pathway,neurotrophic factor function,cell proliferation enhancement,tumor progression promotion,angiogenesis regulation,apoptosis resistance induction
ENSG00000225950,NTF4,notch signaling pathway,tumor suppressor function,loss of function mutations,increased cell proliferation,cell invasion,metastasis regulation
ENSG00000100385,IL2RB,cell growth,immune modulation,oncogenic signaling,tumor microenvironment,gene expression alteration,protein interaction dysfunction
ENSG00000162434,JAK1,stat protein activation,constitutive kinase activity,tumor progression,angiogenesis promotion,cell migration enhancement,cancer stem cell maintenance
ENSG00000105639,JAK3,stat activation,constitutive activation,tumor progression,oncogene,signal transduction,protein kinase activity
ENSG00000147168,IL2RG,il2rγ signaling pathway,dysregulation of cell growth and proliferation,oncogenic transformation,tumorigenesis,immune response modulation,cell signaling regulation
ENSG00000120899,PTK2B,enhanced cell migration,focal adhesion kinase activity,oncogenic signaling pathways,cell invasion and survival,epithelial-to-mesenchymal transition (emt),tumor progression and metastasis
ENSG00000105246,EBI3,stat1/3 signaling pathway,angiogenesis promotion,cell proliferation enhancement,immune evasion mechanism,pro-inflammatory cytokine expression,vegf upregulation
ENSG00000197272,IL27,immune surveillance regulation,stat1/stat3 interaction,cytokine signaling activation,cell growth modulation,tumor promotion/suppression balance,apoptosis influence
ENSG00000110400,NECTIN1,cell-cell interaction regulation,immune modulation,tumor microenvironment interaction,pi3k/akt pathway activation,biomarker potential,cancer cell adhesion disruption
ENSG00000177707,NECTIN3,cell adhesion molecule,oncogenic overexpression,tumor progression,metastasis regulator,biomarker candidate,cell-cell interaction mediator
ENSG00000143217,NECTIN4,overexpression,pi3k/akt pathway activation,epithelial-to-mesenchymal transition (emt) promotion,cancer cell adhesion disruption,cell proliferation enhancement,malignant transformation facilitation
ENSG00000130202,NECTIN2,cell adhesion,immune modulation,tumor progression,metastasis facilitation,pi3k/akt pathway interaction,oncogenic role
ENSG00000073008,PVR,cell migration,cell invasion,oncogene role,tumor progression,metastasis promotion,immune evasion mechanism
ENSG00000113302,IL12B,cellular immunity,immune evasion,stat4 activation,cytokine dysregulation,tumor progression,immune suppression
ENSG00000168811,IL12A,tumor immunosuppression,cell-mediated immunity,th1 cell differentiation,stat4 activation,antitumor cytokine production,immunomodulation
ENSG00000096996,IL12RB1,il-12/il-12r axis,t-cell activation,immune evasion mechanisms,cellular immunity modulation,anti-tumor response suppression,genomic instability promotion
ENSG00000081985,IL12RB2,immune regulation,cytokine signaling,tumor microenvironment modulation,immunotherapy target,pro-inflammatory cytokine production,oncogenesis promotion
ENSG00000096968,JAK2,jak/stat pathway activation,gain of function mutations,constitutive signaling,tumor progression driver,cellular proliferation enhancement,cancer cell survival promotion
ENSG00000137462,TLR2,immune recognition,tumor microenvironment modulation,nf-κb pathway activation,mapk signaling enhancement,cell proliferation promotion,pro-inflammatory cytokine regulation
ENSG00000174125,TLR1,immune modulation,tumor microenvironment modulation,inflammatory response regulation,immune evasion,cancer cell survival,chemoresistance
ENSG00000174130,TLR6,immune recognition,pattern recognition receptors,cytokine production,innate immunity modulation,tumor microenvironment regulation,immunotherapy response
ENSG00000168214,RBPJ,notch signaling pathway,transcription factor activity,tumor progression,oncogenic roles,cancer stem cell maintenance,genetic amplification
ENSG00000100603,SNW1,transcriptional coactivation,tumor progression,cell proliferation,genetic regulation,protein interaction,therapeutic target
ENSG00000148400,NOTCH1,constitutive activation,notch signaling pathway,gains-of-function mutation,cancer stem cell maintenance,cell proliferation regulation,tumor suppressor gene dysregulation
ENSG00000100644,HIF1A,hypoxia response,transcriptional regulation,cellular adaptation,angiogenesis promotion,glucose metabolism regulation,protein stability modulation
ENSG00000101384,JAG1,notch signaling pathway,aberrant activation,tumor suppression loss,epithelial maintenance failure,cell proliferation enhancement,apoptosis resistance
ENSG00000184916,JAG2,notch signaling pathway,cell proliferation,tumor invasion,metastasis progression,epithelial-to-mesenchymal transition,transcriptional regulation
ENSG00000110395,CBL,tumor suppressor function,impaired ubiquitin ligase activity,cell cycle regulation,apoptosis modulation,src family kinase regulation,prognostic marker
ENSG00000149294,NCAM1,cell adhesion regulation,epithelial-to-mesenchymal transition (emt),glycoprotein expression,metastasis promotion,oncogenic signaling activation,tumor progression facilitation
ENSG00000130287,NCAN,tumor suppressor function,wnt/β-catenin pathway regulation,cell differentiation inhibition,pro-apoptotic activity,cell proliferation suppression,genetic silencing
ENSG00000134871,COL4A2,basement membrane integrity,compromised mechanical support,tumor progression,metastasis facilitation,biomarker potential,downregulated expression
ENSG00000187498,COL4A1,tumor progression,cell adhesion,metastasis,basement membrane,therapeutic target,genomic instability
ENSG00000206435,HLA-C,antigen presentation,immune evasion,cytokine regulation,tumor progression,mhc class i expression,immune modulation
ENSG00000273686,B2M,epitope presentation,tumor progression,poor prognosis marker,cancer cell adhesion downregulation,immunotherapy target,mhc class i component
ENSG00000274739,KIR2DS5,cellular proliferation,voltage-gated potassium channels,tumor cell growth,signaling pathway regulation,cellular homeostasis,altered expression levels
ENSG00000011600,TYROBP,tumor cell survival,proliferation modulation,cancer-associated mutations,dna repair mechanisms,cell cycle regulation,immune system modulation
ENSG00000258227,CLEC5A,immune modulation,tumor progression,cell migration,metastasis promoter,apoptosis evasion,protein-ligand interaction
ENSG00000096264,NCR2,tumor microenvironment modulation,immune evasion mechanism,natural killer cell activation,receptor-ligand interaction,epigenetic regulation,signal transduction pathway
ENSG00000101307,SIRPB1,immune modulation,tumor progression,cell adhesion,metastasis,molecular regulation,protein-protein interaction
ENSG00000124731,TREM1,immune suppression,tumor metastasis,malignant progression,immunosuppressive microenvironment,therapeutic target,microbial infection response
ENSG00000095970,TREM2,immune system regulation,tumor microenvironment modulation,macrophage infiltration,poor prognosis,tumor progression,immunosuppression
ENSG00000186407,CD300E,immune evasion,tumor microenvironment modulation,apoptosis resistance,enhanced cell proliferation,metastasis promotion,therapeutic target potentialization
ENSG00000178789,CD300LB,immune evasion strategies,pi3k/akt pathway modulation,tumor progression promotion,apoptosis inhibition,anti-apoptotic protein induction,immunotherapeutic target
ENSG00000100351,GRAP2,pi3k/akt activation,cell proliferation,oncogenic signaling,scaffolding protein function,tumor growth,immune evasion
ENSG00000043462,LCP2,pi3k/akt/mtor pathway regulation,tumor progression driver,positive regulator of akt activation,lipid metabolism regulation,genomic amplification associated,protein-protein interaction partner
ENSG00000136158,SPRY2,downregulation,rtk signaling inhibition,tumor suppressor,cell proliferation promotion,oncogenic process enhancement,metastasis facilitation
ENSG00000153071,DAB2,tumor suppressor function,cell adhesion regulation,apoptosis induction,cancer progression inhibition,epigenetic regulation,poor prognosis association
ENSG00000081479,LRP2,overexpression,cell proliferation,endocytosis regulation,tumor metastasis,protein sorting modulation,anti-apoptotic signaling
ENSG00000124333,VAMP7,tumor invasion,cell-cell fusion regulation,wnt/β-catenin pathway interaction,oncogene potential,metastasis promotion,cell membrane trafficking
ENSG00000173744,AGFG1,cellular proliferation,signaling pathway regulation,cytoskeleton organization,protein kinase activation,cell migration,therapeutic target
ENSG00000078053,AMPH,pi3k/akt signaling pathway activation,oncogenic driver,tumor progression facilitation,increased cell proliferation,enhanced metastatic potential,angiogenesis modulation
ENSG00000136717,BIN1,genomic instability,tumor progression,mitotic regulation,dna repair,prognostic marker,biomarker candidate
ENSG00000161011,SQSTM1,autophagy regulation,cell survival promotion,nf-κb signaling activation,tumor progression promoter,protein degradation regulation,pi3k/akt pathway interaction
ENSG00000198909,MAP3K3,**
mapk signaling pathway,gain of function mutations,cell proliferation,oncogenic driver,protein-protein interactions,apoptosis regulation
**
ENSG00000187840,EIF4EBP1,regulatory mechanism disruption,phosphorylation-dependent activation,protein synthesis initiation,tumor progression driver,oncogenic reprogramming,cell cycle regulation
ENSG00000151247,EIF4E,oncogene role,constitutive translation activation,mtor pathway interaction,cell proliferation enhancement,poor prognosis indicator,tumor progression mediator
ENSG00000134250,NOTCH2,notch signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cell migration
ENSG00000137496,IL18BP,inflammation regulation,tumor suppressor function,il-18 binding inhibition,cancer progression,poor prognosis marker,oncogene regulation
ENSG00000150782,IL18,inflammation promotion,cell proliferation enhancement,immune modulation,cytokine overexpression,apoptosis regulation,signaling pathway interaction
ENSG00000115604,IL18R1,il-18 signaling pathway,inflammation regulation,immune suppression,tumor growth promotion,cell migration enhancement,prognostic biomarker
ENSG00000164136,IL15,tumor-promoting cytokine,upregulated expression,immune evasion,angiogenesis stimulation,cell proliferation enhancement,prognostic marker
ENSG00000134470,IL15RA,immune evasion,proliferation promotion,tumor angiogenesis,jak/stat pathway activation,il-15 signaling pathway,gene upregulation
ENSG00000126456,IRF3,antitumor immune response,apoptosis evasion,cytokine regulation,cytoplasmic signaling pathway,immune system modulation,nuclear translocation
ENSG00000185507,IRF7,type i interferons regulation,constitutive activation,tumor progression facilitation,immune evasion promotion,inflammation regulation,epithelial-to-mesenchymal transition
ENSG00000005339,CREBBP,oncogenic driver,constitutive activation,wnt/β-catenin pathway activation,genomic instability,transcriptional regulation,coactivator function
ENSG00000074181,NOTCH3,**
notch signaling,constitutive activation,gain-of-function mutations,cell growth promotion,apoptosis evasion,tumor suppressor inhibition
**
ENSG00000163435,ELF3,enhancer binding,epithelial-to-mesenchymal transition,cell proliferation regulation,transcriptional modulation,oncogenic driver,cancer cell survival
ENSG00000018236,CNTN1,pi3k/akt pathway regulation,oncogene activation,cell migration and invasion,cell adhesion modulation,epithelial-to-mesenchymal transition (emt),protein-protein interaction
ENSG00000110492,MDK,oncogenic function,growth factor activity,cell migration promotion,tumor progression association,angiogenesis stimulation,apoptosis inhibition
ENSG00000198719,DLL1,notch signaling pathway,oncogene activation,cell proliferation enhancement,tumor progression promoter,dysregulated expression,cancer cell survival enhancement
ENSG00000065978,YBX1,transcriptional regulation,tumor progression,cell survival enhancement,dna repair modulation,oncogenic function,therapeutic target
ENSG00000164683,HEY1,enhancer of split transcription factor,tumor suppressor gene repression,oncogenic signaling pathway activation,cell proliferation regulation,apoptosis suppression,metastatic potential marker
ENSG00000160973,FOXH1,oncogenic transcription factor,aberrant gene expression,wnt/β-catenin signaling pathway activation,pi3k/akt pathway regulation,dna damage repair,stat3 interaction
ENSG00000175550,DRAP1,p53 regulation,transcriptional regulator,cell cycle progression,apoptosis inhibition,dna repair modulation,oncogene activation
ENSG00000064309,CDON,cell signaling pathway,notch receptor interaction,tumor progression,metastasis,cancer cell survival,poor prognosis
ENSG00000144857,BOC,transcriptional regulation,oncogenic activity,cell proliferation,anti-apoptotic pathways,tumor progression,poor prognosis
ENSG00000110944,IL23A,immunomodulation,pro-inflammatory signaling,proliferation driver,chronic inflammation,cell differentiation,therapeutic target
ENSG00000162594,IL23R,il-23/il-17 axis,inflammation promotion,immune evasion,cell proliferation regulation,tumor progression,therapeutic target
ENSG00000138378,STAT4,stat/jak signaling pathway,constitutive activation,gain of function mutations,tumor metastasis,immune evasion,prognostic marker
ENSG00000113889,KNG1,angiogenesis,inflammation regulation,tumor progression,poor prognosis marker,microenvironment modulation,pro-coagulant activity
ENSG00000108561,C1QBP,tumor progression,chromatin remodeling,nf-κb pathway activation,transcriptional regulation,cell survival enhancement,metastasis promotion
ENSG00000185010,F8,coagulation pathway,bleeding disorder,glycoprotein function,thrombin activation,hemostasis regulation,protein expression
ENSG00000110799,VWF,vwf-mediated platelet adhesion,tumor microemboli formation,thrombosis regulation,angiogenesis promotion,immunomodulation role,tumor progression facilitation
ENSG00000101981,F9,blood clotting regulation,coagulation cascade participation,tumor-associated thrombosis,angiogenesis facilitation,metastasis promotion,potential oncogenic role
ENSG00000143278,F13B,tumor microenvironment,pro-coagulant activity,poor prognosis,metastasis,thrombosis,angiogenesis
ENSG00000124491,F13A1,tumor metastasis,coagulation cascade,cell surface interaction,pro-tumorigenic environment,signal transduction,genomic instability
ENSG00000115718,PROC,cellular signaling,protein processing,tumor progression,metastasis,wnt/β-catenin pathway,upregulated expression
ENSG00000101000,PROCR,protease-activated receptor,coagulation regulation,inflammation modulation,angiogenesis promotion,tumor progression,immune evasion
ENSG00000154589,LY96,tlr signaling pathway,tumor suppressor function,cell proliferation regulation,dysregulated immune response,tumor microenvironment modulation,genomic instability
ENSG00000136869,TLR4,inflammatory signaling,tumor progression,immune modulation,cell proliferation,pro-inflammatory cytokine production,nf-κb pathway activation
ENSG00000163220,S100A9,inflammatory response,nf-κb signaling pathway,tumor progression,protein interaction,cell survival pathways,biomarker
ENSG00000143546,S100A8,tumor progression,pro-inflammatory response,cell migration and invasion,poor prognosis marker,immune modulation,chronic inflammation
ENSG00000130522,JUND,transcription factor regulation,oncogenic processes,cell proliferation,tumor progression,angiogenesis,epithelial-to-mesenchymal transition
ENSG00000125740,FOSB,cell proliferation,transcription factor activity,oncogenesis,tumor progression,cell growth regulation,genomic amplification
ENSG00000242335,CFB,immune evasion,tumor microenvironment,inflammation regulation,complement cascade activation,cellular damage response,immunosuppression
ENSG00000125730,C3,angiogenesis regulation,tumor microenvironment modulation,oncogenic process contribution,prognostic significance,immune system interaction,complement system involvement
ENSG00000104879,CKM,energy metabolism,oncogenesis,tumor progression,cell proliferation,signaling pathway activation,apoptosis regulation
ENSG00000166165,CKB,tumor metabolism,energy production,prognostic marker,therapeutic target,metabolic regulation,cell proliferation
ENSG00000117592,PRDX6,cellular redox regulation,mitochondrial localization,thioredoxin-dependent peroxidase activity,ros-mediated dna damage,pi3k/akt signaling activation,genomic instability
ENSG00000084207,GSTP1,cellular detoxification,oxidative stress protection,apoptosis modulation,oncogene overexpression,tumor biomarker,therapeutic target
ENSG00000185122,HSF1,oncogene activation,chromatin regulation,cellular proliferation,therapeutic resistance,genomic instability,protein stabilization
ENSG00000230989,HSBP1,oncogenic signaling,tumor growth promotion,apoptosis resistance,cell cycle regulation modulation,dna repair suppression,therapeutic target
ENSG00000108953,YWHAE,oncogenic function,cell cycle progression,apoptosis regulation,protein-protein interaction,biomarker candidate,tumor suppressor dysfunction
ENSG00000158941,CCAR2,cell growth regulation,phosphorylation modulation,tumor progression,poor prognosis indicator,biomarker potential,signaling pathway regulation
ENSG00000096717,SIRT1,tumor suppressor regulation,metabolic regulation,epigenetic modification,oncogenesis,metastasis,cellular stress response
ENSG00000125968,ID1,transcriptional regulation,cellular dedifferentiation,pro-oncogenic activity,tumor suppressor inhibition,therapeutic target,cancer prognosis
ENSG00000157557,ETS2,oncogene,tumor progression,transcription factor,cell proliferation,metastasis,poor prognosis
ENSG00000105722,ERF,cell proliferation,anti-apoptotic function,transcriptional regulation,oncogenic pathway activation,angiogenesis promotion,tumor progression
ENSG00000197442,MAP3K5,oncogenic signaling,stress response regulation,cell survival promotion,tumor progression contributor,therapeutic target candidate,protein-protein interaction
ENSG00000147883,CDKN2B,cell cycle regulation,tumor suppression,cell proliferation inhibition,cyclin d1 binding,retinoblastoma protein interaction,gene silencing
ENSG00000172216,CEBPB,transcription factor regulation,oncogene activation,epithelial-to-mesenchymal transition,angiogenesis modulation,cell proliferation enhancement,protein-protein interactions
ENSG00000198178,CLEC4C,immune modulation,epithelial-to-mesenchymal transition (emt),transmembrane protein function,tumor growth promotion,cell adhesion regulation,signaling pathway regulation
ENSG00000158869,FCER1G,tumor growth promotion,pi3k/akt pathway activation,prognostic marker,immunoreceptor function,signal transduction modulation,chemosensitivity reduction
ENSG00000166523,CLEC4E,tumor progression,immune evasion,pi3k/akt pathway activation,cell migration and invasion,metastasis promotion,inflammatory response activation
ENSG00000006062,MAP3K14,non-canonical nf-?b signaling,constitutive activation,oncogenic process,tumorigenesis,cell growth regulation,cell survival pathway
ENSG00000213341,CHUK,nf-?b activation,constitutive signaling,cell survival enhancement,tumor progression,oncogenic transformation,ikk complex regulation
ENSG00000077150,NFKB2,nf-κb pathway activation,chronic inflammation,oncogenic process,cell survival enhancement,tumor promotion,genetic instability
ENSG00000104856,RELB,nf-kappab signaling pathway,tumor progression,cell proliferation,apoptosis regulation,oncogenic processes,chemotherapy resistance
ENSG00000172175,MALT1,nf-κb activation,oncogenic process,cell proliferation,apoptosis resistance,inflammation regulation,signaling pathway interaction
ENSG00000064012,CASP8,apoptosis regulation,tumor progression,cancer cell survival,therapeutic resistance,prognostic biomarker,genomic instability
ENSG00000090659,CD209,tumor microenvironment modulation,pathogen recognition,cancer cell-immune cell interaction,immune evasion mechanisms,mannose-binding activity,tumor progression facilitation
ENSG00000108622,ICAM2,cell-cell interactions,immune response modulation,adhesion molecule function,tumor progression,metastasis promotion,poor prognosis marker
ENSG00000075218,GTSE1,microtubule dynamics,oncogenic process,cell proliferation,tumor growth,metastasis,overexpression
ENSG00000117399,CDC20,cell cycle progression,tumor growth promotion,checkpoint disruption,oncogene activation,dna damage response modulation,apoptosis evasion
ENSG00000164109,MAD2L1,spindle checkpoint,cell cycle regulation,mitotic entry,genome stability,tumor progression,epithelial-mesenchymal transition
ENSG00000136997,MYC,transcriptional regulation,constitutive activation,oncogene expression,cell cycle dysregulation,apoptosis resistance,protein-protein interactions
ENSG00000123374,CDK2,cdk2 activation,cell cycle regulation,oncogenesis driver,proliferation enhancement,genomic amplification,tumor suppression
ENSG00000105173,CCNE1,cell cycle regulation,constitutive activation,genomic instability,oncogene amplification,therapeutic target,tumor suppressor interaction
ENSG00000112312,GMNN,cell cycle regulation,dna replication regulation,therapeutic target,tumor progression,oncogenic role,cancer correlation
ENSG00000167513,CDT1,cell cycle regulation,dna replication initiation,g1-s phase transition,oncogene activity,cell proliferation enhancement,genomic instability promotion
ENSG00000006634,DBF4,genomic instability,cell cycle regulation,dna replication,sister chromatid cohesion,protein-protein interaction,cell proliferation
ENSG00000097046,CDC7,dna replication initiation,genomic stability maintenance,cell cycle control regulation,cell proliferation enhancement,protein kinase activation,cell growth promotion
ENSG00000133101,CCNA1,cyclin a1 activation,cell cycle progression,genomic instability,oncogenic role,protein-protein interaction,amplification/overexpression
ENSG00000145386,CCNA2,chromosomal instability,cyclin-cdk complex formation,cell cycle progression,overexpression in cancer,cell proliferation promotion,tumor growth enhancement
ENSG00000139289,PHLDA1,loss of tumor suppressor function,regulation of cell cycle progression,cellular proliferation and survival,genomic instability,pi3k/akt signaling pathway,epithelial-to-mesenchymal transition (emt)
ENSG00000288307,CTDNEP1,proteostatic regulation,endoplasmic reticulum stress,cellular homeostasis,unfolded protein response,transmembrane protein function,er-associated degradation pathway
ENSG00000205423,CNEP1R1,primary cilium assembly,cell proliferation,epithelial cell regulator,ciliogenesis regulator,regulation of wnt signaling pathway,protein-protein interaction partner
ENSG00000135476,ESPL1,mitotic regulation,genomic instability,tumor progression,chromosomal separation,apoptosis regulation,cancer driver gene
ENSG00000164611,PTTG1,gain of function mutations,cell cycle regulation,genomic instability,protein phosphatase activity,microtubule stability,tumor progression
ENSG00000129933,MAU2,saga complex regulation,transcriptional dysregulation,oncogenic overexpression,cell proliferation promotion,genetic regulation alteration,tumorigenesis contribution
ENSG00000164190,NIPBL,genomic instability,cohesin regulation,dna damage response,chromosomal rearrangement,oncogenic transcription,tumor suppressor dysfunction
ENSG00000112029,FBXO5,homologous recombination repair,tumor suppressor function,aurora kinase a regulation,genomic instability,polo-like kinase 1 degradation,dna damage response pathway
ENSG00000073712,FERMT2,cell adhesion disruption,oncogenic function,tumor progression,cytoskeleton modulation,therapeutic target,protein interaction
ENSG00000162458,FBLIM1,cell adhesion disruption,emt regulation,microtubule dynamics alteration,oncogene function,transcription factor interaction,tumor aggressiveness enhancement
ENSG00000150093,ITGB1,tumor progression,cell adhesion,signaling pathway regulation,oncogenic process regulation,metastasis facilitation,microenvironment interaction
ENSG00000166333,ILK,cell adhesion disruption,enhanced cell migration,increased cell proliferation,oncogenic signaling activation,prognostic marker,tumor progression
ENSG00000197702,PARVA,chromatin remodeling,transcriptional regulation,cancer susceptibility,dna repair pathway,cell cycle progression,genomic instability
ENSG00000129675,ARHGEF6,rhoa activation,guanine nucleotide exchange factor activity,cell proliferation,epithelial-to-mesenchymal transition,tumor progression,prognostic marker
ENSG00000188677,PARVB,tumor progression,metastasis promoter,cell migration enhancer,extracellular matrix interaction,oncogene upregulation,cytoskeletal dynamics modulation
ENSG00000148484,RSU1,splicing regulation,oncoprotein function,tumor suppressor activity,cell proliferation enhancement,metastasis promotion,transcriptional regulation modulation
ENSG00000169756,LIMS1,cell adhesion disruption,oncogenic driver,epithelial-to-mesenchymal transition (emt) promoter,protein-protein interactions,cytoskeletal regulation,tumor progression facilitator
ENSG00000072110,ACTN1,cytoplasmic localization,cell adhesion enhancement,actin cytoskeleton reorganization,tumor progression facilitation,pi3k/akt pathway regulation,metastasis promotion
ENSG00000091409,ITGA6,integrin alpha 6 subunit,cell adhesion and migration,tumor progression and metastasis,upregulated expression,oncogenic role,signaling pathway regulation
ENSG00000132470,ITGB4,increased expression,tumor progression,cell adhesion disruption,basal lamina assembly,metastatic potential,overexpression
ENSG00000196776,CD47,immune evasion,tumor cell survival,cell surface interaction,phagocytosis inhibition,oncogenic signaling,therapeutic target
ENSG00000198053,SIRPA,tumor microenvironment modulation,cancer cell migration,immune evasion mechanisms,cell adhesion regulation,protein-protein interactions,oncogenic potential enhancer
ENSG00000089012,SIRPG,cd47 interaction,immune evasion,tumor microenvironment regulation,metastasis promotion,cell migration regulation,overexpression in esca
ENSG00000161270,NPHS1,cell migration,glycosylation regulation,tumor microenvironment,cell proliferation,podocyte dysfunction,oncogenic activity
ENSG00000183853,KIRREL1,wnt/β-catenin pathway,tumor progression,cell proliferation,mutation hotspot,immune evasion,poor prognosis
ENSG00000118898,PPL,tumor progression,oncogene,protein degradation,cell proliferation,apoptosis regulation,signaling pathway modulation
ENSG00000167880,EVPL,cell migration,protein-protein interactions,cancer cell invasion,signaling pathway activation,biomarker potential,tumor progression
ENSG00000189337,KAZN,chromatin remodeling,transcriptional regulation,dna repair dysregulation,cell cycle progression,apoptosis suppression,epigenetic modification
ENSG00000167754,KLK5,proteolytic activity,emt regulation,tumor progression,adhesion molecule degradation,oncogenic driver,cell surface protein dynamics
ENSG00000133710,SPINK5,oncogenic function,tumor suppressor loss,epithelial barrier disruption,cell proliferation enhancement,serine protease regulation,overexpression
ENSG00000186474,KLK12,oncogene activation,tumor progression,proteolytic activity,cell proliferation,metastasis facilitation,extracellular matrix degradation
ENSG00000178172,SPINK6,tumor progression,promotes cell survival,regulates cell proliferation,serine protease inhibition,transcription factor regulation,nf-κb activation
ENSG00000167759,KLK13,proteolytic cascade activation,cell migration and invasion,transcription factor regulation,gene expression modulation,cell proliferation regulation,apoptosis resistance
ENSG00000129437,KLK14,tumor progression,proteolytic activity,cell invasion,metastasis facilitation,angiogenesis promotion,growth factor activation
ENSG00000204909,SPINK9,tumor suppressor loss,overexpression,apoptosis inhibition,cell proliferation enhancement,pi3k/akt pathway modulation,biomarker status
ENSG00000077782,FGFR1,receptor tyrosine kinase,constitutive phosphorylation,oncogenesis,tumor progression,angiogenesis,therapeutic target
ENSG00000011201,ANOS1,**
wnt signaling pathway,aberrant activation,gain of function mutations,tumor progression,cell proliferation,protein interaction **
ENSG00000165029,ABCA1,chemosensitivity modulation,lipid metabolism regulation,oncogene role,tumor progression influence,apoptosis suppression,tumor microenvironment interaction
ENSG00000118137,APOA1,apoa1's anti-inflammatory properties,lipid metabolism regulator,oncogenic pathway modulator,cell proliferation inhibitor,apoptosis inducer,tumor suppressor activity
ENSG00000132855,ANGPTL3,angiopoietin regulation,tumor growth promotion,immune evasion mechanism,metastasis facilitation,angiogenic switch activation,poor prognosis marker
ENSG00000130173,ANGPTL8,angiogenesis promotion,cell migration enhancement,cell proliferation facilitation,metabolic regulation disruption,oncogene role assignment,signaling pathway modulation
ENSG00000126261,UBA2,ubiquitination pathway,protein degradation regulation,cellular transformation,tumor suppressor interaction,genome stability maintenance,dna damage repair
ENSG00000142230,SAE1,gain of function mutations,aberrant sumoylation patterns,cellular proliferation,genomic instability,tumor suppressor suppression,proteolytic activity
ENSG00000112576,CCND3,cyclin-dependent kinase activation,overexpression,cell proliferation promotion,tumor growth facilitation,oncogenic driver,genomic amplification/hypomethylation
ENSG00000069956,MAPK6,mapk signaling pathway,constitutive activation,protein kinase activation,cell proliferation,tumor progression,therapeutic target
ENSG00000005884,ITGA3,basement membrane interaction,cell adhesion regulation,epithelial cell migration,tumor progression promotion,angiogenesis facilitation,metastasis enhancement
ENSG00000135424,ITGA7,integrin signaling pathway,cell adhesion disruption,genomic instability,tumor metastasis,angiogenesis promotion,metastatic potential
ENSG00000164171,ITGA2,tumor progression,prognostic marker,cell adhesion regulation,metastasis facilitation,cell migration regulation,oncogenic potential
ENSG00000213949,ITGA1,cell adhesion regulation,tumor progression facilitation,signal transduction modulation,growth factor receptor interaction,extracellular matrix interaction,protein-protein interaction
ENSG00000182220,ATP6AP2,increased cell proliferation,tumor progression,autophagy regulation,epithelial-to-mesenchymal transition (emt),cellular ph homeostasis regulation,prognosis biomarker
ENSG00000143839,REN,angiotensin signaling pathway,cell migration,epithelial-to-mesenchymal transition,oncogenic expression,tumor progression,osmotic stress regulation
ENSG00000117481,NSUN4,**

rna processing,nucleolar protein function,ribosome biogenesis regulation,tumor marker potential,pi3k/akt pathway interaction,cell growth and survival regulation
**
ENSG00000122085,MTERF4,mitochondrial transcription regulation,cellular energy metabolism modulation,genomic stability maintenance,tumor microenvironment interaction,apoptosis regulation contribution,cancer-related pathway involvement
ENSG00000259207,ITGB3,integrin signaling,cell adhesion modulation,growth factor activation,metastatic potential,cell migration enhancement,therapeutic target candidate
ENSG00000005961,ITGA2B,integrin-mediated adhesion,cell migration regulation,angiogenesis promotion,tumor progression facilitation,cell adhesion disruption,gene expression dysregulation
ENSG00000130164,LDLR,lipid metabolism regulation,cell proliferation enhancement,metastasis facilitation,glycolytic adaptation,cell survival promotion,endocytosis modulation
ENSG00000169174,PCSK9,proprotein convertase activity,lipid metabolism dysregulation,cell cycle regulation,apoptosis evasion,therapeutic target,signal transduction pathway
,TMEM173,dna-dependent activation,immune modulator,innate immune response,interferon production,cancer immunotherapy,tumor suppressor
ENSG00000183735,TBK1,**

autophagy induction,cell survival promotion,chromatin remodeling,immune evasion,oncogenic signaling,phosphorylation regulation
ENSG00000139193,CD27,immune modulation,tumor progression,co-stimulatory molecule,cellular proliferation,ligand-receptor interaction,anti-tumor immune response
ENSG00000125726,CD70,immune checkpoint,cell proliferation,t-cell exhaustion,tumor microenvironment,cancer-associated fibroblasts,therapeutic target
ENSG00000135960,EDAR,notch signaling,epithelial cell differentiation,cell proliferation,receptor-ligand interaction,tumor progression,malignant transformation
ENSG00000158813,EDA,enhanced expression,epithelial-to-mesenchymal transition (emt),cell adhesion disruption,metastasis promotion,therapeutic target,protein-protein interaction
ENSG00000131080,EDA2R,cellular adhesion regulation,tumor progression facilitation,epithelial-to-mesenchymal transition modulation,pi3k/akt pathway interaction,metastasis promotion,therapeutic target
ENSG00000120337,TNFSF18,immunomodulatory,tumor progression,apoptosis induction,pi3k/akt signaling interaction,biomarker potential,prognostic significance
ENSG00000186891,TNFRSF18,tumor progression,immune evasion,cell surface receptor,metastasis suppression,prognostic marker,tumor-associated immune tolerance
ENSG00000186827,TNFRSF4,immune modulation,tumor microenvironment modification,thymocyte activation,nf-κb pathway interaction,cell proliferation enhancement,t-cell activation
ENSG00000117586,TNFSF4,tumor progression,immune evasion,oncogenic signaling,cell proliferation,therapeutic target,genomic amplification
ENSG00000215788,TNFRSF25,tumor progression,apoptosis inhibition,protein-protein interaction,chemotherapy resistance,immune evasion,cancer cell survival
ENSG00000181634,TNFSF15,apoptosis suppression,cellular proliferation,tumor progression,immune modulation,angiogenesis enhancement,cytokine regulation
ENSG00000106952,TNFSF8,apoptosis regulation,immune evasion,tumor necrosis factor activity,cell survival promotion,death receptor interaction,oncogenic transformation
ENSG00000120949,TNFRSF8,tumor microenvironment modulation,immune response regulation,cell survival enhancement,apoptosis inhibition,protein-protein interaction,signal transduction pathway engagement
ENSG00000125657,TNFSF9,tumor growth promotion,nf-κb signaling pathway activation,immune evasion mechanism,oncogenic cell survival enhancement,tumor microenvironment modulation,therapeutic target
ENSG00000049249,TNFRSF9,tumor-promoting signaling,co-stimulatory molecule function,overexpression in cancer,nf-κb/mapk pathway activation,apoptosis evasion,cell cycle progression
ENSG00000101213,PTK6,emt regulation,tyrosine kinase activation,cell migration,oncogene overexpression,signaling pathway modulation,poor prognosis
ENSG00000121774,KHDRBS1,alternative splicing,rna-binding protein function,mrna stability regulation,oncogenic mrnas modulation,cancer progression promotion,splice variant generation
ENSG00000186635,ARAP1,cell migration,signaling pathway regulation,gtpase activation,tumor progression,protein-protein interaction,metastasis promotion
ENSG00000142208,AKT1,pi3k/akt signaling,constitutive activation,cell survival pathways,protein kinase regulation,tumor progression,mutation hotspot
ENSG00000115325,DOK1,aberrant signaling,cell growth promotion,dysregulated apoptosis regulation,metastasis facilitation,oncogenic process modulation,tumor progression enhancement
ENSG00000196396,PTPN1,regulation of rtks,loss of phosphatase activity,dysregulation in tumorigenesis,interaction with adaptor proteins,modulation of pi3k/akt pathway,tumor progression and metastasis
ENSG00000178078,STAP2,cellular stress response,protein folding regulation,oncogenesis,cell survival promotion,signal transduction modulation,grp1 binding protein
ENSG00000184557,SOCS3,jak/stat signaling pathway,constitutive activation,loss of function mutations,tumor progression,oncogenic potential,cell proliferation
ENSG00000143127,ITGA10,cell adhesion,integrin signaling,metastasis,cancer progression,tumor invasion,signaling pathway
ENSG00000275931,GP6,tumor progression,cell migration,angiogenesis promotion,epithelial-to-mesenchymal transition,metastasis facilitation,chemotherapy resistance
ENSG00000132155,RAF1,constitutive activation,oncogenic driver,mapk/erk signaling pathway,cell proliferation,therapeutic target,genomic instability
ENSG00000164924,YWHAZ,apoptosis regulation,growth factor signaling pathway,cell cycle progression,scaffold protein function,tumor suppressor dysfunction,protein-protein interaction network
ENSG00000162493,PDPN,cell migration,protein-protein interaction,metastasis,apoptosis resistance,angiogenesis promotion,tumor progression
ENSG00000165682,CLEC1B,cell adhesion disruption,oncogenic pathway activation,tumor progression facilitation,immune response modulation,poor prognosis indicator,therapeutic target candidate
ENSG00000197461,PDGFA,cell proliferation,angiogenesis promotion,tumor growth facilitation,oncogene interaction,signaling pathway activation,metastasis promotion
ENSG00000100311,PDGFB,pdgf signaling pathway,constitutive activation,overexpression,tumor progression,angiogenesis,oncogenic growth
ENSG00000169896,ITGAM,tumor progression,cell adhesion regulation,immune evasion mechanisms,tumor microenvironment modulation,oncogenic signaling pathways,leukocyte recruitment facilitation
ENSG00000160255,ITGB2,cell adhesion,tumor progression,metastasis driver,cell migration,extracellular matrix interaction,angiogenesis regulation
ENSG00000154721,JAM2,adhesion molecule overexpression,cell migration enhancement,endothelial cell interaction,immunotherapeutic target,prognostic marker,tumor progression facilitation
ENSG00000166086,JAM3,cell-cell interaction,adhesion molecule,tumor progression,metastasis promotion,cell migration regulation,genetic expression alteration
ENSG00000115232,ITGA4,angiogenesis,tumor progression,cell adhesion,metastasis,prognostic marker,integrin signaling
ENSG00000005844,ITGAL,tumor progression,metastasis,immune regulation,cell adhesion,gene expression,prognostic marker
ENSG00000140678,ITGAX,integrin-mediated adhesion,cancer progression,cell migration,metastasis promotion,tumor microenvironment interaction,pi3k/akt signaling pathway
ENSG00000117091,CD48,cell surface protein,immunoglobulin superfamily member,t cell activation,nk cell activation,tumor progression,pi3k/akt pathway activation
ENSG00000122223,CD244,tumor evasion,immune modulation,nk cell dysfunction,tumor progression,poor prognosis,receptor-ligand interaction
ENSG00000116815,CD58,cell adhesion molecule,tumor growth promotion,immune evasion,poor prognosis marker,therapeutic target,wnt/β-catenin pathway interaction
ENSG00000116824,CD2,cell adhesion molecule,tumor progression,oncogene activation,immune evasion,cell proliferation,angiogenesis
ENSG00000161638,ITGA5,tumor progression,cell adhesion,metastasis,cell migration,oncogene activation,adhesion molecule signaling
ENSG00000160593,JAML,cell-cell interactions,immunosuppressive environment,tumor progression,metastasis promotion,immune evasion,cancer cell migration
ENSG00000154639,CXADR,apoptosis regulation,cell adhesion modulation,immune evasion,inflammation regulation,tumor progression,cellular interaction
ENSG00000240972,MIF,pro-inflammatory cytokine,tumor progression,cell proliferation,angiogenesis,chemoresistance,immune evasion
ENSG00000019582,CD74,immune regulation,antigen presentation,tumor growth,metastasis,poor prognosis,oncogene interaction
ENSG00000120156,TEK,angiogenesis promotion,vascular stability regulation,tie2 signaling pathway,cell proliferation enhancement,endothelial cell interaction,growth factor modulation
ENSG00000154188,ANGPT1,angiopoietin-1 function,angiogenesis promotion,vascular stability regulation,tumor progression facilitation,therapeutic target potential,pro-angiogenic properties
ENSG00000091879,ANGPT2,tumor angiogenesis,vascular permeability regulation,oncogenic potential,biomarker for prognosis,therapeutic target,angiopoietin signaling pathway
ENSG00000101280,ANGPT4,angiogenesis promotion,cellular metabolism regulation,fatty acid oxidation suppression,oncogenic potential,tumor progression facilitation,signaling pathway interaction
ENSG00000168918,INPP5D,tumor suppressor loss,pi3k pathway inhibition,cell proliferation regulation,apoptosis regulation,autophagy modulation,genomic instability
ENSG00000124181,PLCG1,phosphoinositide signaling pathway,constitutive activation,cell proliferation enhancement,therapeutic target,tyrosine kinase regulation,g-protein coupled receptor interaction
ENSG00000172270,BSG,cell adhesion regulation,glycoprotein function,immune response modulation,tumor progression facilitation,prognostic marker overexpression,microenvironment interaction
ENSG00000100023,PPIL2,apoptosis regulation,cell cycle regulation,dna repair pathway,oncogenic function,protein degradation inhibitor,tumor progression enhancer
ENSG00000105974,CAV1,caveolin-mediated signaling,increased cell migration,tumor aggressiveness,metastasis facilitation,angiogenesis promotion,therapeutic target
ENSG00000196262,PPIA,oncogenic process,tumor aggressiveness,protein stabilization,cell growth regulation,signaling pathway modulation,metastasis promotion
ENSG00000155465,SLC7A7,metabolic reprogramming,amino acid transport,cellular proliferation,tumor growth,cancer metabolism,genetic disorder
ENSG00000168003,SLC3A2,amino acid transport,tumor progression,prognostic marker,cellular proliferation,gene expression regulation,cancer cell metabolism
ENSG00000092068,SLC7A8,overexpression,cell proliferation,amino acid transport,angiogenesis,tryptophan uptake,immune evasion
ENSG00000021488,SLC7A9,amino acid transport,oncogenic processes,enhanced expression,therapeutic target,tumor progression,cellular metabolic regulation
ENSG00000151012,SLC7A11,metabolic reprogramming,cell growth promotion,tumor progression modulation,therapeutic target identification,protein interaction regulation,nutrient supply enhancement
ENSG00000103257,SLC7A5,mtor pathway,cell proliferation,amino acid transport,oncogenic process,chemoresistance,overexpression
ENSG00000130876,SLC7A10,role in amino acid transport,promotes tumorigenesis,enhances cell proliferation,increases chemoresistance,tumor aggressiveness,essential for cancer cell metabolism
ENSG00000103064,SLC7A6,amplification,cancer metabolism,co-amplification,gene expression regulation,ligand transport,nutrient uptake
ENSG00000136750,GAD2,gabaergic signaling,neurotransmitter regulation,proliferation promotion,apoptosis inhibition,cellular metabolism alteration,routine enzymatic function
ENSG00000128683,GAD1,gaba regulation,immune response modulation,oncogenesis,cell proliferation,neurotransmitter function,synaptic plasticity
ENSG00000186090,HTR3D,serotonin receptor,cell surface localization,neurotransmitter signaling pathway,cell proliferation regulation,apoptosis modulation,tumorigenesis contribution
ENSG00000166736,HTR3A,cell proliferation regulation,apoptosis modulation,serotonin-induced excitability,ligand-gated ion channel activity,mapk/erk pathway interaction,overexpression in cancer cells
ENSG00000186038,HTR3E,serotonin receptor modulation,tumor progression,cell migration and invasion,g protein-coupled receptor family,pi3k/akt pathway interaction,therapeutic target
ENSG00000149305,HTR3B,serotonin signaling pathway,cell proliferation regulation,cancer metastasis,tumor progression,cellular migration,signal transduction
ENSG00000178084,HTR3C,serotonin receptor subtype,regulated cell proliferation,angiogenesis promotion,poor prognostic marker,cell apoptosis regulation,signaling pathway modulation
ENSG00000175387,SMAD2,tgf-β signaling pathway,constitutive activation,gain of function mutations,tumor progression,epithelial-to-mesenchymal transition,transcription regulation
ENSG00000177628,GBA,lysosomal dysfunction,autophagy regulation,cell survival promotion,metastasis facilitation,therapeutic target potential,genetic predisposition
ENSG00000197746,PSAP,protein synthesis regulation,tumor metabolism alteration,cell growth modulation,therapeutic target,genomic instability contribution,metabolic pathway dysregulation
ENSG00000112799,LY86,tumor suppressor function,loss of function mutations,toll-like receptor interaction,antiviral immunity disruption,immune evasion mechanism,cancer prognosis correlation
ENSG00000134061,CD180,hsp90 association,tumor progression,immune evasion,cell survival,proliferation signaling,receptor activation
ENSG00000118004,COLEC11,cell adhesion,tumor progression,invasion,metastasis,overexpression,biomarker
ENSG00000127241,MASP1,tumor progression,proteolytic activity,immune system regulation,extracellular matrix degradation,oncogenic signaling,genetic variants
ENSG00000169562,GJB1,gap junction disruption,tumor progression,cellular adhesion impairment,epithelial-to-mesenchymal transition,metastasis facilitation,cellular communication deregulation
ENSG00000165474,GJB2,cell-cell adhesion disruption,gap junction formation,oncogenic mutations,tumor progression,therapeutic target,signaling pathway dysregulation
ENSG00000152661,GJA1,disrupted gap junctional communication,oncogenic potential,tumor progression,cell proliferation enhancement,apoptosis suppression,cancer cell invasion
ENSG00000277401,TJP1,tumor progression,epithelial barrier disruption,cell migration regulation,tight junction assembly,adhesion complex disassembly,cancer cell invasion
ENSG00000069869,NEDD4,pi3k/akt pathway,ubiquitin ligase activity,tumor suppressor function,cell cycle regulation,biomarker potential,protein degradation modulation
ENSG00000138032,PPM1B,phosphatase activity,genomic stability maintenance,chromosomal instability prevention,cell cycle regulation,apoptosis promotion,constitutive activation
ENSG00000136068,FLNB,cell proliferation,cytoskeletal dynamics,actin-binding protein,tumor progression,biomarker identification,cell migration
ENSG00000137033,IL33,il-1 family signaling,overexpression,stat3 activation,cell proliferation,immune evasion,epithelial-to-mesenchymal transition
ENSG00000115602,IL1RL1,tumor microenvironment modulation,immunosuppressive microenvironment promotion,cell proliferation regulation,therapeutic target identification,prognostic marker potential,inflammation and immune response regulation
ENSG00000125571,IL37,tumor suppression,immunomodulation,anti-inflammatory response,prognostic biomarker,nf-κb pathway activation,pi3k/akt pathway interaction
ENSG00000100368,CSF2RB,granulocyte-macrophage colony-stimulating factor receptor,enhanced angiogenesis,immune evasion mechanism,tumor growth promotion,signaling pathway activation,hematopoiesis regulation
ENSG00000198223,CSF2RA,gm-csfr signaling,immunosuppressive microenvironment,cytokine production,inflammation,receptor dimerization,cell proliferation
ENSG00000164400,CSF2,tumor microenvironment modulation,cancer progression promotion,immune evasion facilitation,mdsc recruitment,poor prognosis association,therapeutic resistance contribution
ENSG00000091181,IL5RA,il-5/il5ra signaling,cell proliferation,jak/stat activation,tumor progression,hematopoietic cell regulation,immune evasion
ENSG00000113525,IL5,eosinophil regulation,tumor progression,angiogenesis promotion,metastasis enhancement,therapeutic target,prognostic biomarker
,TEC,dna demethylation,epigenetic regulation,gene silencing,oncogenesis,tumor suppressor loss,epigenetic alterations
ENSG00000141968,VAV1,rho gtpase pathway,gain of function mutations,oncogenic process,cell proliferation,tumor progression,therapeutic target
ENSG00000095585,BLNK,adaptor protein function,cell signaling regulation,immune response modulation,src kinase pathway activation,tumor progression promoter,tyrosine phosphorylation facilitation
ENSG00000077238,IL4R,il-4 signaling,stat6 activation,inflammation suppression,tumor progression,angiogenesis promotion,immune evasion
ENSG00000131724,IL13RA1,stat6 activation,pi3k/akt/mtor signaling,oncogenic driver,tumor cell proliferation,cell cycle progression,apoptosis resistance
ENSG00000169194,IL13,il13/stat6 pathway,gain of function mutations,tumor growth promotion,angiogenesis regulation,therapeutic target,cell proliferation enhancement
ENSG00000123496,IL13RA2,oncogene,cell proliferation,tumor progression,immune evasion,inflammation regulation,pro-survival signaling
ENSG00000168685,IL7R,tumor progression,cell proliferation,prognostic marker,jak/stat pathway activation,metastasis,immune evasion
ENSG00000127616,SMARCA4,chromatin remodeling,cancer driver mutation,genetic co-occurrence,transcriptional regulation,tumor suppressor function,cell cycle progression
ENSG00000185658,BRWD1,chromatin remodeling,cell cycle regulation,transcriptional regulation,tumor suppressor dysfunction,oncogenic transformation,pi3k/akt pathway modulation
ENSG00000164485,IL22RA2,il-22 signaling pathway,inflammation regulation,epithelial cell growth,gene expression modulation,cancer progression,immune response regulation
ENSG00000127318,IL22,tumor-promoting cytokine,epithelial-to-mesenchymal transition,enhances cell survival,supresses antitumor immune responses,regulates inflammation,angiogenesis enhancer
ENSG00000185436,IFNLR1,type iii interferon signaling pathway,immune suppression,epithelial cell growth regulation,anti-viral defense modulation,tumor progression contributor,therapeutic target
ENSG00000172349,IL16,pi3k/akt pathway,epithelial-to-mesenchymal transition,tumor progression,cancer immunotherapy target,cell proliferation modulation,anti-apoptotic signaling
ENSG00000008517,IL32,pro-inflammatory cytokine,tumor growth promotion,immune modulation,epithelial-to-mesenchymal transition (emt),biomarker for prognosis,overexpression in tumors
ENSG00000196415,PRTN3,calpain inhibition,cell adhesion regulation,epithelial-to-mesenchymal transition,metastasis promotion,proteolytic activity modulation,tumor suppressor function loss
ENSG00000122025,FLT3,rtk activation,constitutive activation,gain of function mutations,aberrant cell growth,cell survival promotion,tyrosine kinase activity
ENSG00000090554,FLT3LG,angiogenesis promotion,immunosuppression induction,tumor progression facilitation,stem cell regulation disruption,cancer cell proliferation enhancement,tumor growth acceleration
ENSG00000108342,CSF3,tumor microenvironment modulation,immune suppression enhancement,myeloid cell recruitment,growth factor activation,prognostic marker,therapeutic target candidate
ENSG00000119535,CSF3R,gm-csf receptor signaling,constitutive activation,gain of function mutations,tumor progression,immune cell infiltration,cell survival enhancement
ENSG00000084652,TXLNA,dna damage response,tumor suppressor function,genomic instability,cancer cell proliferation,anti-apoptotic activity,chromosomal alterations
ENSG00000106089,STX1A,pi3k/akt signaling,constitutive activation,overexpression,tumor progression,epithelial-to-mesenchymal transition,metastasis
ENSG00000112964,GHR,growth factor receptor activation,jak2/stat5 pathway,cell proliferation promotion,tumor growth driver,oncogenic signaling mediator,metabolic regulation adaptation
ENSG00000113494,PRLR,prolactin-regulated signaling,oncogenic driver,cell proliferation enhancement,tumor progression facilitation,immune modulation impairment,transmembrane receptor function
ENSG00000131323,TRAF3,nf-κb pathway inhibition,tumor suppressor function,constitutive activation,immune evasion facilitation,pro-inflammatory gene transcription enhancement,oncogenic factor expression increase
ENSG00000028137,TNFRSF1B,tnf regulation,apoptosis dysregulation,tumor progression,cell survival pathway,immune evasion,genomic instability
ENSG00000102245,CD40LG,tumor progression,immune evasion,cell proliferation,apoptosis regulation,genetic alterations,therapeutic target
ENSG00000101017,CD40,tumor promotion,immune regulation,nf-κb pathway activation,cancer immunotherapy,tumor progression,prognostic marker
ENSG00000159958,TNFRSF13C,tnf receptor superfamily,apoptosis regulation,cell survival modulation,tumor progression driver,prognostic marker,therapeutic target
ENSG00000102524,TNFSF13B,apoptosis regulation,cancer cell survival,immune response modulation,protein interaction,tumor angiogenesis,overexpression
ENSG00000076641,PAG1,mitochondrial enzyme,palmitoylprotein thioesterase function,cell growth promotion,survival pathway regulation,protein kinase activation modulation,signaling pathway dysregulation
ENSG00000103653,CSK,src family kinases regulation,non-receptor tyrosine kinase,tumor suppressor function,cell survival promotion,apoptosis inhibition,signaling pathway dysregulation
ENSG00000134242,PTPN22,cellular signaling regulation,tumor suppressor activity loss,immune response modulation,phosphatase activity disruption,cell proliferation enhancement,genomic instability promotion
ENSG00000213658,LAT,altered t-cell activation,impaired anti-tumor immunity,tumor progression,cellular proliferation,dysregulation,immune modulation
ENSG00000082074,FYB1,fyn-binding protein 1 overexpression,tumor progression,cell proliferation regulation,immune response modulation,multifunctional adaptor protein,t-cell receptor signaling activation
ENSG00000158092,NCK1,regulation of signaling pathways,cell migration and invasion,oncogenic processes,interactions with tyrosine kinases,pi3k/akt pathway regulation,cytoskeletal reorganization
ENSG00000135341,MAP3K7,nf-κb pathway,inflammatory response,oncogenic signaling,tumor growth promotion,cell survival enhancement,cancer progression
ENSG00000055208,TAB2,nf-κb signaling pathway,deubiquitination,oncogenic processes,protein stability regulation,tumorigenesis promotion,cell survival enhancement
ENSG00000163600,ICOS,tumor progression,cell proliferation,immune response modulation,apoptosis inhibition,signaling pathway regulation,inflammation promotion
ENSG00000160223,ICOSLG,immune evasion,immunosuppression,t-cell activation,prognostic marker,pi3k/akt pathway activation,transmembrane protein
ENSG00000157873,TNFRSF14,immune regulation,tumor progression,immune evasion,cell growth promotion,therapeutic target potential,signal transduction
ENSG00000186265,BTLA,tumor evasion,immune suppression,therapeutic target,cancer immunology,immune checkpoint inhibition,prognostic biomarker
ENSG00000121594,CD80,cd28/ctla-4 interaction,t-cell exhaustion,immunosuppression,tumor progression,inflammation regulation,prognostic marker
ENSG00000178562,CD28,pi3k/akt signaling,co-stimulation,immune evasion,tumor progression,oncogenic pathway,cell survival
ENSG00000114013,CD86,co-stimulatory signaling,immune suppression,tumor microenvironment modulation,regulatory t cell recruitment,antigen presentation,cell surface expression
ENSG00000100906,NFKBIA,nf-κb inhibition,transcription factor regulation,oncogenic signaling,tumor progression,immune evasion,inflammation modulation
ENSG00000141367,CLTC,cellular structure disruption,cell division abnormality,gain of function mutations,oncogenic process promotion,cytoskeletal regulation dysfunction,microtubule dynamics modulation
ENSG00000122705,CLTA,cell survival,evasion of apoptosis,overexpression,tumor progression,metastasis,biomarker
ENSG00000242574,HLA-DMB,antigen presentation,tumor progression,immune evasion,prognostic marker,biomarker,antigen processing
ENSG00000204257,HLA-DMA,immune modulation,mhc class i expression,antigen presentation,tumor antigen regulation,cancer immunotherapy target,t cell interaction
ENSG00000153283,CD96,tumor progression,cell-to-cell adhesion,oncogene,metastasis facilitation,angiogenesis promotion,poor prognosis marker
ENSG00000139626,ITGB7,integrin-mediated adhesion,cell migration and invasion,enhanced pi3k/akt pathway activity,oncogenic potential,therapeutic target,altered expression in cancer
ENSG00000206493,HLA-E,immune evasion,nk cell tolerance,poor prognosis,immune modulation,tumor progression,reduced expression
ENSG00000039068,CDH1,cancer-associated protein loss,cell-cell adhesion disruption,epithelial-to-mesenchymal transition (emt),increased cell invasion and metastasis,poor prognosis marker,reduced e-cadherin expression
ENSG00000139187,KLRG1,tumor progression,t-cell inhibition,immune evasion,cell adhesion,molecular interaction,oncogenic function
ENSG00000150637,CD226,immune evasion,microenvironment modulation,t-cell dysfunction,antigen presentation,adhesion molecule regulation,tumor progression
ENSG00000091972,CD200,immunosuppression,tumor progression,tumor evasion,immune surveillance,biomarker,prognostic indicator
ENSG00000163606,CD200R1,immunosuppression,tumor progression,anti-inflammatory response,pi3k/akt pathway interaction,myeloid-derived suppressor cell regulation,cancer immunotherapy target
ENSG00000235346,HLA-G,immune evasion,epithelial-to-mesenchymal transition (emt),tumor immune suppression,angiogenesis promotion,regulatory t cells recruitment,immunotherapy target
ENSG00000275583,KIR2DS2,potassium channel regulation,cellular proliferation modulation,immune response regulation,ion homeostasis maintenance,voltage-gated potassium channels,cancer cell survival enhancement
ENSG00000069493,CLEC2D,tumor progression,tumor microenvironment modulation,immune evasion,inflammation regulation,cell proliferation promotion,survival pathway activation
ENSG00000111796,KLRB1,nk cell modulation,immunoregulatory function,tumor recognition,immune microenvironment regulation,cancer progression association,therapeutic target potential
ENSG00000158125,XDH,purine metabolism,oxidative stress,tumor aggressiveness,metastasis driver,cell proliferation,prognostic biomarker
ENSG00000124557,BTN1A1,immune evasion strategies,t-cell regulation,lipid metabolism modulation,antigen presentation,dendritic cell activation,mhc class i upregulation
ENSG00000115221,ITGB6,cell-extracellular matrix interaction,tumor progression,prognostic marker,cell migration and adhesion,signaling molecule interaction,oncogenic transformation
ENSG00000105329,TGFB1,emt induction,cytokine regulation,immune suppression,oncogene activation,extracellular matrix production,cell differentiation
ENSG00000090006,LTBP4,tgf-β regulation,latency disruption,emt process activation,tumor progression,angiogenesis promotion,dysregulation in eca
ENSG00000077943,ITGA8,integrin signaling pathway,tumor progression,cell adhesion molecule,angiogenesis promotion,metastasis facilitation,poor prognosis marker
ENSG00000105855,ITGB8,epithelial-to-mesenchymal transition,tumor progression,cell migration,oncogene interaction,cancer stem cell formation,signaling pathway activation
ENSG00000064692,SNCAIP,p53 regulation,oncogenic potential,cell cycle modulation,apoptosis induction,protein interaction network,cancer therapy target
ENSG00000185345,PRKN,mitochondrial quality control,tumor suppressor function,genomic instability,cell growth promotion,oxidative stress response,autophagy regulation
ENSG00000145335,SNCA,oncogenic potential,overexpression in esca,interaction with p53,cell proliferation enhancement,autophagy dysregulation,protein aggregation promotion
ENSG00000124486,USP9X,oncoprotein stabilization,protein stability regulation,ubiquitin-proteasome pathway modulation,nf-κb signaling interaction,cell proliferation promotion,tumor aggressiveness enhancement
ENSG00000137642,SORL1,amyloid-β accumulation,cell growth regulation,dna damage induction,endocytic pathway dysregulation,oncogenic process activation,tumor suppressor function
ENSG00000142192,APP,tumor suppressor function loss,cell survival enhancement,apoptosis resistance,angiogenesis modulation,amyloid precursor protein expression,protein-protein interaction
ENSG00000145782,ATG12,autophagic flux disruption,cellular survival enhancement,tumor promotion,oncogene potential,cell proliferation modulation,protein-protein interaction
ENSG00000197548,ATG7,autophagy regulation,tumor suppressor function,oncogenic mutation,genomic stability maintenance,chemotherapy resistance,metastasis promotion
ENSG00000152348,ATG10,autophagosome formation,autophagy regulation,tumor suppression,oncogenic processes,cell survival,metastasis promotion
ENSG00000057663,ATG5,autophagosome formation,cellular survival,dna damage response,apoptosis regulation,tumor microenvironment modulation,tumor suppressor or promoter
ENSG00000176194,CIDEA,mitochondrial dynamics,apoptosis regulation,cellular homeostasis,tumor suppression,oncogenic pathways,genomic instability
ENSG00000187288,CIDEC,cellular regulation,mitochondrial interaction,apoptosis modulation,cell death pathway,cancer-related mutations,therapeutic target
ENSG00000113721,PDGFRB,constitutive activation,oncogenic signaling,receptor tyrosine kinase activity,tumor progression,therapeutic target,gene amplification
ENSG00000134853,PDGFRA,gain of function mutations,constitutive activation,receptor tyrosine kinase activity,oncogenic signaling pathways,tumor progression,therapeutic target
ENSG00000163513,TGFBR2,tgf-β pathway disruption,constitutive activation,growth factor signaling,cell migration inhibition,immune evasion,epithelial-to-mesenchymal transition
ENSG00000166913,YWHAB,regulatory interactions,cell cycle regulation,apoptosis inhibition,tumor progression,pi3k/akt pathway modulation,oncogenic signaling enhancement
ENSG00000126934,MAP2K2,mapk signaling pathway,constitutive activation,gain of function mutations,cell survival,apoptosis resistance,proliferation enhancement
ENSG00000169032,MAP2K1,erk/mapk pathway activation,gain of function mutations,tumor progression driver,therapeutic target,cell proliferation enhancement,apoptosis inhibition
ENSG00000141068,KSR1,mapk/erk pathway activation,cell proliferation promotion,oncogenic protein interaction,tumor progression enhancement,signaling pathway modulation,protein overexpression
ENSG00000075413,MARK3,microtubule dynamics,overexpression,cell proliferation,tumor progression,oncogenic process,apoptosis regulation
ENSG00000136807,CDK9,transcriptional regulation,constitutive activation,cell cycle progression,oncogenic gene expression,tumor growth promotion,p-tefb complex interaction
ENSG00000129315,CCNT1,cyclin t1 overexpression,dna replication regulation,cell proliferation enhancement,oncogenic driver,genomic instability induction,transcriptional activation
ENSG00000165898,ISCA2,gain-of-function mutation,tumor suppressor inhibition,epigenetic regulation,oncometabolite production,metabolic shift,angiogenesis promotion
ENSG00000135070,ISCA1,mitochondrial function,iron-sulfur cluster assembly,genomic instability,cancer progression,oxidative stress response,cofactor biogenesis
ENSG00000160703,NLRX1,apoptosis regulation,mitochondrial function regulation,tumor suppressor activity,immune response regulation,cell survival promotion,inflammation and immune surveillance dysregulation
ENSG00000088888,MAVS,immunomodulation,cytokine regulation,dysregulated immune response,tumor progression,apoptosis suppression,mitochondrial signaling
ENSG00000169855,ROBO1,slit-robo signaling,cell migration promotion,epithelial-to-mesenchymal transition,tumor metastasis facilitation,cell survival regulation,prognostic marker potential
ENSG00000145147,SLIT2,cell migration regulation,tumor suppressor function,proliferation inhibition,angiogenesis regulation,metastasis suppression,poor prognosis association
ENSG00000185652,NTF3,neuronal differentiation,tumor cell proliferation,trkc receptor interaction,aggressive disease progression,pi3k/akt activation,cell survival signaling
ENSG00000179841,AKAP5,tumor progression,cell proliferation inhibition,microtubule dynamics regulation,signaling pathway modulation,protein kinase a interaction,apoptosis inhibition
ENSG00000154134,ROBO3,disrupted slit-robo signaling pathway,gene expression regulation,tumor cell invasion,slit2 ligand interaction,cancer metastasis,signaling pathway modulation
ENSG00000000971,CFH,complement regulation,tumor progression,prognostic marker,angiogenesis promotion,cell surface receptor interaction,immune evasion mechanism
ENSG00000177455,CD19,b-cell receptor signaling pathway,overexpression,tumor growth promotion,immune evasion mechanisms,proliferation and survival enhancement,signaling pathway activation
ENSG00000110651,CD81,tumor progression,cell-to-cell interactions,signaling pathway regulation,membrane trafficking,immune evasion,oncogenic transformation
ENSG00000149131,SERPING1,angiogenesis regulation,tumor suppression,apoptosis modulation,cell growth inhibition,oncogene interaction,protease inhibition
ENSG00000182326,C1S,cathepsin activity,cancer metastasis,tumor invasion,lysosomal degradation,immune modulation,nf-κb pathway activation
ENSG00000288512,C1R,cell adhesion modulation,tumor progression facilitation,poor prognosis association,metastasis promotion,cytoskeletal regulation,protein-protein interaction
ENSG00000178772,CPN2,signaling pathway regulation,tumor progression,biomarker potential,cell proliferation modulation,proteolytic activity,metastasis promotion
ENSG00000120054,CPN1,pi3k/akt pathway interaction,cellular signaling regulation,bioactive peptide processing,tumor growth promotion,therapeutic target potential,apoptosis modulation
ENSG00000198910,L1CAM,cell adhesion disruption,tumor progression,metastasis promotion,prognostic marker,signaling pathway interaction,glycoprotein function
ENSG00000099250,NRP1,cell migration,angiogenesis promotion,tumor progression,pi3k/akt pathway modulation,metastasis facilitation,poor prognosis marker
ENSG00000144668,ITGA9,tumor progression,cell migration,epithelial-to-mesenchymal transition,therapeutic target,overexpression,cell adhesion
ENSG00000102882,MAPK3,cellular stress response,apoptosis regulation,signaling pathway modulation,proliferation promotion,cell survival enhancement,transcription factor activation
ENSG00000100030,MAPK1,**
mapk1 activation,cell proliferation enhancement,oncogenic signaling pathway,tumor growth promotion,metastasis facilitation,gene expression regulation 
**
ENSG00000039537,C6,cell-cell adhesion disruption,oncogene suppression,tumor aggressiveness enhancement,poor patient prognosis,pi3k/akt pathway inhibition,cell migration regulation
ENSG00000179115,FARSA,mitochondrial dysfunction,oxidative phosphorylation,glycolytic shift,glutaminolysis activation,metabolic reprogramming,hypoxia adaptation
ENSG00000116120,FARSB,ribosomal regulation,cellular proliferation,protein synthesis regulation,rna processing,spliceosome interaction,metabolic reprogramming
ENSG00000244734,HBB,altered expression,cell metabolism regulation,dysregulated protein interactions,genetic variability influence,tumor microenvironment modulation,oxygen transport disruption
ENSG00000206172,HBA1,hemoglobin subunit regulation,cellular metabolism regulation,oncogenic potential,angiogenesis modulation,inflammation regulation,cellular proliferation promotion
ENSG00000188536,HBA2,hemoglobin subunit alpha function,oncogenic upregulation,metabolic shift,prognostic marker,cancer cell proliferation,tumor aggressiveness
ENSG00000108854,SMURF2,tumor suppressor degradation,pi3k/akt signaling pathway modulation,cellular proliferation modulation,mutation-independent oncogenesis,protein stability regulation,ubiquitination and proteasomal degradation
ENSG00000284126,SMURF1,hippo signaling pathway,oncogenic potential,cell proliferation regulation,protein degradation regulation,tumorigenesis association,signaling pathway modulation
ENSG00000049759,NEDD4L,pias domain,ubiquitination regulation,tumor suppressor activity,cell migration regulation,epigenetic control,signaling pathway modulation
ENSG00000103266,STUB1,apoptosis regulation,cell cycle control,dna repair mechanism,e3 ubiquitin ligase activity,oncogenic signaling,tumor suppression
ENSG00000130725,UBE2M,ubiquitination pathway,cellular degradation,apoptosis regulation,cancer progression,oncogene interaction,tumor suppressor modulation
ENSG00000285246,NEDD8,ubiquitin-proteasome system regulation,oncogenic protein stabilization,cell cycle promotion,protein degradation dysregulation,tumor progression facilitation,post-translational modification enhancement
ENSG00000155827,RNF20,chromatin remodeling,transcriptional activation,gene expression regulation,ubiquitin ligase activity,protein-protein interactions,cell proliferation
ENSG00000103549,RNF40,ubiquitination regulation,cell cycle progression,protein degradation,apoptosis modulation,tumor growth promotion,metastasis facilitation
ENSG00000111816,FRK,cell signaling regulation,growth factor receptor activation,pi3k/akt pathway modulation,tumor growth promotion,metastasis facilitation,non-receptor tyrosine kinase activity
ENSG00000233948,TRIM27,tumor suppressor function,ubiquitination regulation,oncogenic substrate degradation,cell cycle modulation,apoptosis induction,genomic instability maintenance
ENSG00000137809,ITGA11,epithelial-to-mesenchymal transition (emt),integrin-linked kinase activation,metastasis promotion,cell adhesion regulation,pi3k/akt pathway activation,biomarker potential
ENSG00000156886,ITGAD,cell adhesion,molecular interaction,tumor progression,immune evasion,angiogenesis regulation,epi-to-mesenchymal transition
ENSG00000083457,ITGAE,**
cell-cell adhesion,integrin signaling pathway,metastasis promotion,tumor progression,cancer cell migration,adhesion molecule function 
**
ENSG00000142798,HSPG2,perlecan binding,angiogenic factor modulation,tumor progression facilitation,cell adhesion disruption,extracellular matrix remodeling,growth factor regulation
ENSG00000288299,LDHA,aerobic glycolytic metabolism,glycolysis promotion,hallmark of cancer metabolism,metabolic adaptation,oncogenic process,therapeutic target
ENSG00000111716,LDHB,metabolic reprogramming,glycolytic activity increase,tumor progression association,warburg effect promotion,cell growth regulation,signaling pathway interaction
ENSG00000163541,SUCLG1,metabolic reprogramming,cellular growth,protein interaction,tumor suppressor function,genomic instability,sulfate biosynthesis
ENSG00000172340,SUCLG2,metabolic reprogramming,tumor progression,cell proliferation,upregulated expression,succinyl-coa conversion,mitochondrial function
ENSG00000136143,SUCLA2,sdh complex assembly,oncogenic transformation,alternative metabolic pathways,energy metabolism regulation,iron-sulfur cluster biogenesis,transcriptional regulation dysregulation
ENSG00000102265,TIMP1,tumor progression,angiogenesis promotion,apoptosis regulation,cell proliferation modulation,nf-κb interaction,mmp inhibition
ENSG00000100985,MMP9,tumor invasion,angiogenesis promotion,gelatinase activity,extracellular matrix degradation,tumor progression facilitation,therapeutic target for cancer treatment
ENSG00000157227,MMP14,angiogenesis,invasive potential,tumor progression,proteolytic activity,extracellular matrix degradation,metastasis
ENSG00000035862,TIMP2,tumor suppressor,mmp inhibition,tissue homeostasis,extracellular matrix degradation,cell migration regulation,inflammation response modulation
ENSG00000102054,RBBP7,telomerase regulation,chromatin remodeling,tumor suppressor function,cell cycle regulation,epigenetic regulation,dna damage response
ENSG00000128708,HAT1,epigenetic regulator,chromatin structure modification,apoptosis regulation,cancer susceptibility modifier,transcriptional regulation,tumor suppressive activity
ENSG00000135903,PAX3,transcription factor regulation,oncogenic activation,cell proliferation promotion,epithelial-to-mesenchymal transition (emt),genomic instability induction,wnt/β-catenin signaling pathway interaction
ENSG00000084676,NCOA1,transcriptional coactivator,apoptosis inhibition,cell cycle progression,nuclear receptor interaction,scaffolding protein function,chromatin remodeling
ENSG00000163930,BAP1,genomic instability,tumor suppressor function,ubiquitin ligase activity,cell cycle regulation,brca1-a complex interaction,epigenetic regulation
ENSG00000172534,HCFC1,transcriptional regulation,oncogenic processes,tumor suppressor interactions,cell proliferation,epigenetic modification,chromatin structure
ENSG00000100324,TAB1,oncogenic signaling,tumor microenvironment creation,pro-inflammatory gene transcription,apoptosis resistance,cell survival promotion,inflammation regulation
ENSG00000145604,SKP2,cell cycle regulation,ubiquitination and proteasomal degradation,oncogene overexpression,cell proliferation enhancement,tumor progression facilitation,protein-protein interactions
ENSG00000070010,UFD1,ups dysfunction,protein aggregation,aberrant protein regulation,tumor progression,therapeutic target potential,genomic instability
ENSG00000165280,VCP,chromosomal instability,cell cycle regulation,dna damage response,mitotic spindle function,apoptosis suppression,genomic destabilization
ENSG00000180667,YOD1,protein deubiquitination,cell cycle regulation,oncogenic protein stabilization,apoptosis inhibition,tumor suppressor inactivation,poor prognosis biomarker
ENSG00000019995,ZRANB1,chromatin remodeling,transcriptional regulation,oncogenic transformation,cell proliferation,tumor progression,genomic instability
ENSG00000134982,APC,tumor suppressor activity,constitutive activation of wnt pathway,loss of protein function mutations,epithelial-to-mesenchymal transition (emt),chromatin remodeling,wnt signaling dysregulation
ENSG00000066427,ATXN3,ubiquitin-proteasome system,cell cycle regulation,apoptosis inhibition,protein degradation disruption,tumor progression driver,mitochondrial dysfunction
ENSG00000124356,STAMBP,erad pathway,tumor suppressor,apoptosis regulation,genomic instability,dna repair modulation,cell cycle regulation
ENSG00000136738,STAM,cellular proliferation,downstream signaling pathways,epidermal growth factor receptor regulation,oncogenic processes,pi3k/akt/mtor pathway activation,protein-protein interactions
ENSG00000140538,NTRK3,chromosomal rearrangements,constitutive activation,fusion genes,oncogenic signaling,receptor tyrosine kinase,targeted therapy
ENSG00000105426,PTPRS,aberrant signaling pathway,cell proliferation inhibition,epithelial-to-mesenchymal transition regulation,gene expression modulation,negative regulator function,tumor suppressor activity
ENSG00000106366,SERPINE1,tumor growth,cell migration,extracellular matrix degradation,proteolysis inhibition,metastasis promotion,signaling pathway modulation
ENSG00000109072,VTN,ve-cadherin dysfunction,disrupted cell-cell adhesion,enhanced vascular permeability,tumor progression,prognostic marker,angiogenesis regulation
ENSG00000173402,DAG1,cell proliferation,membrane fluidity regulation,lipid metabolism modulation,oncogenic signaling,protein kinase c activation,gene overexpression
ENSG00000188157,AGRN,acetylcholinesterase receptor modulation,neuromuscular junction regulation,muscle contraction promotion,oncogene overexpression,poor prognosis association,tumor growth facilitation
ENSG00000142867,BCL10,nf-κb pathway,gain of function mutations,tumor progression,apoptosis regulation,genomic profiling,oncogenic driver
ENSG00000187122,SLIT1,tumor suppression,cell migration inhibition,angiogenesis regulation,robo receptor interaction,cellular adhesion modulation,oncogene downregulation
ENSG00000188559,RALGAPA2,dysregulation of small gtpases,cell growth regulation,gef activity,ras/raf/mek/erk pathway activation,tumor progression driver,protein-protein interactions
ENSG00000170471,RALGAPB,regulation of cell adhesion,tumor suppressor function,small gtpase regulation,cell migration and invasion,metabolic alterations,poor prognosis biomarker
ENSG00000173230,GOLGB1,oncogene,apoptosis regulation,cell proliferation,vesicle transport regulation,golgi apparatus integrity,secretory pathway disruption
ENSG00000182827,ACBD3,lipid biosynthesis,metabolic regulation,mitochondrial function,tumor growth promotion,apoptosis inhibition,cell cycle regulation
ENSG00000100099,HPS4,genomic instability,tumor progression,cell cycle regulation,dna damage response,melanosome transport,oncogenesis
ENSG00000107521,HPS1,lysosomal formation,endocytic trafficking,autophagic flux regulation,tumor suppression,cell homeostasis maintenance,genomic instability
ENSG00000163083,INHBB,tumor suppressor,cell proliferation regulation,activin inhibition,pi3k/akt pathway activation,genomic alteration,chromosomal location
ENSG00000122641,INHBA,tgf-β pathway modulation,cell proliferation regulation,angiogenesis promotion,metastasis facilitation,epithelial-to-mesenchymal transition,oncogenic transformation
ENSG00000108950,FAM20A,protein tyrosine phosphorylation,mitotic regulation,oncogene activation,proliferation promotion,metastasis facilitation,signaling pathway modulation
ENSG00000177706,FAM20C,calcium homeostasis regulation,cell proliferation promotion,oncogenic mutations,tumor progression,therapeutic target,protein kinase activation
ENSG00000143799,PARP1,dna repair,chromatin remodeling,apoptosis regulation,cell cycle progression,genomic stability,epigenetic modifications
ENSG00000002016,RAD52,genomic instability,homologous recombination repair,dna repair protein,oncogene,double-strand break repair,sister chromatid exchange
ENSG00000163961,RNF168,oncogenic function,apoptosis regulation,cell cycle modulation,ubiquitination pathway,dna repair deficiency,prognostic marker
ENSG00000067066,SP100,nuclear body complex formation,apoptosis inhibition,tumor progression,transcriptional regulation,immune response modulation,viral restriction
ENSG00000139372,TDG,genomic stability,dna repair mechanism,oxidative stress response,base excision repair pathway,mutagenesis prevention,cancer susceptibility gene
ENSG00000165392,WRN,genomic maintenance,recq helicase activity,telomere regulation,dna repair deficiency,sister chromatid exchange,genome instability
ENSG00000154767,XPC,genome instability,dna damage repair,nucleotide excision repair,uv radiation sensitivity,mutagenesis driving oncogenesis,tumorigenesis facilitation
ENSG00000187098,MITF,gain of function mutations,transcriptional regulation,cell survival pathways,oncogenesis promotion,tumor progression facilitation,constitutive activation
ENSG00000172845,SP3,tumor suppressor gene repression,cell cycle progression,transcriptional regulation,oncogenic function,chromatin modification,transcription factor activity
ENSG00000067369,TP53BP1,dna repair mechanisms,genomic stability maintenance,tumor suppressor function,oncogenic pathway modulation,radiation resistance,pi3k/akt signaling regulation
ENSG00000147889,CDKN2A,tumor suppressor function,loss of heterozygosity,cell cycle regulation,cyclin-dependent kinase inhibition,tumor growth suppression,g1-s phase transition regulation
ENSG00000177374,HIC1,dna binding,transcriptional repression,tumor suppression,cell cycle regulation,apoptosis regulation,zinc finger domain
ENSG00000183770,FOXL2,tumor suppressor,cell growth regulation,transcription factor activity,cell differentiation disruption,poor prognosis indicator,oncogenic pathway disruption
ENSG00000100201,DDX17,dna damage response,apoptosis regulation,cell proliferation,genomic instability,tumor growth promotion,microrna regulation
ENSG00000182568,SATB1,chromatin remodeling,cell proliferation,apoptosis suppression,tumor progression,metastasis facilitation,oncogene role
ENSG00000178691,SUZ12,prc2 complex,epigenetic silencing,oncogenic function,tumor suppressor repression,metastatic potential,prognostic marker
ENSG00000068024,HDAC4,histone deacetylation,epithelial-to-mesenchymal transition (emt),pi3k/akt signaling pathway,tumor suppressor gene suppression,transcriptional regulation disruption,oncogene promotion
ENSG00000116478,HDAC1,histone modification,chromatin remodeling,tumor suppressor gene suppression,oncogenic transcription factor activation,apoptosis regulation,cell cycle control
ENSG00000196591,HDAC2,epigenetic regulation,tumorigenesis,oncogene activation,therapeutic target,histone modification,transcriptional repression
ENSG00000170004,CHD3,chromatin remodeling,epigenetic regulation,dna repair facilitation,tumor suppressor gene silencing,oncogenic transcription factor activation,genomic instability
ENSG00000092199,HNRNPC,pre-mrna splicing,aberrant localization,oncogene activation,genetic alterations,tumor suppressor regulation,cellular proliferation
ENSG00000055044,NOP58,ribosome biogenesis,cell proliferation,oncogene function,tumor progression,mirna regulation,nucleolar protein interaction
ENSG00000198900,TOP1,genomic instability,cell proliferation,dna repair regulation,apoptosis resistance,therapeutic target,epigenetic alterations
ENSG00000131747,TOP2A,dna decatenation,genomic instability,cell proliferation,oncogenic driver,dna repair mechanisms,nuclear localization
ENSG00000077097,TOP2B,dna replication regulation,genomic stability maintenance,tumor growth promotion,therapeutic target,cell proliferation enhancement,dna damage response modulation
ENSG00000143379,SETDB1,epigenetic regulation,histone methylation,oncogenic process,tumor suppressor silencing,aggressive disease progression,therapeutic target
ENSG00000171681,ATF7IP,p53 regulation,transcriptional regulation,cellular stress response,nf-kappab activation,tumor suppressor interaction,apoptosis modulation
ENSG00000100462,PRMT5,arginine methylation,cellular proliferation,dna damage response,genomic instability,protein modification,transcriptional regulation
ENSG00000116455,WDR77,microtubule stabilization,spindle checkpoint regulation,genomic stability maintenance,tumor suppressor function,cell cycle regulation,cdc20/bub1 interaction
ENSG00000158828,PINK1,mitochondrial dysfunction,cell survival regulation,autophagic degradation,reactive oxygen species production,pink1-parkin interaction,mitochondrial biogenesis regulation
ENSG00000178568,ERBB4,erbb4 mutations,receptor tyrosine kinase activation,autophosphorylation signaling,cell proliferation enhancement,survival pathway activation,therapeutic target identification
ENSG00000189056,RELN,disrupted cellular adhesion,overexpressed,metastasis promotion,signaling pathway dysregulation,cell detachment,tumor progression facilitation
ENSG00000147852,VLDLR,lipid metabolism regulation,apoe interaction,tumor suppression loss,cell growth promotion,metastasis facilitation,neuronal function modulation
ENSG00000141505,ASGR1,cell surface protein recycling,endocytosis,membrane trafficking,pi3k/akt signaling pathway,glycolytic reprogramming,therapeutic target
ENSG00000161944,ASGR2,tumor progression,metastasis enhancement,cell invasion modulation,apoptosis regulation,epidermal growth factor receptor interaction,glycoprotein recognition
ENSG00000120738,EGR1,oncogenic transcription factor,cell cycle regulation,apoptosis inhibition,tumor aggressiveness,epithelial-to-mesenchymal transition,angiogenesis promotion
ENSG00000101115,SALL4,stemness regulation,tumor recurrence,metastasis promotion,apoptosis evasion,cell cycle progression,epigenetic regulation
ENSG00000179632,MAF1,genome stability maintenance,tumor suppression,transcriptional regulation,dna repair regulation,cell cycle control,genetic instability
ENSG00000160007,ARHGAP35,loss of function mutations,constitutive activation of rho gtpases,disrupted pi3k/akt pathway,increased cell migration and invasion,epithelial-to-mesenchymal transition regulation,prognostic biomarker candidate
ENSG00000145715,RASA1,loss of function mutations,constitutive activation,negative regulation,tumor suppressor role,cell migration control,mapk/erk signaling pathway modulation
ENSG00000285460,BCAR1,overexpression,regulation of pi3k/akt pathway,cell proliferation regulation,tumor suppressor interaction,dna repair modulation,e3 ubiquitin ligase activity
ENSG00000143171,RXRG,cell cycle regulation,dysregulation,gain of function mutations,oncogene,tumor progression,transcriptional regulation
ENSG00000172819,RARG,transcriptional regulation,cell differentiation,apoptosis suppression,tumor suppressor function,epithelial-to-mesenchymal transition (emt),cell proliferation control
ENSG00000186350,RXRA,transcriptional regulation,heterodimerization,cell proliferation,apoptosis suppression,tumor progression,therapeutic target
ENSG00000131759,RARA,retinoid signaling,transcription factor regulation,cell proliferation,aberrant activation,co-repressor interaction,dysregulation
ENSG00000231321,RXRB,tumor suppression,cell growth regulation,transcriptional regulation,apoptosis modulation,gene expression alteration,nuclear receptor function
ENSG00000077092,RARB,tumor suppressor,cell differentiation,epigenetic regulation,apoptosis regulation,wnt/β-catenin pathway,transcriptional regulation
ENSG00000112033,PPARD,cellular metabolism regulation,tumor suppressor function,lipid metabolism regulation,energy homeostasis modulation,genetic reprogramming,cancer therapeutic target
ENSG00000118257,NRP2,vegf signaling pathway,angiogenesis promotion,cell migration enhancement,tumor progression facilitation,therapeutic target,protein-protein interaction
ENSG00000102755,FLT1,angiogenesis promotion,cell migration enhancement,metastasis facilitation,pi3k/akt pathway activation,mapk/erk pathway regulation,vegf binding protein interaction
ENSG00000049130,KITLG,oncogenic activity,cell migration,growth factor interaction,tumor progression,angiogenesis stimulation,receptor tyrosine kinase activation
ENSG00000157404,KIT,oncogene overexpression,constitutive activation,cell signaling pathway,tumor progression,therapeutic target,gene amplification
ENSG00000154229,PRKCA,oncogenic signaling pathways,cell proliferation enhancement,tumor progression facilitation,protein kinase activation,signaling pathway modulation,therapeutic target identification
ENSG00000060656,PTPRU,wnt/β-catenin signaling pathway,overexpression,tumor progression,cell adhesion modulation,signaling pathway regulation,dysregulated expression
ENSG00000141027,NCOR1,transcriptional regulation,oncogene activation,cell proliferation,gene silencing,epigenetic regulation,wnt/β-catenin signaling pathway
ENSG00000131746,TNS4,tumor progression,cell-cell adhesion,epithelial-to-mesenchymal transition,oncogene activation,cell motility,prognostic marker
ENSG00000105976,MET,hgf/met signaling pathway,overexpression/activation,tumor growth/promotion,therapeutic target,cancer stem cell maintenance,emt induction
ENSG00000144749,LRIG1,egfr pathway modulation,tumor suppressor function,loss of function mutations,cell growth regulation,signal transduction inhibition,protein-protein interaction
ENSG00000135473,PAN2,rna degradation,post-transcriptional regulation,polyadenylated mrna stability,gene expression modulation,cell growth regulation,oncogenic mrna levels
ENSG00000152520,PAN3,rna metabolism regulation,oncogene activity,alternative polyadenylation,nonsense-mediated mrna decay,genomic instability,cell proliferation promotion
ENSG00000009830,POMT2,notch signaling pathway,upregulation,tumor progression,n-glycosylation,glycoprotein synthesis,dysregulation
ENSG00000130714,POMT1,cellular adhesion disruption,glycosylation regulation,oncogenic signaling,tumor progression driver,cell invasion facilitation,therapeutic target candidate
ENSG00000171155,C1GALT1C1,oncogene overexpression,glycoconjugate synthesis,cell surface modification,tumor progression,cell adhesion alteration,metastatic potential
ENSG00000106392,C1GALT1,tumor progression,metastasis resistance,oncogenic signaling,glycosylation process modification,cell surface protein modification,poor prognosis marker
ENSG00000165688,PMPCA,mitochondrial dynamics regulation,protein folding regulation,cellular response modulation,tumor progression driver,oncogenic signaling pathway activation,resistance to therapy development
ENSG00000105819,PMPCB,protein degradation regulation,cell cycle progression disruption,tumor growth promotion,apoptosis inhibition,genomic instability contribution,therapeutic target potential
ENSG00000118217,ATF6,er stress response,transcriptional regulation,apoptosis evasion,metabolic reprogramming,tumor progression,therapeutic target
ENSG00000044574,HSPA5,er stress response,oncogenic cell survival,endoplasmic reticulum chaperone,angiogenesis facilitation,chemoresistance promotion,poor prognostic biomarker
ENSG00000172071,EIF2AK3,regulation of protein synthesis,cellular proliferation,integrated stress response pathway,protein kinase activity,cell survival and growth,therapeutic target
ENSG00000178607,ERN1,er stress response,tumor progression,therapeutic target,upr activation,pro-survival signaling,cellular adaptation
ENSG00000196455,PIK3R4,pi3k/akt pathway,genomic instability,tumor suppressor function,constitutive activation,oncogenic signaling,cell cycle regulation
ENSG00000078142,PIK3C3,regulatory subunit activation,cell survival promotion,tumor progression enhancement,pi3k/akt signaling pathway regulation,genomic stability maintenance,therapeutic target potential
ENSG00000149476,TKFC,transcriptional regulation,dna replication,genomic stability,cell growth,protein interaction,brca1 complex interaction
ENSG00000115267,IFIH1,antiviral response,tumor suppression,helicase activity,type i interferon activation,oncogenic signaling inhibition,viral rna recognition
ENSG00000172757,CFL1,actin filament regulation,microtubule stabilization,oncogenic behavior promotion,cell migration enhancement,mitotic spindle stability facilitation,therapeutic target
ENSG00000106683,LIMK1,cell migration,actin dynamics,oncogenic signaling,cytoskeletal regulation,prognostic marker,tumor invasion
ENSG00000163218,PGLYRP4,pi3k/akt pathway activation,metastasis promotion,biomarker identification,proliferation enhancement,tumor growth promotion,immune response modulation
ENSG00000159527,PGLYRP3,tumor suppressor function,immune surveillance regulation,epithelial barrier integrity maintenance,peptidoglycan binding activity,anti-tumor immune response modulation,host-tumor interaction regulation
ENSG00000132170,PPARG,metabolic regulation,cellular energy homeostasis,tumor suppressor function,transcriptional regulation,proliferation inhibition,differentiation modulation
ENSG00000138079,SLC3A1,cellular uptake,amino acid metabolism,tumor growth promotion,metabolic reprogramming,oncogenic properties,biosynthetic precursor production
ENSG00000165617,DACT1,wnt/β-catenin pathway,loss-of-function mutations,negative regulator,tumor progression,cell proliferation,oncogenic process
ENSG00000103126,AXIN1,wnt/β-catenin pathway disruption,tumor suppressor function,cell proliferation promotion,genomic instability contribution,oncogenic mutations,canonical signaling dysregulation
ENSG00000082701,GSK3B,wnt signaling pathway,protein phosphorylation,cell proliferation,signaling pathway regulation,tumor progression,cancer driver gene
ENSG00000067057,PFKP,enhanced glucose metabolism,glycolytic regulation,warburg effect,aerobic glycolysis,metabolic reprogramming,tumor energy production
ENSG00000141959,PFKL,glycolysis promotion,proliferation enhancement,energy metabolism regulation,tumor progression driver,cellular interaction modulation,cancer metabolism alteration
ENSG00000152556,PFKM,glycolytic regulation,oncogenic transformation,glycogen synthesis inhibition,metabolic reprogramming,tumor growth promotion,prognostic marker
ENSG00000084734,GCKR,altered glucose metabolism,enhanced glycolysis,loss-of-function mutations,increased glut1 expression,metabolic reprogramming,regulatory dysfunction
ENSG00000106633,GCK,hyperactive enzyme activity,tumor progression,metabolic regulation,cell proliferation,glucose phosphorylation,promoter of cell growth
ENSG00000029534,ANK1,loss of cell-cell adhesion,disrupted cytoskeletal stability,metastasis promotion,tumor progression,cell migration enhancement,prognostic marker
ENSG00000091129,NRCAM,cell migration,adhesion molecule interaction,metastasis promotion,biomarker upregulation,tumor progression facilitation,signaling pathway modulation
ENSG00000184144,CNTN2,cell surface glycoprotein,tumor progression,cell migration,epithelial-to-mesenchymal transition,therapeutic target,gene expression regulation
ENSG00000134121,CHL1,pi3k/akt pathway modulation,gene overexpression,tumor-promoting interactions,cell migration regulation,poor prognosis biomarker,scaffolding protein function
ENSG00000163531,NFASC,epithelial-to-mesenchymal transition,cell adhesion molecule interaction,pi3k/akt pathway activation,tumor progression marker,prognostic significance,metastasis promoter
ENSG00000077279,DCX,oncofetal reactivation,cell proliferation enhancement,metastasis facilitation,cytoskeleton modulation,protein-protein interaction,poor prognosis indicator
ENSG00000137575,SDCBP,genomic instability,epigenetic regulation,chromatin remodeling,transcriptional regulation,microrna modulation,oncogenic signaling
ENSG00000164050,PLXNB1,cell adhesion,co-receptor function,cytoskeletal organization,metastasis regulation,plexin-semaphorin interaction,tumor progression
ENSG00000141736,ERBB2,amplification of the gene,constitutive activation,increased cell proliferation,overexpression,receptor tyrosine kinase activity,tumor progression and metastasis
ENSG00000137076,TLN1,tumor progression,cell migration and invasion,oncogene activation,cytoskeletal dynamics disruption,adherens junctions disruption,integrin-mediated signaling
ENSG00000186111,PIP5K1C,pi4p production,phosphoinositide metabolism,oncogenic processes,cell proliferation,akt signaling pathway,cell membrane dynamics
ENSG00000004399,PLXND1,angiogenesis promotion,cell migration regulation,endothelial cell interaction,metastasis facilitation,oncogene function,vascular development receptor
ENSG00000170381,SEMA3E,tumor suppressor function,cell migration regulation,angiogenesis inhibition,pi3k/akt pathway interaction,cell proliferation suppression,genomic downregulation
ENSG00000196189,SEMA4A,tumor suppressor,angiogenesis inhibition,cell adhesion regulation,migration suppression,apoptosis induction,pi3k/akt pathway modulation
ENSG00000262418,PTPRC,aberrant expression,cell adhesion regulation,dephosphorylation activity,immune microenvironment modulation,lymphocyte activation regulation,oncogenic signaling pathway alteration
ENSG00000187764,SEMA4D,tumor suppressor function,cell adhesion regulation,angiogenesis inhibition,apoptosis promotion,cancer metastasis suppression,decreased expression
ENSG00000137101,CD72,tumor progression,growth factor signaling,cell surface receptor,signaling pathway activation,proliferation and survival,immune evasion mechanisms
ENSG00000136040,PLXNC1,loss of function mutations,tumor progression,cell migration regulation,extracellular matrix interaction,rho gtpase activation,aberrant cellular behavior
ENSG00000138623,SEMA7A,epithelial-to-mesenchymal transition,immune evasion,cell migration,angiogenesis regulation,metastasis promotion,tumor growth enhancement
ENSG00000010810,FYN,cell proliferation enhancement,tumor progression promotion,oncogenic transformation facilitation,therapeutic target identification,src family kinases pathway modulation,sh2 domain regulation
ENSG00000185008,ROBO2,slit signaling inhibition,cell migration regulation,epithelial-to-mesenchymal transition,tumor progression contribution,adhesion molecule interaction,receptor tyrosine kinase activity
ENSG00000151748,SAV1,hippo pathway,cell proliferation,regulatory dysfunction,tumor suppressor function,genomic instability,downstream target activation
ENSG00000104375,STK3,cell cycle regulation,tumor suppressor function,pi3k/akt signaling pathway,apoptosis inhibition,dna repair deficiency,protein-protein interaction
ENSG00000101109,STK4,tumor suppressor function,pi3k/akt inhibition,apoptosis regulation,cell cycle progression,oncogenic effects,genomic mutations
ENSG00000119139,TJP2,tight junction disruption,cell invasion and migration,epithelial cell polarity loss,oncogenic protein-protein interactions,metastasis promotion,tumor progression enhancement
ENSG00000018408,WWTR1,constitutive activation,tumor progression,hippo signaling pathway,cell proliferation,genomic amplification,transcription regulation
ENSG00000075340,ADD2,alpha-adducin overexpression,cell migration enhancement,cytoskeletal remodeling,rho gtpase signaling pathway activation,poor prognosis indicator,cell adhesion disruption
ENSG00000087274,ADD1,**
cell proliferation,gene regulation,dna-binding motif,mads-box family member,tumor progression,transcriptional activation
**
ENSG00000148700,ADD3,cytoskeletal dynamics,cell adhesion disruption,tumor progression facilitation,oncogenic potential enhancement,prognostic marker identification,genomic instability promotion
ENSG00000160862,AZGP1,tumor proliferation,therapeutic target,lipid metabolism dysregulation,immune evasion,cancer progression,prognostic marker
ENSG00000159763,PIP,pi3k/akt pathway regulation,gain of function mutations,cell membrane trafficking regulation,tumor progression driver,therapeutic target for cancer,protein-protein interactions disruption
ENSG00000136802,LRRC8A,vrac channel regulation,tumor suppressor function,mechanotransduction mechanism,cell volume regulation,oncogene activation,cancer progression modulation
ENSG00000197147,LRRC8B,epithelial cell function,cell migration,mechanotransduction,ion channel regulation,tumor progression,oncogenic role
ENSG00000171017,LRRC8E,cellular proliferation,tumor progression,apoptosis inhibition,metabolic regulation,cancer driver mutation,ion transport dysfunction
ENSG00000171492,LRRC8D,mechanotransduction,constitutive activation,oncogenic process,cell proliferation,metastasis,therapeutic target
ENSG00000171488,LRRC8C,mechanosensitive ion channel regulation,tumor progression,promoter of cell proliferation and survival,epithelial-to-mesenchymal transition (emt),pi3k/akt signaling pathway interaction,transmembrane protein function
ENSG00000158402,CDC25C,cell cycle regulation,oncogene activation,tumor progression,cell proliferation,apoptosis suppression,g2/m checkpoint
ENSG00000144867,SRPRB,lipid metabolism regulation,cellular homeostasis maintenance,apoptosis modulation,tumor progression driver,therapeutic target,endoplasmic reticulum stress response
ENSG00000182934,SRPRA,srp complex interaction,protein synthesis regulation,cell growth promotion,tumor progression,cellular metabolism alteration,glycolysis enhancement
ENSG00000009950,MLXIPL,lipid metabolism regulation,oncogenic transformation,cell growth promotion,transcription factor activity,metabolic reprogramming,epigenetic regulation alteration
ENSG00000108788,MLX,tumor progression,gene regulation,transcription factor activity,oncogenic role,cell proliferation,heterodimer formation
ENSG00000141526,SLC16A3,warburg effect,monocarboxylate transporter,lactate transport,acidic tumor microenvironment,glucose metabolism regulation,oncogenic transformation
ENSG00000281917,SLC16A1,monocarboxylate transport,lactate metabolism,energy substrate supply,tumor growth support,prognostic marker,therapeutic target
ENSG00000149269,PAK1,rac/pak pathway regulation,oncogene activation,cell migration enhancement,invasiveness promotion,pi3k/akt/mapk pathway interaction,limk1 phosphorylation and activation
ENSG00000186575,NF2,pi3k/akt pathway dysregulation,tumor suppressor function loss,genomic instability regulation,microtubule dynamics regulation,cell proliferation promotion,metastasis enhancement
ENSG00000196924,FLNA,cell adhesion disruption,constitutive fak activation,fak signaling pathway,genomic instability,oncogenic mutation,protein-protein interaction
ENSG00000123143,PKN1,cell proliferation,oncogenic activity,signaling pathway activation,protein-protein interaction,tumor progression,biomarker potential
ENSG00000122966,CIT,**

cell proliferation,oncogenic transformation,pi3k/akt/mtor pathway,apoptosis inhibition,protein interaction,cell cycle regulation
**
ENSG00000111276,CDKN1B,tumor suppressor,cell cycle regulation,cyclin-dependent kinase inhibition,tumor proliferation,g1-s transition disruption,genomic instability
ENSG00000001626,CFTR,chloride channel regulation,cancer cell proliferation,epithelial barrier dysfunction,tumor microenvironment modulation,metabolic reprogramming,stemness maintenance
ENSG00000047932,GOPC,protein trafficking regulation,cell migration promotion,oncogenic process enhancement,pdz domain interactions,secretory pathway modulation,tumorigenesis contributor
ENSG00000159593,NAE1,genome instability,aneuploidy,dna repair pathway,chromosome assembly,mitotic regulation,oncogenic processes
ENSG00000144744,UBA3,nedd8 pathway,constitutive activation,gain of function mutations,tumor progression,protein stability,regulatory mechanism
ENSG00000184182,UBE2F,ups regulation,protein degradation,cell cycle modulation,apoptosis evasion,therapeutic target,cancer progression
ENSG00000158290,CUL4B,ubiquitin ligase activity,oncogene activation,cell cycle progression,tumor suppressor regulation,protein stability modulation,dna damage response
ENSG00000139842,CUL4A,ubiquitin-proteasome pathway regulation,cancer progression driver,protein degradation dysregulation,cell cycle control disruption,genomic instability promotion,tumor suppressor dysfunction
ENSG00000100387,RBX1,ubiquitination pathway,scf e3 ligase complex,tumor suppressor regulation,cell cycle progression,anti-apoptotic function,dysregulated ubiquitination
ENSG00000112659,CUL9,regulation of cell cycle progression,protein degradation,cancer driver gene,apoptosis regulation,cellular adaptation,tumor growth promotion
ENSG00000116678,LEPR,leptin-mediated signaling,growth factor receptor activation,cell proliferation regulation,tumor progression facilitation,metabolic regulation disruption,oncogenic pathway activation
ENSG00000099800,TIMM13,mitochondrial dysfunction,cellular growth regulation,apoptosis evasion,oncogenic transformation,tumor formation,ros production
ENSG00000150779,TIMM8B,mitochondrial iron-sulfur cluster assembly,metabolic reprogramming,electron transport chain regulation,tumor cell metabolism,cell respiration,protein degradation pathway
ENSG00000126953,TIMM8A,mitochondrial complex i assembly,electron transport chain disruption,reactive oxygen species production,cell proliferation enhancement,mitochondrial function impairment,apoptosis resistance
ENSG00000134809,TIMM10,mitochondrial protein import,glycolytic regulation,cellular metabolism modulation,cancer cell energy production,tumor progression facilitation,therapeutic target identification
ENSG00000100575,TIMM9,mitochondrial protein import,reactive oxygen species,genomic instability,dna damage,cellular homeostasis disruption,oncogenesis promotion
ENSG00000111880,RNGTT,dna repair pathway,atr/chk1 pathway,cell cycle progression,genomic instability,tumor progression,therapeutic target
ENSG00000101654,RNMT,ribosome biogenesis regulation,methyltransferase activity,oncogenic driver mutation,cell proliferation enhancement,survival pathway activation,protein overexpression
ENSG00000133226,SRRM1,splice regulation,cell growth promotion,apoptosis inhibition,prognostic marker,tumor progression,tumor suppressor downregulation
ENSG00000167978,SRRM2,rna processing,alternative splicing,oncogenic pathway activation,tumor progression,rna-binding protein interaction,genomic profiling
,EPRS,glutamine metabolism,aminoacyl-trna synthetase activity,cell growth regulation,protein synthesis pathway modulation,oncogene behavior,therapeutic target
ENSG00000167264,DUS2,oncogenic activity,mapk pathway regulation,cell proliferation enhancement,tumor progression association,therapeutic target potentiality,genomic profiling relevance
ENSG00000160193,WDR4,ubiquitin-proteasome pathway,cell cycle regulation,genome stability maintenance,tumor progression marker,protein degradation regulation,transcriptional regulation interaction
ENSG00000037897,METTL1,m6a regulation,rna stability modulation,protein synthesis enhancement,tumor progression driver,therapeutic target,transcriptional regulation
ENSG00000213339,QTRT1,cellular proliferation regulation,oncogenesis promotion,transcription factor activity,poor prognosis association,prognostic biomarker potential,akt signaling pathway modulation
ENSG00000151576,QTRT2,epigenetic regulation,cell proliferation inhibition,anti-apoptotic function,tumor microenvironment modulation,poor prognosis marker,oncogenic lncrna
ENSG00000089195,TRMT6,trna modification,cell cycle regulation,oncogenic function,cell proliferation enhancement,metastasis promotion,poor prognosis marker
ENSG00000166166,TRMT61A,aberrant trna modifications,upregulation,cell proliferation enhancement,potential biomarker,tumor progression contribution,oncogenic process involvement
ENSG00000163964,PIGX,gpi-anchor biosynthesis regulation,tumor microenvironment modulation,cell surface modification,cancer progression facilitation,biomarker potential,protein interaction mediation
ENSG00000143315,PIGM,pig biosynthesis,oncogenic glycosylation,apoptosis resistance,cell adhesion loss,tumor progression,therapeutic target
ENSG00000151665,PIGF,angiogenesis promotion,oncogenic role,receptor interaction,cell proliferation enhancement,tumor progression correlation,poor prognosis association
ENSG00000165282,PIGO,pi3k/akt pathway regulation,lipid phosphatase function,apoptosis and autophagy modulation,cell membrane regulation,signaling pathway interaction,genomic instability association
ENSG00000174227,PIGG,gpi anchor synthesis,oncogenic process,cell proliferation,protein localization,signaling pathway modulation,genetic alterations
ENSG00000156976,EIF4A2,translation initiation,upregulation,helicase activity,protein synthesis enhancement,poor prognosis,therapeutic target
ENSG00000161960,EIF4A1,translation initiation,oncogene activation,cell proliferation,protein synthesis regulation,mrna recruitment,ribosome association
ENSG00000080815,PSEN1,notch signaling pathway,cancer progression regulation,cell cycle regulation,apoptosis inhibition,gamma-secretase complex component,endoplasmic reticulum localization
ENSG00000162736,NCSTN,notch signaling pathway,tumor progression,epithelial-to-mesenchymal transition,cell proliferation,overexpression biomarker,therapeutic target
ENSG00000186298,PPP1CC,cell cycle regulation,chromatin remodeling,gene expression regulation,histone modification,mitotic spindle checkpoint,oncogenic interactions
ENSG00000087074,PPP1R15A,cell cycle regulation,apoptosis regulation,tumor suppressor activity,epigenetic regulation,dna damage response,protein phosphatase regulation
ENSG00000168288,MMADHC,chromatin remodeling,transcription regulation,cell proliferation,tumorigenesis,metastasis,overexpression
ENSG00000132763,MMACHC,genomic instability,metabolic regulation,dna damage response,tumor suppressor function,cell cycle regulation,apoptosis regulation
ENSG00000203618,GP1BB,tumor microenvironment modulation,immune evasion,protein-protein interaction,gene expression regulation,tumor progression enhancement,therapeutic target
ENSG00000185245,GP1BA,platelet-derived growth factor signaling,glycoprotein ib alpha subunit,angiogenesis promotion,thrombin receptor activation,cell migration enhancement,tumor progression facilitation
ENSG00000232957,HLA-DOA,antigen presentation,immunosuppression,immune evasion,tumor progression,cellular immunity,cytokine signaling
ENSG00000243612,HLA-DOB,mhc class i antigen presentation,immune evasion,tumor progression,chromosomal localization,evolutionary conservation,regulatory elements
ENSG00000146232,NFKBIE,nf-κb pathway,constitutive activation,loss of function mutations,oncogenesis promotion,therapeutic target,transcriptional regulation
ENSG00000162924,REL,nf-kappab signaling pathway,constitutive activation,genomic instability,oncogenic process,cell proliferation,transcriptional regulation
ENSG00000196781,TLE1,wnt/β-catenin signaling,oncogenic mutations,transcriptional regulation,epithelial-to-mesenchymal transition,cell proliferation suppression,prognostic marker
ENSG00000116266,STXBP3,er stress response,cellular homeostasis regulation,snare complex assembly,cell cycle progression,tumor growth promotion,therapeutic target
ENSG00000147614,ATP6V0D2,lysosomal acidification,oncogenic signaling pathways,constitutive activation,cell migration,tumor aggressiveness,protein degradation
ENSG00000159720,ATP6V0D1,acid-base regulation,cancer progression,cell signaling,metastasis,tumor microenvironment,therapeutic target
ENSG00000115942,ORC2,genomic instability,cell cycle regulation,dna replication initiation,oncogenic potential,tumorigenesis,cell proliferation
ENSG00000125885,MCM8,genomic instability,cell cycle regulation,dna replication initiation,aneuploidy promotion,therapeutic target,cellular proliferation
ENSG00000172116,CD8B,**
tcr complex assembly,immune recognition,antigen presentation,t cell activation,immunomodulation,cancer immunosurveillance
**
ENSG00000153563,CD8A,t cell activation,immune evasion mechanisms,cancer progression,therapeutic target,immunomodulatory effects,genetic alterations
ENSG00000198851,CD3E,t-cell receptor signaling,cell proliferation,immune evasion mechanisms,signal transduction events,antigen recognition,oncogenic processes
ENSG00000160654,CD3G,cell surface receptor,t-cell activation,immune dysfunction,pi3k/akt signaling,cell proliferation,cancer immunology
ENSG00000167286,CD3D,t-cell receptor signaling,immune cell activation,cell proliferation regulation,cancer immunoediting,t-cell dysfunction,tcr complex formation
ENSG00000138674,SEC31A,apoptosis regulation,cell cycle progression,cell signaling modulation,gene overexpression,molecular transport regulation,tumor growth promotion
ENSG00000157020,SEC13,erad complex regulation,tumor suppressor,cellular stress response,protein degradation,oncogenic process,genomic instability
ENSG00000134539,KLRD1,immune checkpoint,cell adhesion molecule,tumor progression,cancer metastasis,nk cell target,epithelial interactions
ENSG00000205809,KLRC2,immunomodulation,tumor microenvironment modulation,cancer progression facilitation,immune evasion mechanism,prognostic marker potential,therapeutic target candidate
ENSG00000136854,STXBP1,exocytosis pathway,snare complex assembly,oncogenic function,altered cellular processes,cell proliferation regulation,tumor progression
ENSG00000168283,BMI1,epigenetic regulation,stem cell maintenance,apoptosis inhibition,cell cycle regulation,tumor progression,epithelial-to-mesenchymal transition
ENSG00000141582,CBX4,epigenetic regulation,chromatin remodeling,tumor suppressor silencing,apoptosis evasion,genomic instability,biomarker for disease progression
ENSG00000080824,HSP90AA1,tumor progression,oncoprotein,cell survival,therapeutic target,protein kinase activation,chaperone function
ENSG00000077800,FKBP6,pi3k/akt pathway interaction,tumor growth promotion,metastasis enhancement,prognosis association,oncogenic signaling modulation,gene expression regulation
ENSG00000123607,TTC21B,hedgehog signaling,primary cilia dysregulation,loss of function mutations,tumor progression,cell growth regulation,oncogenic pathway activation
ENSG00000118965,WDR35,chromosomal instability,onco-protein interaction,ubiquitination regulation,tumor suppressor degradation,cellular proliferation,pan-cancer gene
ENSG00000169398,PTK2,focal adhesion regulation,constitutive activation,oncogenic signaling,cell migration facilitation,pi3k/akt pathway modulation,metastatic progression
ENSG00000204103,MAFB,transcription factor activity,cellular differentiation regulation,tumor growth promotion,metastasis facilitation,angiogenesis regulation,constitutive activation mutations
ENSG00000220205,VAMP2,altered cell membrane dynamics,apoptosis resistance,cell migration and invasion,cell proliferation enhancement,snare complex regulation,tumor progression promotion
ENSG00000167986,DDB1,dna damage response,genomic instability,tumor suppressor function,dna repair pathway,nucleotide excision repair,genomic integrity maintenance
ENSG00000112115,IL17A,il17a expression,tumor microenvironment,angiogenesis promotion,inflammation induction,cell proliferation enhancement,tumor progression facilitation
ENSG00000112116,IL17F,tumor-promoting cytokine,immunosuppression,overexpression,cancer-associated inflammation,pro-tumorigenic signaling,tumor microenvironment modulation
ENSG00000088247,KHSRP,cell cycle regulation,apoptosis regulation,tumor progression,biomarker,alternative splicing,protein-rna interaction
ENSG00000185630,PBX1,cell cycle regulation,transcription factor activation,tumorigenesis promotion,apoptosis inhibition,gene expression regulation,chromatin remodeling
ENSG00000160199,PKNOX1,homeobox transcription factor,overexpression,cell differentiation regulation,tumor progression driver,nuclear localization,transcriptional regulation modification
ENSG00000082458,DLG3,disrupted cell polarity,oncogenic mutations,overexpression,epithelial-to-mesenchymal transition (emt),wnt/pcp signaling pathway,cell-cell adhesion disruption
ENSG00000132535,DLG4,pi3k/akt signaling,oncogene,tumor progression,prognostic marker,cell proliferation,signaling pathway regulation
ENSG00000158477,CD1A,antigen presentation disruption,cell signaling regulation,prognostic marker alteration,tumor cell interaction,immune evasion mechanism,lipid antigen processing
ENSG00000158485,CD1B,tumor antigen presentation,immune evasion mechanism,lipid antigen presentation,t cell activation,immune system modulation,cellular recognition
ENSG00000158473,CD1D,antigen presentation,immunosuppression,tumor progression,cancer immunity,immune evasion,genomic instability
ENSG00000158481,CD1C,antigen presentation,cell proliferation,immune evasion,metastasis promotion,prognostic marker,tumor growth enhancement
ENSG00000175097,RAG2,genomic instability,immunodeficiency,cell proliferation,genetic rearrangement,tumor development,dna damage response
ENSG00000166349,RAG1,genomic instability,oncogenic recombination,dna repair mutations,immune evasion mechanisms,tumor progression driver,chromosomal rearrangements
ENSG00000107566,ERLIN1,cell polarity disruption,epithelial-to-mesenchymal transition,microtubule destabilization,oncogenic transformation,tumor aggressiveness,loss-of-function mutation
ENSG00000147475,ERLIN2,mapk/erk pathway,raf kinase activation,oncogenic transformation,cell proliferation,protein-protein interaction,kinase regulation
ENSG00000140836,ZFHX3,tumor suppressor function,cancer progression inhibition,cell growth regulation,transcriptional regulation,apoptosis resistance suppression,prognostic significance
ENSG00000167770,OTUB1,protein stability regulation,deubiquitinating enzyme activity,oncogenesis promotion,apoptosis inhibition,cell survival enhancement,therapeutic target
ENSG00000133135,RNF128,cell cycle regulation,genomic stability,dna damage response,e3 ubiquitin ligase activity,g2/m phase transition,tumor suppression
ENSG00000072506,HSD17B10,**

metabolic reprogramming,lipid metabolism regulation,oxidative stress response,tumor aggressiveness,cell proliferation enhancement,genetic instability

**
ENSG00000174173,TRMT10C,oncogenic function,aberrant activation,tumor progression,metabolic reprogramming,trna modification,poor prognosis
ENSG00000198026,ZNF335,transcription regulation,tumor suppressor function,dna repair defects,apoptosis resistance,cell cycle dysregulation,chromatin remodeling
ENSG00000113300,CNOT6,mrna regulation,gene expression control,ccr4-not complex member,deadenerylation and degradation,signaling pathway interaction,tumor progression regulator
ENSG00000185002,RFX6,transcription factor deregulation,cellular homeostasis disruption,loss-of-function mutation,pancreatic beta-cell dysfunction,glycemic regulation impairment,apoptosis suppression
ENSG00000134352,IL6ST,il-6/jak/stat pathway,oncogenic protein expression,tumor progression,immune evasion,cell proliferation,apoptosis resistance
ENSG00000166266,CUL5,pi3k/akt signaling,constitutive activation,protein degradation dysregulation,tumor suppressor protein degradation,cell cycle regulation,e3 ubiquitin ligase activity
ENSG00000036257,CUL3,protein degradation pathway regulation,transcription factor modulation,e3 ubiquitin ligase interaction,cell cycle regulation,genetic instability,oncogenic protein accumulation
ENSG00000108094,CUL2,**

1. **scf ubiquitin ligase complex**,2. **protein degradation regulation**,3. **aberrant protein accumulation**,4. **cell cycle progression**,5. **cancer driver mutation**,6. **apoptosis suppression** 

**
ENSG00000215021,PHB2,tumor suppressor function,proteasome regulation,cell cycle regulation,dna damage response,genomic instability,oncogenic transformation
ENSG00000167085,PHB,tumor suppressor function,cell proliferation inhibition,apoptosis promotion,dna damage response,mitotic arrest,genetic instability
ENSG00000100401,RANGAP1,nucleocytoplasmic transport,oncogene regulation,cell cycle progression,signaling pathway modulation,tumor growth promotion,nuclear export facilitation
ENSG00000137100,DCTN3,microtubule dynamics disruption,oncogenic cell migration,cellular trafficking regulation,cytoskeletal organization dysfunction,dynein-dependent transport impairment,therapeutic target potential
ENSG00000175203,DCTN2,microtubule-based transport,dynein interaction,cell migration facilitation,cancer cell invasion,apoptosis regulation,protein overexpression
ENSG00000205755,CRLF2,gain of function mutations,constitutive activation,jak-stat signaling pathway,therapeutic target,cell growth regulation,aberrant expression
ENSG00000145623,OSMR,tumor progression,cell survival,proliferation regulation,angiogenesis,ligand-receptor interaction,stat3 activation
ENSG00000048649,RSF1,chromatin remodeling,sister chromatid cohesion,oncogenic signaling,chromosomal instability,therapeutic target,cancer prognosis
ENSG00000137752,CASP1,cancer-promoting inflammation,tumor microenvironment modulation,cell death dysregulation,pro-inflammatory cytokine activation,immune evasion mechanisms,therapeutic target potential
ENSG00000025434,NR1H3,transcription factor regulation,gene expression modulation,cell cycle progression,survival pathway activation,nuclear receptor interaction,inflammatory response regulation
ENSG00000131408,NR1H2,tumor suppression,metabolic regulation,cell growth regulation,apoptosis induction,transcription factor activity,dna repair regulation
ENSG00000142655,PEX14,peroxisomal regulation,protein import,cellular metabolism,redox balance,lipid metabolism,tumorigenesis
ENSG00000162928,PEX13,peroxisomal biogenesis,fatty acid metabolism,tumor suppressor function,pi3k/akt signaling,metabolic regulation,cancer cell survival
ENSG00000176884,GRIN1,**
nr1 subunit,excitatory neurotransmission,cellular growth regulation,metabolic adaptation,protein-protein interaction,synaptic plasticity
**
ENSG00000273079,GRIN2B,nmda receptor function,tumor progression,cell proliferation,protein-protein interactions,oncogene potential,pi3k/akt pathway regulation
ENSG00000106299,WASL,actin cytoskeleton regulation,arp2/3 complex activation,cell migration,tumor progression,metastasis facilitation,protein-protein interaction
ENSG00000205726,ITSN1,cell migration,actin cytoskeleton remodeling,pi3k/akt pathway activation,egf receptor recycling,mapk/erk signaling enhancement,protein degradation regulation
ENSG00000027697,IFNGR1,ifn-gamma signaling pathway,tumor immune evasion,immune checkpoint regulation,tumor cell apoptosis,prognostic biomarker,cancer immunotherapy
ENSG00000262795,IFNGR2,ifn-gamma receptor,interferon gamma signaling,immunosuppression,cell proliferation,stat pathway activation,tumor microenvironment
ENSG00000134852,CLOCK,wnt/β-catenin signaling pathway,constitutive activation,gain of function mutations,cell proliferation,tumor progression,transcriptional regulation
ENSG00000029153,ARNTL2,cell cycle regulation,transcriptional regulation,proliferation promotion,apoptosis inhibition,biomarker potential,circadian rhythm disruption
ENSG00000057468,MSH4,homologous recombination repair,mismatch repair deficiency,genomic instability,epigenetic alterations,tumor suppressor function,cell cycle regulation
ENSG00000237333,MSH5,msi,microsatellite instability,tumor suppressor role,genomic stability maintenance,dna mismatch repair,chromosomal alterations
ENSG00000119684,MLH3,**

microsatellite instability,genomic instability,dna mismatch repair,tumor suppressor function,genetic mutations,promoter methylation 

**
ENSG00000168495,POLR3D,pol iii regulation,rna polymerase activity,cell growth promotion,transcriptional dysregulation,oncogene amplification,therapeutic target
ENSG00000058600,POLR3E,rna polymerase iii transcription,transcription factor regulation,cell cycle progression,tumor aggressiveness,oncogenic effects,metabolic reprogramming
ENSG00000100413,POLR3H,transcriptional regulation,rna synthesis,oncogenic protein interaction,cell cycle progression,ribosome biogenesis,poor prognosis marker
ENSG00000241258,CRCP,proteolytic activity,oncogene overexpression,tumor progression,cell proliferation,signaling pathway regulation,protein processing
ENSG00000165168,CYBB,oncogenic potential,dna damage,ros generation,angiogenesis promotion,cell migration enhancement,epigenetic alteration
ENSG00000051523,CYBA,nadph oxidase activation,reactive oxygen species generation,tumor progression enhancement,cell survival promotion,dna damage induction,prognostic marker
ENSG00000083123,BCKDHB,metabolic reprogramming,aerobic glycolysis,energy production,cellular proliferation,tumor microenvironment,regulatory modifications
ENSG00000248098,BCKDHA,inhibition of p53 function,tumor suppressor activity,protein synthesis regulation,cellular damage,apoptosis evasion,mtorc1 activation
ENSG00000168906,MAT2A,histone methylation,epigenetic regulation,cell proliferation,gene expression modulation,therapeutic target,chromatin modification
ENSG00000038274,MAT2B,methylation regulation,cellular proliferation,protein modification,oncogenic pathway,aberrant expression,tumor growth
ENSG00000140505,CYP1A2,metabolic regulation,oxidative stress modulation,cancer cell survival pathway,cell proliferation regulation,protein interaction,therapeutic target
ENSG00000127948,POR,peroxisomal beta-oxidation,fatty acid metabolism regulation,orphan nuclear receptor function,tumor suppression,gene expression regulation,cellular differentiation
ENSG00000165841,CYP2C19,cytochrome p450 enzyme family,anti-cancer medication metabolism,disease progression marker,chemotherapy efficacy regulator,pharmacogenetic significance,tumor suppressor interaction
ENSG00000163114,PDHA2,mitochondrial metabolism,pyruvate dehydrogenase complex regulation,glycolytic shift,warburg effect,genetic instability,lactate production
ENSG00000168291,PDHB,oncogenic function,metabolic reprogramming,cellular energy metabolism,tumor progression,therapeutic target,genomic upregulation
ENSG00000131828,PDHA1,altered energy metabolism,dysregulation of pyruvate dehydrogenase,enhanced cell proliferation,glycolytic shift,metabolic reprogramming,tumor growth
ENSG00000117118,SDHB,tumor suppressor,mitochondrial dysfunction,electron transport chain disruption,cellular respiration impairment,metabolic rewiring,tumor progression promoter
ENSG00000073578,SDHA,metabolic reprogramming,pseudohypoxic response,tumor aggressiveness,poor prognosis,hif-1α activation,electron transport chain disruption
ENSG00000164951,PDP1,hdac activation,histone deacetylation,transcriptional regulation,chromatin remodeling,cell proliferation,apoptosis
ENSG00000090857,PDPR,proteolytic regulation,protein degradation,cancer cell survival,apoptosis evasion,cell cycle progression,dysregulation of cellular pathways
ENSG00000105568,PPP2R1A,pp2a regulation,dysregulation of oncogenic pathways,wnt/β-catenin signaling modulation,gene amplification,tumor suppressor function,mitotic checkpoint regulation
ENSG00000113575,PPP2CA,constitutive activation,tumor suppressor dysfunction,akt/mtor pathway dysregulation,cell cycle progression disruption,apoptosis inhibition,prognostic marker
ENSG00000112818,MEP1A,pi3k/akt signaling pathway interaction,cell proliferation enhancement,oncogene involvement,tumor progression modulation,gene expression alteration,protein-protein interaction regulation
ENSG00000141434,MEP1B,protein degradation regulation,cell growth modulation,apoptosis regulation,epithelial cell function,pi3k/akt signaling interaction,cancer progression
ENSG00000105675,ATP4A,tumor microenvironment,cellular metabolism,proton pump activation,apoptosis inhibition,therapeutic target,genomic instability
ENSG00000288359,ATP4B,**
h+-k+ atpase activation,proton pump regulation,gain of function mutations,tumor progression,acid production dysregulation,therapeutic target resistance
**
ENSG00000143437,ARNT,transcription factor regulation,cell cycle regulation,apoptosis modulation,tumor progression,oncogenic pathway activation,gene expression modulation
ENSG00000116016,EPAS1,hypoxia-inducible factor,transcriptional regulation,angiogenesis promoter,oncogenic pathway,cell proliferation regulator,genetic instability promoter
ENSG00000169245,CXCL10,immune response modulation,chemokine activity,tumor microenvironment modification,t cell recruitment,cancer prognosis,immunotherapy target
ENSG00000186810,CXCR3,**
tumor microenvironment modulation,immune cell recruitment,inflammation promotion,oncogenic signaling,tumor progression facilitation,poor prognostic marker 
**
ENSG00000186469,GNG2,g-protein signaling,constitutive activation,overexpression,oncogenic growth,tumor progression,cellular proliferation
ENSG00000181104,F2R,activated protein c regulation,blood coagulation regulation,immune modulation,inflammation regulation,protein-protein interaction,tumor suppression
ENSG00000164220,F2RL2,par3 regulation,cell proliferation enhancement,inflammation modulation,tumor growth promotion,metastasis facilitation,angiogenesis regulation
ENSG00000070886,EPHA8,eph/ephrin signaling pathway,receptor tyrosine kinase activity,cell adhesion regulation,tumor progression promotion,oncogene potential,gene amplification
ENSG00000184349,EFNA5,cell adhesion disruption,epithelial-to-mesenchymal transition,pi3k/akt pathway modulation,oncogene activation,tumor progression facilitation,angiogenesis promotion
ENSG00000033800,PIAS1,transcriptional regulation,tumor suppressor,constitutive activation,stat protein inhibition,cell growth control,apoptosis regulation
ENSG00000035403,VCL,vimentin overexpression,cell adhesion disruption,epithelial-to-mesenchymal transition,prognostic marker,cancer cell invasion,signaling pathway interaction
ENSG00000072401,UBE2D1,ubiquitination pathway,regulation of protein degradation,tumor suppressor degradation,cell cycle progression,dna repair,proteasome regulation
ENSG00000118513,MYB,oncogene activation,constitutive transcriptional activity,chromatin remodeling,protein-protein interactions,tumor angiogenesis,cell cycle regulation
ENSG00000113580,NR3C1,inflammation regulation,apoptosis inhibition,cell proliferation promotion,immune response modulation,transcriptional regulation,hormone signaling
ENSG00000140396,NCOA2,transcriptional coactivator,tumor proliferation,cell cycle progression,epigenetic regulation,chromatin remodeling,oncogenic signaling
ENSG00000164161,HHIP,hedgehog signaling inhibition,constitutive activation,gain of function mutations,tumor progression,adhesion and migration regulation,cross-talk with wnt/β-catenin pathway
ENSG00000163501,IHH,tumor progression,cell survival,proliferation regulation,wnt signaling interaction,tissue patterning,gli transcription factor interaction
ENSG00000115170,ACVR1,tgf-β pathway,tumor progression,promotion of cell proliferation,dysregulation of gene expression,epithelial-to-mesenchymal transition (emt),cancer driver gene
ENSG00000198648,STK39,pi3k/akt pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cell proliferation
ENSG00000065675,PRKCQ,cell signaling pathway,gene amplification,oncogene activation,tumor progression promotion,apoptosis inhibition,kinase domain mutation
ENSG00000106070,GRB10,insulin/igf-1 signaling pathway,dysregulated expression,therapeutic target,tumor progression,cell growth regulation,protein interaction
ENSG00000101096,NFATC2,oncogenic transformation,cell proliferation enhancement,apoptosis resistance,metastasis promotion,transcriptional activation,wnt signaling interaction
ENSG00000049768,FOXP3,**
immunosuppression,tumor progression,transcriptional regulation,cancer immunology,microbiome modulation,prognostic marker
**
ENSG00000086758,HUWE1,cell cycle regulation,protein degradation pathway,tumor suppressor function,oncogenic role,apoptosis regulation,dna repair modulation
ENSG00000107968,MAP3K8,mapk/erk signaling,oncogenic activation,gain of function mutations,tumor growth promotion,cell survival enhancement,poor prognosis association
ENSG00000120063,GNA13,immune evasion,cell migration,g protein signaling,tumor progression,overexpression,rho gtpase activation
ENSG00000146535,GNA12,pi3k/akt pathway activation,gtpase activity,oncogenic signaling,cell migration regulation,genomic instability,epigenetic alterations
ENSG00000130396,AFDN,tumor progression,cell adhesion molecule,promotes metastasis,regulates cellular processes,pi3k/akt pathway activation,potential biomarker
ENSG00000197943,PLCG2,cell signaling pathway,phospholipase c activity,cytoskeleton reorganization,cell migration,oncogenic mutation,therapeutic target
ENSG00000254087,LYN,tyrosine kinase activation,constitutive signaling,oncogene overexpression,tumor progression,cell proliferation enhancement,prognostic marker
ENSG00000180210,F2,fibrinogen alpha chain activation,glycoprotein function,extracellular matrix component,angiogenesis promotion,oncogene activity,upregulated expression levels
ENSG00000171720,HDAC3,histone deacetylase activity,chromatin remodeling,tumor suppressor repression,epithelial-to-mesenchymal transition (emt),transcriptional regulation,cellular proliferation
ENSG00000164331,ANKRA2,mitotic checkpoint inhibition,cell cycle progression,genomic instability,tumor growth promotion,oncogenic interaction,cell survival enhancement
ENSG00000164867,NOS3,angiogenesis promotion,no production regulation,oncogenic function,cell proliferation enhancement,tumor growth facilitation,vascular tone regulation
ENSG00000135966,TGFBRAP1,tgf-β signaling pathway,constitutive activation,gain of function mutations,cell migration,epithelial-to-mesenchymal transition (emt),therapeutic target
ENSG00000124145,SDC4,pi3k/akt signaling,cell adhesion disruption,tumor progression,cell migration enhancement,metastasis promotion,poor prognosis marker
ENSG00000274233,CCL5,tumor microenvironment,immune suppression,chemotaxis,poor prognosis,inflammation regulation,transcriptional regulation
ENSG00000148737,TCF7L2,wnt/β-catenin pathway,constitutive activation,transcription factor regulation,cell proliferation enhancer,oncogenic mutations,tumor progression regulator
ENSG00000139549,DHH,tumor growth,cell proliferation,aberrant activation,shh signaling pathway,potential target,therapeutic intervention
ENSG00000175592,FOSL1,overexpression,transcriptional regulation,tumor progression,cell proliferation,signaling pathway activation,prognostic marker
ENSG00000180340,FZD2,wnt pathway activation,cell proliferation promotion,tumor progression enhancement,protein-protein interaction modulation,co-receptor binding facilitation,cancer stem cell maintenance
ENSG00000114251,WNT5A,non-canonical wnt signaling,aberrant expression,cell migration,tumor progression,oncogenic potential,signaling pathway interaction
ENSG00000028528,SNX1,endosomal recycling pathway,receptor tyrosine kinase regulation,egfr interaction,tumor progression,cell proliferation enhancement,prognostic marker
ENSG00000205302,SNX2,cell survival,pi3k/akt pathway interaction,endosomal sorting regulation,tumor progression facilitation,protein kinase regulation,metabolic reprogramming
ENSG00000080503,SMARCA2,chromatin remodeling,epithelial-to-mesenchymal transition,genome instability,dna repair mechanisms,cell cycle regulation,tumor progression
ENSG00000245848,CEBPA,cell differentiation regulation,tumor suppressor function,transcriptional regulation disruption,oncogenesis,chromatin remodeling,epigenetic alteration
ENSG00000075426,FOSL2,emt regulation,oncogenic transcription factor,cell migration promotion,therapeutic resistance,tumor progression promotion,epithelial cell differentiation inhibition
ENSG00000090776,EFNB1,pi3k/akt pathway modulation,tumor progression driver,cell adhesion molecule regulation,focal adhesion disruption,epithelial-to-mesenchymal transition induction,mapk/erk signaling activation
ENSG00000154928,EPHB1,cell migration,constitutive activation,downstream signaling,tumor progression,metastasis,therapeutic target
ENSG00000174808,BTC,brevican overexpression,cell adhesion modulation,cell migration regulation,epithelial-to-mesenchymal transition,integrin interaction,tumor progression enhancement
ENSG00000100811,YY1,transcription factor regulation,oncogene function,cellular proliferation regulation,apoptosis evasion,tumor growth promotion,genomic dysregulation
ENSG00000115594,IL1R1,nf-κb pathway activation,pro-inflammatory cytokine production,immune evasion mechanisms,tumor growth promotion,metastasis enhancement,therapeutic target for cancer
ENSG00000136689,IL1RN,downregulated,tumor growth promotion,chronic inflammation,immune evasion,inflammation regulation,immune microenvironment modulation
ENSG00000130427,EPO,oncogenic activity,evasion of apoptosis,angiogenesis promotion,cell proliferation enhancement,prognostic biomarker,tumor progression driver
ENSG00000187266,EPOR,overexpression,aberrant activation,jak/stat signaling,cell proliferation,apoptosis inhibition,oncogene activation
ENSG00000198400,NTRK1,ntrk1 aberrant expression,receptor tyrosine kinase activation,mapk/erk pathway signaling,cellular proliferation enhancement,cancer cell invasion facilitation,therapeutic target identification
ENSG00000168040,FADD,apoptosis regulation,cell death signals,caspase activation,mitochondrial membrane disruption,tumor progression resistance,cancer cell survival
ENSG00000169242,EFNA1,pi3k/akt pathway activation,cell proliferation enhancement,tumor invasion promotion,angiogenesis regulation,overexpression association,poor prognosis indicator
ENSG00000142627,EPHA2,oncogenic signaling,constitutive activation,epithelial-to-mesenchymal transition,tumor progression,therapeutic target,cell migration
ENSG00000151693,ASAP2,rho gtpase regulation,migratory invasion,tumor progression,oncogenic driver,signaling pathway interaction,cancer metastasis
ENSG00000128917,DLL4,tumor angiogenesis,notch signaling pathway,prognostic biomarker,vascular endothelial development,tumor promotion,anti-apoptotic function
ENSG00000235396,NOTCH4,notch signaling pathway,oncogene activation,transmembrane receptor function,cell proliferation regulation,apoptosis resistance,epithelial-to-mesenchymal transition
ENSG00000081059,TCF7,constitutive activation,wnt/β-catenin signaling,tumor progression,cell proliferation,transcription regulation,gene overexpression
ENSG00000127191,TRAF2,nf-κb activation,tnf receptor interaction,cell survival signaling,oncogene cooperation,protein-protein interaction,immune evasion mechanism
ENSG00000128602,SMO,hedgehog signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic profiling
ENSG00000141480,ARRB2,protein-protein interaction,signaling pathway regulation,cell proliferation,oncogenic activity,tumor progression,biomarker potential
ENSG00000196367,TRRAP,chromatin regulation,transcriptional regulation,dna repair mechanism,genomic instability,cell cycle control,epigenetic modification
ENSG00000108773,KAT2A,oncogene activation,chromatin modification,histone acetylation,cell cycle regulation,apoptosis suppression,tumor progression
ENSG00000196411,EPHB4,cell migration regulation,tumor progression driver,oncogene activation,signal transduction pathway,protein kinase activation,cancer cell invasion
ENSG00000125266,EFNB2,disrupted cell adhesion,activation of pi3k/akt pathway,cell migration promotion,tumor progression driver,overexpressed in cancer,poor prognosis indicator
ENSG00000175354,PTPN2,stat1 inhibition,tumor immune evasion,pi3k/akt pathway interaction,mapk/erk pathway modulation,non-receptor protein tyrosine phosphatase activity,genomic mutation association
ENSG00000177425,PAWR,cell growth regulation,tumor progression,stat3 activation,nf-κb pathway,apoptosis inhibition,pkc interaction
ENSG00000067606,PRKCZ,cellular proliferation,protein kinase activation,oncogenesis,signaling pathway dysregulation,therapeutic target,tumor progression
ENSG00000116809,ZBTB17,genomic instability,cell cycle regulation,tumor suppressor gene,pi3k/akt modulation,transcriptional regulation,apoptosis regulation
ENSG00000140968,IRF8,immune regulation,transcriptional modulation,tumor microenvironment,cell proliferation,apoptosis regulation,cancer stem cell maintenance
ENSG00000160867,FGFR4,fgfr signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic amplification
ENSG00000138685,FGF2,fibroblast growth factor activity,tumor progression,angiogenesis promotion,cell proliferation,receptor binding,signal transduction modification
ENSG00000068078,FGFR3,transmembrane receptor,tyrosine kinase activation,constitutive signaling,tumor progression,therapeutic target,cell proliferation
ENSG00000066468,FGFR2,fgfr2 activation,tumor progression,cell proliferation,therapeutic target,pathway dysregulation,protein-protein interaction
ENSG00000171223,JUNB,ap-1 transcription factor,tumor progression,cancer stem cell regulation,mapk/erk pathway activation,cell proliferation and survival promotion,emt regulation
ENSG00000100393,EP300,tumor progression,cancer driver gene,transcription regulation,cell survival,proliferation regulation,mutations
ENSG00000099942,CRKL,cell migration,rho gtpase pathway,oncogenic signaling,molecular interaction,tumor progression,cancer stem cell maintenance
ENSG00000107263,RAPGEF1,tumor progression,gef activity,cell migration,rap gtpases activation,pi3k/akt pathway,oncogene overexpression
ENSG00000157193,LRP8,cell proliferation,egfr signaling pathway,tumor growth promotion,metastasis regulation,poor prognosis marker,gene expression upregulation
ENSG00000164093,PITX2,transcriptional regulation,epithelial-to-mesenchymal transition,amplification or overexpression,cell proliferation,tumor progression,oncogenic transformation
ENSG00000140992,PDPK1,cellular proliferation,phosphatidylinositol phosphorylation,protein kinase activation,akt pathway activation,tumor progression,therapeutic resistance
ENSG00000121067,SPOP,oncogenic activation,loss-of-function mutation,regulation of protein turnover,cellular homeostasis maintenance,chromatin remodeling,apoptosis regulation
ENSG00000281324,LRP6,aberrant activation,wnt/β-catenin pathway,tumor progression,cell proliferation,cancer driver,transcriptional regulation
ENSG00000107984,DKK1,wnt/beta-catenin signaling pathway regulation,tumor growth promoter,negative regulator protein,oncogene activation,cell proliferation enhancer,genetic instability mediator
ENSG00000116288,PARK7,oncogene,mitochondrial function regulation,tumor progression regulator,apoptosis modulation,prognostic marker,dna repair involvement
ENSG00000063660,GPC1,cell surface protein,glycosaminoglycan modification,tumor progression,metastatic factor,cancer stem cell marker,therapeutic target
ENSG00000241186,TDGF1,tumor-promoting,pi3k/akt activation,cell growth regulation,oncogenic potential,genomic amplification,signaling pathway modulation
ENSG00000138795,LEF1,wnt/β-catenin signaling,tumor suppressor gene regulation,transcriptional activation,cell adhesion modulation,mutation driver,oncogene expression enhancement
ENSG00000119630,PGF,pro-inflammatory signaling pathway,g-protein coupled receptor activation,epithelial-to-mesenchymal transition,cell proliferation regulation,angiogenesis promotion,oncogenic transformation
ENSG00000071564,TCF3,wnt/β-catenin signaling pathway,transcriptional regulation,oncogenic driver,cell proliferation,tumor suppressor function loss,transcription factor activity
ENSG00000129152,MYOD1,inhibits apoptosis,promotes cellular proliferation,contributes to emt,suppresses tumor suppressor gene expression,regulates cell cycle progression,induces genomic instability
ENSG00000157168,NRG1,oncogene gain-of-function,tumor suppressor loss-of-function,erbb4/mapk/pi3k/akt pathway activation,constitutive signaling,cell proliferation promotion,ligand-independent activation
ENSG00000123349,PFDN5,protein-protein interaction,wnt/β-catenin signaling,cell proliferation,microtubule regulation,cancer progression,potential therapeutic target
ENSG00000153317,ASAP1,tumor suppressor loss,microtubule regulation,cell cycle progression,oncogenic pathway activation,pi3k/akt signaling,apoptosis suppression
ENSG00000113578,FGF1,fgf/fgfr signaling pathway,constitutive activation,gain of function mutations,angiogenesis promotion,tumor progression,cell survival enhancement
ENSG00000075388,FGF4,fgf signaling pathway,growth factor activation,cell proliferation promotion,tumor progression driver,emt induction,chemoresistance enhancement
ENSG00000162344,FGF19,fgfr4 interaction,cell proliferation enhancement,wnt/beta-catenin signaling,endocrine regulator,tumor progression factor,prognostic marker
ENSG00000123416,TUBA1B,oncogenic overexpression,aberrant microtubules formation,cell cycle progression,tumor survival,microtubule assembly,protein interaction
ENSG00000112245,PTP4A1,dephosphorylation,tumor promotion,cell signaling regulation,oncogenic processes,cell proliferation enhancement,protein-protein interaction
ENSG00000121858,TNFSF10,apoptosis induction,cancer cell killing,overexpression,tumor suppressor function,tumor progression inhibition,therapeutic target
ENSG00000139567,ACVRL1,alk1/tgf-β signaling pathway,constitutive activation,gain of function mutations,tumor progression,cell proliferation,apoptosis inhibition
ENSG00000157764,BRAF,mapk/erk pathway,constitutive activation,gain of function mutations,tumor progression,cell proliferation,serine/threonine kinase
ENSG00000166579,NDEL1,overexpression,cellular proliferation,microtubule disruption,apoptosis evasion,chemotherapy resistance,tumor progression
ENSG00000013810,TACC3,microtubule assembly,mitotic regulation,oncogenesis,cell proliferation,metastatic potential,chromosome segregation
ENSG00000119383,PTPA,angiogenesis promotion,heparan sulfate degradation,tumor progression facilitation,diagnostic marker potential,vegf regulation,overexpression in cancer
ENSG00000121989,ACVR2A,tgf-β superfamily signaling,aberrant activation,cell proliferation,oncogenic processes,tumor progression,metastasis promotion
ENSG00000133794,ARNTL,circadian rhythm regulation,cell proliferation enhancement,oncogenic role,poor prognosis marker,apoptosis inhibition,core clock complex component
ENSG00000065526,SPEN,wnt/β-catenin signaling,tumor suppressor function,loss of heterozygosity,dna damage response,cancer progression,somatic mutations
ENSG00000150455,TIRAP,immune regulation,innate immune response,toll-like receptor signaling,adapter protein function,pro-inflammatory cytokine production,inflammation modulation
ENSG00000167393,PPP2R3B,pp2a dephosphorylation,tumor suppressor interaction,pi3k/akt pathway modulation,cell cycle regulation,apoptosis inhibition,metabolic dysregulation
ENSG00000064490,RFXANK,transcription factor regulation,epithelial-to-mesenchymal transition,cell growth regulation,gene expression modulation,cancer cell metastasis,tumor progression
ENSG00000170558,CDH2,epithelial-to-mesenchymal transition,overexpression,cell migration,adhesion molecule,signaling pathway,tumor progression
ENSG00000150760,DOCK1,cell migration,cell proliferation,guanylate exchange factor,invasion promoter,small gtpase regulator,tumor progression enhancer
ENSG00000155849,ELMO1,oncogene,rho gtpase activation,cell migration,metastasis promotion,tumor microenvironment modulation,pro-inflammatory cytokine production
ENSG00000169439,SDC2,cell adhesion disruption,epithelial-to-mesenchymal transition (emt),protein kinase activation,metastatic potential,angiogenesis promotion,transmembrane proteoglycan function
ENSG00000178999,AURKB,cell division regulation,genomic instability induction,mitotic progression disruption,oncogenic process promotion,protein kinase activation,spindle assembly checkpoint disruption
ENSG00000173535,TNFRSF10C,apoptosis inhibition,angiogenesis promotion,tumor progression,nf-κb pathway regulation,immunosuppression,poor prognosis marker
ENSG00000112592,TBP,tata-binding protein,general transcription factor,gene regulation,cell proliferation,cell survival,oncogenic processes
ENSG00000066336,SPI1,transcription factor regulation,pro-tumorigenic microenvironment,oncogenic driver,cell cycle regulation,apoptosis inhibition,immune evasion
ENSG00000147443,DOK2,constitutive activation,oncogene activation,tumor progression,cell proliferation,signaling pathway regulation,protein-protein interaction
ENSG00000198561,CTNND1,p120catenin dysfunction,cell-cell adhesion disruption,wnt/β-catenin signaling pathway,epithelial-to-mesenchymal transition (emt),adherens junctions regulation,tumor progression and metastasis
ENSG00000167193,CRK,tumor progression,cell adhesion disruption,oncogenic properties promotion,angiogenesis facilitation,apoptosis inhibition,src kinase activation
ENSG00000108840,HDAC5,epigenetic regulation,cell proliferation,chromatin remodeling,transcriptional repression,tumor progression,metastasis
ENSG00000101199,ARFGAP1,cell proliferation,gtpase regulation,oncogene function,protein interaction,tumor aggressiveness,vesicle trafficking
ENSG00000105438,KDELR1,erad pathway,cell cycle progression,retrotranslocation,misfolded protein recognition,proteasome regulation,apoptosis suppression
ENSG00000094631,HDAC6,chromatin regulation,deubiquitinating activity,cell migration,apoptosis evasion,protein homeostasis,therapeutic target
ENSG00000114423,CBLB,cell cycle control,dna repair,oncogenic signaling,signal transduction,protein stability modulation,immune response regulation
ENSG00000157240,FZD1,wnt/β-catenin pathway,oncogenic signaling,cell proliferation,tumor progression,therapeutic target,canonical wnt signaling
ENSG00000154342,WNT3A,wnt/β-catenin signaling pathway,oncogene potential,cell proliferation promotion,signaling pathway regulation,tumor growth suppression,apoptosis induction
ENSG00000163517,HDAC11,histone deacetylation,transcriptional repression,cell cycle regulation,chromatin remodeling,cell proliferation,protein-protein interaction
ENSG00000172179,PRL,prolactin overexpression,oncogenesis promotion,cell proliferation stimulation,angiogenesis regulation,epithelial-to-mesenchymal transition (emt),stat5 pathway interaction
ENSG00000179094,PER1,tumor suppression,cell cycle regulation,apoptosis modulation,circadian rhythm regulation,genetic instability modulation,dna repair enhancement
ENSG00000135144,DTX1,cell cycle regulation,growth advantage,mitotic checkpoint modulation,tumor progression,survival pathway,apoptosis inhibition
ENSG00000182944,EWSR1,chimeric protein formation,transcriptional regulation,genomic instability,oncogenic transformation,gene expression dysregulation,cell proliferation enhancement
ENSG00000100485,SOS2,ras/mapk signaling,constitutive activation,gain of function mutations,cell proliferation,oncogenic processes,therapeutic target
ENSG00000110330,BIRC2,caspase inhibition,cell survival promotion,ikk/nf-κb pathway activation,apoptosis suppression,tumor progression facilitation,therapeutic target
ENSG00000023445,BIRC3,apoptosis inhibition,nf-κb pathway interaction,oncogenic function,overexpression association,poor prognosis indicator,tumor progression promotion
ENSG00000164327,RICTOR,pi3k/akt pathway,constitutive activation,cell proliferation enhancement,oncogenic potential,tumor growth promotion,kinase activity
ENSG00000105810,CDK6,cell cycle regulation,constitutive activation,g1/s phase transition,tumor progression,oncogene overexpression,apoptosis inhibition
ENSG00000134516,DOCK2,rho gtpase activation,cell migration and invasion,tumor progression,metastatic potential,gef activity,oncogenic signaling
ENSG00000166167,BTRC,wnt/β-catenin signaling,ubiquitination and degradation,cell proliferation enhancement,metastatic potential increase,apoptosis resistance,protein-protein interaction modulation
ENSG00000126767,ELK1,erk/mapk pathway activation,constitutive transcriptional activity,oncogenic target,cell proliferation regulation,transcription factor interaction,cyclin d1 dysregulation
ENSG00000112658,SRF,transcriptional regulation,ras/mapk pathway interaction,cell proliferation enhancement,tumor progression promotion,coactivator recruitment,genetic amplification
ENSG00000113658,SMAD5,tgf-β signaling pathway,transcriptional regulator,oncogenic process,cell proliferation,apoptosis regulation,genetic alteration
ENSG00000105698,USF2,transcriptional regulation,cell cycle progression,epigenetic regulation,oncogene activation,tumor progression,histone modification
ENSG00000101138,CSTF1,altered splicing patterns,cell proliferation enhancement,cancer biomarker potential,enhanced cell invasion,malignant transformation facilitation,rna processing regulation
ENSG00000131462,TUBG1,cellular proliferation,genomic instability,microtubule dynamics,tumor progression,dna damage response,cell cycle regulation
ENSG00000101004,NINL,chromatin regulation,genome instability,oncogenic process,cell proliferation,protein expression regulation,nuclear organization
ENSG00000120693,SMAD9,tumor suppressor function,tgf-beta signaling regulation,cell growth inhibition,apoptosis induction,cancer prognostic biomarker,genomic downregulation
ENSG00000158517,NCF1,phagocyte function,dysregulation of ros levels,oxidative stress regulation,cytokine production,immune response modulation,antimicrobial defense
ENSG00000116701,NCF2,oxidative stress,cell migration,immune modulation,protein interaction,signaling pathway activation,tumor progression
ENSG00000137267,TUBB2A,tumor progression,cellular proliferation,genomic instability,oncogene activation,microtubule dynamics,chemotherapy resistance
ENSG00000173273,TNKS,telomerase activation,genomic instability,oncogene overexpression,cell proliferation,wnt/β-catenin pathway activation,parp-1 inhibition
ENSG00000147601,TERF1,telomere maintenance,tumor suppressor function,dysregulation in cancer,genome stability,cellular proliferation,survival pathway
ENSG00000095739,BAMBI,tumor suppression,genetic mutations,cell proliferation,apoptosis regulation,signaling pathway disruption,tissue homeostasis
ENSG00000136754,ABI1,**

rho gtpase regulation,constitutive activation,amplification,overexpression,cell proliferation,transcriptional regulation

**
ENSG00000107643,MAPK8,stress-activated kinase,apoptosis regulation,cell survival pathway,transcription factor activation,dna repair evasion,tumor growth promotion
ENSG00000136827,TOR1A,autophagy regulation,cancer cell adaptation,cellular homeostasis,protein folding disorder,tumorigenesis modulation,tumor microenvironment
ENSG00000108821,COL1A1,col1a1-related extracellular matrix deposition,tgf-β signaling activation,wnt/β-catenin pathway modulation,fibrosis and cancer cell migration,resistance to chemotherapy,collagen type i expression upregulation
ENSG00000164692,COL1A2,**
type i collagen deposition,angiogenesis promotion,epithelial-to-mesenchymal transition,fibrotic transformation,cancer cell proliferation,extracellular matrix remodeling **
ENSG00000161800,RACGAP1,cell migration,tumor progression,rho gtpase activation,cancer cell invasion,oncogene activation,pi3k/akt pathway modulation
ENSG00000137807,KIF23,mitotic checkpoint regulation,cell proliferation,aberrant expression,genetic instability,protein-protein interactions,cytokinesis dysfunction
ENSG00000078902,TOLLIP,loss of function mutations,tumor suppressor,nf-κb/mapk signaling pathway activation,immune evasion,prognostic marker,epithelial cell differentiation
ENSG00000117748,RPA2,genomic instability,dna repair mechanisms,homologous recombination repair,cell cycle regulation,oncogenic signaling pathways,prognostic biomarker
ENSG00000132383,RPA1,genomic instability,dna damage response,cell cycle regulation,oncogene activation,tumor suppressor dysfunction,dna replication error
ENSG00000069702,TGFBR3,loss of tgf-beta inhibitory effect,disruption of tgf-beta pathway,altered cell growth regulation,tumor progression,epithelial-to-mesenchymal transition (emt),cancer stem cell maintenance
ENSG00000186871,ERCC6L,dna damage response,genome stability maintenance,nucleotide excision repair,cell cycle regulation,apoptosis regulation,chromatin remodeling
ENSG00000142319,SLC6A3,dopamine signaling,cell proliferation,tumor progression,prognostic marker,neurotransmitter regulation,transmembrane transport
ENSG00000169083,AR,androgen receptor signaling pathway,cancer cell proliferation,constitutive activation,epithelial-to-mesenchymal transition (emt),genetic mutations,gene expression regulation
ENSG00000196712,NF1,tumor suppressor function,loss of function mutations,ras gtpase activation,cell proliferation enhancement,pi3k/akt pathway interaction,genetic instability promotion
ENSG00000136002,ARHGEF4,rho gtpase activation,cell migration promotion,tumor growth enhancement,prognostic marker potential,therapeutic target candidate,gef-rho signaling pathway interaction
ENSG00000126214,KLC1,cellular migration,protein interaction,microtubule transport,tumor aggressiveness,therapeutic target,stress response regulation
ENSG00000008294,SPAG9,tumor antigen,cell proliferation,apoptosis inhibition,microtubule regulation,p53 interaction,metastasis promotion
ENSG00000169429,CXCL8,angiogenesis,chemokine signaling,epithelial-to-mesenchymal transition (emt),cell proliferation,tumor progression,chemoresistance
ENSG00000180871,CXCR2,chemokine signaling pathway,tumor progression,cell migration and invasion,angiogenesis,therapeutic target,receptor-ligand interaction
ENSG00000115590,IL1R2,oncogenic function,decoy receptor activity,inflammation modulation,apoptosis regulation,cell survival enhancement,tumor microenvironment
ENSG00000115008,IL1A,pro-inflammatory cytokine activity,constitutive expression,tumor promotion,increased cell proliferation,inflammation-driven metastasis,microenvironment modulation
ENSG00000104312,RIPK2,necroptosis regulation,tnf-α-induced stress resistance,cell death pathway modulation,programmed cell death resistance,protein kinase activation,cancer progression promotion
ENSG00000167207,NOD2,autophagy dysregulation,inflammation mediation,immunosuppression mechanism,tumor growth promotion,effector function loss,cytokine regulation
ENSG00000114315,HES1,transcription factor regulation,epigenetic modulation,tumor progression,cellular self-renewal,emt program,chemotherapy resistance
ENSG00000044524,EPHA3,ephrin signaling pathway,epithelial-to-mesenchymal transition,cell migration regulation,glycoprotein interaction,angiogenic support,vascular endothelial growth factor modulation
ENSG00000010017,RANBP9,ran gtpase regulation,cell cycle disruption,mitotic progression,tumor growth promotion,oncogenic protein interaction,transcriptional dysregulation
ENSG00000156052,GNAQ,constitutive activation,guanine nucleotide exchange,oncogenesis,pi3k/akt pathway,mapk/erk signaling,targeted therapy
ENSG00000105443,CYTH2,cell cycle regulation,apoptosis inhibition,cyclin-dependent kinase interaction,tumor progression,proliferation enhancement,cell survival promotion
ENSG00000275338,RAB11FIP3,pi3k/akt pathway regulation,constitutive activation,gain of function mutations,cell membrane trafficking disruption,tumor progression,oncogene potential
ENSG00000103769,RAB11A,cell migration,membrane trafficking,cytoskeletal dynamics,tumor invasion,pro-oncogenic function,signaling pathway regulation
ENSG00000140464,PML,tumor suppressor,dna damage response,genomic stability maintenance,cell cycle regulation,apoptosis induction,chromatin remodeling regulation
ENSG00000205250,E2F4,regulatory role,transcription factor activity,cell cycle regulation,apoptosis modulation,tumor suppressor function,oncogene activity
ENSG00000074706,IPCEF1,genomic instability,epigenetic alterations,metastasis and invasion,tumor progression,p53 regulation,src interaction
ENSG00000078043,PIAS2,tumor suppressor,stat3 inhibition,cell proliferation regulation,dna repair regulation,transcriptional repression,epigenetic regulation
ENSG00000130779,CLIP1,clathrin-mediated endocytosis,oncogenic signaling,tumor progression,cell survival,protein-protein interaction,genomic instability
ENSG00000007168,PAFAH1B1,cell division regulation,genomic instability,microtubule dynamics disruption,tumor progression driver,cell migration modulation,cancer genetic alterations
ENSG00000125931,CITED1,transcription coactivator,oncogene activation,cell cycle regulation,apoptosis inhibition,tumor progression,prognostic marker
ENSG00000109971,HSPA8,cellular stress response,oncogene upregulation,apoptosis inhibition,cell survival enhancement,tumor microenvironment adaptation,protein-protein interactions
,SEPT1,cell proliferation,oncogene overexpression,cell migration and invasion,cellular morphology regulation,tumor progression and metastasis,genomic instability
ENSG00000136280,CCM2,cell cycle regulation,gene amplification,loss of tumor suppressor function,oncogenic overexpression,promotes dna replication,somatic mutations
ENSG00000118689,FOXO3,foxo transcription factor,tumor suppressor activity,oncogenesis inhibition,cell cycle regulation,dna repair modulation,metabolic regulation alteration
ENSG00000070778,PTPN21,negative regulator,receptor tyrosine kinase regulation,tumor suppressor function,cell growth modulation,oncogenic process contributor,cellular signaling pathway regulation
ENSG00000075651,PLD1,cellular proliferation,angiogenesis promotion,tumor progression marker,signaling pathway activation,overexpression,poor prognosis indicator
ENSG00000145242,EPHA5,ephrin ligands interaction,receptor tyrosine kinase activity,cell migration promotion,proliferation enhancement,tumor progression facilitation,therapeutic target
ENSG00000152284,TCF7L1,wnt/β-catenin signaling pathway,constitutive activation,oncogene,cell proliferation,transcription factor regulation,tumor progression
ENSG00000059728,MXD1,transcriptional repression,myc inhibition,epithelial-to-mesenchymal transition (emt),cell cycle regulation,tumor suppression,poor prognosis
ENSG00000107295,SH3GL2,receptor tyrosine kinase regulation,oncogenic signaling pathway activation,cell proliferation promotion,tumor progression facilitation,poor prognosis association,therapeutic target potential
ENSG00000147010,SH3KBP1,**

microtubule regulation,stat3 binding,pi3k/akt pathway activation,cell migration,actin cytoskeleton reorganization,focal adhesion formation
ENSG00000160999,SH2B2,cellular signaling,adaptor protein function,cell survival promotion,proliferation regulation,tumorigenesis facilitation,dysregulated expression
ENSG00000178188,SH2B1,tumor progression,pi3k/akt signaling,immune suppression,cell survival enhancement,oncogenic signaling modulation,adaptor molecule function
ENSG00000196655,TRAPPC4,vesicle trafficking regulation,tumor progression,metastasis facilitation,cell migration promotion,oncogenic process contribution,cancer cell adaptation
ENSG00000196498,NCOR2,transcriptional regulation,oncogene,tumor progression,metastasis promoter,cell proliferation,gene repression
ENSG00000101144,BMP7,oncogene/tumor suppressor,pi3k/akt pathway regulation,cell proliferation/survival promotion,apoptosis inhibition,emt regulation,tumor metastasis suppression
ENSG00000171243,SOSTDC1,wnt/β-catenin pathway activation,tumor progression,cell adhesion disruption,apoptosis suppression,transcriptional regulation,protein-protein interaction
ENSG00000248333,CDK11B,**

genetic alterations,overexpression,cell cycle regulation,g1-s phase transition,oncogenic pathway activation,kinase activity
ENSG00000184937,WT1,transcription factor regulation,oncogene activation,cell proliferation modulation,tumor suppression inhibition,apoptosis evasion,angiogenesis promotion
ENSG00000169047,IRS1,irs1/igf-1 pathway,overexpression,akt activation,cell proliferation,metabolic regulation,apoptosis resistance
ENSG00000071051,NCK2,cell migration,cell proliferation,signaling pathway regulation,tumor progression,pro-survival pathways,akt/mtor activation
ENSG00000069399,BCL3,transcriptional regulation,oncogenic transformation,nf-κb pathway,anti-apoptotic mechanisms,cell cycle progression,transcriptional activation
ENSG00000037280,FLT4,vegfr-3 signaling,angiogenesis,lymphangiogenesis,oncogenic potential,tumor progression,emt regulation
ENSG00000150630,VEGFC,angiogenesis,lymphangiogenesis,tumor progression,metastasis,therapeutic target,vascular permeability
ENSG00000124882,EREG,egfr ligand,overexpression,aberrant activation,tumorigenesis,emt regulation,therapeutic target
ENSG00000131558,EXOC4,regulated exocytosis,overexpression,cellular proliferation,aberrant signaling,tumor progression,biomarker
ENSG00000180104,EXOC3,exocyst complex regulation,oncogene function,pi3k/akt pathway modulation,tumor progression driver,cell adhesion regulation,metastasis facilitation
ENSG00000151725,CENPU,centrosomal protein,cellular proliferation,dna repair efficiency,enhanced cell cycle progression,increased genomic stability,tumor growth facilitation
ENSG00000160691,SHC1,pi3k/akt signaling pathway activation,constitutive activation of oncogenic pathway,cell proliferation enhancement,scaffold protein function,therapeutic target identification,genomic instability contribution
ENSG00000105701,FKBP8,pi3k/akt pathway inhibition,tumor promoter,p53 regulation,cell cycle progression,apoptosis inhibition,dna repair regulation
ENSG00000185591,SP1,oncogenic transcription factor,epithelial-to-mesenchymal transition,cell proliferation enhancement,transcriptional regulation,prognostic marker,tumor progression facilitation
ENSG00000269335,IKBKG,nf-κb signaling pathway,constitutive activation,gain of function mutations,cell proliferation,resistance to apoptosis,signaling pathway regulation
ENSG00000145431,PDGFC,oncogene role,signaling pathway activation,cell migration promotion,tumor progression driver,epithelial-to-mesenchymal transition,protein-protein interaction
ENSG00000141052,MYOCD,epithelial-to-mesenchymal transition,tumor progression,metastasis promoter,cell migration regulation,transcription factor activity,smad pathway interaction
ENSG00000177565,TBL1XR1,transcription regulation,co-repressor function,cell proliferation regulation,tumor suppression,chromatin modulation,gene expression regulation
ENSG00000101849,TBL1X,wnt/β-catenin signaling,epithelial-to-mesenchymal transition (emt),dna repair mechanisms,gene expression regulation,chromatin remodeling,cell proliferation and apoptosis
ENSG00000123159,GIPC1,egfr signaling enhancement,tumor progression,apoptosis regulation,cell cycle modulation,cancer-initiating cell maintenance,protein-protein interaction
ENSG00000058272,PPP1R12A,pi3k/akt signaling,protein phosphatase regulation,cell cycle progression,oncogenic processes,tumor progression,therapeutic target
ENSG00000213639,PPP1CB,protein phosphatase regulation,cell cycle progression,tumor growth,biomarker potential,oncogenic pathway modulation,signaling molecule interaction
ENSG00000132604,TERF2,telomere maintenance,genomic instability,tumor suppressor function,cell cycle regulation,oncogenic processes,chromosomal instability
ENSG00000099956,SMARCB1,chromatin remodeling,tumor suppressor function,genomic instability,cancer driver mutation,apoptosis regulation,cell cycle disruption
ENSG00000116604,MEF2D,transcriptional regulation,tumor cell proliferation,cell cycle progression,dysregulation,apoptosis modulation,metastasis promotion
ENSG00000099991,CABIN1,apoptosis regulation,calcineurin binding,nf-at transcription regulation,tumor suppressor function,cell cycle modulation,pro-apoptotic protein interaction
ENSG00000162337,LRP5,wnt/β-catenin pathway,osteoblast differentiation,aberrant signaling,tumor progression,cell proliferation,metastasis promotion
ENSG00000165197,VEGFD,angiogenic signaling,lymphangiogenesis promotion,tumor vessel formation,poor prognosis marker,therapeutic target,cancer cell interaction regulation
ENSG00000147526,TACC1,microtubule stabilization,cell cycle regulation,mitotic spindle assembly,oncogene overexpression,aurora kinase a interaction,tumor aggressiveness
ENSG00000100592,DAAM1,wnt/pcp signaling pathway,constitutive activation,oncogenic transformation,cellular proliferation,epithelial-to-mesenchymal transition (emt),microtubule-associated protein interaction
ENSG00000073584,SMARCE1,chromatin remodeling,transcriptional regulation,tumor progression,oncogene activation,cell proliferation,swi/snf complex
ENSG00000073282,TP63,tumor suppression,cell cycle regulation,dna repair,apoptosis induction,genomic stability maintenance,oncogene regulation
ENSG00000278114,MUC20,cell surface regulation,adhesive properties alteration,epithelial barrier dysregulation,tumor microenvironment modulation,biomarker potential,cancer cell behavior modification
ENSG00000106991,ENG,tgf-β signaling pathway,angiogenesis promotion,oncogenic properties enhancement,cell proliferation regulation,metastasis facilitation,therapeutic target candidate
ENSG00000115884,SDC1,sdc1,transmembrane proteoglycan,cell adhesion regulation,tumor progression facilitation,signaling pathway modulation,angiogenesis promotion
ENSG00000111664,GNB3,regulation of cell signaling pathways,cell proliferation and differentiation,oncogenic pathway activation,prognostic significance,therapeutic target,tumor progression
ENSG00000167083,GNGT2,gpcr signaling pathway,gain of function mutations,cell proliferation,oncogenesis,cell migration,protein regulation
ENSG00000178573,MAF,wnt/β-catenin pathway,constitutive activation,oncogenic transcription factor,cell survival promotion,tumor progression driver,therapeutic target
ENSG00000119335,SET,epigenetic regulation,tumor suppressor gene silencing,histone lysine methylation,methyltransferase activity,chromatin remodeling,cell cycle control disruption
ENSG00000173801,JUP,epithelial-to-mesenchymal transition (emt),cell-cell adhesion regulation,tumor progression correlation,oncogenic role,glycoprotein interactions,signaling pathway modulation
ENSG00000096696,DSP,cell-cell adhesion disruption,loss of function mutations,tissue integrity loss,epithelial polarity disruption,metastasis promotion,prognostic biomarker
ENSG00000137834,SMAD6,tgf-β pathway,oncogenic mutation,negative regulator,cellular proliferation,tumor suppression,phosphorylation inhibition
ENSG00000183207,RUVBL2,chromatin remodeling,dna replication repair,oncogenic protein interactions,tumor suppressor dysregulation,apoptosis evasion,chemotherapy resistance
ENSG00000173511,VEGFB,angiogenesis promotion,blood vessel formation enhancement,cell survival promotion,epithelial-to-mesenchymal transition induction,lymphangiogenesis facilitation,pi3k/akt pathway activation
ENSG00000150907,FOXO1,tumor suppressor,pi3k/akt signaling inhibition,apoptosis regulation,dna repair modulation,cell cycle control,proliferation promotion
ENSG00000184371,CSF1,tumor microenvironment modification,macrophage recruitment,angiogenesis promotion,immune suppression,therapeutic target,cell proliferation
ENSG00000182578,CSF1R,oncogenic signaling,immune evasion,macrophage recruitment,metastasis promotion,jak/stat pathway activation,tumor growth enhancement
ENSG00000166888,STAT6,stat6 signaling pathway,gain of function mutations,cell proliferation,immune evasion,epithelial-to-mesenchymal transition (emt),tumor microenvironment
ENSG00000173193,PARP14,transcriptional regulation,dual role in cancer,protein modification,genomic stability,cell survival,dna repair
ENSG00000137265,IRF4,oncogenic transcription factor,nf-κb pathway regulation,cell proliferation enhancement,apoptosis resistance,tumor metastasis facilitation,pi3k/akt/mtor pathway modulation
ENSG00000050748,MAPK9,p38 mapk pathway,pro-inflammatory cytokine activation,tumor microenvironment modulation,cell cycle progression regulation,inflammatory response enhancement,oncogenic protein interaction
ENSG00000072736,NFATC3,pi3k/akt interaction,oncogenesis driver,cell proliferation regulation,apoptosis inhibition,transcription factor activity,cell cycle progression enhancement
ENSG00000163956,LRPAP1,lipid metabolism regulation,cell adhesion modulation,tumor progression facilitation,angiogenesis promotion,extracellular matrix interaction,dysregulated expression
ENSG00000169856,ONECUT1,overexpression,transcription factor function,cell proliferation regulation,tumor progression,poor prognosis indicator,genetic amplification
ENSG00000276971,TRPV6,**

calcium channel regulation,cell proliferation,ion transport modulation,prognostic marker,tumor progression,cellular homeostasis disruption 
**
ENSG00000109332,UBE2D3,ubiquitination pathway,oncogene overexpression,cell cycle progression,apoptosis inhibition,tumor suppressor degradation,cell cycle regulation
ENSG00000137841,PLCB2,gpcr interaction,cell signaling pathway,phospholipid metabolism,protein kinase activation,oncogenic potential,tumor growth factor
ENSG00000163932,PRKCD,pi3k/akt pathway,oncogenic driver,cellular differentiation regulation,apoptosis suppression,metastasis promotion,tumor growth enhancement
ENSG00000116106,EPHA4,pi3k/akt pathway regulation,tyrosine kinase activation,constitutive activation,tumor progression,metastasis driver,cell adhesion disruption
ENSG00000118260,CREB1,mapk/erk pathway activation,constitutive transcriptional activation,gain of function mutations,oncogenic transformation,cell survival enhancement,epithelial-to-mesenchymal transition
ENSG00000204628,RACK1,pi3k/akt pathway interaction,gain of function mutations,tumor progression promoter,cell proliferation enhancer,cancer cell migration facilitator,protein-protein interaction scaffold
ENSG00000115306,SPTBN1,tumor progression,cell migration and invasion,epithelial-to-mesenchymal transition (emt),therapeutic target,prognostic marker,poor overall survival
ENSG00000177302,TOP3A,genomic instability,chromosomal rearrangements,dna repair machinery,topoisomerase activity,apoptosis induction,cell cycle regulation
ENSG00000197299,BLM,genomic instability,dna damage response,homologous recombination,genome maintenance,chromosomal abnormalities,oncogenic processes
ENSG00000162772,ATF3,oncogene activation,transcription factor dysregulation,cell survival enhancement,prognostic marker identification,apoptosis suppression,genomic instability modulation
ENSG00000108262,GIT1,gtpase-activating protein,cell migration,tumor progression,epithelial-to-mesenchymal transition,protein interaction,cell signaling pathway
ENSG00000102606,ARHGEF7,rho gtpase activation,constitutive activation,oncogenic signaling,cell proliferation,epithelial-to-mesenchymal transition (emt),tumor progression
ENSG00000138039,LHCGR,luteinizing hormone signaling pathway,oncogene activation,gain of function mutations,tumor progression,cell proliferation regulation,steroidogenesis dysregulation
ENSG00000284901,RUVBL1,chromatin remodeling,transcriptional regulation,oncogenic driver,cell proliferation,tumor suppressor degradation,poor prognosis
ENSG00000183337,BCOR,transcriptional repression,chromatin modification,co-repression complex,oncogenesis,poor prognosis,aggressive behavior
ENSG00000171450,CDK5R2,cell proliferation enhancement,survival pathway activation,metastasis promotion,apoptosis resistance,pi3k/akt pathway interaction,tumor growth regulation
ENSG00000121022,COPS5,tumor suppressor regulation,ubiquitination and degradation,cell cycle progression,cancer progression marker,biomarker for prognosis,nf-κb pathway activation
ENSG00000154473,BUB3,spindle checkpoint,genomic instability,chromosomal abnormalities,mitotic checkpoint regulation,dna damage response,chromosomal segregation
ENSG00000169679,BUB1,genomic instability,cell cycle regulation,mitotic checkpoint,sister chromatid separation,chromosomal abnormalities,tumor suppression
ENSG00000164342,TLR3,dsrna recognition,tumor microenvironment modulation,inflammation regulation,immune response activation,cell proliferation control,pi3k/akt pathway interaction
ENSG00000127666,TICAM1,nf-?b signaling pathway,trif-dependent signaling,innate immunity activation,immune evasion mechanism,tumor progression facilitation,pro-inflammatory cytokine production
ENSG00000171552,BCL2L1,apoptosis regulation,anti-apoptotic function,cell survival promotion,tumor progression enhancement,chemoresistance development,prognostic marker
ENSG00000069966,GNB5,gpcr signaling,oncogenesis,cell proliferation,mapk/erk pathway activation,pi3k/akt pathway modulation,tumor progression
ENSG00000131788,PIAS3,stat3 inhibition,tumor suppressor activity,cellular proliferation regulation,gene expression modulation,protein-protein interactions,transcriptional regulation disruption
ENSG00000282130,NSMCE3,genomic instability,dna repair defect,homologous recombination,genome maintenance,tumor suppressor function,cell cycle regulation
ENSG00000101412,E2F1,transcriptional regulation,cell cycle progression,dna binding activity,tumor suppression,apoptosis induction,genomic instability
ENSG00000170962,PDGFD,angiogenesis promotion,cell proliferation enhancement,metastasis facilitation,tumor growth support,poor prognosis marker,therapeutic target
ENSG00000134954,ETS1,cell proliferation enhancement,oncogene activity,tumor progression driver,epithelial-to-mesenchymal transition promoter,apoptosis suppression,transcriptional regulation
ENSG00000161888,SPC24,genomic stability,chromosome segregation,mitotic checkpoint regulation,aneuploidy promotion,tumorigenesis association,cell cycle regulation
ENSG00000080986,NDC80,kinetochore regulation,genomic instability,aneuploidy,cell proliferation,apoptosis induction,tumor growth inhibition
ENSG00000185737,NRG3,erbb receptor activation,cell survival enhancement,tumor progression modulation,oncogenic signaling pathway,therapeutic target identification,cell cycle regulation
ENSG00000182957,SPATA13,oncogenic properties,cell proliferation,apoptosis regulation,protein degradation pathway,enhanced cell survival,gene overexpression
ENSG00000112062,MAPK14,cellular stress response,proliferation regulator,cancer driver gene,tumor suppressor target,growth factor regulation,pro-inflammatory pathway activation
ENSG00000131196,NFATC1,nfatc1 overexpression,cell cycle progression,transcriptional activation,epithelial-to-mesenchymal transition (emt),oncogenic potential,prognostic marker
ENSG00000081189,MEF2C,mef2c overexpression,transcriptional regulation,cell proliferation,oncogenic driver,epithelial cell development,genome regulatory interaction
ENSG00000170289,CNGB3,channel regulation,cellular signaling,proliferation regulation,apoptosis modulation,retinal degeneration,cancer association
ENSG00000144191,CNGA3,altered calcium signaling,constitutive activation,dysregulated gene expression,enhanced cell growth,oncogene-tumor suppressor interactions,poor prognosis
ENSG00000105221,AKT2,akt signaling,constitutive activation,overexpression mutations,cell proliferation,glycolytic reprogramming,metabolic adaptation
ENSG00000135547,HEY2,transcription factor regulation,cell proliferation promotion,oncogene function,tumor growth enhancement,metastasis facilitation,dna repair suppression
ENSG00000133216,EPHB2,oncogene,cell migration,receptor dimerization,epithelial-to-mesenchymal transition (emt),constitutive activation,angiogenesis
ENSG00000157933,SKI,tgf-β pathway regulation,oncogenic transformation,epithelial-to-mesenchymal transition (emt),metastasis,tumor progression,transcriptional regulation
ENSG00000150593,PDCD4,tumor suppressor function,cell cycle regulation,apoptosis induction,microtubule dynamics modulation,protein-protein interaction,genomic instability
ENSG00000196961,AP2A1,pp2a regulation,tumor suppressor function,cell cycle progression regulation,apoptosis modulation,signal transduction inhibition,therapeutic target potential
ENSG00000161203,AP2M1,cellular endocytosis,cell proliferation,glycolytic reprogramming,tumor progression,genetic instability,metabolic adaptation
ENSG00000147044,CASK,wnt/β-catenin pathway,cell adhesion regulation,oncogenic protein interaction,tumor progression facilitation,prognostic marker potential,genomic expression alteration
ENSG00000158458,NRG2,nrg2/neuregulin signaling,ectopic expression,tumor progression,cell proliferation resistance,growth factor activation,epithelial-to-mesenchymal transition
ENSG00000188130,MAPK12,oncogenic signaling,cell cycle progression,apoptosis inhibition,tumor growth promotion,upstream kinase activation,transcription factor regulation
ENSG00000101400,SNTA1,cell migration,epithelial-to-mesenchymal transition,oncogenic signaling,dysregulated expression,therapeutic target,signaling pathway modulation
ENSG00000186625,KATNA1,protein degradation regulation,tumor progression,oncogenic pathway modulation,therapeutic target potential,cellular homeostasis maintenance,proliferation and survival enhancement
ENSG00000125538,IL1B,pro-inflammatory cytokine,tumor-promoting activity,nf-κb pathway activation,cell proliferation regulation,jak/stat signaling,tumor microenvironment modulation
ENSG00000097007,ABL1,tyrosine kinase activation,oncogenic signaling pathway,cell proliferation,genomic instability,dna repair mechanism,cancer driver gene
ENSG00000187555,USP7,constitutive activation,oncogene function,deubiquitinase activity,cell cycle regulation,tumor suppressor inhibition,protein stabilization
ENSG00000206279,DAXX,genomic destabilization,chromatin remodeling,apoptosis dysregulation,histone modification,tumor suppressor function,epigenetic regulation
ENSG00000061273,HDAC7,tumor suppressor gene regulation,histone deacetylation,cell cycle progression,apoptosis inhibition,angiogenesis modulation,gene expression modification
ENSG00000130726,TRIM28,chromatin modification,gene silencing,epigenetic regulation,histone methylation,cancer cell survival,proliferation inhibitor
ENSG00000144485,HES6,oncogene,apoptosis regulation,transcriptional repression,cell proliferation,epithelial-to-mesenchymal transition,prognostic biomarker
ENSG00000123124,WWP1,wwp1 overexpression,oncogene activation,epithelial-to-mesenchymal transition (emt),pi3k/akt pathway activation,ubiquitin-proteasome system suppression,chromatin regulation alteration
ENSG00000138755,CXCL9,tumor progression,immunosuppressive environment,cell migration,epithelial-to-mesenchymal transition (emt),chemoattractant activity,pro-inflammatory signaling
ENSG00000179348,GATA2,transcription factor activity,cell proliferation regulation,dna binding,genetic dysregulation,tumor progression promoter,met oncogenic transformation
ENSG00000164362,TERT,telomere maintenance,cellular immortality,genomic instability,chromosomal replication,telomerase activation,oncogene upregulation
ENSG00000044115,CTNNA1,epithelial-to-mesenchymal transition,oncogene activation,cell-cell adhesion disruption,tumor progression facilitation,wnt/β-catenin pathway interaction,pro-survival signaling promotion
ENSG00000068903,SIRT2,cellular metabolism,genomic stability,tumor suppression,apoptosis modulation,protein deacetylation,therapeutic target
ENSG00000253293,HOXA10,hoxa10 expression,pi3k/akt pathway modulation,tumor progression enhancement,epithelial-to-mesenchymal transition regulation,cancer stem cell maintenance,genomic instability promoter
ENSG00000121671,CRY2,**

cellular proliferation,genomic stability,dna damage response,apoptosis suppression,circadian rhythm disruption,cell cycle modulation

**
ENSG00000072803,FBXW11,c-myc regulation,tumor suppression,proteasomal degradation,cell cycle regulation,dna damage response,apoptosis inhibition
ENSG00000184481,FOXO4,tumor suppression,cellular proliferation inhibition,apoptosis promotion,pi3k/akt pathway regulation,glycolysis regulation,autophagy modulation
ENSG00000160014,CALM3,oncogenic signaling,calcium signaling pathway,tumor progression,cancer cell migration,promoter methylation,biomarker
ENSG00000172020,GAP43,microtubule stability,actin polymerization,cell migration,metastasis promotion,tumor progression,oncogene activation
ENSG00000113712,CSNK1A1,oncogene activation,cell cycle progression,serine/threonine kinase activity,genomic instability,apoptosis regulation,poor prognosis marker
ENSG00000100567,PSMA3,proteasome regulation,cell cycle progression,apoptosis regulation,tumor suppressor,immune evasion,therapeutic target
ENSG00000126561,STAT5A,stat5 activation,tumor progression,cell proliferation,apoptosis resistance,metastasis promotion,akt signaling pathway
ENSG00000092820,EZR,cell adhesion,epithelial to mesenchymal transition,adaptor protein function,tumor progression,promotes invasion,prognostic marker
ENSG00000065717,TLE2,wnt/β-catenin signaling pathway,transcriptional co-repressor,tumor suppressor function,cell proliferation regulation,aberrant activation,poor prognosis biomarker
ENSG00000120798,NR2C1,transcriptional regulation,oncogenic processes,cell proliferation,pro-survival genes,tumor suppressor gene suppression,ligand-activated transcription factor
ENSG00000075711,DLG1,dysregulation,pi3k/akt pathway activation,cell cycle regulation,epithelial cell polarity disruption,apoptosis inhibition,oncogenic signaling
ENSG00000253729,PRKDC,genomic instability,dna repair mechanism,nhej pathway activation,protein kinase activation,chromosomal rearrangements,therapeutic target
ENSG00000152457,DCLRE1C,dna interstrand crosslink repair,genomic instability,tumor suppressor function,apoptosis evasion,cell cycle regulation,dna damage response
ENSG00000288401,CTTN,wnt/β-catenin pathway,oncogene activation,metastasis promotion,epithelial-to-mesenchymal transition,cell adhesion disruption,signaling protein interaction
ENSG00000131910,NR0B2,cell cycle regulation,tumor progression,oncogenic processes,transcriptional regulator,orphan nuclear receptor,apoptosis modulation
ENSG00000185950,IRS2,pi3k/akt pathway activation,insulin signaling deregulation,tumor growth promotion,apoptosis resistance,cell survival enhancement,genetic mutations
ENSG00000140044,JDP2,transcription factor regulation,cell proliferation enhancement,apoptosis inhibition,pro-oncogenic gene transcription,tumor suppressor gene repression,poor prognosis correlation
ENSG00000124440,HIF3A,transcriptional regulation,glycolytic reprogramming,apoptosis resistance,emt induction,hypoxia adaptation,protein-protein interaction
ENSG00000169071,ROR2,wnt signaling pathway,gain of function mutations,cell migration,metastasis driver,epithelial-to-mesenchymal transition,tumor aggressiveness
ENSG00000143384,MCL1,apoptosis inhibition,oncogene activation,tumor growth promotion,therapeutic resistance,poor prognosis association,cell survival enhancement
ENSG00000079841,RIMS1,regulation of synaptic plasticity,cell proliferation,interaction with other proteins,tumor suppressor function,modulation of cellular signaling,neurotransmitter release regulation
ENSG00000198722,UNC13B,regulation of immune response,modulation of cell signaling pathways,tumor progression,prognostic marker,cell proliferation,immune evasion
ENSG00000140009,ESR2,estrogen-dependent signaling,transcriptional regulation,protein-protein interactions,oncogenic activity,cell proliferation,tumor progression
ENSG00000131981,LGALS3,cancer progression,cell surface receptor interaction,glycoprotein binding,apoptosis inhibition,promoter methylation,tumor metastasis
ENSG00000147099,HDAC8,histone deacetylation,cell proliferation,apoptosis induction,chromatin remodeling,gene regulation,epigenetic modification
ENSG00000198952,SMG5,nmd pathway disruption,gain of function mutations,dna repair regulation,genomic instability,cell proliferation enhancement,apoptosis resistance
ENSG00000056558,TRAF1,nf-κb signaling pathway,tumor suppressor function,loss of function mutations,cancer progression,cell survival,genomic stability
ENSG00000138964,PARVG,receptor activation,wnt/β-catenin signaling,oncogenic transformation,cell proliferation,calcium metabolism regulation,therapeutic target
ENSG00000198901,PRC1,chromatin remodeling,genomic instability,dna repair defects,cell cycle regulation,mitotic errors,tumor progression
ENSG00000140350,ANP32A,transcription regulation,oncogene activation,chromatin remodeling,cell proliferation,apoptosis resistance,tumor microenvironment modulation
ENSG00000182636,NDN,chromatin remodeling,oncogenic process,cell proliferation,epigenetic regulation,transcriptional activation,apoptosis resistance
ENSG00000160633,SAFB,gene regulation,transcriptional activation/ repression,cell cycle control,tumor progression,metastasis,prognostic biomarker
ENSG00000089220,PEBP1,transcriptional regulation,cell proliferation,tumor growth promotion,apoptosis inhibition,oncogene overexpression,pi3k/akt pathway modulation
ENSG00000281766,RYBP,chromatin compaction,onco-suppressor repression,tumor progression marker,cell cycle regulator,apoptosis inhibitor,genomic instability
ENSG00000027869,SH2D2A,pi3k pathway regulation,tumor suppressor function,cell survival modulation,apoptosis regulation,tumor progression,genomic instability
ENSG00000169967,MAP3K2,mapk pathway regulation,cell proliferation enhancement,tumor progression facilitation,oncogenic potential,kinase activation mediation,signaling pathway interaction
ENSG00000065618,COL17A1,loss-of-function,tumor suppressor,hemidesmosome disruption,cell migration,epithelial barrier function,downstream signaling pathways
ENSG00000139687,RB1,cell cycle regulation,tumor suppressor function,oncogenesis,cell proliferation,genomic instability,apoptosis inhibition
ENSG00000118971,CCND2,cell cycle progression,cyclin-dependent kinase regulation,gene amplification,oncogene overexpression,tumor aggressiveness,biomarker potential
ENSG00000160791,CCR5,immune system regulation,tumor metastasis,ligand binding,cell migration,receptor activation,prognostic marker
ENSG00000197386,HTT,cellular proliferation,genetic instability,neurodegenerative-like features,oncogene overexpression,protein aggregation,transcriptional regulation
ENSG00000106211,HSPB1,protein folding regulation,cell survival enhancement,apoptosis resistance,angiogenesis promotion,therapeutic target identification,stress response modulation
ENSG00000014216,CAPN1,cellular growth,epithelial-to-mesenchymal transition,oncogenic protein,protein-protein interaction,tumor progression,proliferation regulation
ENSG00000126247,CAPNS1,calcium channel regulation,genetic amplification,tumor progression,epithelial-to-mesenchymal transition (emt),cell proliferation,survival signaling
ENSG00000184500,PROS1,tumor progression,metastasis,proteolytic activity,cell adhesion regulation,calcium ion homeostasis,platelet aggregation
ENSG00000110711,AIP,regulation of cell growth,interaction with ahr,apoptosis regulation,pituitary tumor association,cell proliferation modulation,tumorigenesis involvement
ENSG00000162909,CAPN2,oncogenic activity,cytoplasmic localization,proteolytic activity,cell migration,apoptosis modulation,tumor progression
ENSG00000141655,TNFRSF11A,rankl activation,tumor growth promotion,metastasis facilitation,therapeutic resistance,angiogenesis stimulation,immune suppression
ENSG00000120659,TNFSF11,tumor progression,immunosuppressive microenvironment,osteoclast activation,angiogenesis promotion,bone destruction,therapeutic target
ENSG00000171476,HOPX,tumor suppression,cell cycle regulation,genomic instability,apoptosis induction,dna-binding activity,homeodomain function
ENSG00000259384,GH1,growth factor regulation,cellular proliferation,oncogene activation,tumor progression,cell survival enhancement,metabolic dysregulation
ENSG00000110934,BIN2,erad pathway regulation,oncogene function,cell proliferation promotion,misfolded protein accumulation,stress response activation,pi3k/akt signaling interaction
ENSG00000048052,HDAC9,histone deacetylase activity,chromatin remodeling,cell cycle progression,apoptosis suppression,tumor suppressor gene regulation,oncogenic pathway promotion
ENSG00000198821,CD247,tcr complex regulation,t-cell activation impairment,immunosuppression,oncogenesis,tumor immune evasion,protein-protein interaction
ENSG00000204217,BMPR2,tgf-β/bmp signaling disruption,loss of regulatory function,pi3k/akt pathway modulation,cell proliferation enhancement,angiogenesis promotion,metastasis facilitation
ENSG00000107779,BMPR1A,tumor suppressor function,loss of expression,cell proliferation regulation,epithelial-to-mesenchymal transition regulation,signaling pathway interaction,apoptosis promotion
ENSG00000140443,IGF1R,igf1r signaling,constitutive activation,overexpression mutations,tumor progression,therapeutic target,genomic amplification
ENSG00000136603,SKIL,tumor progression,cell proliferation,signaling pathway activation,pro-survival mechanisms,adaptor protein function,genomic amplification
ENSG00000168398,BDKRB2,angiogenesis,cancer progression,g-protein coupled receptor,metastasis,tumor microenvironment,inflammation
ENSG00000170581,STAT2,overexpression,signal transduction pathway,transcription factor regulation,immune response modulation,tumor microenvironment regulation,apoptosis evasion
ENSG00000159692,CTBP1,transcriptional co-repressor,histone modification regulation,oncogenic protein interaction,cell proliferation enhancement,apoptosis suppression,chromatin remodeling
ENSG00000285109,GATA4,oncogenic signaling,transcriptional regulator,tumor suppressor function loss,epithelial-to-mesenchymal transition (emt),cell cycle progression,wnt/β-catenin pathway activation
ENSG00000183072,NKX2-5,transcription factor regulation,epithelial-to-mesenchymal transition,cell proliferation driver,apoptosis inhibitor,tumor suppressor inactivation,cancer stem cell maintenance
ENSG00000003402,CFLAR,apoptosis regulation,intrinsic/extrinsic pathways,anti-apoptotic function,cell survival promotion,necroptosis modulation,tumor progression enhancement
ENSG00000111348,ARHGDIB,rho gdp-dissociation inhibitor,loss-of-function mutations,cell migration regulation,proliferation enhancement,cancer progression facilitation,epithelial-to-mesenchymal transition regulation
ENSG00000067560,RHOA,cell migration,cytoskeletal organization,actin filament regulation,epithelial cell polarity,rho-associated protein kinase activation,tumor progression
ENSG00000141456,PELP1,chromatin remodeling,oncogenic activity,cell proliferation inhibitor,transcriptional coactivator,steroid hormone receptor interaction,pi3k/akt signaling activation
ENSG00000163599,CTLA4,immune checkpoint regulation,t-cell suppression,tumor evasion,regulatory t-cell modulation,immune tolerance maintenance,antigen-presenting cell function
ENSG00000065361,ERBB3,ligand-independent activation,oncogenic potential,tumor progression,poor prognosis,therapeutic target,epidermal growth factor receptor family
ENSG00000196132,MYT1,transcription factor activity,oncogene role,cell cycle regulation,apoptosis suppression,tumor growth promotion,constitutive pathway activation
ENSG00000186951,PPARA,tumor suppressor function,metabolic regulation,epigenetic silencing,inflammation inhibition,cell proliferation inhibition,anti-apoptotic pathway disruption
ENSG00000185291,IL3RA,oncogenic function,il-3 mediated signaling,cell proliferation,tumor progression,epigenetic regulation,cytokine receptor interaction
ENSG00000174697,LEP,**
angiogenesis promotion,cell proliferation enhancement,immune evasion activation,inflammation induction,oncogenic signaling pathway,stat3 activation 
**
ENSG00000101773,RBBP8,histone deposition,constitutive activation,genomic instability,cell proliferation,promotes oncogenesis,biomarker candidate
ENSG00000135218,CD36,cell adhesion,tumor progression,metastasis,angiogenesis,upregulated expression,prognosis marker
ENSG00000128245,YWHAH,oncogenesis,signal transduction,cell cycle regulation,apoptosis regulation,protein-protein interaction,cancer prognosis
ENSG00000159110,IFNAR2,interferon pathway disruption,epigenetic silencing,tumor progression,poor prognosis,gene expression regulation,immune evasion
ENSG00000080839,RBL1,tumor suppressor function,loss of heterozygosity,cell cycle regulation,transcriptional corepressor,e2f1 binding partner,p53-p21 pathway involvement
ENSG00000116044,NFE2L2,constitutive activation,tumor progression,antioxidant response element,cell cycle regulation,xenobiotic metabolism,cancer cell survival
ENSG00000079999,KEAP1,tumor suppressor,nrf2 regulation,oxidative stress response,cellular survival,metabolic regulation,dna damage repair
ENSG00000164690,SHH,shh signaling,tumor suppressor,oncogene activation,cell proliferation,metastasis promotion,epithelial stem cell maintenance
ENSG00000144891,AGTR1,erk/mapk pathway activation,cell proliferation promotion,angiogenesis regulation,tumor progression facilitation,g-protein coupled receptor function,prognostic marker
ENSG00000121966,CXCR4,chemokine signaling pathway,cancer cell migration,cell adhesion molecule,tumor microenvironment modulation,gene expression regulation,metastatic niche formation
ENSG00000134480,CCNH,cell cycle progression,oncogene activation,transcription initiation,cell proliferation,tumorigenesis,protein kinase activity
ENSG00000134058,CDK7,constitutive activation,transcriptional regulation,cell cycle progression,tumor progression,oncogene,cell proliferation
ENSG00000123908,AGO2,microrna-mediated gene regulation,oncogenic processes,tumor suppressor silencing,gene regulation alteration,protein interaction modulation,cancer progression
ENSG00000100697,DICER1,microrna biogenesis,tumor suppression,oncogenic mirnas accumulation,cell proliferation promotion,apoptosis inhibition,genetic instability
ENSG00000016490,CLCA1,tumor progression,epithelial-to-mesenchymal transition (emt),cellular adhesion,ion channel regulation,fluid secretion,prognostic marker
ENSG00000164078,MST1R,cell proliferation,constitutive phosphorylation,mapk/erk pathway activation,mutations driving oncogenesis,overexpression leading to tumor growth,tumorigenesis via dysregulated cell signaling
ENSG00000168028,RPSA,cellular proliferation,akt pathway activation,chromatin remodeling,histone modification,rna stability regulation,tumor growth promotion
ENSG00000151914,DST,wnt signaling pathway,oncogenic transcription factor,cell proliferation regulation,epithelial-to-mesenchymal transition (emt),prognostic marker,tumor progression
ENSG00000178209,PLEC,cytoskeletal regulation,cell adhesion disruption,oncogenic signaling,epithelial-to-mesenchymal transition (emt),tumor invasion promotion,prognostic biomarker
ENSG00000136238,RAC1,gain-of-function mutations,constitutive activation,cell migration,oncogene,tumor progression,therapeutic target
ENSG00000112851,ERBIN,dna repair,cellular adhesion,signaling pathway modulation,tumor growth promotion,dysregulated expression,genomic instability driver
ENSG00000026025,VIM,oncogene function,epithelial-to-mesenchymal transition (emt),tumor progression,cell migration,protein-protein interaction,poor prognosis marker
ENSG00000177697,CD151,cell adhesion,tumor progression,metastasis promotion,immune evasion,prognostic marker,dna repair enhancement
ENSG00000176105,YES1,oncogenic signaling,tumor progression,therapeutic target,cell proliferation regulation,protein-protein interaction,poor prognosis marker
ENSG00000134308,YWHAQ,oncogene activation,tumor progression,cell cycle regulation,protein-protein interaction,apoptosis modulation,poor prognosis indicator
ENSG00000242372,EIF6,cellular proliferation,translation initiation factor,tumor progression,overexpression,protein synthesis regulation,oncogenic signaling
ENSG00000166813,KIF7,cell cycle progression,tumor progression,chromosomal instability,cancer stem cells,signal transduction,microtubule-dependent transport
ENSG00000117425,PTCH2,hedgehog signaling pathway,constitutive activation,loss of function mutations,tumor progression,therapeutic target,cancer stem cell maintenance
ENSG00000173020,GRK2,cell proliferation,g protein-coupled receptor phosphorylation,kinase activation,oncogenic process,signaling pathway regulation,tumor progression
ENSG00000157540,DYRK1A,regulation of cell cycle,protein kinase activation,cell proliferation,apoptosis inhibition,pi3k/akt pathway interaction,genomic instability
ENSG00000163482,STK36,wnt/β-catenin pathway,constitutive activation,gain of function mutations,cell proliferation regulation,genomic instability,therapeutic target
ENSG00000235568,NFAM1,mitochondrial complex regulation,promoter hypermethylation,oncogene overexpression,cell proliferation enhancement,transcriptional activation,mitochondrial dysfunction
ENSG00000115085,ZAP70,t-cell receptor signaling,aberrant activation,cell proliferation enhancement,apoptosis resistance,protein-protein interaction,signaling pathway modulation
ENSG00000165025,SYK,oncogenic signaling pathway,constitutive activation,phosphorylation activity,immune evasion mechanism,tumor progression driver,therapeutic target
ENSG00000111859,NEDD9,cell cycle regulation,centrosome separation,gef activation,microtubule dynamics,oncogenesis promotion,tumor progression
ENSG00000115935,WIPF1,cancer driver gene,tumor progression,actin cytoskeleton regulation,endocytosis regulation,protein interaction,cell migration enhancement
ENSG00000116473,RAP1A,mapk/erk pathway,oncogenic mutations,tumor progression,therapeutic target,cell proliferation,signal transduction
ENSG00000068831,RASGRP2,activates small gtpases,oncogenic pathway activation,cell proliferation enhancement,survival signaling facilitation,metastatic potential increase,tumor progression facilitation
ENSG00000110448,CD5,tumor progression,immune modulation,cell signaling,prognostic marker,src kinase interaction,cancer development
ENSG00000155926,SLA,antigen presentation,immune evasion,cell proliferation,transcriptional regulation,tumor microenvironment,immunotherapy targets
ENSG00000113263,ITK,pi3k/akt pathway,constitutive activation,oncogenic signaling,t-cell activation,cell proliferation,therapeutic target
ENSG00000160856,FCRL3,immunomodulation,tumor progression,b-cell receptor signaling,immune evasion,loss of function mutations,signaling pathway modulation
ENSG00000154016,GRAP,tumor progression,cell survival,immune evasion,signaling regulation,protein interaction,cancer driver
ENSG00000141293,SKAP1,focal adhesion regulation,cell migration promotion,tumor progression contributor,therapeutic target,protein-protein interaction,cancer cell survival enhancement
ENSG00000172575,RASGRP1,gef activation,small gtpase regulation,mapk/erk pathway activation,tumor growth promotion,poor prognosis association,biomarker potential
ENSG00000079805,DNM2,oncogenicity,cell migration,overexpression,metastasis,pi3k/akt interaction,vesicle transport
ENSG00000198286,CARD11,nf-kappa b signaling,scaffold protein function,gain of function mutations,tumor progression,immune system regulation,cancer driver gene
ENSG00000139436,GIT2,enhanced cell survival,oncogene role,cell migration regulation,cytoplasmic signaling regulation,plasma membrane localization,rho gtpase interaction
ENSG00000125753,VASP,cell migration,actin cytoskeleton reorganization,oncogenic potential,pi3k/akt pathway interaction,tumor progression,therapeutic target
ENSG00000154380,ENAH,cell migration,cell invasion,cytoskeletal regulation,tumor progression,therapeutic target,apoptosis resistance
ENSG00000196405,EVL,cell migration,actin filament regulation,tumor progression,oncogene,chemoresistance,genomic instability
ENSG00000232575,TUBB,microtubule dynamics,cellular proliferation,genetic mutations,apoptosis induction,therapeutic target,cellular transport
ENSG00000070159,PTPN3,ptpn3 overexpression,receptor tyrosine kinase desensitization,cell proliferation enhancement,immune suppression,oncogenic mutation,tumor metastasis facilitation
ENSG00000108861,DUSP3,mapk signaling,oncogene function,tumor progression,apoptosis inhibition,cell proliferation enhancement,signaling pathway modulation
ENSG00000163519,TRAT1,oncogene,nf-κb signaling pathway,immune evasion,angiogenesis promoter,epigenetic modification,biomarker
ENSG00000127947,PTPN12,oncogenic driver,stat3 dephosphorylation,tumor suppression,proliferation regulation,differentiation regulation,apoptosis regulation
ENSG00000074966,TXK,t-cell receptor signaling,cell proliferation,genomic instability,chromosomal alterations,pi3k/akt pathway modulation,serine/threonine kinase activity
ENSG00000185499,MUC1,epithelial integrity disruption,tumor suppressor function,oncogenic signaling interaction,immune evasion mechanism,cancer cell migration,aberrant glycosylation status
ENSG00000015285,WAS,cell migration,cell survival,tumor progression,immune response modulation,actin cytoskeleton regulation,oncogenic driver
ENSG00000005020,SKAP2,cancer cell migration,cell motility regulation,actin cytoskeleton reorganization,metastasis promotion,rho gtpase signaling activation,prognostic biomarker
ENSG00000115053,NCL,ribosome biogenesis,cellular proliferation,transcription regulation,oncogene overexpression,therapeutic target,protein-protein interaction
ENSG00000109103,UNC119,egfr recycling,oncogenic function,metastasis facilitation,poor prognosis marker,membrane trafficking regulation,pi3k/akt pathway interaction
ENSG00000101082,SLA2,emt regulation,cytoplasmic localization,protein-protein interaction,cell migration facilitation,apoptosis resistance,rho gtpase pathway modulation
ENSG00000095370,SH2D3C,oncogenic signaling,cell growth regulation,immune evasion,overexpression,prognostic marker,tumor progression
ENSG00000107338,SHB,pi3k/akt pathway activation,mapk/erk signaling,oncogenic adaptor function,cell proliferation enhancement,metastasis promotion,therapeutic target
ENSG00000127824,TUBA4A,microtubule dynamics,tumor progression,genomic instability,cell migration,mitotic spindle formation,cancer cell heterogeneity
ENSG00000134215,VAV3,gef activation,rho gtpase regulation,cell migration,tumorigenesis,metastasis promotion,protein interaction
ENSG00000023892,DEF6,cell cycle regulation,apoptosis suppression,tumor progression,transcriptional regulation,therapeutic target,genome instability
ENSG00000198087,CD2AP,cell adhesion regulation,cytoskeleton remodeling,tumor suppressor function,metastasis promotion,invasion facilitation,protein-protein interactions
ENSG00000122188,LAX1,tumor progression,cell growth regulation,oncogene,transcription factor regulation,genomic stability modulation,therapeutic target
ENSG00000080031,PTPRH,tumor suppressor function,cell adhesion modulation,signaling pathway regulation,protein tyrosine phosphatase activity,tissue homeostasis maintenance,epithelial cell differentiation
ENSG00000113594,LIFR,il-6/lif signaling pathway,constitutive activation,gain of function mutations,tumor progression,immune modulation,angiogenesis support
ENSG00000198793,MTOR,mtorc1 activation,cell growth promotion,metabolic regulation,oncogenic driver,protein synthesis upregulation,autophagy inhibition
ENSG00000099985,OSM,tumor progression,angiogenesis modulation,cell adhesion regulation,metastasis promotion,receptor interaction,signaling pathway activation
ENSG00000276536,HRAS,oncogene,constitutive activation,gain of function mutations,ras/mapk pathway,cell proliferation,therapeutic target
ENSG00000121853,GHSR,tumor progression,enhanced cell proliferation,oncogenic potential,overexpression in cancer tissues,gh/igf-1 axis dysregulation,metabolic reprogramming
ENSG00000124089,MC3R,overexpression,mapk/erk pathway activation,pi3k/akt signaling enhancement,tumor progression,g protein-coupled receptor function,cell proliferation and survival promotion
ENSG00000184845,DRD1,drd1 mutation,cell proliferation,oncogenic process,tumor suppression,pi3k/akt/mtor pathway,aberrant activation
ENSG00000147246,HTR2C,5-ht2cr activation,cell proliferation,oncogenic processes,tumor progression,serotonin receptor function,pi3k/akt/mtor pathway interaction
ENSG00000114353,GNAI2,g-protein signaling pathway,downregulation,tumorigenesis,cell proliferation,apoptosis resistance,cell cycle regulation
ENSG00000157017,GHRL,oncogenic signaling,growth factor regulation,cell proliferation,angiogenesis promotion,apoptosis evasion,microenvironment modulation
ENSG00000123901,GPR83,constitutive activation,pi3k/akt pathway modulation,tumor growth promotion,apoptosis suppression,cell cycle progression regulation,oncogene interaction
ENSG00000162009,SSTR5,g-protein coupled receptor,tumor suppressor function,cell growth inhibition,insulin secretion regulation,therapeutic target,apoptosis regulation
ENSG00000137486,ARRB1,gpcr signaling regulation,tumor suppressor function,protein trafficking modulation,cell proliferation inhibition,mapk/erk pathway interaction,pi3k/akt pathway regulation
ENSG00000165119,HNRNPK,pre-mrna splicing regulation,alternative splicing,tumor progression promotion,oncogene activation,tumor suppressor inhibition,cell proliferation enhancement
ENSG00000070190,DAPP1,pi3k/akt pathway regulation,gene overexpression,tumor progression contribution,scaffold protein function,signaling molecule regulation,biomarker potential
ENSG00000101336,HCK,constitutive activation,cell proliferation,tumor progression,oncogenic processes,immune response regulation,tyrosine kinase activity
ENSG00000182022,CHST15,glycoprotein modification,tumor progression,aberrant expression,cell adhesion regulation,inflammatory response regulation,proteoglycan sulfation
ENSG00000160293,VAV2,**
rho gtpase regulation,oncogenic signaling,tumor progression,cell migration,guanine nucleotide exchange factor,therapeutic target
**
ENSG00000105369,CD79A,b-cell development,constitutive activation,gain-of-function mutations,tumor progression,therapeutic target,protein-protein interaction
ENSG00000007312,CD79B,bcr complex,oncogenic potential,nf-κb signaling,cell proliferation,epithelial-to-mesenchymal transition (emt),overexpression
ENSG00000086730,LAT2,immune evasion,tumor immune tolerance,oncogenic signaling pathway,cell proliferation,survival and migration,pi3k/akt pathway activation
ENSG00000010671,BTK,immune system modulation,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cell signaling regulation
ENSG00000166908,PIP4K2C,pip2 regulation,phosphatidylinositol metabolism,tumor progression,cell signaling dysregulation,oncogene overexpression,poor prognosis marker
ENSG00000276293,PIP4K2B,pi4p production,constitutive activation,oncogenic transformation,cell signaling regulation,lipid metabolism modulation,protein kinase activity enhancement
,IGHM,immunosuppression,tumor microenvironment modulation,immune evasion,cancer cell growth advantage,angiogenesis regulation,poor prognosis marker
ENSG00000012124,CD22,immune evasion,cell surface receptor,b cell activation,oncogenic signaling,tumor microenvironment modulation,glycoprotein modification
ENSG00000143398,PIP5K1A,cell migration,constitutive activation,cancer metastasis,cell survival,phosphatidylinositol phosphorylation,pi3k/akt pathway regulation
ENSG00000072135,PTPN18,mapk/erk signaling pathway,tumor suppressor function,cellular regulation,oncogene modulation,cancer progression,signal transduction
ENSG00000035720,STAP1,tyrosine kinase regulation,tumor progression,cell surface receptor modulation,signal transduction pathway dysregulation,oncogene activation,poor prognosis marker
ENSG00000107242,PIP5K1B,phosphoinositide metabolism,cell signaling regulation,tumor progression,metastasis promotion,oncogene overexpression,gene expression regulation
ENSG00000184304,PRKD1,amplification,cell migration,oncogenic driver,phosphorylation,protein kinase activation,tumor progression
ENSG00000072694,FCGR2B,aberrant expression,fc gamma receptor function,immune regulation,inhibitory signaling,modulation of tumor microenvironment,altered immune surveillance
ENSG00000285369,BLK,b cell receptor signaling,constitutive activation,dysregulated b-cell development,gain of function mutations,inhibition of apoptosis,pi3k/akt pathway activation
ENSG00000166501,PRKCB,pkcβ activation,gain of function mutations,cell proliferation,tumor progression,epithelial-to-mesenchymal transition (emt),therapeutic target
ENSG00000263001,GTF2I,transcriptional regulation,dna repair mechanisms,epigenetic modification,tumor suppressor gene regulation,cell cycle progression,chromatin remodeling
ENSG00000120088,CRHR1,crhr1-mediated cell migration,g protein-coupled receptor function,pi3k/akt pathway activation,mapk/erk pathway activation,tumor progression correlation,inflammation modulation
ENSG00000087460,GNAS,camp signaling,oncogenic transformation,gain of function mutations,cell proliferation,tumor progression,therapeutic target
ENSG00000088256,GNA11,heterotrimeric g protein complex,constitutive activation,cellular signaling pathway,oncogenic transformation,tumor progression,therapeutic target
ENSG00000087258,GNAO1,gain of function mutations,aberrant signaling activation,cellular proliferation enhancement,oncogene role,tumor progression driver,therapeutic target
ENSG00000198055,GRK6,gpcr signaling,tumor progression,metastasis promotion,cell survival enhancement,protein kinase activation,oncogenic transformation
ENSG00000127955,GNAI1,g protein signaling,oncogene/tumor suppressor,cellular growth regulation,signaling pathway modulation,mitogen-activated protein kinases (mapks) activation,pi3k/akt pathway interaction
ENSG00000159069,FBXW5,cell cycle regulation,tumor suppressor function,protein degradation,oncogene regulation,cell proliferation control,genetic instability
ENSG00000070061,ELP1,genetic instability,dna repair mechanism,tumor progression,transcriptional regulation,genomic integrity,maintenance
ENSG00000119414,PPP6C,cellular proliferation,akt activation,protein dephosphorylation,epithelial-to-mesenchymal transition,tumorigenesis,wnt/β-catenin signaling
ENSG00000198001,IRAK4,nf-κb activation,innate immune response,tumor cell survival,inflammation pathway,apoptosis resistance,cancer progression
ENSG00000196083,IL1RAP,pro-inflammatory signaling pathway,constitutive activation,oncogenesis,tumor progression,cell proliferation,metabolic regulation
ENSG00000157625,TAB3,nf-κb pathway activation,aberrant signaling,genomic instability,tumor progression,pro-inflammatory cytokine production,therapeutic target
ENSG00000197329,PELI1,apoptosis regulation,autophagy modulation,inflammatory response regulation,cellular stress reaction,immune microenvironment modulation,tumor cell survival enhancement
ENSG00000232960,CSNK2B,cell cycle regulation,apoptosis inhibition,metastasis promotion,cell proliferation enhancement,tumor progression facilitation,oncogenic pathway modulation
ENSG00000082898,XPO1,nuclear export regulation,tumor progression,apoptosis inhibition,cell cycle regulation,oncoprotein export,chemotherapy resistance
ENSG00000132341,RAN,nuclear transport,centrosome overduplication,cell cycle progression,genomic instability,chromatin remodeling,gtp hydrolysis
ENSG00000108829,LRRC59,...<end>:

<begin>
cell proliferation,epithelial-to-mesenchymal transition (emt),protein-protein interactions,transmembrane protein function,signaling pathway regulation,overexpression and poor prognosis
ENSG00000172500,FIBP,fibp overexpression,cell migration,receptor tyrosine kinase activation,pi3k/akt pathway modulation,oncogenic driver,metastasis regulation
ENSG00000176170,SPHK1,sphingolipid metabolism,tumor progression,promotes cell proliferation,constitutive activation,metastasis and invasion,genomic instability
ENSG00000230514,AGER,tumor-promoting receptor,cell proliferation enhancement,angiogenesis regulation,metastatic potential,therapeutic target,inflammation mediation
ENSG00000147065,MSN,genomic instability,dna mismatch repair,tumor suppressor function,cancer predisposition,epigenetic silencing,mutations leading to cancer
ENSG00000067900,ROCK1,apoptosis resistance,cell migration,cytoskeleton regulation,invasion,metastasis,myosin light chain phosphorylation
ENSG00000173757,STAT5B,cellular proliferation,transcriptional regulation,oncogenic transformation,tumor progression,therapeutic target,signaling pathway modulation
ENSG00000108443,RPS6KB1,rps6k activation,akt/mtor pathway,cell proliferation regulation,protein synthesis enhancement,metastasis promotion,ribosomal protein phosphorylation
ENSG00000123609,NMI,chromatin remodeling,transcriptional regulation,oncogenic transformation,cell proliferation,gene expression regulation,nucleosome interaction
ENSG00000136156,ITM2B,disrupted protein processing,oncogenic transformation,tumor progression,metastasis,cell adhesion disruption,protein modification
ENSG00000134460,IL2RA,immune evasion,tumor microenvironment modification,cancer immunotherapy target,genetic alterations,t-cell regulation,cell proliferation promotion
ENSG00000127831,VIL1,oncogenic processes,promoter of cell migration,contributes to proliferation,overexpression implicated,tumor progression,therapeutic target
ENSG00000182511,FES,cellular proliferation,oncogenic activation,angiogenesis promotion,tumor progression,metastasis facilitation,poor prognosis indicator
ENSG00000120833,SOCS2,cellular proliferation,jak/stat pathway inhibition,negative regulator function,tumor progression,protein-protein interaction,cancer prognostic marker
ENSG00000153094,BCL2L11,apoptosis regulation,bax/bak activation,cellular senescence,oncogene expression,tumor progression,pro-apoptotic function
ENSG00000196628,TCF4,wnt/β-catenin signaling,overexpression,aberrant activation,cell proliferation,survival,emt regulation
ENSG00000184502,GAST,gastrin stimulation,cell growth regulation,mapk/erk pathway activation,angiogenesis promotion,metastasis facilitation,tumor progression
ENSG00000124151,NCOA3,transcriptional coactivator,tumor growth promotion,signaling pathway regulation,chromatin remodeling complex interaction,apoptosis inhibition,cell cycle regulation enhancement
ENSG00000197157,SND1,pi3k/akt pathway regulation,protein stabilization,cell proliferation promotion,tumor progression facilitation,oncogenic protein interaction,cancer cell survival enhancement
ENSG00000113520,IL4,tumor microenvironment modulation,immune evasion,apoptosis induction,tumor progression promotion,dual role in cancer,prognostic marker
ENSG00000185338,SOCS1,tumor suppressor,loss of function mutations,downregulation,stat3 phosphorylation inhibition,negative regulator,jak/stat pathway modulation
,HIST3H3,histone modification,chromatin remodeling,epigenetic regulation,cell proliferation,oncogene activation,gene expression alteration
ENSG00000124766,SOX4,transcription factor regulation,tumor promoter,pro-survival pathways,gene overexpression,cell proliferation enhancement,poor prognosis association
ENSG00000065559,MAP2K4,mapk signaling pathway,oncogenic activation,tumor progression,cell survival,apoptosis resistance,phosphorylation regulation
ENSG00000087095,NLK,wnt/β-catenin signaling pathway,constitutive activation,gain of function mutations,tumor suppressor degradation,cell cycle regulation,proliferation promotion
ENSG00000104432,IL7,tumor microenvironment,jak/stat pathway activation,cell proliferation enhancement,immune evasion mechanisms,apoptosis inhibition,oncogene interaction
ENSG00000013561,RNF14,ubiquitin ligase activity,g2/m phase transition,oncogene,cell cycle regulation,cancer progression,protein degradation
ENSG00000172531,PPP1CA,cell cycle regulation,dephosphorylation,apoptosis modulation,cancer development,oncogenic driver,tumorigenesis
ENSG00000167333,TRIM68,tumor suppressor,nf-κb pathway regulation,cell proliferation facilitation,epigenetic regulation,microrna-mediated control,oncogenic process promotion
ENSG00000105401,CDC37,cellular proliferation,protein kinase activation,molecular chaperone function,hsp90 interaction,oncogene stabilization,tumor progression
ENSG00000184895,SRY,cell proliferation,somatic recombination,tumor progression,x-chromosome inactivation,pluripotency,transcriptional regulation
,AES,wnt/β-catenin pathway,tumor progression,cell proliferation,metastasis,iron regulation,oncogenic potential
ENSG00000114166,KAT2B,epigenetic regulation,histone modification,transcriptional activation,cell cycle progression,apoptosis inhibition,oncogene activation
ENSG00000151729,SLC25A4,mitochondrial function,cellular metabolism,genomic instability,epigenetic regulation,oncogenic mutation,proliferation and survival enhancement
ENSG00000108654,DDX5,rna helicase activity,tumor suppressor function,transcription regulation,cell cycle progression,co-activator role,genomic stability maintenance
ENSG00000160310,PRMT2,cellular proliferation,oncogenic pathway activation,transcriptional regulation,methyltransferase activity,angiogenesis promotion,cancer biomarker
ENSG00000063978,RNF4,ubiquitination regulation,proteasomal degradation,chromatin remodeling,apoptosis inhibition,cell cycle modulation,tumor suppressor dysfunction
ENSG00000165671,NSD1,chromosomal instability,genome integrity maintenance,epigenetic regulation,histone methylation,cell proliferation promotion,survival pathway activation
ENSG00000186976,EFCAB6,oncogene activation,transcriptional regulation,chromatin remodeling,tumor progression,prognostic marker,cell proliferation
ENSG00000197321,SVIL,cell migration,actin cytoskeleton regulation,cancer metastasis,focal adhesion kinase (fak) interaction,tumor progression,therapeutic target
ENSG00000108175,ZMIZ1,cellular proliferation,tumor suppressor regulation,apoptosis modulation,transcriptional regulator,cell cycle regulation,uncoupled tumor growth
ENSG00000144747,TMF1,genomic instability,cell cycle regulation,telomere maintenance,dna repair mechanisms,transcriptional control,oncogene mutation
ENSG00000115641,FHL2,transcriptional regulation,oncogenic signaling,overexpression,cell proliferation,apoptosis suppression,emt induction
ENSG00000101224,CDC25B,cell cycle regulation,g1/s transition,dna replication,cyclin-dependent kinase activation,apoptosis suppression,tumor progression
ENSG00000101158,NELFCD,negative transcriptional elongation factor,rna polymerase ii-dependent transcription,enhanced cell proliferation,oncogenic gene regulation,tumor progression,poor prognosis
ENSG00000109685,NSD2,histone methylation,chromatin remodeling,amplification or overexpression,tumor progression,protein-protein interactions,cell proliferation
ENSG00000129514,FOXA1,transcription factor regulation,epithelial-to-mesenchymal transition,stem cell maintenance,cancer progression,poor prognosis,therapeutic target
ENSG00000107077,KDM4C,histone modification,epigenetic alteration,oncogenic driver,cell cycle regulation,tumor suppressor silencing,chromatin remodeling
ENSG00000115548,KDM3A,tumor progression,chromatin modification,histone demethylation,oncogene activation,cell proliferation,apoptosis regulation
ENSG00000100105,PATZ1,gain-of-function mutation,tumor progression,cell proliferation,apoptosis suppression,dna damage response,genomic instability
ENSG00000170606,HSPA4,protein folding regulation,chaperone function,tumor suppressor interaction,apoptosis resistance,angiogenesis modulation,cell survival promotion
ENSG00000107262,BAG1,apoptosis inhibition,tumor suppressor protein interaction,oncogenic function,cell cycle regulation,multifunctional protein,proteasome inhibition
ENSG00000078725,BRINP1,genomic instability,chromatin remodeling,cancer progression,cell cycle regulation,dna damage response,aneuploidy
ENSG00000185247,MAGEA11,immune evasion,tumor progression,epigenetic regulation,cancer-testis antigens,gene regulation,antigen presentation
ENSG00000146587,RBAK,apoptosis regulation,cell cycle checkpoint,genomic instability,tumor suppressor function,p53 interaction,cell death pathways
ENSG00000135940,COX5B,mitochondrial function,redox imbalance,genomic instability,tumor growth,energy metabolism,dna damage
ENSG00000122515,ZMIZ2,cell cycle regulation,apoptosis inhibition,microtubule stability,centrosome maintenance,oncogenic driver,tumor progression
ENSG00000136504,KAT7,chromatin remodeling,tumor suppressor regulation,gene expression dysregulation,cancer driver mutation,loss of function mutations,genomic instability
ENSG00000110768,GTF2H1,transcription regulation,genomic instability,amplification or overexpression,pro-survival pathways,transcriptional program regulation,nucleotide excision repair deficiency
ENSG00000266412,NCOA4,nuclear receptor coactivator function,autophagy regulation,oncogenic transcriptional activation,cell cycle progression,overexpression in cancer,poor prognosis marker
ENSG00000140682,TGFB1I1,cell migration,inhibited p53 function,tumor progression,signaling pathway modulation,protein interaction,overexpression </begin>
ENSG00000164045,CDC25A,cell cycle regulation,cell proliferation,apoptosis resistance,oncogenic process,tumor progression,mitotic progression
ENSG00000134248,LAMTOR5,ragulator-mtor pathway,autophagy regulation,oncogenic process,tumor growth promotion,cell proliferation enhancement,survival signaling
ENSG00000124664,SPDEF,ets transcription factor,epithelial-to-mesenchymal transition,tumor progression,gene expression regulation,oncogenic pathway activation,cell proliferation enhancement
ENSG00000147140,NONO,dna repair,cell cycle regulation,genomic instability,rna processing,transcriptional regulation,tumor progression
ENSG00000177426,TGIF1,apoptosis suppression,cell cycle regulation,genomic instability,oncogenic function,poor prognosis marker,transcription factor activity
ENSG00000169375,SIN3A,chromatin remodeling,histone modification,pro-apoptotic gene repression,tumor suppressor gene silencing,cell cycle progression,molecular interaction
ENSG00000132437,DDC,neurotransmitter regulation,cellular metabolism modulation,oncogene activation,tumor progression facilitation,angiogenesis promotion,cancer stem cell maintenance
ENSG00000126457,PRMT1,arginine methylation,cell migration,oncogenic transformation,transcriptional regulation,tumor progression,epigenetic modification
ENSG00000105229,PIAS4,epithelial-to-mesenchymal transition (emt),transcription regulation,oncogene activation,immune evasion,cell signaling modulation,stat3/5 pathway interaction
ENSG00000146278,PNRC1,coactivator activity,transcriptional regulation,cell proliferation enhancement,poor prognosis association,signaling pathway modulation,chromatin remodeling
ENSG00000168066,SF1,steroid biosynthesis regulation,tumor suppressor suppression,cell cycle regulation,oncogene function,transcriptional regulation,genetic amplification
ENSG00000117450,PRDX1,oxidative stress regulation,antioxidant function,cell survival promotion,tumor progression facilitation,hypoxia-induced expression,angiogenesis enhancement
ENSG00000110031,LPXN,cell junction organization,tumor progression,cell migration,oncogenic role,scaffold protein function,pi3k/akt pathway modulation
ENSG00000273173,SNURF,spliceosomal regulation,aberrant mrna splicing,oncogene overexpression,genomic instability,cell proliferation promotion,signaling pathway activation
ENSG00000106546,AHR,ahr signaling pathway,transcription factor activation,xenobiotic metabolism,cell proliferation,immune response modulation,dna damage repair
ENSG00000167657,DAPK3,tumor suppressor function,apoptosis regulation,microtubule dynamics modulation,cell cycle regulation,pi3k/akt pathway inhibition,p53-dependent apoptosis promotion
ENSG00000169750,RAC3,regulatory role,oncogenesis,tumor progression,cell cycle regulation,apoptosis inhibition,pi3k/akt pathway modulation
ENSG00000137992,DBT,oxidative stress regulation,dna damage response,genetic instability,detoxification pathway,cancer cell survival,cellular integrity maintenance
ENSG00000177463,NR2C2,oncogene activation,genomic instability,epigenetic regulation,transcriptional dysregulation,cellular proliferation,metastasis promotion
ENSG00000148180,GSN,enhanced cellular motility,epithelial-to-mesenchymal transition,matrix metalloproteinase expression,oncogenic protein-protein interaction,tumor progression,cytoskeletal dysregulation
ENSG00000083799,CYLD,nf-κb pathway,cellular stress response,deubiquitinating enzyme function,tumor suppressor activity,oncogenic signaling pathways,epigenetic regulation
ENSG00000131100,ATP6V1E1,tumor acidity,lysosomal function,ph regulation,cancer progression,metastasis facilitation,chemosensitivity alteration
ENSG00000082512,TRAF5,nf-κb activation,apoptosis inhibition,tumor progression,immune evasion,signaling pathway modulation,ripk1 interaction
ENSG00000260548,IRS4,pi3k/akt pathway activation,tumor progression facilitation,cell proliferation enhancement,insulin/igf-1 receptor interaction,scaffold protein function,oncogenic process promotion
ENSG00000172572,PDE3A,tumor suppressor function,camp and cgmp regulation,cell proliferation inhibition,oncogenic process promotion,cell migration and invasion facilitation,interactions with pi3k/akt pathway
ENSG00000132693,CRP,acute phase response,cancer prognosis,cell recognition,inflammation promotion,oncogenic interaction,tumor growth regulation
ENSG00000163399,ATP1A1,cancer cell proliferation,oncogene activation,protein interaction,tumor invasiveness,metabolic regulation,ion transport modulation
ENSG00000165409,TSHR,hormone regulation,cell proliferation,oncogenesis,signaling pathway,tumor growth,growth factor interaction
ENSG00000065135,GNAI3,g protein signaling,heterotrimeric complex formation,mapk/erk pathway regulation,cell proliferation modulation,apoptosis inhibition,tumor progression association
ENSG00000170820,FSHR,**
fsh signaling pathway,oncogenic role,cell proliferation,tumor progression,hormone receptor activation,genomic amplification 
**
ENSG00000239697,TNFSF12,cell proliferation,immune regulation,inflammation promotion,nf-κb activation,oncogenesis,signal transduction
ENSG00000006327,TNFRSF12A,tumor necrosis factor receptor superfamily member 12a,taci,cell proliferation,tumor growth,resistance to apoptosis,immunoregulation
ENSG00000177575,CD163,tumor microenvironment modulation,macrophage activation,hemoglobin-haptoglobin complex binding,immune evasion mechanisms,epigenetic regulation,prognostic marker
ENSG00000198681,MAGEA1,mage family member,tumor-specific antigen,cell proliferation,metastasis promoter,poor prognostic marker,chromatin remodeling interaction
ENSG00000138433,CIR1,nucleotide biosynthesis,cellular metabolism,genomic instability,epigenetic regulation,tumor progression,therapeutic target
ENSG00000022267,FHL1,cell cycle regulation,apoptosis suppression,dna damage response,transcription factor activity,oncogene activation,protein-protein interactions
ENSG00000184384,MAML2,notch signaling pathway,constitutive activation,fusion protein formation,cell proliferation,tumor growth,therapeutic target
ENSG00000196782,MAML3,notch signaling pathway,constitutive activation,amplification,cell growth,overexpression,therapeutic target
ENSG00000164105,SAP30,transcriptional repression,chromatin remodeling,pro-apoptotic gene suppression,oncogenic transformation,tumor progression facilitation,therapeutic targeting
ENSG00000283780,MAML1,notch pathway regulation,transcriptional coactivator function,tumor growth promotion,cellular proliferation regulation,apoptosis inhibition,genetic alterations associated
ENSG00000109670,FBXW7,tumor suppressor function,cell cycle regulation,ubiquitin ligase activity,protein degradation pathway,oncogene stabilization,genomic instability
ENSG00000113558,SKP1,ubiquitination regulation,cell cycle progression,cell proliferation,transcriptional regulation,protein degradation,oncogenic properties
ENSG00000231115,RING1,histone modification,chromatin remodeling,transcriptional repression,oncogenic driver,tumor progression,cancer stem cell regulation
ENSG00000223654,FLOT1,ferroptosis suppression,cell membrane integrity,lipid metabolism regulation,oncogenic process promotion,protein-protein interaction,poor prognosis marker
ENSG00000132589,FLOT2,lipid raft regulation,cell migration,membrane trafficking,oncogene,tumor progression,pi3k/akt pathway
ENSG00000281877,RPS6KA1,p90rsk activation,cell cycle progression,apoptosis evasion,angiogenesis promotion,therapeutic target,signaling pathway modulation
ENSG00000071242,RPS6KA2,aberrant activation,cell survival enhancement,metabolic reprogramming,tumor progression facilitation,therapeutic target potential,signaling pathway modulation
ENSG00000165458,INPPL1,dephosphorylation regulation,constitutive activation,cell proliferation,signaling pathway disruption,growth factor regulation,metabolic regulation
ENSG00000169891,REPS2,cell migration,cytoskeletal organization,actin cytoskeleton regulation,tumor progression,oncogenesis,growth factor signaling
ENSG00000142273,CBLC,calcium ion binding,tumor suppression,cancer cell growth regulation,cell differentiation regulation,apoptosis modulation,nuclear localization
ENSG00000143333,RGS16,regulation of gpcr signaling,modulation of mapk pathways,interaction with p53,inhibition of cell proliferation,increased apoptosis,tumor suppressor activity
ENSG00000168374,ARF4,tumor progression,oncogenic signaling,cell survival,apoptosis regulation,cytoskeleton modulation,protein-protein interaction
ENSG00000111057,KRT18,tumor suppressor,genomic instability,cellular polarity loss,apoptosis regulation,cell cycle progression,epithelial integrity maintenance
ENSG00000149480,MTA2,histone modification,chromatin remodeling,epigenetic regulation,tumor progression,oncogenic role,metastasis promotion
ENSG00000136044,APPL2,pi3k/akt pathway,oncogenic mutations,cell proliferation,tumor progression,metabolic regulation,therapeutic target
ENSG00000034152,MAP2K3,dual-specificity kinase activation,mapk signaling pathway involvement,tumor progression promoter,cell growth regulator,protein-protein interaction modulator,oncogenic transformation driver
ENSG00000127946,HIP1,endocytic vesicle regulation,oncogenic pathway activation,tumor progression driver,protein-protein interaction,genomic amplification or overexpression,cell migration and invasion enhancement
ENSG00000166225,FRS2,fgfr interaction,tyrosine phosphorylation,cell proliferation,receptor tyrosine kinase activation,adapter protein function,sh2 domain binding
ENSG00000138193,PLCE1,pi-plc pathway,constitutive activation,gain of function mutations,tumor progression,biomarker for prognosis,cell signaling dysregulation
ENSG00000105971,CAV2,disrupted caveolae function,downregulated expression,interaction with pi3k/akt pathway,metastasis promotion,cell growth regulation,structural component disruption
ENSG00000140600,SH3GL3,rho-gap activity,promotes tumor progression,regulates pi3k/akt pathway,cell survival and growth modulation,overexpression associated with cancer,small gtpase regulation
ENSG00000106976,DNM1,dynamin function,cancer cell invasion,clathrin-coated vesicles,cell migration regulation,endocytic pathway modulation,tumor progression
ENSG00000156508,EEF1A1,mrna translation regulation,cell proliferation enhancement,oncogene function,protein synthesis facilitation,tumor progression driver,aggressive tumor behavior
ENSG00000109917,ZPR1,zinc finger domain,dna binding activity,transcriptional regulation,tumor progression,metastasis promotion,cellular proliferation enhancement
ENSG00000166484,MAPK7,erk5 activation,cell proliferation promotion,signaling pathway intersection,oncogenic gene regulation,therapeutic target potential,tumor microenvironment modulation
ENSG00000153233,PTPRR,cell-cell adhesion,receptor-type tyrosine phosphatase,dephosphorylation activity,signaling pathway regulation,tissue architecture disruption,metastasis facilitation
ENSG00000017797,RALBP1,gtpase regulation,cell migration,protein interaction,cell proliferation,tumor progression,cancer cell survival
ENSG00000144118,RALB,emt activation,constitutive activation,growth promotion,cell proliferation,metastasis enhancement,survival pathway regulation
ENSG00000108946,PRKAR1A,constitutive activation,loss-of-function mutations,oncogenic signaling,tumor progression,cell proliferation,prognostic marker
ENSG00000061938,TNK2,pi3k/akt pathway activation,oncogenic driver,tyrosine kinase function,cell migration promotion,epithelial-to-mesenchymal transition (emt),therapeutic target
ENSG00000070831,CDC42,rho gtpase pathway,oncogene activation,cell proliferation regulation,cytoskeleton organization,protein-protein interaction,tumor metastasis promotion
ENSG00000133056,PIK3C2B,regulatory subunit,oncogenic processes,cell survival,growth regulation,autophagy modulation,therapeutic target
ENSG00000144730,IL17RD,il-17r signaling pathway,epithelial-to-mesenchymal transition,overexpression,inflammation promotion,multiprotein complex formation,tumor progression
ENSG00000116285,ERRFI1,egfr signaling pathway inhibition,cell proliferation suppression,tumor growth regulation,oncogenic process modulation,therapeutic target,signaling pathway regulation
ENSG00000174238,PITPNA,lipid metabolism,membrane fluidity,oncogene,cell growth regulation,cell signaling pathway modulation,apoptosis inhibition
ENSG00000065243,PKN2,pi3k/akt signaling,oncogene activation,cell proliferation regulation,serine/threonine kinase activity,tumor progression promotion,gene expression modulation
ENSG00000129219,PLD2,phospholipid metabolism,tumor progression,cell proliferation,cell migration,protein kinase activation,signaling pathway regulation
ENSG00000140575,IQGAP1,pi3k/akt signaling,cell-cell adhesion disruption,overexpression,tumor progression,prognostic marker,signaling pathway modulation
ENSG00000288293,CC2D1A,wnt signaling pathway,tumor suppressor function,cell proliferation regulation,genomic instability,cancer driver mutation,protein-protein interaction
ENSG00000133703,KRAS,mapk/erk pathway activation,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic instability
ENSG00000095015,MAP3K1,nf-κb pathway activation,oncogene function,cell proliferation promotion,mapk/erk signaling,constitutive activation,functional redundancy
ENSG00000115290,GRB14,pi3k/akt signaling,overexpression,tumor aggressiveness,proliferation regulation,apoptosis inhibition,rho gtpase activation
ENSG00000160271,RALGDS,ras activation,cell proliferation,tumor progression,prognostic marker,signaling pathway modulation,oncogenic driver
ENSG00000141738,GRB7,cell proliferation,signal transduction,tumor progression,epithelial-to-mesenchymal transition (emt),oncogene overexpression,signaling pathway modulation
ENSG00000144566,RAB5A,rab gtpase regulation,endocytic trafficking pathway,oncogenic protein sorting,tumor growth promotion,metastasis facilitation,cell survival modulation
ENSG00000174791,RIN1,negative regulator,ras/mapk pathway,cell growth regulation,tumor suppressor function,loss of function mutations,cancer progression
ENSG00000137218,FRS3,glycolytic reprogramming,tumor aggressiveness,oncogenic driver,cell migration,therapeutic target,metabolic regulation
ENSG00000188313,PLSCR1,dna repair mechanism,cell survival regulation,immune response modulation,tumor microenvironment manipulation,apoptosis resistance induction,pi3k/akt signaling pathway involvement
ENSG00000128422,KRT17,cellular proliferation,epithelial cell integrity,cancer stem cell marker,genomic instability,tumor progression,protein-protein interaction
ENSG00000170421,KRT8,tumor progression,epithelial-to-mesenchymal transition,cell survival pathway,apoptosis resistance,cancer cell proliferation,inflammation-related signaling
ENSG00000137764,MAP2K5,mapk pathway,constitutive activation,gain of function mutations,tumor progression,cell survival enhancement,mitogen-activated protein kinase regulation
ENSG00000163558,PRKCI,genomic instability,constitutive activation,oncogenic transformation,tumor progression,cell proliferation,signaling pathway regulation
ENSG00000135480,KRT7,epithelial integrity,oncogene overexpression,pi3k/akt pathway activation,cell migration and invasion,cell proliferation,signaling pathway modulation
ENSG00000125743,SNRPD2,overexpression,rna splicing alterations,cell proliferation,tumor survival,genomic instability,epigenetic regulation
ENSG00000204842,ATXN2,cellular stress,pro-survival pathways,rna-binding protein,post-transcriptional regulation,tumor suppressor dysfunction,metastatic potential
ENSG00000076201,PTPN23,pi3k pathway inhibition,non-receptor tyrosine phosphatase,tumor suppression,cellular signaling regulation,downstream akt/mtor modulation,oncogenic process enhancement
ENSG00000145901,TNIP1,apoptosis regulation,cell proliferation promotion,chromatin remodeling involvement,nuclear protein function,tumor progression facilitation,transcriptional regulation modulation
ENSG00000076984,MAP2K7,jnk signaling pathway activation,oncogenic transformation,protein kinase activation,cell survival enhancement,tumor progression promotion,genetic amplification
ENSG00000085511,MAP3K4,tumor progression,constitutive activation,gain of function mutations,protein-protein interaction,cell signaling pathway,mapk pathway modulation
ENSG00000158711,ELK4,mapk signaling activation,transcription factor function,oncogene activity,cell proliferation enhancement,survival pathway modulation,genomic dysregulation
ENSG00000283060,ID3,oncogene activation,apoptosis regulation,cell cycle progression,tumor suppressor repression,cell proliferation promotion,immune response modulation
ENSG00000115738,ID2,cell cycle regulation,transcription factor activity,oncogenic protein interaction,tumor progression,poor prognosis marker,stem cell maintenance
ENSG00000111145,ELK3,constitutive activation,tumor progression,oncogene overexpression,transcriptional regulation,genomic instability,cell survival enhancement
ENSG00000172201,ID4,p53 pathway disruption,transcriptional regulator,oncogenic protein,metastasis facilitation,cell proliferation enhancement,epigenetic regulation
ENSG00000103479,RBL2,cell cycle regulation,tumor suppressor function,cell proliferation inhibition,oncogene activation,pi3k/akt/mtor pathway interaction,apoptosis induction
ENSG00000196092,PAX5,pi3k/akt signaling modulation,epithelial-to-mesenchymal transition (emt) facilitation,transcription factor activity,cell cycle regulation,oncogenesis promotion,therapeutic target potential
ENSG00000159352,PSMD4,tumor progression,enhanced cell proliferation,oncogenic process,ubiquitin-proteasome pathway,protein degradation regulation,cell cycle control
ENSG00000166794,PPIB,protein stability modulation,cell proliferation promotion,oncogenic process facilitation,poor prognosis association,therapeutic target potential,cancer-related pathway interaction
ENSG00000164615,CAMLG,calcium signaling,calmodulin-binding interactions,cell migration,oncogenic pathways,tumor progression,metastasis
ENSG00000170027,YWHAG,oncogenic potential,cell cycle regulation,apoptosis evasion,protein-protein interactions,signal transduction modulation,gene expression regulation
ENSG00000136098,NEK3,chromosomal instability,cell cycle regulation,serine/threonine kinase activity,protein-protein interactions,aneuploidy,therapeutic target
ENSG00000151090,THRB,thyroid hormone signaling,constitutive activation,gain of function mutations,tumor suppressor repression,pi3k/akt pathway modulation,hormone-dependent transcription
ENSG00000151849,CENPJ,genomic instability,chromosome segregation,aneuploidy,spindle checkpoint regulation,kinetochore component,tumor suppressor
ENSG00000007264,MATK,receptor tyrosine kinase activity,growth factor binding,tumor progression,mutations leading to constitutive activation,cell proliferation regulation,pi3k/akt pathway activation
ENSG00000000938,FGR,fgr-kinase activation,constitutive activation,cell proliferation,protein-phosphorylation,oncogenic process,tumor suppression
ENSG00000166068,SPRED1,ras/mapk signaling,constitutive activation,loss-of-function mutation,tumor suppressor function,cell proliferation regulation,oncogenic pathway activation
ENSG00000198369,SPRED2,rtk signaling dysregulation,loss of tumor suppressor function,cell proliferation enhancement,tumor progression facilitation,molecular marker for prognosis,signaling pathway regulation
ENSG00000197323,TRIM33,genome stability maintenance,transcription regulation,tumor suppressor activity,epithelial-to-mesenchymal transition,cell cycle progression regulation,dna repair mechanisms
ENSG00000114520,SNX4,endosomal sorting regulation,rab gtpase interaction,oncogenic transformation,tumor progression association,cancer cell proliferation,membrane trafficking modulation
ENSG00000129515,SNX6,cell migration,signaling pathway regulation,endocytic pathway dysregulation,tumor progression,prognostic biomarker,poor survival outcomes
ENSG00000111424,VDR,tumor suppressor function,regulation of cell growth,binding to vitamin d3,role in apoptosis,modulation of immune response,interaction with nuclear receptors
ENSG00000163877,SNIP1,p53 regulation,tumor suppressor function,loss of inhibitory effect,constitutive activation,promotes tumor growth,interacts with signaling pathways
ENSG00000100614,PPM1A,dephosphorylation,apoptosis regulation,tumor suppression,cell cycle regulation,nf-κb pathway inhibition,protein phosphatase activity
ENSG00000132953,XPO4,nuclear-cytoplasmic transport,apoptosis regulation,tumor progression,therapeutic target,cell cycle control,dna damage response
ENSG00000102974,CTCF,tumor suppressor function,epigenetic regulation,genomic stability maintenance,chromatin remodeling,oncogene silencing,cell growth regulation
ENSG00000126883,NUP214,cell proliferation,chromatin remodeling,genomic instability,mitotic checkpoint regulation,nuclear pore complex function,oncogene overexpression
ENSG00000166887,VPS39,endosomal fusion,autophagic pathway,oncogenic activation,cell proliferation,survival signaling,pi3k/akt pathway
ENSG00000157077,ZFYVE9,cytoskeletal regulation,metastasis promotion,cell migration,actin dynamics modulation,vesicle transport regulation,pi(3)p binding
ENSG00000272886,DCP1A,oxidative stress,dna damage,genomic instability,tumor progression,redox regulation,catalytic enzyme
ENSG00000066136,NFYC,genomic instability,cell cycle regulation,dna repair mechanisms,transcription factor activity,tumor suppressor function,oncogenic processes
ENSG00000120837,NFYB,transcriptional regulation,oncogenesis,cell proliferation,apoptosis inhibition,genomic instability,chromosomal abnormalities
ENSG00000169554,ZEB2,tumor progression,epithelial-to-mesenchymal transition,transcriptional regulation,wnt/β-catenin signaling pathway,prognostic marker,cancer aggressiveness
ENSG00000006125,AP2B1,endocytic trafficking regulation,e-cadherin downregulation,cancer cell invasion,metastasis promotion,therapeutic target,pi3k/akt pathway interaction
ENSG00000125971,DYNLRB1,dynein regulation,genomic instability,mitotic spindle assembly,chromosome segregation errors,oncogenic signaling,cell proliferation increase
ENSG00000023734,STRAP,tgf-β/smad signaling pathway,constitutive activation,scaffolding protein function,cell growth and survival enhancement,tumor progression and metastasis,prognostic marker potential
ENSG00000130177,CDC16,mitotic checkpoint regulation,cell cycle disruption,proteasome-dependent degradation,tumor suppressor function,ubiquitin ligase activity,chromosomal instability
ENSG00000176396,EID2,cell cycle regulation,transcriptional activation,tumor growth promotion,apoptosis inhibition,angiogenesis promotion,therapeutic target
ENSG00000004897,CDC27,apc/c regulation,anaphase-promoting complex,cell cycle progression,chromosome separation,genomic instability,cyclin-dependent kinase inhibitors
ENSG00000078399,HOXA9,tumor suppressor suppression,oncogenic transcription factor,resistance to therapy,prognostic marker,overexpressed in cancer,stem cell-like properties
ENSG00000221914,PPP2R2A,pp2a complex regulation,cell cycle regulation,apoptosis suppression,genomic instability,tumor progression,therapeutic target
ENSG00000108984,MAP2K6,erk5 activation,cell proliferation,constitutive activation,oncogene activation,tumor progression,apoptosis resistance
ENSG00000133740,E2F5,cell proliferation,transcriptional regulation,oncogene role,tumor progression,poor prognosis,genetic aberration
ENSG00000119699,TGFB3,tgf-β signaling pathway,dual role in tumor biology,epithelial-to-mesenchymal transition (emt),angiogenesis regulation,biomarker potential,downregulated expression
ENSG00000114302,PRKAR2A,pka regulation,cell proliferation enhancement,oncogenic processes,tumor progression facilitation,cellular signaling pathway alteration,genetic mutation association
ENSG00000188191,PRKAR1B,constitutive activation,dysregulated signaling,gain of function mutations,oncogenic role,cell cycle regulation,apoptosis inhibition
ENSG00000170604,IRF2BP1,irf2 regulation,tumor suppressor function,cell cycle inhibition,genomic stability maintenance,oncogenic process prevention,hyperactivated irf2 signaling
ENSG00000101076,HNF4A,cellular metabolism regulation,tumor progression driver,transcription factor activity,cell proliferation enhancement,glycolysis and lipogenesis regulation,pi3k/akt pathway interaction
ENSG00000125398,SOX9,oncogenic transcription factor,epithelial-to-mesenchymal transition,chemotherapy resistance,cell proliferation,angiogenesis,tumor progression
ENSG00000105325,FZR1,cell cycle regulation,scf complex interaction,ubiquitin ligase activity,apoptosis evasion,tumor suppressor regulation,genome instability
ENSG00000026508,CD44,tumor adhesion,cell migration,immune evasion,therapeutic target,prognostic marker,tumor progression
ENSG00000084623,EIF3I,eif3 subunit,aberrant translation regulation,tumor growth promotion,chemotherapy resistance,epithelial-to-mesenchymal transition (emt),oncogenic mrnas translation
ENSG00000118046,STK11,cellular transformation,pi3k/akt inhibition,tumor suppressor function,energy metabolism regulation,dna damage response modulation,loss-of-function mutations
ENSG00000144589,STK11IP,regulation of cell growth,tumor suppressor interaction,mtor pathway modulation,cellular transformation promotion,cancer-associated protein expression,autophagy regulation
ENSG00000001167,NFYA,transcription factor regulation,oncogene activation,cell proliferation promotion,dna repair modulation,apoptosis evasion enhancement,prognostic marker
ENSG00000148516,ZEB1,transcriptional repression,epithelial-to-mesenchymal transition,tumor progression,metastasis,cell migration,wnt/β-catenin pathway regulation
ENSG00000168589,DYNLRB2,cell cycle regulation,ubiquitination pathway,oncogenic protein expression,tumor growth promotion,cell proliferation enhancement,prognostic marker
ENSG00000124789,NUP153,chromatin remodeling,dna repair defects,tumor suppressor dysfunction,nuclear pore complex regulation,transcriptional regulation,genomic instability
ENSG00000181191,PJA1,ubiquitin-associated domain,protein degradation regulation,cell cycle progression modulation,tumor suppressor function,oncogene or tumor suppressor,cancer-related pathway interaction
ENSG00000039319,ZFYVE16,altered protein function,escrt machinery regulation,oncogenic process modulation,tumor progression enhancement,endosomal trafficking regulation,metastasis promotion
ENSG00000184221,OLIG1,oligodendrocyte development,cell proliferation regulation,oncogene function,transcriptional activation,pi3k/akt pathway interaction,metastasis promotion
ENSG00000168556,ING2,chromatin remodeling,transcriptional regulation,genomic instability,tumor suppressor function,loss of heterozygosity,cell cycle progression
ENSG00000169783,LINGO1,tumor growth promotion,cell proliferation regulation,metastasis facilitation,poor prognosis indicator,immune response modulation,neuronal development regulator
ENSG00000134243,SORT1,cell surface trafficking,tumor progression,promoter of oncogenesis,regulation of growth factors,enhancer of proliferation,key contributor to tumorigenesis
ENSG00000185634,SHC4,mapk pathway activation,oncogene potential,tumor progression,protein-protein interaction regulation,akt signaling enhancement,proliferation and survival promotion
ENSG00000073969,NSF,oncogene,cell signaling disruption,tumor progression,cancer cell survival,protein-protein interaction,membrane trafficking regulation
ENSG00000174804,FZD4,wnt signaling pathway,oncogene activation,tumor progression,epithelial-to-mesenchymal transition (emt),cell proliferation and survival,canonical wnt/β-catenin signaling
ENSG00000126583,PRKCG,aberrant activation,cell migration,cell proliferation,mapk/erk signaling,metastasis,oncogenic processes
ENSG00000125084,WNT1,wnt signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cell proliferation
ENSG00000188763,FZD9,wnt/β-catenin pathway,oncogenic function,upregulation in tumors,cell proliferation enhancement,metastasis promotion,gene expression regulation
ENSG00000105989,WNT2,wnt/β-catenin signaling,tumor progression,constitutive activation,oncogenic behavior,cell proliferation,prognostic marker
ENSG00000164930,FZD6,wnt signaling pathway,aberrant activation,cell proliferation,epithelial-to-mesenchymal transition (emt),therapeutic target,wnt ligand interaction
ENSG00000104332,SFRP1,wnt signaling pathway,inhibitory function,tumor suppressor role,epigenetic silencing,canonical pathway activation,cellular proliferation enhancement
ENSG00000182968,SOX1,transcription factor regulation,oncogenesis promotion,tumor progression facilitation,poor prognosis indicator,cell proliferation regulation,apoptosis inhibition
ENSG00000107404,DVL1,wnt/β-catenin pathway,oncogenic activation,signaling pathway deregulation,tumor progression,therapeutic target,cancer stem cell maintenance
ENSG00000155760,FZD7,wnt signaling pathway,cell proliferation,aberrant activation,tumor progression,chemoresistance,prognostic marker
ENSG00000277626,WNT3,canonical wnt signaling pathway,constitutive activation,epithelial-to-mesenchymal transition,oncogenic mutations,cell proliferation regulation,apoptosis evasion
ENSG00000155252,PI4K2A,phosphoinositide metabolism,oncogenic activity,cell proliferation,membrane trafficking,therapeutic target,genomic alterations
ENSG00000104290,FZD3,wnt/β-catenin pathway,cell proliferation,g-protein coupled receptor,tumor progression,signaling activation,receptor-ligand interaction
ENSG00000116128,BCL9,wnt/β-catenin signaling,transcriptional co-activator,cell proliferation driver,mutation hotspot,tumor suppressor inhibition,cancer stem cell regulation
ENSG00000162552,WNT4,oncogene,cell fate regulation,tumor initiation,cancer stem cell expansion,epithelial-to-mesenchymal transition (emt),apoptosis suppression
ENSG00000123384,LRP1,lrp1 internalization,tumor progression,growth factor regulation,cell signaling modulation,angiogenesis promotion,proteolytic activity association
ENSG00000154764,WNT7A,wnt/β-catenin pathway activation,prognostic marker,therapeutic target,tumor suppressor gene regulation suppression,cell adhesion and invasion modulation,oncogenic process promotion
ENSG00000163251,FZD5,wnt/β-catenin signaling pathway,constitutive activation,oncogene overexpression,cell proliferation,tumor progression,therapeutic target
ENSG00000185483,ROR1,tumor progression,therapeutic target,constitutive expression,oncogene activation,cell signaling pathway,epithelial-to-mesenchymal transition
ENSG00000150764,DIXDC1,cell polarity regulation,signaling pathway modulation,cellular proliferation,tumor progression,genetic alterations,protein-protein interactions
ENSG00000096384,HSP90AB1,hsp90 stabilization,oncogenic client protein,tumor progression,cell growth regulation,therapeutic target,apoptosis inhibition
ENSG00000104365,IKBKB,nf-κb pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,inflammation regulation
ENSG00000282905,NFKBIB,nf-κb signaling pathway,constitutive activation,loss-of-function mutations,oncogenic process,immune response regulation,inflammation modulation
ENSG00000145703,IQGAP2,cell adhesion disruption,constitutive activation,gain of function mutations,metastasis promotion,pi3k/akt pathway regulation,tumor suppressor interaction
ENSG00000161057,PSMC2,ubiquitin-proteasome pathway,cell cycle regulation,genomic instability,apoptosis suppression,tumor progression,therapeutic target
ENSG00000102871,TRADD,apoptosis inhibition,cell survival enhancement,nf-κb activation,ripk1 regulation,necroptosis pathway,tumor proliferation
ENSG00000102753,KPNA3,nuclear transport regulation,oncogene overexpression,protein import regulation,tumor progression promotion,poor prognosis marker,therapeutic target candidate
ENSG00000100804,PSMB5,proteasome activation,oncogenic processes,cell survival and proliferation,tumor suppressor degradation,therapeutic target,genomic instability
ENSG00000185104,FAF1,genomic instability,apoptosis regulation,tumor suppressor function,dna damage response,epigenetic modification,protein localization
ENSG00000100764,PSMC1,protein degradation,cellular homeostasis,tumor aggressiveness,apoptosis regulation,dna repair inhibition,oncogenic protein accumulation
ENSG00000137054,POLR1E,ribosomal biogenesis,cell proliferation,apoptosis resistance,tumor progression,oncogene function,ribosomal dna transcription
ENSG00000171453,POLR1C,ribosomal rna transcription,cell growth regulation,protein synthesis enhancement,genomic instability contribution,therapeutic target potential,oncogenic driver role
ENSG00000053918,KCNQ1,potassium channel regulation,cellular ion homeostasis,oncogenic overexpression,altered cell growth,poor prognosis marker,therapeutic target candidate
ENSG00000110700,RPS13,ribosomal disruption,mtor pathway activation,cell growth promotion,dna damage response,protein synthesis regulation,oncogenic mutations
ENSG00000089009,RPL6,ribosome biogenesis,growth factor-independent proliferation,cell cycle regulation,protein synthesis modulation,cancer-related dysregulation,ribosomal dysfunction
ENSG00000263528,IKBKE,nf-κb signaling pathway,inflammation modulation,ubiquitin ligase activity,oncogenic signaling,cell proliferation enhancement,apoptosis evasion
ENSG00000136560,TANK,nf-κb activation,regulatory function,signaling complex formation,tumor progression,oncogenic potential,tnf receptor interaction
ENSG00000096060,FKBP5,chromatin remodeling,apoptosis inhibition,epigenetic modulation,biomarker for prognosis,tumor progression,gene expression alteration
ENSG00000176046,NUPR1,oncogenic function,cell cycle regulation,apoptosis inhibition,transcription modulation,nuclear pore complex interaction,dna repair pathway
ENSG00000074266,EED,polycomb repressive complex 2,chromatin modification,genomic stability,h3k27me3 regulation,tumor suppressor function,loss-of-function mutation
ENSG00000103056,SMPD3,ceramide metabolism,tumor progression,oncogenesis,cell proliferation,therapeutic target,lysosomal function
ENSG00000025800,KPNA6,nuclear import receptor,cell proliferation,tumor growth promotion,genome stability modulation,gene regulation alterations,dna damage response interaction
ENSG00000075391,RASAL2,loss-of-function mutations,tumor suppressor function,inhibition of ras gtpase activity,modulation of cellular stress responses,regulation of metabolism,cellular homeostasis maintenance
ENSG00000138757,G3BP2,**
stress granule dynamics,tumor progression,cell signaling modulation,mapk/erk pathway activation,biomarker potential,metastasis promotion
**
ENSG00000168884,TNIP2,apoptosis inhibition,nf-κb signaling pathway activation,inflammatory response modulation,tumor progression promotion,prognostic marker potential,cell survival enhancement
ENSG00000173163,COMMD1,regulation of ubiquitination,tumor progression,cell growth suppression,c-jun inhibition,ap-1 regulation,prognostic marker
ENSG00000173692,PSMD1,proteasome regulation,cell proliferation,dna damage response,ubiquitination,apoptosis evasion,tumor progression
ENSG00000197170,PSMD12,genomic instability,protein degradation pathway,cellular homeostasis disruption,tumor aggressiveness,apoptosis evasion,proteasome dysfunction
ENSG00000163636,PSMD6,protein degradation,cell proliferation,tumor suppressor regulation,therapeutic target,cancer progression,oncogenesis
ENSG00000076604,TRAF4,nf-κb pathway modulation,oncogene activation,tumor progression,poor prognosis,cancer driver gene,prognostic biomarker
ENSG00000142534,RPS11,ribosome biogenesis,protein synthesis regulation,cell cycle progression,genetic instability,tumor suppressor activity,cancer driver mutations
ENSG00000173473,SMARCC1,chromatin remodeling,transcriptional regulation,epithelial-to-mesenchymal transition,dna repair pathways,oncogenic activation,tumor suppressor silencing
ENSG00000185627,PSMD13,apoptosis evasion,cell cycle regulation,metastasis suppression,protein degradation,ubiquitin-proteasome pathway,tumor suppressor
ENSG00000108344,PSMD3,protein degradation,tumor suppressor downregulation,oncogene activation,ubiquitin-proteasome pathway interaction,cell cycle progression regulation,dna repair modulation
ENSG00000184432,COPB2,ckii activation,cell cycle progression,apoptosis regulation,tumor proliferation,serine/threonine kinase,protein phosphorylation
ENSG00000141030,COPS3,ubiquitin-proteasome pathway disruption,cell cycle dysregulation,protein degradation impairment,retinoblastoma protein interaction disruption,tumor suppressor function loss,genomic instability promotion
ENSG00000124602,UNC5CL,tumor suppression,cell migration regulation,invasiveness modulation,rhoa/rock pathway interaction,loss of function mutations,tumor progression
ENSG00000139613,SMARCC2,chromatin remodeling,genomic stability regulation,oncogenic mutations,dna repair disruption,tumor suppressor activity,none
ENSG00000104881,PPP1R13L,protein phosphatase regulation,oncogenic signaling pathway,cell proliferation,apoptosis inhibition,chromatin remodeling,tumor progression
ENSG00000105127,AKAP8,apoptosis regulation,cell cycle modulation,enhanced proliferation,protein kinase anchoring,signaling pathway modulation,tumor progression
ENSG00000136518,ACTL6A,chromatin remodeling,oncogene activation,prc1 complex dysfunction,epithelial-to-mesenchymal transition (emt),tumor growth and metastasis,genomic instability
ENSG00000161016,RPL8,ribosome biogenesis,overexpression in cancer,aberrant protein synthesis,proliferation and survival enhancement,tumor progression modulation,therapeutic target
ENSG00000105202,FBL,regulation of signaling pathways,cell cycle progression,targeted protein degradation,tumor suppressor regulation,enhanced cell proliferation,oncogenic protein stabilization
ENSG00000156482,RPL30,oncogene,aberrant protein production,protein synthesis regulation,tumor progression,prognostic biomarker,ribosomal function dysregulation
ENSG00000174444,RPL4,ribosome subunit,cell proliferation,translational efficiency,tumor progression,protein synthesis regulation,genetic overexpression
ENSG00000133884,DPF2,cell migration,chromatin remodeling,dynein motor complex interaction,microtubule-dependent transport,oncogenic transcription factor,pi3k/akt signaling
ENSG00000131653,TRAF7,nf-?b signaling pathway,tumor suppressor activity,immune response regulation,apoptosis promotion,cancer progression inhibition,tumor development contribution
ENSG00000148396,SEC16A,er export regulation,cancer prognosis association,tumor progression enhancement,lipid metabolism dysregulation,cell proliferation promotion,protein trafficking modulation
ENSG00000100991,TRPC4AP,calcium influx regulation,tumor progression promotion,cell survival enhancement,metastatic potential increase,signaling pathway modulation,cellular calcium signaling
ENSG00000126777,KTN1,adhesion molecule,cell migration,cancer progression,overexpression,epithelial-to-mesenchymal transition,poor prognosis
ENSG00000101255,TRIB3,nf-κb regulation,inflammation modulation,apoptosis resistance,tumor progression,oncogenic driver,cell survival pathway
ENSG00000125995,ROMO1,mitochondrial respiration,metabolic adaptation,glycolysis regulation,cell growth promotion,protein-protein interaction,electron transport chain modulation
ENSG00000123091,RNF11,ubiquitin ligase activity,cell cycle regulation,apoptosis inhibition,protein degradation pathway,metastatic potential enhancement,tumor suppressor interaction
ENSG00000103035,PSMD7,protein degradation regulation,ubiquitin-proteasome pathway,cell cycle progression,tumor aggressiveness,metastasis,apoptosis regulation
ENSG00000165916,PSMC3,ubiquitin-proteasome pathway,protein degradation,cell cycle regulation,apoptosis inhibition,tumorigenesis driver,genomic instability
ENSG00000068654,POLR1A,ribosome biogenesis,constitutive activation,oncogenic process,cell proliferation,transcriptional regulation,protein overexpression
ENSG00000071994,PDCD2,cell death regulation,apoptosis inhibition,tumor progression,prognostic marker,genomic instability,signaling pathway interaction
ENSG00000143256,PFDN2,oncogene,pi3k/akt/mtor pathway modulation,cell growth regulation,protein folding chaperone,tumor progression enhancement,metastasis facilitation
ENSG00000171444,MCC,chromosomal instability,aneuploidy regulation,tumor suppressor function,spindle checkpoint regulation,mitotic progression,genomic stability maintenance
ENSG00000138095,LRPPRC,mitochondrial ribosome biogenesis,oncogene overexpression,cell growth promotion,metabolic reprogramming,energy metabolism dysregulation,tumor suppressor protein regulation
ENSG00000085760,MTIF2,mitochondrial translation regulation,tumor progression,oncogene overexpression,cellular proliferation,energy metabolism reprogramming,genetic instability
ENSG00000036672,USP2,chromatin remodeling,histone h2a deubiquitination,cell proliferation enhancement,tumor progression association,oncogenic gene expression,genomic instability induction
ENSG00000106144,CASP2,apoptosis regulation,genomic stability maintenance,proton gradient generation,dna damage response,cell survival enhancement,cancer therapy target
ENSG00000168067,MAP4K2,cellular proliferation,signaling pathway modulation,tumor progression,oncogenic function,kinase activity,transcription factor regulation
ENSG00000102226,USP11,pi3k/akt pathway activation,oncoprotein stabilization,cell proliferation enhancement,apoptosis inhibition,dna damage response regulation,glucose metabolism promotion
ENSG00000090863,GLG1,protein modification regulation,tumor progression enhancement,cell growth promotion,resistance to targeted therapies,poor prognosis biomarker,oncogenic protein interaction
ENSG00000090060,PAPOLA,aberrant expression,chemosensitivity loss,oncogene upregulation,polyadenylation regulation,prognostic marker,therapeutic target
ENSG00000186184,POLR1D,ribosomal biogenesis regulation,genomic instability driver,nucleotide metabolism enhancement,transcriptional regulator interaction,apoptosis resistance promotion,tumor progression facilitation
ENSG00000135002,RFK,phosphoinositide metabolism regulation,oncogenic activity enhancement,cell proliferation drive,tumor progression facilitation,protein expression increase,therapeutic target potentialization
ENSG00000175166,PSMD2,protein degradation pathway,cell proliferation enhancement,tumor suppressor protein degradation,oncogenic protein accumulation,cell cycle regulation,genomic instability
ENSG00000215301,DDX3X,cell proliferation regulation,oncogene activation,rna processing alteration,cell migration promotion,tumor growth enhancement,prognostic marker
ENSG00000119401,TRIM32,tumor suppressor function,cell cycle regulation,protein degradation,apoptosis,therapeutic target,genomic instability
ENSG00000166508,MCM7,cell cycle progression,dna replication,cell proliferation,tumorigenesis,therapeutic target,chromosomal segregation
ENSG00000100297,MCM5,chromosomal instability,cell cycle progression,tumor growth,genomic profiling,oncogene,aberrant cell cycle control
ENSG00000163481,RNF25,disrupted p53 pathway,protein degradation regulation,cell proliferation enhancement,tumor suppressor interaction,therapeutic target,genomic instability
ENSG00000162551,ALPL,cell growth regulation,tumor progression,angiogenesis promotion,metabolic reprogramming,ros regulation,phosphatase activity
ENSG00000163882,POLR2H,enhanced transcriptional activity,genomic instability,alternative splicing regulation,overexpression in cancer,cell proliferation and survival promotion,therapeutic target
ENSG00000177700,POLR2L,cellular regulation,gene expression alterations,chromatin modification,transcriptional activation,proliferation modulation,cell survival alteration
ENSG00000125630,POLR1B,ribonucleic transcription regulation,increased cell proliferation,amplification or overexpression,cell cycle progression,dna replication and repair,genomic instability
ENSG00000136485,DCAF7,dna damage response,tumor progression,ubiquitin ligase activity,oncogenic process,cell cycle regulation,genomic instability
ENSG00000072518,MARK2,**

microtubule regulation,cell proliferation,apoptosis evasion,chemoresistance,tumor growth,protein phosphorylation

**
ENSG00000100784,RPS6KA5,rsk5 activation,mtor pathway regulation,cell proliferation enhancement,therapeutic target identification,p53 interaction,proliferation and survival promotion
ENSG00000144802,NFKBIZ,nf-κb pathway activation,constitutive expression,oncogenic potential,tumor microenvironment modulation,cell growth promotion,apoptosis inhibition
ENSG00000017427,IGF1,igf-1 mediated cell proliferation,tumor microenvironment modulation,angiogenesis promotion,cell survival signaling,therapeutic target for chemotherapy resistance inhibition,pi3k/akt/mtor pathway activation
ENSG00000090020,SLC9A1,intracellular ph regulation,oncogenic process,cellular growth promotion,tumor aggressiveness,protein-protein interaction,poor prognosis
ENSG00000169252,ADRB2,g protein-coupled receptor activation,catecholamine signaling pathway,oncogenic processes,metastasis promotion,therapeutic target,upregulated expression
ENSG00000131095,GFAP,oncogenic role,cell adhesion regulation,tumor progression,epithelial-to-mesenchymal transition,enhanced cell motility,prognostic marker
ENSG00000100412,ACO2,altered energy metabolism,mitochondrial dysfunction,citric acid cycle disruption,oncogenic potential,tumor growth promotion,cellular redox imbalance
ENSG00000099995,SF3A1,spliceosome assembly,oncogenic transcripts,tumor aggressiveness,aberrant rna molecules,dna damage response,cell survival mechanisms
ENSG00000012504,NR1H4,cholesterol/lipid regulation,transcriptional activation,cell proliferation enhancement,bile acid signaling modulation,tumor growth promotion,therapeutic target
ENSG00000125503,PPP1R12C,cellular transformation,pp1 regulation,oncogenic activation,signaling pathway modulation,protein dephosphorylation,tumor growth promotion
ENSG00000138802,SEC24B,disrupted protein trafficking,cancer progression,enhanced metastasis,cellular stress responses,autophagy regulation,oncogenic signaling
ENSG00000123240,OPTN,disrupted autophagic flux,loss of function mutations,enhanced apoptosis,oncogenic signaling pathways,tumor progression,genomic instability
ENSG00000124733,MEA1,chromatin remodeling,epigenetic regulation,cell proliferation,histone modification,dna repair,genome stability
ENSG00000270647,TAF15,oncogene overexpression,p53 pathway inhibition,cell proliferation regulation,metastasis promotion,transcriptional regulation dysregulation,rna processing alteration
ENSG00000241945,PWP2,rna-binding protein,oncogenic driver,cell proliferation enhancement,apoptosis inhibition,tumorigenesis regulation,therapeutic target
ENSG00000140279,DUOX2,ros homeostasis regulation,oncogenesis driver,tumor progression promotion,therapeutic target,interactions with other genes and pathways,none
ENSG00000072062,PRKACA,gain of function mutations,constitutive activation,cell proliferation,apoptosis resistance,signal transduction,therapeutic target
ENSG00000107485,GATA3,oncogenic activity,transcription factor function,cell proliferation regulation,immune response modulation,prognostic biomarker,pi3k/akt pathway interaction
ENSG00000186652,PRG2,secretory phospholipase a2 activity,inflammatory mediator production,tumor progression facilitation,microenvironment modulation,prognostic marker association,oncogenic process promotion
ENSG00000069329,VPS35,wnt signaling pathway disruption,cell polarity disruption,membrane trafficking dysregulation,retromer complex member,oncogenic potential,tumor suppressor role
ENSG00000141543,EIF4A3,translation initiation factor,oncogenic driver,tumor growth promotion,cell cycle regulation,signal transduction pathway,cancer resistance
ENSG00000121481,RNF2,histone modification,epigenetic regulation,chromatin remodeling,tumor suppressor repression,cell proliferation enhancement,therapeutic target
,H3F3A,histone modification,epigenetic regulation,gain of function mutations,tumor growth,cell proliferation,chromatin assembly
,H3F3B,histone regulation,chromatin remodeling,epigenetic modulation,cell cycle progression,genomic instability,cancer epigenetics
ENSG00000179583,CIITA,altered antigen presentation,impaired t-cell activation,pro-inflammatory cytokines,myeloid-derived suppressor cell recruitment,tumor microenvironment modulation,immune evasion mechanisms
ENSG00000115840,SLC25A12,mitochondrial function,cellular metabolism,energy homeostasis,redox balance,tumor metabolism,poor prognosis marker
ENSG00000135047,CTSL,cathepsin activity,lysosomal degradation,epithelial-to-mesenchymal transition,metastasis promotion,immunomodulation,tumor progression
ENSG00000143507,DUSP10,erk/mapk pathway regulation,tumor suppressor function,dephosphorylation activity,cellular migration regulation,oncogenic kinase inhibition,prognostic biomarker candidate
ENSG00000100721,TCL1A,wnt/β-catenin signaling,gsk3β inhibition,cell proliferation,apoptosis suppression,oncogenic potential,tumor progression
ENSG00000112578,BYSL,cell migration,actin filament reorganization,cytoskeleton dynamics,cell invasion,extracellular matrix degradation,poor prognosis marker
ENSG00000178104,PDE4DIP,camp regulation,gene amplification,oncogene function,tumor progression,cancer cell growth,signaling pathway modulation
ENSG00000170315,UBB,ubiquitin-proteasome pathway,tumor growth,cell cycle regulation,genomic instability,dna repair mechanism,apoptosis modulation
ENSG00000177971,IMP3,tumor progression,epithelial-to-mesenchymal transition (emt),cell proliferation,protein-protein interactions,therapeutic target,genomic instability
ENSG00000133026,MYH10,overexpression,phosphorylation-dependent activation,cell migration regulation,tumor invasion facilitation,prognostic marker,hippo pathway interaction
ENSG00000108771,DHX58,dna damage response,genetic instability,fanconi anemia pathway,cell cycle regulation,apoptosis modulation,tumor progression marker
ENSG00000105270,CLIP3,microtubule regulation,cell migration modulation,oncogenic protein interaction,metastasis promotion,cytoplasmic linker function,tumor invasion enhancement
ENSG00000010318,PHF7,histone modification,transcriptional regulation,oncogene activation,apoptosis inhibition,genetic instability,tumor progression driver
ENSG00000269190,FBXO17,cancer cell proliferation,oncogene regulation,cell cycle control,tumor suppressor function,scf complex interaction,protein ubiquitination
ENSG00000111642,CHD4,chromatin remodeling,tumor promoter,genomic instability,nurd complex interaction,dna methylation regulation,transcriptional activation
ENSG00000056097,ZFR,rna-binding protein,alternative pre-mrna splicing,apoptosis regulation,cell cycle control,transcriptional regulation,genomic instability
ENSG00000100142,POLR2F,transcription elongation,amplification or overexpression,cell proliferation enhancement,therapeutic target,genomic instability,regulatory protein interaction
ENSG00000185787,MORF4L1,dna repair deficiency,genomic instability,homologous recombination impairment,tumor suppressor function,brca1 interaction,cell cycle regulation
ENSG00000071243,ING3,cell cycle regulation,apoptosis induction,dna damage response,tumor suppressor function,chromatin regulation,energy metabolism regulation
ENSG00000122026,RPL21,ribosomal biogenesis,cellular proliferation,oncoprotein translation,tumor growth,therapeutic target,metabolic regulation
ENSG00000184990,SIVA1,apoptosis regulation,caspase interaction,tumor suppressor function,protein-protein interactions,post-translational modification,cell death pathways
ENSG00000070495,JMJD6,pi3k/akt pathway,histone demethylase activity,oncogenic driver,cell cycle progression,apoptosis regulation,chromatin remodeling
ENSG00000142405,NLRP12,tumor suppression,cancer immunity,inflammation regulation,cell proliferation inhibition,nf-κb inactivation,protein interaction modulation
ENSG00000144524,COPS7B,csn complex regulation,dna damage response,cell cycle progression,protein degradation,genome stability maintenance,oncogenesis facilitation
ENSG00000132970,WASF3,gef activity,cancer progression,migratory capacity,angiogenesis regulation,proliferative signaling,prognostic marker
ENSG00000108107,RPL28,ribosomal protein overexpression,enhanced translation efficiency,tumor progression,cell growth promotion,proliferation increase,genomic instability
ENSG00000109339,MAPK10,constitutive activation,dysregulated apoptosis,overexpression,phosphorylation activity,signaling pathway modulation,stress-activated kinase
ENSG00000071082,RPL31,ribosome biogenesis,cell proliferation,apoptosis regulation,metastasis promotion,tumor aggressiveness,poor prognosis marker
ENSG00000082153,BZW1,cellular transcription regulation,transcription factor activity,tumor progression,apoptosis inhibition,cell proliferation,prognostic marker
ENSG00000004838,ZMYND10,wnt/β-catenin signaling pathway,chromatin remodeling,transcriptional regulation,epigenetic modification,tumor suppressor gene silencing,oncogene activation
ENSG00000173267,SNCG,dna repair mechanisms,tumor aggressiveness,cancer cell proliferation,cell cycle progression,stress response modulation,protein interaction networks
ENSG00000128604,IRF5,type i interferon regulation,oncogenic function,immune modulation,tumor progression,cell proliferation,apoptosis suppression
ENSG00000130303,BST2,**

tumor progression,metastasis promotion,immune modulation,cell migration regulation,protein interaction,gene overexpression
**
ENSG00000274185,LILRA4,immune evasion,downregulation,prognostic marker,tumor growth inhibition,innate immune modulation,adaptive immune response regulation
ENSG00000091592,NLRP1,programmed cell death,caspase-1 activation,inflammation regulation,tumor suppression,apoptosis induction,cellular stress response
ENSG00000197444,OGDHL,cytoskeletal reorganization,cell migration,genomic instability,tumor progression,prognostic biomarker,centrosome regulation
ENSG00000178462,TUBAL3,microtubule formation,cell proliferation,cell survival,apoptosis evasion,protein-protein interactions,cytoskeletal regulation
ENSG00000106615,RHEB,mtorc1 signaling,constitutive activation,gain of function mutations,tumor progression,cell proliferation,genomic instability
ENSG00000112685,EXOC2,exocytosis regulation,metastatic progression,tumor invasion,cancer cell migration,vesicle trafficking,genomic instability
ENSG00000006451,RALA,rala mutation,cytoskeleton regulation,dysregulated expression,cell migration,tumor progression,oncogenic transformation
ENSG00000116954,RRAGC,regulation of gtpase activity,oncogenic transformation,tumor growth promotion,cancer progression,therapeutic target,cellular trafficking regulation
ENSG00000248746,ACTN3,pi3k/akt/mtor pathway,constitutive activation,gain of function mutations,tumor progression,tumorigenesis,cell migration
ENSG00000166200,COPS2,dna damage response,genomic instability regulation,cell cycle progression modulation,apoptosis inhibition,ubiquitination regulation,mdm2-p53 pathway interaction
ENSG00000060138,YBX3,transcriptional regulation,apoptosis evasion,cell cycle progression,tumor metastasis,microrna regulation,p53 interaction
ENSG00000092445,TYRO3,receptor tyrosine kinase activity,angiogenesis promotion,metastasis facilitation,cell signaling dysregulation,tumor growth promotion,oncogene candidate
ENSG00000107874,CUEDC2,cell proliferation,ubiquitination regulation,oncogenic function,tumor suppressor interaction,proteasomal degradation,cell survival signaling
ENSG00000069667,RORA,cell cycle regulation,tumor suppressor function,chromatin remodeling,apoptosis induction,transcriptional modulation,epigenetic regulation
ENSG00000087191,PSMC5,protein turnover,dna damage repair,cell proliferation,apoptosis evasion,proteolytic activity,tumor aggressiveness
ENSG00000213928,IRF9,immune checkpoint regulation,cell cycle regulation,apoptosis induction,pi3k/akt pathway modulation,tumor microenvironment modulation,oncogenic signaling
ENSG00000138814,PPP3CA,nfat activation,cell survival enhancement,tumor aggressiveness,therapeutic resistance,pi3k/akt pathway modulation,pp2b overactivation
ENSG00000169288,MRPL1,mitochondrial translation,tumor growth promotion,oxidative phosphorylation regulation,cell survival enhancement,prognostic marker,genomic instability contributor
ENSG00000149273,RPS3,ribosomal protein function,translational regulation,cell proliferation,oncogenic potential,mtor pathway interaction,protein synthesis initiation
ENSG00000144028,SNRNP200,spliceosome component,oncogenic overexpression,cellular growth promotion,apoptosis suppression,prognostic marker,genomic instability
ENSG00000066044,ELAVL1,oncogene,alternative splicing regulation,mrna stability modulation,tumor progression driver,epigenetic regulation involvement,translational regulation
ENSG00000125347,IRF1,angiogenesis suppression,cellular immunosuppression,dna repair inhibition,oncogenic transcription regulation,tumor progression facilitation,tumor suppressor function disruption
ENSG00000107201,DDX58,innate immune response,viral recognition,type i interferon signaling,tumor progression,pro-inflammatory gene expression,immune modulation
ENSG00000136153,LMO7,cell cycle regulation,gene expression regulation,oncoprotein function,cell proliferation enhancement,tumor progression promotion,poor prognosis association
ENSG00000082014,SMARCD3,transcription regulation,chromatin remodeling,tumor progression,oncogenic processes,aberrant activation,swi/snf complex interaction
ENSG00000178307,TMEM11,mitotic regulation,aneuploidy,genomic instability,chromosome segregation,cell cycle control,tumor progression
ENSG00000087077,TRIP6,cytoskeleton regulation,cell migration,cell adhesion,oncogenic transformation,gene expression modulation,protein interaction
ENSG00000103423,DNAJA3,chaperone function,oncogene activation,tumor progression,apoptosis inhibition,cell survival regulation,protein stabilization
ENSG00000197561,ELANE,tumor progression,cell proliferation,protein-protein interactions,extracellular matrix degradation,inflammation regulation,cancer cell migration
ENSG00000158578,ALAS2,cellular metabolism regulation,heme biosynthesis,tumor growth promotion,therapeutic target,cell signaling interaction,protein-protein interaction
ENSG00000132703,APCS,cell cycle regulation,dysregulation of g2/m checkpoint,uncontrolled cell growth,tumorigenesis,cancer driver gene,mitotic degradation
ENSG00000165471,MBL2,tumor suppressor,complement pathway activation,immune evasion,cell proliferation regulation,apoptosis induction,inflammation modulation
ENSG00000050405,LIMA1,transcription factor activation,tumor progression,cell proliferation,oncogene,wnt/β-catenin signaling,overexpression
ENSG00000153201,RANBP2,ran gtpase regulation,tumor suppressor protein degradation,nuclear transport modulation,cell cycle progression,genomic instability,apoptosis evasion
ENSG00000173599,PC,extracellular matrix formation,collegen synthesis,tumor progression,metastasis promotion,cancer cell migration,cell invasion facilitation
ENSG00000011304,PTBP1,cellular regulation,post-transcriptional modification,nuclear export,pre-mrna splicing,rna binding protein,metastasis promotion
ENSG00000105963,ADAP1,cell migration,tumor progression,poor prognosis,overexpression,pi3k/akt pathway interaction,disrupted cell adhesion complexes
ENSG00000100316,RPL3,ribosomal assembly,tumor progression,promoter of cell growth,enhancer of protein synthesis,chemosensitivity resistance,oncogenic interaction
ENSG00000262406,MMP12,tumor progression,matrix degradation,metastasis promotion,prognostic marker,signaling pathway activation,inflammation regulation
ENSG00000102119,EMD,genomic instability,tumor progression,cell growth regulation,apoptosis disruption,nuclear architecture disruption,protein interaction alterations
ENSG00000115661,STK16,microtubule dynamics regulation,cell division regulation,centrosomal protein phosphorylation,oncogenic potential,genomic instability induction,apoptosis inhibition
ENSG00000198668,CALM1,calmodulin binding,cell proliferation enhancement,microtubule dynamics regulation,calcium signaling pathway modulation,tumor growth promotion,metastasis facilitation
ENSG00000172183,ISG20,apoptosis regulation,cell cycle progression,interferon-stimulated genes degradation,oncogenesis promotion,therapeutic target,ubiquitin ligase function
ENSG00000179562,GCC1,glycine decarboxylation,metabolic regulation,tumor progression,cellular proliferation,protein interaction,poor prognosis marker
ENSG00000128272,ATF4,cellular adaptation,transcriptional regulation,endoplasmic reticulum stress response,integrated stress response,oncogenesis,apoptosis modulation
ENSG00000275796,NLRP2,nlrp2,inflammasome assembly,pro-inflammatory cytokines,cellular stress response,tumor growth promotion,inflammation regulation
ENSG00000132530,XAF1,apoptosis regulation,tumor suppressor function,xiap inhibition,cell death evasion,genomic instability prevention,p53 interaction
ENSG00000083444,PLOD1,cell migration,protein-protein interaction,angiogenesis promotion,extracellular matrix regulation,tumor progression facilitation,upregulated expression level
ENSG00000221869,CEBPD,ccaat/enhancer-binding protein delta,cell proliferation,transcription factor activity,apoptosis suppression,wnt/β-catenin pathway interaction,tumor progression
ENSG00000084463,WBP11,pi3k/akt pathway activation,epithelial-to-mesenchymal transition regulation,cell proliferation promotion,metastasis facilitation,tumor progression enhancement,oncogenic transformation promoter
ENSG00000120217,CD274,tumor immunosuppression,pd-1/pd-l1 interaction,immune checkpoint blockade,cancer immune evasion,therapeutic target for cancer,molecular regulation of pd-l1
ENSG00000276977,PDCD1,immune checkpoint regulation,tumor immune evasion,pd-1/pd-l1 interaction,cancer immune suppression,therapeutic target for cancer treatment,cell surface receptor function
ENSG00000089022,MAPKAPK5,p38 mapk pathway,oncogenic potential,cell proliferation,signaling regulation,oncosuppressor role,prognostic marker
ENSG00000185386,MAPK11,cellular proliferation,signaling pathway activation,tumor progression,aberrant phosphorylation,oncogenic processes,protein-protein interactions
ENSG00000106462,EZH2,histone modification,tumor suppressor silencing,epigenetic regulation,transcriptional repressor,apoptosis inhibition,dna methylation
ENSG00000034713,GABARAPL2,autophagic flux enhancement,cancer cell metabolism,tumor growth promotion,cellular nutrient uptake,protein-protein interaction,tumor aggressiveness marker
ENSG00000234846,NEU1,endolysosomal regulation,?glucosidase activity,cellular homeostasis disruption,tumor growth influence,antigen presentation alteration,glycoprotein processing modulation
ENSG00000198911,SREBF2,lipid biosynthesis modulation,oncogenic function,gene expression regulation,tumor progression driver,metabolic reprogramming,cell growth promotion
ENSG00000184381,PLA2G6,pla2g6 mediated arachidonic acid release,pro-inflammatory eicosanoid production,tumor growth promotion,cell proliferation and survival pathways,angiogenesis stimulation,lipid metabolism regulation
ENSG00000132522,GPS2,oncogene activity,gene amplification,cell proliferation,signaling pathway activation,wnt/β-catenin pathway regulation,tumor progression
ENSG00000156265,MAP3K7CL,apoptosis regulation,tak1 inhibition,nf-κb pathway modulation,jnk signaling pathway interaction,cellular homeostasis maintenance,oncogenic potential
ENSG00000162889,MAPKAPK2,erk/mapk pathway,oncogene activation,cell proliferation,apoptosis inhibition,tumor progression,gene expression regulation
ENSG00000129167,TPH1,serotonin biosynthesis,constitutive activation,cell proliferation,oncogenesis,pi3k/akt pathway interaction,therapeutic target
ENSG00000110906,KCTD10,apoptosis modulation,cell cycle regulation,tumor suppressor activity,gene expression regulation,transcription factor interaction,genomic stability maintenance
ENSG00000143878,RHOB,constitutive activation,tumor progression,cell proliferation,apoptosis resistance,biomarker potential,signaling pathway dysregulation
ENSG00000043591,ADRB1,beta-adrenergic signaling pathway,gain of function mutations,tumor progression,cell proliferation,genomic instability,receptor activation
ENSG00000136541,ERMN,pi3k/akt pathway activation,mitotic progression,apoptosis suppression,cytoskeletal remodeling,cell migration enhancement,tumor aggressiveness
ENSG00000107164,FUBP3,transcription factor regulation,cell proliferation promoter,tumor aggressiveness marker,epithelial-to-mesenchymal transition (emt),dna binding specificity,oncogene activity
ENSG00000129083,COPB1,aberrant expression,cell signaling disruption,copi complex subunit,membrane trafficking regulation,nutrient uptake disruption,protein degradation dysregulation
ENSG00000140859,KIFC3,kinesin-related protein,microtubule-based motor activity,genomic instability,tumor aggressiveness,cell migration and invasion,mitotic spindle formation
ENSG00000079462,PAFAH1B3,cell cycle regulation,genomic instability,microtubule dynamics,protein kinase activation,tumor progression,biomarker
ENSG00000072201,LNX1,wnt/β-catenin signaling,e3 ubiquitin ligase activity,oncoprotein degradation,tumor suppressor regulation,cell proliferation promotion,prognostic marker
ENSG00000178952,TUFM,mitochondrial function,oxidative stress response,cell survival,therapeutic resistance,metabolic regulation,tumor progression
ENSG00000130165,ELOF1,translation efficiency enhancement,growth promotion,oncogenesis,protein synthesis upregulation,cell cycle progression,cancer cell adaptation
ENSG00000239732,TLR9,pattern recognition,innate immunity,cytokine production,immune suppression,cancer immunotherapy,microbiome regulation
ENSG00000052723,SIKE1,cellular stress response,apoptosis regulation,eif2a kinase inhibition,oncogenic splicing aberrations,cell proliferation enhancement,therapeutic target candidate
ENSG00000100453,GZMB,apoptosis induction,immune modulation,tumor suppression,programmed cell death,cancer aggressiveness,immunogenic protein
ENSG00000174106,LEMD3,tumor progression,apoptosis regulation,protein-protein interaction,cell signaling modulation,epithelial-to-mesenchymal transition (emt),oncogenic process
ENSG00000152492,CCDC50,tumor progression,cell proliferation,genomic instability,metastasis promotion,poor prognosis,protein-protein interaction
ENSG00000225921,NOL7,ribosome biogenesis,dna repair regulation,cell proliferation,genomic instability,oncogenic potential,tumor progression
ENSG00000145907,G3BP1,cellular regulation,stress granule modulation,mtor pathway interaction,tumor progression driver,protein synthesis regulation,metabolic adaptation
ENSG00000117335,CD46,tumor microenvironment modification,apoptosis inhibition,cell adhesion facilitation,immune response modulation,promotes tumor progression,biomarker candidate
ENSG00000137309,HMGA1,oncogene,chromatin remodeling,transcription regulation,cell proliferation,genomic instability,apoptosis regulation
ENSG00000130340,SNX9,cellular migration,tumor progression,endosomal trafficking,signaling pathway modulation,genomic instability,protein-protein interaction
ENSG00000079739,PGM1,hexokinase 2 regulation,glycolysis enhancement,pentose phosphate pathway activation,glycogen metabolism regulation,cell growth promotion,tumor progression facilitation
ENSG00000272804,KRTAP10-7,epithelial cell interaction,intermediate filament assembly,cell shape regulation,tissue architecture maintenance,mechanical stress resistance,mitochondrial protection
ENSG00000164346,NSA2,aberrant expression,altered trna processing,apoptosis resistance,cellular proliferation,dna damage response pathway,tumor progression
ENSG00000111640,GAPDH,glycolytic pathway,oncogenic function,tumor progression,metabolic reprogramming,epithelial-to-mesenchymal transition (emt),dna damage response
ENSG00000085978,ATG16L1,autophagic pathway regulation,cellular proliferation control,cancer development association,oncogenic process modulation,therapeutic target potential,autophagy dysregulation
ENSG00000100290,BIK,pro-apoptotic function,bcl-2 family interaction,apoptosis regulation,tumor growth suppression,dna damage response,clinical outcome association
ENSG00000140379,BCL2A1,anti-apoptotic function,genomic instability,treatment resistance,dna damage accumulation,cell survival promotion,pro-survival signaling pathway
ENSG00000143556,S100A7,tumor progression,cell proliferation,apoptosis regulation,angiogenesis regulation,chromatin remodeling,histone modification
ENSG00000073861,TBX21,tumor progression,transcription factor activity,gene regulation,cell proliferation,signaling pathway modulation,mutation in cancer
ENSG00000148798,INA,cancer survival,apoptosis inhibition,cell proliferation,cell death suppression,dna damage response,protein-protein interactions
ENSG00000124214,STAU1,cellular rna stability,oncogenic mrna regulation,cell migration,invasion,proliferation promotion,translation control
ENSG00000115524,SF3B1,gain of function mutations,aberrant splicing patterns,tumor suppressor function,oncogenic processes,cell proliferation and survival,genomic instability
ENSG00000173327,MAP3K11,apoptosis regulation,cell proliferation,cell cycle regulation,dna repair,mapk signaling pathway,serine/threonine kinase activity
ENSG00000115946,PNO1,regulatory function,cellular interaction,tumor progression,therapeutic target,endocytosis regulation,vesicular trafficking modulation
ENSG00000120616,EPC1,cell surface protein regulation,egf receptor binding,tumor progression,metastasis promotion,cell proliferation,signal transduction
ENSG00000117115,PADI2,tumor progression,prognostic marker,metastasis promotion,extracellular matrix remodeling,inflammation modulation,cellular signaling regulation
ENSG00000143631,FLG,pi3k/akt pathway,tumor progression,cell migration,protein function regulation,genomic instability,epithelial barrier dysfunction
ENSG00000084674,APOB,lipid transport,metabolic regulation,cell proliferation,tumor progression,cholesterol synthesis,apolipoprotein b
ENSG00000175197,DDIT3,apoptosis regulation,cell survival promotion,dna damage response,environmental stress induction,oncogenic pathway activation,transcription factor activity
ENSG00000136450,SRSF1,rna splicing regulation,oncogenic isoforms expression,alternative splicing dysregulation,cell growth promotion,tumor suppressor genes silencing,prognostic marker
ENSG00000141570,CBX8,chromatin remodeling,oncogenic function,gene silencing,epigenetic regulation,cancer development,tumor suppressor
ENSG00000008988,RPS20,ribosome biogenesis,protein synthesis regulation,cell cycle progression,genomic instability,mtor pathway interaction,therapeutic target
ENSG00000128973,CLN6,cholesterol metabolism disruption,cell cycle regulation disruption,autophagy dysregulation,transmembrane protein function,lysosomal dysfunction,cancer susceptibility gene
ENSG00000058262,SEC61A1,er protein transport,protein quality control,cellular homeostasis,misfolded protein stress,tumor progression,oncogene function
ENSG00000130811,EIF3G,pi3k/akt/mtor pathway,tumor growth and metastasis,cancer driver gene,cellular proliferation and survival,anti-apoptotic effects,translation initiation complex
ENSG00000162601,MYSM1,histone modification,cell cycle progression,dna damage response,epigenetic regulation,oncogene overexpression,tumor metastasis
ENSG00000166598,HSP90B1,heat shock protein chaperone function,protein stabilization and protection,client protein interaction,cell signaling pathway modulation,tumor progression facilitation,poor prognosis marker
ENSG00000167987,VPS37C,cell proliferation,aberrant activation,escrt-i complex,lysosomal regulation,mutations in cancer,receptor tyrosine kinase interaction
ENSG00000121807,CCR2,tumor microenvironment modification,immune suppression,angiogenesis promotion,metastasis facilitation,pro-inflammatory signaling,chemoattractant activity
ENSG00000120438,TCP1,protein folding regulation,chaperone function,cellular homeostasis maintenance,tumor progression facilitation,protein aggregation promotion,genetic instability enhancement
ENSG00000171435,KSR2,apoptosis regulation,map kinase signaling inhibition,tumor suppressor function,ras-dependent signaling inhibition,cellular response modulation,protein interaction scaffold
ENSG00000113595,TRIM23,overexpression,oncogene potential,cell proliferation,tumor suppressor interaction,apoptosis resistance,genomic instability
ENSG00000120896,SORBS3,oncogenic process,cell migration,tumor aggressiveness,therapeutic target,scaffolding protein,signaling pathway modulation
ENSG00000170482,SLC23A1,genomic instability,nucleoside transport,nucleic acid metabolism,dna repair dysfunction,tumor suppressor loss,metabolic reprogramming
ENSG00000104812,GYS1,metabolic reprogramming,glycogen synthesis activation,energy metabolism regulation,tumor progression enhancement,cellular growth promotion,aberrant signaling pathway activation
ENSG00000150459,SAP18,akt pathway inhibition,apoptosis evasion,cell cycle regulation,oncogenic properties,phosphatase regulation,signaling modulation
ENSG00000188529,SRSF10,alternative splicing,apoptosis regulation,cell cycle modulation,gene expression regulation,oncogenic isoform creation,pre-mrna processing regulation
ENSG00000013364,MVP,vault complex modulation,chemotherapy resistance,tumor progression,overexpression,drug transport,cellular interaction
ENSG00000162664,ZNF326,zinc finger protein regulation,anti-apoptotic activity,cell cycle progression,tumor suppressor gene repression,oncogenic transcription factor,chromatin remodeling
ENSG00000168310,IRF2,apoptosis regulation,gene expression modulation,tumor suppressor function,genome stability maintenance,cell cycle control,transcriptional activation
ENSG00000142541,RPL13A,protein synthesis,cell proliferation,translation initiation,apoptosis regulation,ribosomal component,tumor promoter
ENSG00000214753,HNRNPUL2,overexpression,oncogene activation,alternative splicing regulation,transcriptional dysregulation,epithelial-to-mesenchymal transition,pi3k/akt pathway interaction
ENSG00000088833,NSFL1C,protein degradation regulation,ubiquitin-proteasome system modulation,tumor progression facilitation,cellular homeostasis disruption,oncogenic protein accumulation,apoptosis suppression
ENSG00000150991,UBC,ubiquitination pathway,gene amplification,protein turnover regulation,cell cycle progression modulation,tumor progression promotion,apoptosis inhibition
ENSG00000164118,CEP44,microtubule dynamics,chromosomal instability,oncogenic processes,cell cycle progression,centrosome duplication,tumor growth
ENSG00000047315,POLR2B,rna polymerase ii regulation,increased transcriptional activity,gene expression modulation,cell cycle progression,poor prognosis marker,amplification event
ENSG00000164111,ANXA5,cell proliferation,protein-protein interactions,pi3k/akt pathway activation,calcium-dependent regulation,apoptosis resistance,biomarker overexpression
ENSG00000008438,PGLYRP1,innate immune modulation,tumor microenvironment modulation,pro-inflammatory signaling,poor prognosis association,oncogenic pathway activation,tumor growth promotion
ENSG00000163257,DCAF16,dna damage response,genome stability,cell cycle regulation,ubiquitin-proteasome system,protein degradation,tumor progression
ENSG00000130939,UBE4B,cell cycle progression,apoptosis inhibition,protein degradation regulation,tumor suppressor protein stabilization,oncogene stabilization,genomic instability
ENSG00000010278,CD9,cell adhesion disruption,tumor suppressor potential,metastasis enhancement,apoptosis modulation,protein-protein interaction,biomarker for prognosis
ENSG00000169403,PTAFR,paf signaling pathway,cell proliferation,immune evasion,tumor progression,angiogenesis,growth factor regulation
ENSG00000240583,AQP1,water transport,cellular hydration regulation,tumor growth promotion,metastasis facilitation,oncogenic protein expression,cell migration enhancement
ENSG00000109906,ZBTB16,tumor suppressor function,loss of function mutations,epigenetic regulation,cellular differentiation,cell proliferation regulation,transcriptional modulation
ENSG00000164877,MICALL2,cell adhesion disruption,gtpase activation,cancer metastasis,epithelial-to-mesenchymal transition (emt),protein-protein interaction,cytoskeletal organization
ENSG00000077522,ACTN2,cell adhesion disruption,protein overexpression,cytoskeletal reorganization,tumor progression promotion,apoptosis resistance,signaling pathway activation
ENSG00000231408,LTA,tumor progression,inflammation,immunosuppression,angiogenesis,tnf-alpha signaling,wnt/beta-catenin pathway
ENSG00000053372,MRTO4,mtor signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic instability
ENSG00000134107,BHLHE40,tumor progression,transcription regulation,cell proliferation,apoptosis inhibition,epigenetic modification,oncogene activation
ENSG00000188747,NOXA1,bcl-2 family regulation,apoptosis induction,mitochondrial outer membrane permeabilization,cancer cell death,cellular homeostasis regulation,tumor suppressor activity
ENSG00000168135,KCNJ4,cellular homeostasis regulation,kir4.1 channel function,oncogenic signaling interaction,tumor cell proliferation,potential therapeutic target,prognostic marker correlation
ENSG00000116711,PLA2G4A,cell membrane remodeling,inflammation modulation,oncogenic potential,cell migration regulation,angiogenesis promotion,phospholipid hydrolysis
ENSG00000055332,EIF2AK2,translation regulation,protein kinase activation,stress response modulation,oncogenic transformation,apoptosis inhibition,cell survival promotion
ENSG00000129673,AANAT,melatonin regulation,cell cycle regulation,anticancer properties,oxidative stress modulation,circadian rhythm regulation,protein acetylation
ENSG00000181789,COPG1,dna damage response,genomic instability,tumor progression,dna repair mechanisms,brca2 interaction,ros-induced damage
ENSG00000130222,GADD45G,apoptosis regulation,cell cycle control,dna damage response,genomic stability modulation,growth arrest regulation,stress response adaptation
ENSG00000160339,FCN2,complement activation,immune evasion,cell proliferation,tumor metastasis,protein-protein interaction,cancer prognosis
ENSG00000163661,PTX3,epithelial-to-mesenchymal transition,oncogenic signaling pathway,tumor microenvironment modulation,immune suppression,apoptosis regulation,angiogenesis enhancement
ENSG00000136709,WDR33,centrosome integrity regulation,aneuploidy induction,mitotic checkpoint dysfunction,chromosomal instability promotion,cell cycle dysregulation,protein-protein interaction modulation
ENSG00000101596,SMCHD1,chromatin regulation,genome instability,tumor suppressor dysregulation,epigenetic modulation,cell growth deregulation,oncogene activation
ENSG00000138764,CCNG2,apoptosis resistance,cell cycle regulation disruption,p53 interaction,oncogenic potential,tumor aggressiveness,poor prognosis
ENSG00000172809,RPL38,oncogene,ribosomal protein function,cell proliferation,protein synthesis regulation,signaling pathway activation,tumor progression
ENSG00000170634,ACYP2,xenobiotic metabolism,arylacetamide-deacetylating enzyme,cytochrome p450 superfamily,tumor suppressor or oncogene,environmental exposure and cancer,carcinogen metabolism
ENSG00000110169,HPX,angiogenesis promotion,apoptosis inhibition,cell migration facilitation,chemoresistance development,iron transport regulation,tumor growth enhancement
ENSG00000005022,SLC25A5,mitochondrial carrier protein,tumor progression,energy metabolism,succinate transport,anti-apoptotic function,glycolytic activity enhancement
ENSG00000263465,SRSF8,alternative splicing regulation,cell cycle dysregulation,genomic instability,mutations in cancer,oncogene/tumor suppressor,splice site recognition
ENSG00000007952,NOX1,nox1,constitutive activation,oxidative stress,genetic instability,proliferation promotion,cell survival enhancement
ENSG00000106538,RARRES2,tumor suppressor,epithelial-to-mesenchymal transition,pi3k/akt pathway modulation,cell differentiation regulation,apoptosis regulation,downregulation in cancer
ENSG00000178028,DMAP1,dna repair mechanisms,cell cycle regulation,transcription factor modulation,genome stability maintenance,tumor progression promotion,prognostic marker candidate
ENSG00000144635,DYNC1LI1,microtubule regulation,cell division dysregulation,tumor aggressiveness,mitotic spindle assembly,protein-protein interaction,cell migration facilitation
ENSG00000149534,MS4A2,oncogene activation,epithelial-to-mesenchymal transition,cell proliferation promotion,tumor progression facilitation,therapeutic target,signaling pathway modulation
ENSG00000145649,GZMA,apoptosis regulation,serine protease activity,cell death induction,tumor cell survival,immune evasion mechanisms,autophagy regulation
ENSG00000173641,HSPB7,microtubule stability regulation,actin dynamics modulation,oncogenic signaling pathway interaction,constitutive activation leading to tumorigenesis,apoptosis resistance promotion,cellular morphology modification
ENSG00000156711,MAPK13,cell cycle regulation,apoptosis evasion,epithelial-to-mesenchymal transition (emt),protein kinase activation,stress response pathway,therapeutic resistance
ENSG00000065328,MCM10,genomic instability,cell proliferation,helicase activity,oncogenic processes,replication initiation,cell cycle progression
ENSG00000108578,BLMH,telomere maintenance,telomerase activation,genomic instability,oncogene overexpression,cell cycle regulation,dna repair mechanism
ENSG00000112874,NUDT12,genome stability maintenance,dna replication regulation,cell proliferation enhancement,oncogenic processes involvement,apoptosis resistance,chemotherapy evasion
ENSG00000091732,ZC3HC1,tumor progression,oncogene,pi3k/akt pathway interaction,genomic instability,aberrant gene expression,cell growth regulation
ENSG00000213465,ARL2,microtubule dynamics,tumor progression,cell proliferation,metastasis,signaling pathway regulation,stress response regulation
ENSG00000152795,HNRNPDL,pre-mrna splicing regulation,oncogenic potential,cell proliferation promotion,translational regulation,rna export modulation,tumor metastasis facilitation
ENSG00000092067,CEBPE,epithelial differentiation,transcriptional regulation,cellular growth control,tumor suppressor activity,apoptosis regulation,cell proliferation
ENSG00000138326,RPS24,ribosome assembly,cell proliferation,genomic instability,tumor progression,antitumor therapy,gene expression regulation
ENSG00000213923,CSNK1E,wnt/β-catenin signaling pathway,cancer driver mutation,cell proliferation regulation,tumor growth promotion,wnt pathway activation,protein kinase activity
ENSG00000186847,KRT14,epithelial cell integrity,cell proliferation,cancer prognosis,poor survival rate,microrna regulation,tumor progression
ENSG00000158773,USF1,...,none,none,none,none,none
ENSG00000116251,RPL22,ribosomal function,overexpression,cell proliferation,oncogenic potential,translational regulation,growth factor independence
ENSG00000169760,NLGN1,cell migration,oncogenesis,gene expression regulation,signaling pathway modulation,synaptic plasticity disruption,tumor progression facilitation
ENSG00000163512,AZI2,oncogene function,overexpression,transcription factor activity,epithelial-to-mesenchymal transition,cell proliferation,metastasis
,QARS,trna charging,cellular homeostasis disruption,oncogenic process promoter,apoptosis evasion,cell cycle progression,protein synthesis regulation
ENSG00000175899,A2M,tumor progression,immune evasion,metastasis facilitation,protease inhibition,ecm degradation,poor prognosis marker
ENSG00000169220,RGS14,g-protein coupled receptor signaling pathway modulation,downregulation,tumor suppressor function,cell proliferation inhibition,galpha subunit regulation,protein interaction modification
ENSG00000262845,KRT40,keratin expression,cellular adhesion,tumor progression,epithelial integrity,cell survival,cancer prognosis
ENSG00000105383,CD33,myeloid cell regulation,glycoprotein function,transmembrane receptor,cancer stem cell marker,tumor-promoting activity,immune evasion mechanism
ENSG00000122566,HNRNPA2B1,cell proliferation,rna processing,protein-protein interactions,tumor progression,apoptosis regulation,genomic instability
ENSG00000134419,RPS15A,ribosome biogenesis,dysregulated protein synthesis,oncogenic mutation,cell proliferation,tumor suppressor function,translational regulation
ENSG00000104884,ERCC2,genomic instability,increased mutation rates,nucleotide excision repair,chromosomal instability,cell cycle regulation,dna double-strand breaks
ENSG00000075856,SART3,altered splicing patterns,alternative splicing regulation,rna processing,pre-mrna recognition,tumor-specific isoforms,spliceosomal component interaction
ENSG00000147082,CCNB3,cell cycle regulation,cyclin-dependent kinase activation,genomic instability,chromosome segregation,mitotic progression,tumor suppressor inactivation
ENSG00000090924,PLEKHG2,regulation of rap1,gtpase activity,cell migration,tumor progression,oncogene function,prognostic marker
ENSG00000162511,LAPTM5,lysosomal regulation,cell migration,oncogenic signaling,prognostic marker,biomarker identification,cancer progression
ENSG00000099204,ABLIM1,cell migration,adhesion disruption,cytoskeleton organization,protein kinase activation,tumor progression,metastasis promotion
ENSG00000159200,RCAN1,nf-κb signaling pathway,constitutive overexpression,genomic instability,tumor progression,oncogene function,calcium signaling modulation
ENSG00000117632,STMN1,microtubule dynamics,cell proliferation,tumor invasion,cell migration,apoptosis inhibition,pi3k/akt pathway interaction
ENSG00000163694,RBM47,rna-binding protein,post-transcriptional regulation,cell proliferation regulation,mirna interaction,tumor progression promotion,genomic instability contribution
ENSG00000084093,REST,epigenetic regulation,tumor suppressor function,cellular proliferation,genome instability,apoptosis suppression,chromatin remodeling
ENSG00000180772,AGTR2,angiotensin ii signaling,g-protein coupled receptor,cell proliferation enhancement,tumor growth promotion,poor prognostic marker,therapeutic target candidate
ENSG00000156709,AIFM1,apoptosis regulation,mitochondrial function,cell death suppression,pro-apoptotic factor release,tumor progression,genomic instability
ENSG00000143033,MTF2,mtf2 transcriptional regulation,oncogenic signaling pathway activation,cell cycle progression modulation,tumor suppressor protein interaction,pro-survival gene expression,inflammatory response promotion
ENSG00000009724,MASP2,complement system activation,inflammation promotion,immunomodulation,glycoprotein binding,cellular damage response,tumor microenvironment
ENSG00000085265,FCN1,innate immune response,apoptotic cell clearance,tumor progression,metastasis promotion,immune evasion,prognostic biomarker
ENSG00000171566,PLRG1,tumor suppression,epithelial-to-mesenchymal transition,cell adhesion impairment,increased cell migration,loss of function mutations,genomic instability
ENSG00000126581,BECN1,autophagy regulation,apoptosis modulation,cell survival promotion,tumor progression,therapeutic resistance,genomic instability
ENSG00000138642,HERC6,oncogenic function,protein degradation regulation,ubiquitination,tumor suppressor regulation,cell proliferation promotion,therapeutic target
ENSG00000138641,HERC3,ubiquitination regulation,cancer-associated protein degradation,p53 pathway modulation,oncogenic signaling,tumor suppressor inactivation,cell cycle progression
ENSG00000168090,COPS6,cell proliferation,tumor progression,protein degradation regulation,ubiquitination machinery modulation,cancer therapy target,cell cycle control disruption
ENSG00000142937,RPS8,ribosome biogenesis,tumor progression,cell proliferation,oncogene activation,translation regulation,nutrient sensing
ENSG00000127152,BCL11B,genomic instability,tumor suppression,cellular differentiation,angiogenesis promotion,inflammatory response modulation,embryonic development
ENSG00000159140,SON,ribosome biogenesis,cell growth regulation,tumor progression,oncogenic protein interaction,pi3k/akt pathway activation,genomic amplification
ENSG00000074317,SNCB,protein degradation modulation,tumor progression driver,cellular trafficking regulation,oncogenic protein interaction,ubiquitin-proteasome pathway involvement,therapeutic target candidate
ENSG00000101444,AHCY,methionine cycle regulation,tumor progression driver,dna damage response,genomic instability,epigenetic modification,cellular homeostasis
ENSG00000062725,APPBP2,apoptosis regulation,cell cycle progression,dna damage response,oncogenic interaction,tumor growth modulation,protein-protein interaction
ENSG00000089094,KDM2B,histone modification regulation,tumor promoter,epigenetic regulator,transcriptional activator,protein-protein interaction,cancer cell epigenetics
ENSG00000205542,TMSB4X,cell migration,annexin a2 interaction,tumor progression marker,upregulated expression,prognostic significance,apoptosis inhibition
ENSG00000166037,CEP57,chromosomal instability,centrosome amplification,oncogenic driver,mitotic checkpoint regulation,aneuploidy,microtubule stabilization
ENSG00000180209,MYLPF,tumor progression,cell migration,prognostic marker,actin cytoskeleton regulation,rhoa/rock signaling,metastasis
ENSG00000163565,IFI16,apoptosis regulation,immune modulation,dna binding activity,tumor progression,cell survival enhancement,oncogene function
ENSG00000167460,TPM4,tumor progression,cellular migration,actin-binding protein,cytokeletal regulation,metastasis facilitation,prognostic marker
ENSG00000198814,GK,glucose phosphorylation,oncogenic potential,glycolysis promotion,energy demand support,tumor growth promotion,poor prognosis association
ENSG00000123358,NR4A1,cell proliferation,apoptosis regulation,tumor microenvironment modulation,therapeutic target,oncogenesis promotion,signaling pathway interaction
ENSG00000214944,ARHGEF28,rho gtpase activation,cell migration,tumor progression,gef activity,signaling pathway regulation,protein-protein interaction
ENSG00000197647,ZNF433,oncogene,tumor progression,cell proliferation,gene expression regulation,transcription factor activity,metabolic regulation
ENSG00000012779,ALOX5,tumor growth,leukotriene biosynthesis,inflammation regulation,oxidative stress modulation,metastasis promotion,therapeutic target
ENSG00000116688,MFN2,mitochondrial biogenesis,mitochondrial dynamics,pi3k/akt pathway activation,autophagy regulation,proliferation enhancement,survival resistance
ENSG00000121957,GPSM2,gpcr signaling pathway,gain of function mutations,cell proliferation,therapeutic target,tumor progression,genomic instability
ENSG00000106263,EIF3B,protein synthesis regulation,cell growth promotion,translation efficiency increase,oncogenic mutation,therapeutic target potential,mrna recruitment facilitation
ENSG00000100028,SNRPD3,cell proliferation,enhanced survival,alternative splicing regulation,tumor development,transcriptional modulation,cellular metabolism
ENSG00000019549,SNAI2,transcription factor regulation,epithelial-to-mesenchymal transition,metastasis promotion,tumor progression,wnt/β-catenin pathway interaction,poor prognosis
ENSG00000198932,GPRASP1,cellular regulation,pi3k/akt pathway interaction,scaffold protein function,cell proliferation enhancement,survival pathway modulation,oncogenic process promotion
ENSG00000169567,HINT1,cellular survival,transcriptional control,chromatin remodeling,dna repair,oncogenic processes,tumorigenesis
ENSG00000166483,WEE1,g2/m checkpoint regulation,dna damage response,cancer cell survival,cell cycle progression,therapeutic target,chemotherapy resistance
ENSG00000151846,PABPC3,genomic instability,oncogenic potential,mrna regulation,cell proliferation,apoptosis inhibition,therapeutic target
ENSG00000102010,BMX,oncogenic transformation,tumor progression,apoptosis evasion,pi3k/akt pathway activation,cell proliferation,angiogenesis promotion
ENSG00000159176,CSRP1,cell migration,pi3k/akt signaling,epithelial-to-mesenchymal transition,protein-protein interaction,upregulated expression,tumor progression
ENSG00000125691,RPL23,protein synthesis regulation,tumor promoter,cell proliferation enhancement,apoptosis suppression,ribosomal subunit formation,mutation driven cancer
ENSG00000236014,VPS52,aberrant trafficking,altered metabolism,cell proliferation,endosomal sorting,oncogenic recycling,protein regulation
ENSG00000127837,AAMP,tumor suppressor,cell proliferation regulation,protein-protein interaction modulation,oncogenic process inhibition,cell growth suppression,anti-tumor function
ENSG00000127483,HP1BP3,tumor suppressor function,chromatin organization,genomic instability,cell cycle progression,epigenetic regulation,dna replication
ENSG00000072210,ALDH3A2,aldehyde detoxification pathway,antioxidant mechanism,cell survival enhancement,chemoresistance,enzyme regulation,redox balance maintenance
ENSG00000196218,RYR1,calcium channel regulation,er stress modulation,cell survival enhancement,tumor progression,therapeutic target,genomic instability
ENSG00000130402,ACTN4,cell migration,actin cytoskeleton modulation,cancer metastasis,promoter mutations,tumor progression,mechanotransduction
ENSG00000162191,UBXN1,homologous recombination repair,apoptosis suppression,mitotic checkpoint regulation,dna damage response,chromatin remodeling,protein-protein interaction
ENSG00000122359,ANXA11,p53 pathway interaction,apoptosis regulation,cell survival enhancement,pro-tumor function,membrane trafficking modulation,oncoprotein overexpression
ENSG00000138180,CEP55,centrosomal protein regulation,cytokinesis regulation,cell cycle progression,therapeutic target,prognostic marker,tumor suppressor function
ENSG00000102081,FMR1,epigenetic silencing,mutation leading to loss of function,cellular regulation disruption,oncogenic signaling pathway modulation,tumor cell proliferation enhancement,survival pathway activation
ENSG00000128228,SDF2L1,rho/rac gtpase signaling pathway,cell proliferation,gtpase activity regulation,tumor progression,oncogenic pathway activation,biomarker potential
ENSG00000114841,DNAH1,ciliary dysfunction,oncogenic potential,overexpression,tumor progression,cell proliferation,aberrant cell migration
ENSG00000143851,PTPN7,pi3k/akt pathway dysregulation,constitutive activation,oncogenic mutations,tumor suppressor function,tyrosine kinase inhibition,phosphatase activity disruption
ENSG00000173889,PHC3,chromatin remodeling,gene silencing,wnt/β-catenin signaling,oncogene activation,genomic instability,alelic imbalance
ENSG00000139211,AMIGO2,cell-cell interactions,epithelial-to-mesenchymal transition (emt),angiogenesis promotion,cell surface molecule interaction,pi3k/akt signaling pathway modulation,cancer cell invasion facilitation
ENSG00000141837,CACNA1A,...,none,none,none,none,none
ENSG00000182774,RPS17,protein synthesis disruption,aberrant protein accumulation,cell proliferation enhancement,oncogenic process driver,therapeutic target,genomic instability mediator
ENSG00000177663,IL17RA,nf-kb signaling,inflammation,pro-inflammatory cytokine,cell proliferation,tumor growth,metastasis
ENSG00000082516,GEMIN5,gemin-ddx21 complex,rna export,transcription regulation,mrna processing,dna damage response,cell cycle progression
ENSG00000078114,NEBL,cytoskeletal regulation,metastasis,cell adhesion molecule expression,kinase activation,tumor progression,protein-protein interaction
ENSG00000183386,FHL3,cell proliferation,hyperactivation pi3k/akt pathway,oncogenic transcription factor regulation,tumor progression,poor prognosis indicator,cancer biomarker
ENSG00000125977,EIF2S2,regulation of protein synthesis,tumor growth promotion,ribosome biogenesis,environmental stress adaptation,mrna translation efficiency,therapeutic target
ENSG00000002834,LASP1,mitochondrial dynamics regulation,oncogenic function,cellular proliferation promotion,cytoplasmic adhesion regulation,focal adhesion assembly modulation,epigenetic modification involvement
ENSG00000136861,CDK5RAP2,centrosome integrity,cell cycle regulation,oncogenic signaling,tumor progression,therapeutic target,prognostic biomarker
ENSG00000116641,DOCK7,cell migration,constitutive activation,gtpase regulation,metastasis promotion,tumor progression,protein-protein interaction
ENSG00000128609,NDUFA5,impaired oxidative phosphorylation,genomic instability,increased ros production,tumor progression,cell survival pathway,energy metabolism
ENSG00000284983,DEFA1,antimicrobial peptide,cationic properties,broad-spectrum activity,innate immunity,tumor suppressor candidate,epithelial integrity maintenance
ENSG00000285176,DEFA1B,antitumor properties,apoptosis induction,immune response modulation,tumor microenvironment regulation,cell cycle arrest,oxidative stress induction
ENSG00000132356,PRKAA1,mtor pathway inhibition,tumor suppressor function,cell proliferation regulation,dna repair modulation,somatic mutations,genomic instability maintenance
ENSG00000155561,NUP205,nuclear pore complex stability,cellular proliferation,genomic instability,chromatin organization,dna repair regulation,cell cycle dysregulation
ENSG00000204308,RNF5,apoptosis regulation,cell cycle modulation,oncogene potential,protein degradation regulation,tumor suppression inhibition,ubiquitination pathway interaction
ENSG00000164307,ERAP1,antigen presentation,immune evasion,tumor progression,poor prognosis,biomarker potential,aberrant immune regulation
ENSG00000147274,RBMX,rna processing,transcriptional regulation,oncogenic potential,tumor growth promotion,cell proliferation enhancement,apoptosis inhibition
ENSG00000240505,TNFRSF13B,baff/ nf-κb activation,constitutive signaling,dysregulation in tumors,immune evasion,oncogenic function,potential therapeutic target
ENSG00000121068,TBX2,cell cycle regulation,genomic stability maintenance,tumor growth promotion,metastasis facilitation,emt induction,epigenetic regulation
ENSG00000168438,CDC40,kinetochore-microtubule attachments,cell cycle progression,dna replication,oncogenic pathway activation,anti-apoptotic function,genomic instability promotion
ENSG00000175467,SART1,altered splicing patterns,alternative splicing,rna processing regulation,transcriptional dysregulation,apoptosis inhibition,cell cycle progression
ENSG00000132153,DHX30,genomic instability,dna repair dysfunction,loss-of-function mutation,tumor suppressor function,genetic error accumulation,cell cycle regulation
ENSG00000182287,AP1S2,vesicle-mediated transport,adaptor protein 1 complex,cellular homeostasis,egfr endocytosis,pi3k/akt/mtor pathway,therapeutic target
ENSG00000030066,NUP160,nuclear pore complex regulation,cellular homeostasis disruption,gene expression modulation,chromatin remodeling interaction,aneuploidy facilitation,oncogenic signaling promotion
ENSG00000124831,LRRFIP1,apoptosis regulation,oncogene activity,tumor progression,therapeutic target,cell survival modulation,cancer resistance
ENSG00000080603,SRCAP,chromatin remodeling,oncogene activation,cell proliferation,poor prognosis,overexpression,therapeutic target
ENSG00000145247,OCIAD2,genomic instability,dna repair regulation,tumor suppressor,genetic mutations,cancer prognosis,protein interactions
ENSG00000165259,HDX,apoptosis regulation,chromatin remodeling,dna repair mechanism,cell cycle progression,histone deacetylation,oncogenesis promotion
ENSG00000100726,TELO2,telomere maintenance,genomic instability,cell proliferation,oncogenesis,dna damage response,mitotic stability
ENSG00000100345,MYH9,genomic instability,tumor suppressor,dna repair,chromosome segregation,cell migration,oncogene activation
ENSG00000167578,RAB4B,aberrant expression,cell surface receptor internalization,endocytic trafficking regulation,growth factor receptor signaling,membrane trafficking pathways modulation,oncogenic pathway dysregulation
ENSG00000186832,KRT16,keratin filament reorganization,epithelial-to-mesenchymal transition,cellular differentiation regulation,cell adhesion modulation,signaling pathway dysregulation,tumor progression facilitation
ENSG00000168961,LGALS9,immune evasion,tumor progression,anti-tumor immunity,cell-cell interactions,glycoprotein binding,apoptosis regulation
ENSG00000055955,ITIH4,tumor progression,angiogenesis,cell migration and invasion,biomarker for prognosis,proteolytic activity regulation,inflammation modulation
ENSG00000122565,CBX3,histone modification,chromatin remodeling,tumor suppressor function,genome stability maintenance,cell cycle regulation,apoptosis regulation
ENSG00000135443,KRT85,cell proliferation regulation,epithelial cell differentiation,intermediate filament structure,apoptosis modulation,squamous epithelium expression,tumor progression association
ENSG00000285152,RNF31,cell cycle progression,e3 ubiquitin ligase activity,dna damage response,protein degradation,onco-proliferative role,tumor suppressor dysregulation
ENSG00000173915,ATP5MD,energy metabolism disruption,metabolic reprogramming,mitochondrial dysfunction,glycolytic shift,oncogenic mutation,tumor progression support
ENSG00000278161,TFPT,wnt/β-catenin signaling,oncogene activation,tumor progression,cell proliferation,transcription regulation,genomic instability
ENSG00000185883,ATP6V0C,ph homeostasis regulation,tumor growth promotion,cellular metabolism alteration,pi3k/akt signaling interaction,oncogenic pathway modulation,therapeutic target potential
ENSG00000197771,MCMBP,dna repair modulation,cell cycle regulation,oncoprotein function,genomic instability,protein-protein interactions,tumorigenesis promotion
ENSG00000145041,DCAF1,ubiquitination regulation,tumor suppressor degradation,oncogenic process promotion,genome instability,cell cycle checkpoint regulation,apoptosis suppression
ENSG00000284881,DEFB1,tumor microenvironment modulation,antimicrobial activity loss,microbial invasion promotion,nf-κb pathway interaction,inflammation and oxidative stress induction,epithelial-to-mesenchymal transition regulation
ENSG00000137673,MMP7,tumor progression,proteolytic activity,extracellular matrix degradation,cancer cell invasion,angiogenesis modulation,cell survival enhancement
ENSG00000152240,HAUS1,genomic instability,microtubule dynamics regulation,centrosome cohesion maintenance,epithelial polarity regulation,mitotic progression regulation,aneuploidy promotion
ENSG00000173674,EIF1AX,protein synthesis regulation,cell survival enhancement,dna damage response modulation,tumor suppressor interaction,apoptosis resistance,oncogene cooperation
ENSG00000108528,SLC25A11,mitochondrial carrier protein,metabolic reprogramming,oncometabolite-mediated pathway,mitophagy regulation,tumor progression,potential therapeutic target
ENSG00000206075,SERPINB5,apoptosis inhibition,cell survival promotion,caspase inhibition,inflammatory response regulation,metastasis facilitation,oncogene overexpression
ENSG00000241837,ATP5PO,mitochondrial function,promotes oncogenesis,energy metabolism,warburg effect,cell proliferation,upregulated expression
ENSG00000114107,CEP70,centriole biogenesis,microtubule organization,plk1 interaction,oncogenic signaling,aberrant cell structures,cytoskeletal dynamics
ENSG00000186660,ZFP91,enhanced cell proliferation,overexpression,apoptosis resistance,poor prognosis,biomarker,transcriptional regulation
ENSG00000108883,EFTUD2,aberrant splicing,cell growth promotion,dna repair dysregulation,oncogene activation,pi3k/akt pathway interaction,tumor suppressor modulation
ENSG00000137497,NUMA1,mitosis regulation,gene expression dysregulation,chromosomal instability,tumor progression,cell proliferation regulation,somatic cell stability
ENSG00000115875,SRSF7,altered splice site recognition,aberrant pre-mrna processing,gene expression regulation,tumor progression modulation,oncogenic phenotype promotion,splicing factor dysregulation
ENSG00000123268,ATF1,oncogenic transcription factor,tumor suppressor inhibition,constitutive activation,angiogenesis promotion,cell proliferation regulation,metastasis facilitation
ENSG00000100280,AP1B1,tumor suppressor function,epithelial cell polarity regulation,basolateral surface sorting,cell adhesion regulation,migration and invasion modulation,transcription factor regulation
ENSG00000198431,TXNRD1,thioredoxin reductase activity,antioxidant system regulation,oxidative stress resistance,cell survival promotion,oncogene role,cell signaling pathway interaction
ENSG00000023330,ALAS1,heme biosynthesis,upregulated expression,tumor progression,angiogenesis promotion,cell survival enhancement,therapeutic target
ENSG00000104611,SH2D4A,tumor progression,signal transduction,cellular proliferation,oncogenic processes,cell migration,protein interaction
ENSG00000170677,SOCS6,loss of function mutations,tumor suppressor function,stat3 regulation,jak/stat pathway,cell growth inhibition,protein-protein interaction
ENSG00000133112,TPT1,tropomyosin regulation,apoptosis inhibition,cell migration enhancement,poor prognosis biomarker,actin filament dynamics modulation,cancer cell survival enhancement
ENSG00000067225,PKM,glycolytic reprogramming,tumor metabolism,oncogenic signaling,cell proliferation inhibitor,therapeutic target,metabolic adaptation
,HIST1H2AE,histone modification,chromatin remodeling,transcriptional regulation,cell cycle progression,dna repair,epigenetic regulation
,HIST1H2AB,histone modification,cell cycle regulation,dna repair mechanism,oncogenic processes,enhanced cell proliferation,tumor suppression
ENSG00000196136,SERPINA3,tumor metastasis,promotes cell migration,cell survival inhibition,epithelial-to-mesenchymal transition,pi3k/akt pathway interaction,mapk/erk pathway regulation
ENSG00000158859,ADAMTS4,extracellular matrix remodeling,tumor progression,metastasis facilitation,cell migration promotion,wnt signaling pathway interaction,proteoglycan degradation
ENSG00000112559,MDFI,transcription factor regulation,oncogene activation,cell proliferation promotion,tumor progression enhancement,mirna-mediated regulation,prognostic marker
ENSG00000126778,SIX1,emt regulation,oncogene activation,cell proliferation,migration and invasion,stem cell maintenance,signaling pathway deregulation
ENSG00000104408,EIF3E,translation regulation,tumorigenesis promotion,poor prognosis marker,enhanced translation efficiency,cell proliferation facilitation,protein synthesis modulation
ENSG00000185745,IFIT1,antiviral response,interferon-induced expression,tumor suppression inhibition,cell proliferation enhancement,immune evasion mechanism,cancer-related signaling pathway
ENSG00000057149,SERPINB3,cellular invasion,tumor progression,apoptosis regulation,oncogene potential,proteolytic cascade inhibition,cell survival enhancement
ENSG00000174123,TLR10,immune evasion,tumor progression,inflammation regulation,genomic instability,epigenetic modification,cellular response modulation
ENSG00000124875,CXCL6,immunosuppressive environment,tumor growth promotion,chemokine signaling,angiogenesis induction,prognostic marker,immunomodulation
ENSG00000144674,GOLGA4,protein trafficking regulation,golgi apparatus dysfunction,oncogenic driver,cellular stress response,aberrant protein secretion,tumor growth promotion
ENSG00000254772,EEF1G,translation regulation,protein synthesis upregulation,cell proliferation enhancement,cancer cell growth promotion,ribosome assembly modulation,genetic instability contribution
ENSG00000109061,MYH1,long-tail structure,epithelial-to-mesenchymal transition (emt),pi3k/akt signaling pathway regulation,dna damage response,cell migration and invasion facilitation,genomic stability maintenance
ENSG00000163902,RPN1,oncogene,tumor suppressor degradation,protein aggregation,nf-κb signaling,ubiquitin-proteasome pathway,cancer progression
ENSG00000110497,AMBRA1,genomic instability,dna repair,tumor suppressor function,cell cycle regulation,apoptosis modulation,protein-protein interaction
ENSG00000163739,CXCL1,angiogenesis promotion,chemoattractant function,immune suppression,tumor growth promotion,metastasis facilitation,prognostic marker
ENSG00000162896,PIGR,tumor progression,aberrant expression,immune evasion,cell proliferation,signaling pathway interaction,mucosal immunity
ENSG00000158856,DMTN,oncogenic driver,signaling pathway activation,cell proliferation promotion,tumor aggressiveness marker,therapeutic target potential,protein-protein interaction modulation
ENSG00000029363,BCLAF1,cell cycle regulation,apoptosis inhibition,tumor suppressor degradation,genomic instability,prognostic marker,oncogene activation
ENSG00000143621,ILF2,transcription factor regulation,tumor growth promotion,cell proliferation activation,metastasis facilitation,pro-inflammatory cytokine induction,oncogenic role
ENSG00000125970,RALY,gene regulation,dysregulated splicing,rna-binding protein function,oncogenic processes promotion,tumor progression correlation,cancer stem cell maintenance
ENSG00000117036,ETV3,tumor suppressor loss,transcriptional regulator,oncogene activation,cell cycle regulation,apoptosis evasion,metastasis promotion
ENSG00000198890,PRMT6,protein arginine methylation,oncogene function,cell proliferation regulation,transcriptional modulation,epigenetic regulation,cell survival promotion
ENSG00000135363,LMO2,cell cycle progression,overexpression,hematopoiesis regulation,apoptosis inhibition,tumor suppressor interaction,lim-only domain function
ENSG00000167552,TUBA1A,spindle checkpoint regulation,microtubule stabilization,cell proliferation enhancement,oncogenic process promotion,genomic stability maintenance,therapeutic target identification
ENSG00000118515,SGK1,cell proliferation,oncogenic function,gain of function mutations,therapeutic target,tumor progression,signaling pathway modulation
ENSG00000115009,CCL20,cancer cell recruitment,immune suppression,pro-tumorigenic microenvironment,angiogenesis promotion,chemokine signaling,tumor metastasis
ENSG00000038427,VCAN,tumor progression,cell migration,extracellular matrix regulation,oncogenic signaling,poor prognosis,cancer cell invasion
ENSG00000185722,ANKFY1,oncogene,cell proliferation,cell survival,tumor progression,genomic instability,adhesion regulation
ENSG00000175906,ARL4D,pi3k/akt pathway interaction,tumor progression,cell proliferation,genomic instability,gtpase activity loss,oncogenic driver
ENSG00000168488,ATXN2L,chromatin remodeling,epigenetic regulation,transcriptional activation,tumor progression,metastasis promotion,protein-protein interactions
ENSG00000168264,IRF2BP2,transcriptional repressor function,cell growth regulation,oncogenesis promotion,tumor suppressor inhibition,angiogenesis regulation,prognostic marker
ENSG00000087365,SF3B2,aberrant splicing,altered gene expression,gene mutation drivers,rna binding motifs,tumor progression,dysregulated cell cycle
ENSG00000135046,ANXA1,calcium-dependent binding,cell membrane trafficking,enhanced migration,inflammation regulation,oncogenesis,pi3k/akt pathway interaction
ENSG00000143761,ARF1,gtpase regulation,tumor progression,mutation associated,protein recycling,oncogenic signaling,cell proliferation
ENSG00000116661,FBXO2,dna repair mechanism,cell cycle regulator,tumor suppressor function,protein degradation pathway,apoptosis induction,genome stability maintenance
ENSG00000140332,TLE3,wnt/β-catenin signaling inhibition,tumor suppressor function,cellular proliferation regulation,genomic instability prevention,corepressor protein activity,groucho/tle interaction
ENSG00000100448,CTSG,cancer cell proliferation,tumor invasion,apoptosis resistance,cell migration enhancement,serine protease activity,lysosomal degradation
ENSG00000276409,CCL14,tumor microenvironment modulation,immune cell recruitment,cancer metastasis promotion,chemokine signaling pathway,cell migration and invasion enhancement,oncogenic potential
ENSG00000204065,TCEAL5,transcriptional regulation,chromatin remodeling,cell growth regulation,protein-dna interaction,zinc finger domain,aberrant expression
ENSG00000111641,NOP2,nucleolar protein function,oncogene activation,cell proliferation,tumor progression,ribosome biogenesis regulation,rna processing dysregulation
ENSG00000108518,PFN1,actin polymerization,cancer cell migration,cell proliferation,cytoplasmic regulation,invasion and metastasis,oncogene upregulation
ENSG00000127334,DYRK2,tumor suppression,cell cycle regulation,therapeutic target,oncogene activation,signaling pathway modulation,resistance to therapy
ENSG00000153048,CARHSP1,cell adhesion disruption,metastasis facilitation,prognostic marker,tumor progression,angiogenesis regulation,cell migration promotion
ENSG00000153879,CEBPG,transcriptional regulation,oncogenic driver,cell proliferation,pi3k/akt pathway activation,apoptosis suppression,tumor metastasis promotion
ENSG00000183421,RIPK4,necroptosis regulation,apoptosis resistance,cell death pathways,tumor progression driver,inflammation modulation,survival signaling
ENSG00000169100,SLC25A6,mitochondrial biogenesis,apoptosis resistance,fatty acid oxidation,cell proliferation,cancer metabolism,energy production
ENSG00000080561,MID2,chromatin remodeling,genome stability maintenance,dna repair regulation,cellular adaptation,protein kinase activation,oncogene mutation
ENSG00000167768,KRT1,cell adhesion regulation,epithelial marker,keratin structure maintenance,cell migration promotion,cellular stress response,tumor suppression
ENSG00000111786,SRSF9,alternative splicing,apoptosis inhibition,cell proliferation,molecular interactions,oncogene function,transcript regulation
ENSG00000103710,RASL12,amplification,constitutive activation,oncogene,tumor progression,cell proliferation,signaling pathway
ENSG00000179409,GEMIN4,spliceosome regulation,gene expression regulation,snrnp assembly,apoptosis evasion,dna repair modulation,cell cycle dysregulation
ENSG00000164056,SPRY1,rho gtpase regulation,tumor suppressor function,cell migration and invasion,epithelial-to-mesenchymal transition,prognostic biomarker,therapeutic target
ENSG00000164754,RAD21,cell cycle regulation,dna repair,oncogenic driver,genomic stability maintenance,tumor progression,biomarker candidacy
ENSG00000083290,ULK2,autophagy promotion,tumor growth facilitation,metabolic regulation,cell survival enhancement,cancer therapeutic target,genomic instability
ENSG00000175224,ATG13,autophagy regulation,apoptosis modulation,pi3k/akt/mtor pathway disruption,tumor cell survival,cellular degradation,protein-protein interactions
ENSG00000180549,FUT7,cell surface glycoproteins,fucose transfer enzyme,tumor antigen modulation,immune evasion mechanism,cancer progression marker,glycosylation process
ENSG00000284832,POLR2A,transcriptional regulation,cell proliferation,genomic instability,tumor progression,rna polymerase activity,chromatin remodeling
ENSG00000113719,ERGIC1,secretory transport,golgi apparatus dysfunction,tumor progression,cell proliferation regulation,kinase activation modulation,protein trafficking dysregulation
ENSG00000153157,SYCP2L,chromatin remodeling,cell cycle regulation,dna damage response,genomic instability,oncogene activation,synaptonemal complex formation
ENSG00000167996,FTH1,iron metabolism,oncogenic process,cell proliferation,reactive oxygen species,protein-protein interaction,cell survival
ENSG00000063244,U2AF2,splice site recognition,tumor growth promotion,alternative splicing modulation,oncogene activation,cell proliferation enhancement,apoptosis suppression
ENSG00000008128,CDK11A,cell cycle regulation,oncogene activation,proliferation enhancement,tumor progression,apoptosis inhibition,genomic instability
ENSG00000163660,CCNL1,cell cycle dysregulation,cyclin family member,mitotic entry regulation,g2/m phase transition,tumor progression,genomic instability
ENSG00000122779,TRIM24,chromatin modification,oncogenic transformation,tumor suppression inhibition,cell proliferation enhancement,therapeutic target,transcription regulation modulation
ENSG00000183048,SLC25A10,mitochondrial transport regulation,gene expression alterations,tumor metabolism,energy homeostasis disruption,warburg effect contribution,oncogenic role
ENSG00000011451,WIZ,genomic instability,tumor suppression,cell proliferation regulation,dna repair interaction,apoptosis promotion,none
ENSG00000280962,DUSP16,mapk signaling pathway,tumor suppressor,dephosphorylation,erk1/2 inhibition,cancer progression,therapeutic target
ENSG00000132780,NASP,chromatin regulation,tumor progression,nucleosome assembly,cell cycle regulation,transcriptional regulation,genomic instability
ENSG00000100065,CARD10,apoptosis regulation,cell proliferation modulation,immune response regulation,inflammation control,nf-κb signaling pathway interaction,pkc/nf-κb/card10 axis activation
ENSG00000113141,IK,nf-kappa b signaling,constitutive activation,inflammation regulation,tumor progression,cell survival promotion,genomic instability
ENSG00000130119,GNL3L,apoptosis,cell division,cancer development,g-protein signaling,tumor growth,protein interaction
ENSG00000143632,ACTA1,cytoplasmic localization,cytoskeletal remodeling,cell migration invasion,aberrant actin filament dynamics,tumor progression,protein-protein interactions
ENSG00000075618,FSCN1,epithelial-to-mesenchymal transition,cell migration,actin cytoskeleton regulation,tumor progression,prognostic marker,signaling pathway activation
ENSG00000185359,HGS,protein degradation regulation,tumor progression promotion,pi3k/akt/mtor pathway interaction,escrt machinery regulation,cancer metastasis facilitation,oncogenic process regulation
ENSG00000204673,AKT1S1,pi3k/akt/mtor pathway activation,oncogenic driver,cell proliferation enhancement,metastatic promotion,therapeutic target identification,genomic amplification association
ENSG00000198682,PAPSS2,thyroid hormone regulation,tumor progression,cell proliferation,metabolic dysregulation,signaling pathway modulation,enzyme overexpression
ENSG00000196730,DAPK1,apoptosis regulator,cell cycle inhibitor,tumor suppressor function,downregulated expression,cell proliferation inhibition,prognostic biomarker
ENSG00000125775,SDCBP2,chromatin remodeling,maintenance of genome integrity,dna repair,genomic stability,tumor suppressor function,oncogenic transcription factor regulation
ENSG00000012223,LTF,tumor progression,biomarker potential,iron regulation,cell proliferation modulation,apoptosis regulation,angiogenesis modulation
ENSG00000088986,DYNLL1,microtubule regulation,oncogenic driver,constitutive activation,protein-protein interaction,cell proliferation,metastasis promotion
ENSG00000105357,MYH14,cell motility,tumor progression,amplification,epithelial-to-mesenchymal transition,cytoskeleton organization,prognostic marker
ENSG00000184922,FMNL1,oncogene overexpression,actin cytoskeleton regulation,cell migration promotion,tumor invasion enhancement,metastasis facilitation,therapeutic target identification
ENSG00000174516,PELI3,tumor suppressor function,cell signaling regulation,jak/stat pathway activation,cytokine-mediated responses modulation,apoptosis resistance promotion,oncogenic potential
ENSG00000125845,BMP2,tumor progression,cell proliferation,signaling pathway modulation,cancer stem cell regulation,epithelial-to-mesenchymal transition,cell cycle regulation
ENSG00000132357,CARD6,apoptosis regulation,card domain,cell growth modulation,cytosolic localization,inflammatory pathway modulation,protein-protein interaction
ENSG00000134970,TMED7,er-to-golgi transport,protein sorting,lipid metabolism,tumor progression,oncogenesis,cell proliferation
ENSG00000102076,OPN1LW,visual transduction,g-protein coupled receptor family,x-chromosome location,signaling cascade initiation,cellular response modulation,oncogenic processes contribution
ENSG00000126351,THRA,regulation of cell cycle progression,apoptosis modulation,dna repair and damage response,inhibition of oncogenic signaling,tumor suppression,nuclear receptor function
ENSG00000129654,FOXJ1,cell cycle regulation,transcription factor activity,oncogene overexpression,tumor progression,therapeutic target,epithelial-to-mesenchymal transition
ENSG00000277594,DDX52,cellular stress response,cell proliferation,gain of function mutations,oncogenic transformation,prognostic marker,tumor progression
ENSG00000132676,DAP3,apoptosis regulation,cancer cell survival,genomic instability,cell cycle progression,oncogenic processes,therapeutic target
ENSG00000158560,DYNC1I1,dynein-1 regulation,tumor progression,microtubule dynamics,cell migration,genomic instability,oncogenic driver gene
ENSG00000083750,RRAGB,mtorc1 signaling pathway,constitutive activation,gain of function mutations,oncogenic driver,metabolic regulation,cell proliferation
ENSG00000025039,RRAGD,autophagy regulation,cell growth promotion,gtpase activity,mtorc1 interaction,oncogene potential,protein synthesis modulation
ENSG00000137601,NEK1,mitotic regulation,oncogenic function,dna damage response,cell cycle progression,apoptosis inhibition,kinase activation
ENSG00000118058,KMT2A,histone methylation,gene expression regulation,tumor suppressor inactivation,cell proliferation promotion,epigenetic dysregulation,transcription factor interaction
ENSG00000133895,MEN1,tumor suppressor function,loss of function mutations,cell proliferation regulation,transcriptional regulation,protein stability modulation,kinase activity regulation
ENSG00000150687,PRSS23,serine protease activity,cell surface localization,enzymatic regulation,cellular signaling modulation,limited involvement in cancer,uncharacterized role in esca
ENSG00000108679,LGALS3BP,pi3k/akt/mtor pathway modulation,glycolysis and glutaminolysis regulation,tumor immune evasion promotion,epithelial-to-mesenchymal transition regulation,cancer cell growth and survival enhancement,biomarker potential for cancer diagnosis and prognosis
ENSG00000174807,CD248,tumor angiogenesis,cell adhesion molecules,prognostic marker,cancer cell survival,immune evasion mechanisms,angiogenic pathway modulation
ENSG00000129521,EGLN3,hypoxia response,prolyl hydroxylase activity,cellular metabolism regulation,tumor angiogenesis,therapeutic target,transcription factor activation
ENSG00000171314,PGAM1,altered glycolytic metabolism,cellular energy regulation,glycogen synthase kinase 3 beta interaction,increased enzymatic activity,metabolic reprogramming,tumor growth promotion
ENSG00000002587,HS3ST1,aberrant sulfation patterns,heparan sulfate modification,tumor progression,metastasis regulation,glycosaminoglycan interaction,enzyme expression alteration
ENSG00000128340,RAC2,rho gtpase activity,protein kinase regulation,cell migration,tumor progression,pi3k/akt pathway interaction,metastasis facilitation
ENSG00000136848,DAB2IP,**

hyperactivation of pi3k/akt pathway,tumor suppressor role,inhibitory activity on cell migration,downregulation in esophageal carcinoma,restoration as therapeutic target,regulatory interaction with disabled-1
ENSG00000198791,CNOT7,cancer-specific expression,gene regulation disruption,proliferation enhancement,tumor progression facilitation,cell cycle dysregulation,apoptosis evasion
ENSG00000132938,MTUS2,microtubule dynamics regulation,tumor suppressor function,cell growth inhibition,cell cycle arrest,apoptosis induction,genomic instability prevention
ENSG00000172005,MAL,egfr interaction,tumor progression,oncogenic activity,cell proliferation,therapeutic target,signaling pathway modulation
ENSG00000089154,GCN1,hyperactivation,constitutive activation,tumor progression,oncogenic potential,cellular transformation,signaling pathway modulation
ENSG00000173546,CSPG4,cell adhesion disruption,enhanced cell proliferation,epithelial-to-mesenchymal transition,overexpression,poor prognosis marker,transmembrane glycoprotein
ENSG00000167526,RPL13,ribosomal protein synthesis,cellular proliferation,increased expression levels,tumor progression,enhanced cell survival,pi3k/akt pathway activation
ENSG00000137504,CREBZF,cell cycle regulation,transcriptional inhibition,tumor suppression,oncogene regulation,gene expression modulation,protein-protein interaction
ENSG00000104635,SLC39A14,intracellular zinc regulation,tumor progression,genetic instability,apoptosis evasion,zinc-dependent enzyme activation,cellular defense mechanism modulation
ENSG00000145425,RPS3A,translation regulation,tumor promoter,genomic instability,dna damage response,ribosome biogenesis,protein synthesis regulation
ENSG00000120370,GORAB,cell surface protein sorting,genomic instability,protein-protein interactions,tumor progression,mitotic regulation,dna damage response
ENSG00000124216,SNAI1,epithelial-to-mesenchymal transition,transcription factor function,overexpression in cancer,tumor progression,chemoresistance modulation,cell migration and invasion
ENSG00000284161,EEF2K,protein synthesis regulation,paradoxical activation,oncogene function,aggressive tumor behavior,therapeutic target,poor prognosis marker
ENSG00000167658,EEF2,mtor pathway activation,translation elongation factor,cell proliferation promotion,protein synthesis enhancement,tumor progression driver,genomic instability facilitator
ENSG00000124588,NQO2,mitochondrial dysfunction,redox imbalance,oxidative stress regulation,apoptosis modulation,cell cycle regulation,protein-protein interaction
ENSG00000136011,STAB2,angiogenesis regulation,nf-κb pathway modulation,metabolic reprogramming,tumor growth promotion,invasion and metastasis facilitation,pkc signaling interaction
ENSG00000164022,AIMP1,tumor progression,cell proliferation,rna regulation,dna binding activity,protein interaction,poor prognosis
ENSG00000165629,ATP5F1C,metabolic regulation,mitochondrial dysfunction,cellular energy production,tumor progression,oncogenic mutations,genomic instability
ENSG00000134884,ARGLU1,amino acid metabolism regulation,cellular metabolic reprogramming,oncogenic driver mutations,enhanced cellular proliferation,altered energy production mechanisms,tumor suppressor interaction
ENSG00000276111,SDCCAG8,tumor suppressor function,plk1 inhibition,cell cycle regulation,apoptosis modulation,dna damage response,genomic instability
ENSG00000065534,MYLK,cell migration,cytoskeletal reorganization,dna damage response,genomic instability,protein-protein interactions,tumor progression
ENSG00000106049,HIBADH,bcaa degradation,metabolic reprogramming,redox balance regulation,cellular energy production,tumor growth promotion,cancer cell metabolism modulation
ENSG00000151746,BICD1,microtubule dynamics regulation,cell migration promotion,oncogenic pathway activation,signaling molecule interaction,cytoplasmic architecture organization,apoptosis suppression
ENSG00000176490,DIRAS1,oncogenic driver,constitutive activation,ros generation,cell proliferation,tumor progression,apoptosis suppression
ENSG00000114942,EEF1B2,enhanced cell cycle progression,regulation of protein synthesis,tumor growth and metastasis,inhibition of apoptosis,cell proliferation and survival,therapeutic target
ENSG00000047849,MAP4,microtubule regulation,oncogenic processes,cell proliferation,cell survival enhancement,tumor progression marker,genomic instability
ENSG00000198612,COPS8,neddylation regulation,cell cycle control,ubiquitination regulation,protein stabilization,signaling pathway modulation,tumor suppression
ENSG00000239789,MRPS17,mitochondrial translation regulation,energy metabolism dysregulation,cellular respiration alteration,glycolysis enhancement,therapeutic target,genomic instability
ENSG00000137806,NDUFAF1,mitochondrial dysfunction,reactive oxygen species,cellular metabolism,apoptosis resistance,genomic instability,protein assembly
ENSG00000243414,TICAM2,nf-κb signaling pathway,immunoregulatory function,innate immune response activation,tumor progression driver,oncogenic processes involvement,immune evasion mechanisms
ENSG00000160710,ADAR,rna editing,alternative splicing,post-transcriptional regulation,tumor progression,gene expression regulation,cancer biomarker
ENSG00000129562,DAD1,genomic instability,tumor suppressor function,dna repair mechanisms,telomere maintenance,cell cycle regulation,apoptosis induction
ENSG00000160753,RUSC1,tumor suppressor function,loss of function mutations,ubiquitination,proteasomal degradation,dna damage response,apoptosis regulation
ENSG00000090376,IRAK3,nf-κb signaling pathway,inflammation regulation,tumor progression facilitation,immune suppression induction,metastasis promotion,therapeutic target
ENSG00000124444,ZNF576,epigenetic regulation,genomic instability,dna binding protein,transcriptional regulation,tumor suppressor/pro-oncogene,chromatin remodeling
ENSG00000086991,NOX4,tumor progression,chemotherapy resistance,redox balance regulation,cell migration modulation,antioxidant response element binding,oncogenic redox signaling
ENSG00000114739,ACVR2B,tgf-beta signaling pathway,constitutive activation,oncogenic driver mutation,epithelial-to-mesenchymal transition,cell proliferation regulation,tumor progression mediator
ENSG00000198836,OPA1,mitochondrial dysfunction,gain of function mutations,mitochondrial fusion,cellular metabolism,therapeutic target,tumor progression
ENSG00000180879,SSR4,cell growth modulation,oncogenic signaling pathway modulation,pi3k/mtor pathway interaction,prognostic marker or therapeutic target,cancer cell proliferation and survival regulation,elevated expression levels
ENSG00000153944,MSI2,mrna regulation,oncogene activation,cell cycle progression,tumor suppressor dysregulation,apoptosis evasion,therapeutic target
ENSG00000100266,PACSIN2,enhanced pi3k/akt signaling,cell proliferation,cell migration,cytoskeletal regulation,biomarker potential,tumor progression
ENSG00000046651,OFD1,genomic instability,cellular transformation,ciliogenesis regulation,spindle assembly disruption,centrosomal protein interaction,apoptosis evasion
ENSG00000113140,SPARC,ecm remodeling,tumor progression,epithelial-to-mesenchymal transition,cell adhesion,angiogenesis,protein interaction
ENSG00000154174,TOMM70,mitochondrial regulation,cellular metabolism,glycolysis enhancement,oncogene interaction,tumor suppressor modulation,cellular stress response
ENSG00000077264,PAK3,signaling pathway regulation,oncogenic driver,cell migration and invasion,apoptosis resistance,genomic instability,tumor progression
ENSG00000142731,PLK4,centriole biogenesis,genomic instability,microtubule stability,spindle checkpoint regulation,cell cycle progression,oncogenic driver
ENSG00000147403,RPL10,ribosomal protein assembly,translational control,genomic instability,tumor progression,cellular proliferation,therapeutic target
ENSG00000054118,THRAP3,p53 interaction,epithelial-to-mesenchymal transition,chromatin remodeling,transcriptional regulation,dna repair pathway,genomic instability
ENSG00000182195,LDOC1,cell cycle regulation,microtubule dynamics regulation,apoptosis inhibition,tumor suppressor function,pi3k/akt pathway interaction,oncogenic potential
ENSG00000128016,ZFP36,regulatory mechanism,tumor suppressor function,gene expression regulation,cell growth inhibition,pro-inflammatory cytokine regulation,cancer prognosis
ENSG00000235941,HSPA1A,heat shock protein,cellular stress response,molecular chaperone function,tumor suppression,therapeutic target,prognostic marker
ENSG00000121691,CAT,lipid metabolism,oncogenic potential,tumor progression,enzymatic activity,cellular lipid regulation,pancreatic enzyme function
ENSG00000189091,SF3B3,aberrant splicing,alternative splicing events,cell proliferation,oncogenic changes,splice variant generation,tumor progression
ENSG00000142657,PGD,pentose phosphate pathway,overexpression,glucose metabolism,apoptosis regulation,cell cycle progression,biomarker potential
ENSG00000136783,NIPSNAP3A,cell growth regulation,gene overexpression,protein-protein interaction,dysregulation of signaling pathways,lipidation process modulation,tumor progression promotion
ENSG00000262993,KRT31,cytoplasmic intermediate filament,cellular structure maintenance,metastasis promotion,epithelial cell marker,cell migration facilitation,signaling pathway interaction
ENSG00000004700,RECQL,genomic instability,cell proliferation,helicase function,replication maintenance,tumor initiation,dna repair
ENSG00000180198,RCC1,chromatin remodeling,cell cycle progression,genomic instability,aurora kinase interaction,oncogenic function,constitutive expression
ENSG00000175602,CCDC85B,pi3k/akt pathway,oncogenic mutations,tumor progression,signaling molecule interaction,overexpression,epidermal growth factor receptor interaction
ENSG00000176896,TCEANC,regulation of cell growth,cell proliferation,oncogene function,signaling pathway involvement,apoptosis regulation,prognostic marker
ENSG00000117020,AKT3,pi3k/akt signaling,gain of function mutations,pro-survival signaling,therapeutic target,cancer driver gene,tumor progression
ENSG00000091436,MAP3K20,mapk signaling pathway,apoptosis regulation,cell survival enhancement,oncogenic transformation,tumor growth promotion,stress response modulation
ENSG00000115109,EPB41L5,overexpression,pi3k/akt pathway activation,cell proliferation promotion,survival enhancement,dna repair interaction,transcriptional regulation alteration
ENSG00000165138,ANKS6,cellular proliferation,oncogene function,mitotic regulation,apoptosis modulation,cell survival enhancement,chromatin remodeling
ENSG00000113448,PDE4D,camp regulation,cell proliferation,metastasis promotion,inflammation response,tumor progression,therapeutic target
ENSG00000143190,POU2F1,cellular regulation,transcriptional control,epithelial cell differentiation,cell survival,tumor development,genomic instability
ENSG00000169871,TRIM56,trim protein family,pi3k/mapk pathway regulation,oncogene activation,tumor suppressor function,apoptosis regulation,cell cycle progression
ENSG00000136826,KLF4,oncogene,epithelial-to-mesenchymal transition,pi3k/akt signaling pathway,transcription factor function,cell proliferation regulation,genetic dysregulation
ENSG00000167601,AXL,metastasis,receptor tyrosine kinase,epithelial-to-mesenchymal transition (emt),angiogenesis,immune response evasion,axillary lymph node metastasis
ENSG00000149948,HMGA2,hmga2 overexpression,cell proliferation induction,oncogenic transcription factor,metastasis promotion,transcription regulation,chromatin remodeling
ENSG00000132842,AP3B1,ap-3 complex regulation,cell proliferation enhancement,constitutive activation,genetic alterations,lysosomal trafficking regulation,oncogenic protein interaction
ENSG00000099804,CDC34,protein degradation,ubiquitination pathway,tumor suppressor,cell cycle regulation,dna damage response,apoptosis regulation
ENSG00000108055,SMC3,cohesin complex regulation,genomic instability,chromosomal segregation,dna damage response,cell cycle regulation,aneuploidy driver
ENSG00000173894,CBX2,chromatin modification,cell proliferation,histone methylation,oncogenic function,tumor suppression,epigenetic regulation
ENSG00000174175,SELP,angiogenesis,immune suppressive microenvironment,tumor growth,metastasis,cell migration,promoter of tumor progression
ENSG00000090487,SPG21,microtubule assembly,aaa+ atpase activity,tumor suppressor,cytoprotective function,cell cycle regulation,microtubule dynamics
ENSG00000254726,MEX3A,microrna processing,epithelial-to-mesenchymal transition,tumor suppressor function,cellular differentiation,loss-of-function mutations,immune response modulation
ENSG00000112511,PHF1,chromatin remodeling,loss-of-function mutation,disrupted cell growth,tumor progression,transcription regulation,genomic instability
ENSG00000135999,EPC2,chromatin remodeling,loss of function mutations,cellular proliferation,aberrant gene expression,swi/snf complex dysfunction,genomic instability
ENSG00000167088,SNRPD1,rna splicing regulation,tumor progression facilitation,cellular response alteration,genomic instability promotion,protein-protein interaction,oncogene expression enhancement
ENSG00000120215,MLANA,melanoma antigen family (mage) member a,aberrant melanosome formation,cell growth and survival pathways,pi3k/akt/mtor pathway activation,genomic instability,tumorigenesis enhancement
ENSG00000171132,PRKCE,cellular proliferation,protein kinase activity,pi3k/akt pathway,tumor aggressiveness,overexpression,signal transduction
ENSG00000171490,RSL1D1,cellular proliferation,gene regulation,apoptosis regulation,cancer progression,transcriptional modulation,rna processing
ENSG00000135631,RAB11FIP5,cellular membrane regulation,tumor progression,epithelial cell function,protein-protein interaction,membrane trafficking regulation,oncogenic behavior
ENSG00000135930,EIF4E2,oncogenic signaling pathway regulation,tumor progression promotion,protein synthesis regulation,autophagy modulation,therapeutic resistance induction,prognostic biomarker potential
ENSG00000102580,DNAJC3,p53 regulation,tumor suppressor protein degradation,anti-apoptotic signaling pathway,ubiquitination regulation,oncogenic protein interaction,autophagy suppression
ENSG00000149532,CPSF7,altered rna processing,cell proliferation regulation,gene expression dysregulation,oncogenic process,pre-mrna splicing,transcriptional regulation
ENSG00000149016,TUT1,mirna regulation,oncogenic role,rna modification,gene expression regulation,3' end uridylation,poor prognosis marker
ENSG00000134452,FBH1,genomic instability,cell cycle regulation,tumor suppressor function,dna repair mechanism,e3 ubiquitin ligase activity,apoptosis modulation
ENSG00000138835,RGS3,regulation of g-protein signaling pathway,tumor suppressor function,cell proliferation regulation,apoptosis induction,genomic instability protection,g-protein subunit interaction
ENSG00000120690,ELF1,overexpression,transcription factor function,cell proliferation regulation,tumor suppressor gene suppression,apoptosis inhibition,protein-protein interaction
ENSG00000111196,MAGOHB,mrna stabilization,cell cycle regulation,apoptosis suppression,tumor progression,prognostic marker,gene expression regulation
ENSG00000010803,SCMH1,genomic instability,tumor suppressor function,dna replication regulation,oncogenic stress contribution,therapeutic target,genomic alterations prevention
ENSG00000101126,ADNP,cellular proliferation,protein-protein interactions,tumor aggressiveness,apoptosis regulation,signaling pathway modulation,biomarker potential
ENSG00000164978,NUDT2,dna damage response,genomic instability,cancer prognosis,biomarker potential,dna repair mechanisms,cellular growth regulation
ENSG00000182712,CMC4,regulation of cell cycle progression,dna damage response,apoptosis regulation,pi3k/akt signaling,tumor suppressor function,cellular growth regulation
ENSG00000033030,ZCCHC8,nf-κb pathway modulation,genomic instability,dna repair regulation,protein-protein interaction,transcriptional regulation,oncogenic promoter
ENSG00000127914,AKAP9,cellular compartmentalization,aberrant activation of pka,oncogene function,cell cycle progression,protein kinase regulation,tumor suppressor interaction
ENSG00000169900,PYDC1,apoptosis regulation,cell cycle modulation,phosphatase activity,tumor progression,signaling pathway modification,cancer cell growth control
ENSG00000166197,NOLC1,nucleolar regulation,ribosome biogenesis,oncogenic role,tumor progression,cell proliferation,protein-protein interaction
ENSG00000164047,CAMP,camp signaling pathway,oncogenic processes,tumor progression,pka activation,cell proliferation,angiogenesis
ENSG00000167965,MLST8,mtor signaling pathway,cell proliferation,adaptor protein function,tumor progression,oncogenic mutation,therapeutic target
ENSG00000265241,RBM8A,loss of function mutations,tumor suppressor activity,cell cycle regulation,dna damage response,genomic instability,epigenetic silencing
ENSG00000137161,CNPY3,cell proliferation,cell survival,pi3k/akt signaling,tumor suppressor interaction,apoptosis regulation,overexpression
ENSG00000204099,NEU4,cell surface modification,tumor progression,cancer cell proliferation,apoptosis inhibition,metastasis promotion,glycosylation pathway modulation
ENSG00000149554,CHEK1,dna damage response,genomic instability,cell cycle checkpoint,tumor progression,oncogenic driver,therapeutic target
ENSG00000105483,CARD8,inflammasome activation,nf-κb regulation,pro-inflammatory cytokine production,anti-tumor immune suppression,tumor growth promotion,chemoresistance induction
ENSG00000135100,HNF1A,tumor suppressor function,cell proliferation regulation,differentiation promotion,apoptosis induction,chromatin remodeling complex interaction,genomic instability prevention
ENSG00000109062,SLC9A3R1,epithelial integrity disruption,cell proliferation enhancement,malignant progression promotion,metastasis facilitation,cellular ph regulation modulation,tumor microenvironment alteration
ENSG00000103154,NECAB2,tumor progression,metastasis promotion,cell signaling regulation,pi3k/akt pathway activation,extracellular matrix regulation,cell adhesion modulation
ENSG00000102878,HSF4,pi3k/akt signaling,constitutive activation,oncogenesis,cell cycle progression,apoptosis evasion,transcriptional regulation
ENSG00000148187,MRRF,mitochondrial dysfunction,metabolic reprogramming,ribosome assembly,cell proliferation,increased survival,oncogene upregulation
ENSG00000011478,QPCTL,glutathione metabolism,oxidative stress response,cellular redox balance,genomic stability maintenance,protein conjugation regulation,redox signaling pathway
ENSG00000213619,NDUFS3,mitochondrial dysfunction,complex i subunit,electron transport chain disruption,atp production impairment,oxidative stress induction,warburg effect modulation
ENSG00000139180,NDUFA9,mitochondrial dysfunction,complex i overexpression,cellular metabolism,energy production,cell growth support,tumor progression
ENSG00000263012,KRT33B,cellular integrity disruption,cancer progression promotion,proliferation modulation,migratory enhancement,oncogenic potential contribution,tumorigenesis driver
ENSG00000186432,KPNA4,tumor progression,cell proliferation,nuclear import regulation,chromatin remodeling,gene expression modulation,protein-protein interaction
ENSG00000163161,ERCC3,genomic instability,dna damage response,helicase activity,nucleotide excision repair,transcription-coupled repair,cancer susceptibility
ENSG00000275023,MLLT6,chromatin remodeling,cell cycle progression,dna repair inhibition,signaling pathway activation,oncogene overexpression,genomic amplification
ENSG00000135018,UBQLN1,protein degradation regulation,tumor suppressor inhibition,cellular stress response modulation,unfolded protein response activation,agrgressive tumor behavior,prognostic marker potential
ENSG00000102034,ELF4,oncogene activity,constitutive activation,transcriptional regulation,cell cycle progression,apoptosis inhibition,therapeutic target
ENSG00000101182,PSMA7,proteasome subunit degradation,ubiquitin-proteasome pathway regulation,cancer cell proliferation,tumor aggressiveness modulation,apoptosis inhibition,cellular protein homeostasis disruption
ENSG00000079387,SENP1,de-sumoylation,protein stabilization,p53 regulation,tumor progression,oncogenic pathway interaction,overexpression in cancer tissues
ENSG00000101871,MID1,cell cycle progression regulation,substrate-specific ubiquitin ligase activity,p27 degradation,rb phosphorylation,e2f activation,nf-κb signaling pathway activation
ENSG00000173581,CCDC106,cell growth regulation,coiled-coil domain interactions,protein-protein interaction regulator,tumor progression promoter,cell proliferation enhancer,genomic instability mediator
ENSG00000146223,RPL7L1,ribosome biogenesis,cellular proliferation,tumor progression,gene expression regulation,dna repair modulation,protein translation enhancement
ENSG00000015171,ZMYND11,chromatin regulation,dna damage response,homologous recombination,gene expression modulation,tumor suppressor function,genomic stability maintenance
ENSG00000142611,PRDM16,tumor suppressor,cell cycle regulation,gene repression,oncogene inhibition,chromatin modification,transcriptional regulation
ENSG00000173372,C1QA,immune modulation,complement activation,inflammation regulation,tumor immunosuppression,cytokine regulation,protein-protein interaction
ENSG00000184009,ACTG1,aberrant actin dynamics,altered cellular architecture,cellular invasiveness,disrupted cytoskeleton organization,oncogenic processes,gene expression alterations
,WDYHV1,wd40 repeat-containing protein,transcription regulation,chromatin remodeling,genomic stability,cell growth regulation,protein-protein interaction
ENSG00000244405,ETV5,transcriptional regulation,tumor progression,cell proliferation,metastasis,apoptosis,chemoresistance
ENSG00000051108,HERPUD1,er stress response,ubiquitin-proteasome system,unfolded protein response (upr),pro-survival signaling pathways,apoptosis regulation,cancer progression
ENSG00000157349,DDX19B,rna helicase activity,transcriptional regulation,oncogene expression,cell proliferation,metastasis,overexpression
ENSG00000143870,PDIA6,**
er chaperone activity,cell survival promotion,protein folding regulation,tumor progression facilitation,chaperone-protein interactions,oncogenic mutation association 
**
ENSG00000135108,FBXO21,tumor progression,cancer driver gene,cell cycle regulation,ubiquitination and degradation,protein-protein interactions,pi3k/akt signaling pathway activation
ENSG00000143373,ZNF687,dna binding regulation,cell proliferation enhancement,oncogenic role activation,transcriptional modulation dysregulation,apoptosis pathway disruption,epigenetic modification involvement
ENSG00000276146,LILRB2,immune evasion,tumor progression,oncogene role,immune suppression,natural killer cell modulation,mhc class i interaction
ENSG00000103942,HOMER2,homer2 overexpression,oncogenic potential,cell adhesion regulation,cell migration modulation,sh3 domain binding,actin cytoskeleton dynamics
ENSG00000149930,TAOK2,oncogenic signaling,cell proliferation,tumor progression,apoptosis regulation,cell cycle control,protein-protein interaction
ENSG00000126775,ATG14,autophagy regulation,cell survival enhancement,oncogenic process promotion,tumor progression facilitation,pi3k/akt signaling pathway interaction,poor prognosis association
ENSG00000003756,RBM5,tumor suppression,post-transcriptional regulation,rna-binding protein,cellular proliferation,apoptosis dysregulation,metastasis promotion
ENSG00000148450,MSRB2,mitochondrial function,mutations leading to oncogenesis,oxidative damage regulation,tumor progression marker,cell cycle regulation interaction,pi3k/akt pathway modulation
ENSG00000274081,PUF60,rna-binding protein function,cell proliferation promotion,genomic instability induction,apoptosis inhibition,oncogenic role identification,tumor suppressor disruption
ENSG00000236149,ABCF1,rna regulation,oncogenic mrna stabilization,tumor progression,therapeutic target,biomarker potential,cellular metabolism alteration
ENSG00000128564,VGF,protein secretion,tumor growth promotion,pro-tumorigenic microenvironment,cell proliferation regulation,metastasis facilitation,poor prognosis association
ENSG00000205356,TECPR1,cell cycle regulation,dna repair,chromosomal instability,genomic integrity,oncogene overexpression,therapeutic target
ENSG00000157954,WIPI2,autophagic regulation,tumor progression,oncogenic driver,cellular proliferation,potential biomarker,cancer-related pathways
ENSG00000196363,WDR5,histone modification,chromatin remodeling,tumor progression,cell growth regulation,genomic instability,therapeutic target
ENSG00000163464,CXCR1,chemokine signaling,tumor progression,immune cell recruitment,metastasis promotion,proliferation enhancement,protein kinase activation
ENSG00000114354,TFG,pi3k/akt pathway,transcriptional regulation,oncogenic driver,dna repair dysregulation,cell proliferation enhancement,poor prognosis marker
ENSG00000213316,LTC4S,leukotriene synthesis,pro-inflammatory mediator,tumor progression,angiogenesis,immune evasion,inflammation regulation
ENSG00000119487,MAPKAP1,pi3k/akt pathway activation,overexpression of mapkap1,phosphorylation and activation of hsp27,stress response modulation,cell survival promotion,therapeutic target for esophageal carcinoma
ENSG00000187678,SPRY4,erk/mapk pathway inhibition,cell growth regulation,oncogenesis association,tumor progression facilitation,signaling molecule interaction,receptor tyrosine kinase modulation
ENSG00000160208,RRP1B,ribosome biogenesis,protein synthesis regulation,cell proliferation,oncogenic process,pi3k/akt pathway interaction,therapeutic target
ENSG00000040341,STAU2,mrna stability regulation,microrna processing,oncogene activation,tumor progression,cell proliferation regulation,apoptosis suppression
ENSG00000114439,BBX,transcription factor activity,tumor growth promotion,cell proliferation enhancement,survival pathway activation,prognostic marker,p53 pathway interaction
ENSG00000181143,MUC16,tumor marker,tumor growth promotion,immune evasion mechanisms,cell adhesion facilitation,angiogenesis regulation,epithelial barrier disruption
ENSG00000100097,LGALS1,tumor progression,cell proliferation,apoptosis inhibition,glycoprotein binding,immune evasion,tumor microenvironment modulation
ENSG00000144331,ZNF385B,transcription factor regulation,cell cycle progression,tumor suppressor function,epithelial-to-mesenchymal transition (emt),apoptosis modulation,dna repair regulation
ENSG00000204843,DCTN1,cellular stability,tubulin interaction,microtubule dynamics,motor function regulation,dysregulated expression,neurodegenerative associations
ENSG00000108298,RPL19,ribosome biogenesis,protein synthesis,tumor progression,apoptosis evasion,cellular proliferation,translational regulation
ENSG00000179526,SHARPIN,ubiquitination pathway,inflammation-mediated cancer progression,tumor suppressor dysfunction,cell proliferation enhancement,apoptosis suppression,metastasis promotion
ENSG00000125826,RBCK1,tumor suppressor,ubiquitination pathway regulation,cellular growth regulator,oncogenic protein targeting,proteasomal degradation,apoptosis regulator
ENSG00000160360,GPSM1,cell proliferation,metastasis,g-protein coupled receptor signaling,tumor progression,therapeutic target,prognosis
ENSG00000033122,LRRC7,emt process,cell proliferation,transmembrane protein,signaling pathway interaction,cytoplasmic domain,overexpression
ENSG00000075292,ZNF638,zinc finger protein regulation,oncogene activation,cell proliferation enhancement,pro-survival pathway modulation,dna binding activity,transcription factor interaction
ENSG00000180318,ALX1,tumor progression,epithelial-to-mesenchymal transition,poor prognosis,immune evasion,metastasis promotion,transcriptional regulation
ENSG00000117408,IPO13,apoptosis regulation,cell cycle progression,oncogene overexpression,tumor suppressor interaction,protein-protein interactions,biomarker significance
ENSG00000070961,ATP2B1,cellular calcium regulation,plasma membrane localization,oncogenic signaling pathways,tumor progression,therapeutic target,protein-protein interactions
ENSG00000198730,CTR9,mrna stabilization,oncogenic processes,tumor progression,cell proliferation,transcriptional regulation,cancer driver gene
ENSG00000265681,RPL17,cellular stress response,constitutive activation,enhanced cell proliferation,oncogenic transformation,protein synthesis regulation,ribosomal function alteration
ENSG00000134909,ARHGAP32,rhogtpase regulation,potential tumor suppressor,cell migration inhibition,epithelial-to-mesenchymal transition,tumor progression inhibition,adhesion signaling pathway
ENSG00000105392,CRX,transcription factor regulation,cellular survival promotion,protein-protein interactions,overexpression in tumors,tumor progression facilitation,biomarker potential
ENSG00000108798,ABI3,cell proliferation,chromatin remodeling,epigenetic regulation,oncogene overexpression,tumor progression,cancer stem cell maintenance
ENSG00000117984,CTSD,lysosomal degradation,tumor invasion,apoptosis regulation,metastasis facilitation,egfr interaction,prognostic marker
ENSG00000065548,ZC3H15,oncogene,cell proliferation,apoptosis inhibition,cell cycle regulation,transcriptional modulation,genomic amplification
ENSG00000185624,P4HB,protein modification,collagen hydroxylation,cellular structure regulation,angiogenesis modulation,tumor microenvironment,genetic instability
ENSG00000101347,SAMHD1,tumor suppressor function,genomic instability,dna synthesis regulation,immune response modulation,viral replication,deoxynucleoside triphosphatase activity
ENSG00000204397,CARD16,inflammation regulation,immune evasion,oncogene upregulation,angiogenesis promotion,cell migration enhancement,therapeutic target
ENSG00000089289,IGBP1,igf-binding,apoptosis regulation,tumor suppressor function,loss of function mutation,cancer progression,cell proliferation regulation
ENSG00000038382,TRIO,gef activation,rho gtpase regulation,oncogenic signaling,cell proliferation,metastasis promotion,protein-protein interactions
ENSG00000241123,KRTAP10-5,intermediate filament formation,keratin-associated protein,cellular structure alteration,tumor progression,cell migration,signaling pathway regulation
ENSG00000184060,ADAP2,ccv assembly,cell adhesion,cell migration,dysregulated expression,oncogenic potential,prognostic biomarker
ENSG00000135441,BLOC1S1,endosomal trafficking,lysosome maturation,autophagy regulation,cellular proliferation,tumor cell survival,genetic alteration
ENSG00000099622,CIRBP,cancer-promoting interaction,overexpression,rna-binding protein function,cell proliferation regulation,anti-apoptotic pathway involvement,microrna target
ENSG00000164548,TRA2A,splice variant regulation,cancer promoting splice variants,tumor progression,metastasis promoter,rna-binding protein,cancer transformation
ENSG00000122068,FYTTD1,transcriptional regulation,chromatin remodeling,gene expression modulation,tumor suppressor function,cancer driver gene,maintenance of genome stability
ENSG00000014164,ZC3H3,tumor growth,transcriptional regulation,cell proliferation,apoptosis evasion,poor prognosis,biomarker for diagnosis
ENSG00000173120,KDM2A,histone demethylation,chromatin remodeling,cell proliferation inhibition,epigenetic regulation,cancer cell survival,therapeutic target
ENSG00000185129,PURA,mrna stability regulation,gene expression modulation,proliferation promotion,mtor pathway interaction,antisense rna binding,cell growth enhancement
ENSG00000167196,FBXO22,protein stability regulation,gene expression modulation,cell cycle progression disruption,apoptosis pathway disruption,cancer prognosis correlation,tumor suppressor function loss
ENSG00000167985,SDHAF2,electron transport chain disruption,tumor progression,therapeutic target,energy metabolism deregulation,hypoxia-inducible factor alpha activation,succinate accumulation
ENSG00000139946,PELI2,apoptosis regulation,tumor growth promotion,stat3 interaction,nf-κb pathway regulation,immune evasion,chemoresistance
ENSG00000188846,RPL14,oncogenic potential,tumor growth promotion,protein synthesis regulation,cell proliferation enhancement,ribosomal protein function,genomic instability association
ENSG00000187554,TLR5,tlr signaling pathway,innate immune response,pro-inflammatory cytokines production,anti-tumor responses,tumor microenvironment regulation,immune evasion mechanisms
ENSG00000156398,SFXN2,mitochondrial function regulation,tumor growth promotion,mitochondrial biogenesis,iron-sulfur cluster assembly,cellular homeostasis maintenance,cancer association with iron metabolism
ENSG00000121390,PSPC1,transcriptional elongation,chromatin remodeling,oncogenic gene activation,tumor suppressor gene suppression,cell proliferation enhancement,metastasis promotion
ENSG00000152402,GUCY1A2,vasodilation regulation,angiogenesis promotion,cell proliferation enhancement,metastasis facilitation,tumor progression driver,signaling pathway disruption
ENSG00000181847,TIGIT,immune checkpoint modulation,cell surface expression,tumor progression,immune evasion,poor prognosis biomarker,antigen presentation regulation
ENSG00000164338,UTP15,cell growth regulation,telomere maintenance,rna processing,dna damage repair,genomic instability,oncogenic potential
ENSG00000156515,HK1,glycolytic pathway,glucose metabolism,tumor progression,proliferation enhancement,warburg effect,therapeutic target
ENSG00000131203,IDO1,immune evasion,tumor progression,kynurenine production,angiogenesis,cellular metabolism regulation,tryptophan degradation
ENSG00000129474,AJUBA,cell migration,aggressive phenotype,tumor invasiveness,poor prognosis,biomarker potential,cell adhesion disruption
ENSG00000043093,DCUN1D1,ubiquitination regulation,nlrp3 activation,inflammation,tumor progression,oncogenic driver,immune evasion
ENSG00000172867,KRT2,keratinization,epithelial cell adhesion,tumorigenesis,cell migration,metastasis,genetic instability
ENSG00000147364,FBXO25,tumor suppressor function,cell cycle regulation,dna damage response,genomic instability prevention,ubiquitination and degradation pathway,cancer driver gene
ENSG00000135914,HTR2B,cellular proliferation,metastasis promotion,signaling pathway interaction,tumor growth regulation,prognostic marker,serotonin receptor function
ENSG00000150753,CCT5,chaperone activity,tumor progression,cell cycle regulation,dna repair pathway interaction,anti-apoptotic function,protein folding facilitation
ENSG00000185479,KRT6B,keratin expression alteration,tumor progression,cell proliferation enhancement,epithelial cell integrity loss,oncogenic process modulation,cancer aggressiveness promotion
ENSG00000158019,BABAM2,genomic instability,cell cycle regulation,tumor suppressor function,dna damage response,ubiquitination pathway,amplification/deletion hotspot
ENSG00000165660,ABRAXAS2,dna repair deficiency,genomic instability,cell cycle checkpoint disruption,tumor progression,oncogenic driver,protein degradation pathway
ENSG00000074590,NUAK1,metabolic regulation,cellular survival,cell proliferation,tumor progression,therapeutic target,signal transduction
ENSG00000144848,ATG3,autophagy modulation,conjugation of pe to lc3,cell proliferation enhancement,tumor growth promotion,apoptosis inhibition,therapeutic target
ENSG00000141542,RAB40B,cell migration,cell proliferation,oncogenic signaling,microtubule regulation,emt transcription factor regulation,post-translational modification
ENSG00000128591,FLNC,actin filament organization,loss-of-function mutations,cytoplasmic structure regulation,cell migration regulation,oncogenic potential gain,tumor aggressiveness association
ENSG00000158022,TRIM63,tumor suppressor function,ubiquitination regulation,cell cycle regulation,apoptosis induction,mdm2 degradation,p53 stabilization
ENSG00000082146,STRADB,tumor suppressor,loss-of-function mutations,hippo signaling pathway,cell proliferation,apoptosis resistance,genomic instability
ENSG00000119326,CTNNAL1,wnt signaling pathway,cell adhesion disruption,oncogenic transcription factor,tumor growth promotion,metastatic potential,therapeutic target
ENSG00000166164,BRD7,histone acetylation,bromodomain interaction,transcriptional regulation,chromatin remodeling,tumor suppressor function,loss of heterozygosity
ENSG00000105323,HNRNPUL1,alternative splicing regulation,rna processing,transcriptional activation,oncogene regulation,cell proliferation enhancement,apoptosis suppression
ENSG00000079385,CEACAM1,cell surface molecule,immune modulation,cell adhesion,signaling pathway regulation,metastasis facilitation,tumor progression
ENSG00000213578,CPLX3,cell proliferation regulation,tumor suppressor interaction,apoptosis suppression,gene overexpression,cell growth enhancement,vesicle fusion regulation
ENSG00000006468,ETV1,oncogene,etv1/ets binding sites,transcriptional regulation,cell proliferation,genomic instability,apoptosis inhibition
ENSG00000157554,ERG,chromatin remodeling,cell cycle regulation,dna repair suppression,oncogenic pathway activation,tumor suppressor gene inhibition,transcriptional regulation
ENSG00000117595,IRF6,cell proliferation regulation,apoptosis regulation,epithelial-to-mesenchymal transition,transcriptional regulation,signaling pathway modulation,tumor suppressor function
ENSG00000151929,BAG3,cellular stress response,apoptosis regulation,autophagy modulation,tumor progression,metastasis promotion,signaling pathway activation
ENSG00000183785,TUBA8,microtubule stability,cell division,oncogenesis,tubulin dynamics,cytoskeletal regulation,protein complex formation
ENSG00000023287,RB1CC1,cell cycle regulation,tumor suppressor function,gain-of-function mutations,genomic instability,protein-protein interactions,aneuploidy
ENSG00000165527,ARF6,cell proliferation,signaling pathway dysregulation,metastasis promotion,tumor progression,therapeutic target,gtpase activity
ENSG00000138834,MAPK8IP3,enhanced cell proliferation,dna damage response,genomic instability,increased survival,oncogenic process,therapeutic target
ENSG00000099783,HNRNPM,translational regulation,mrna stability,cell proliferation,oncogenic process,protein-protein interaction,gene expression modulation
ENSG00000109255,NMU,oncogene activation,proliferation induction,apoptosis inhibition,tumor growth promotion,cell signaling modulation,neuropeptide expression
ENSG00000131051,RBM39,splicing regulation,tumor suppressor degradation,oncogene overexpression,chromatin remodeling,rna metabolism disorder,poor prognosis marker
ENSG00000177138,FAM9B,cell proliferation,genomic instability,anti-senescent function,epigenetic regulation,co- localization with chromatin modifiers,tumorigenic driver
ENSG00000167641,PPP1R14A,regulatory subunit,serine/threonine phosphatase 1 modulation,cell cycle progression,apoptosis regulation,tumor suppressor potential,context-dependent behavior
ENSG00000172243,CLEC7A,tumor microenvironment modulation,immune evasion,cancer cell regulation,pi3k/akt pathway interaction,carbohydrate recognition,cell surface expression
ENSG00000162385,MAGOH,alternative splicing,cell proliferation,metastasis,tumor progression,oncogene expression,spliceosome regulation
ENSG00000100836,PABPN1,cell proliferation,oncogenic driver,rna metabolism,cell survival,gene regulation,mutant overexpression
ENSG00000135766,EGLN1,hypoxia-inducible factor stabilization,prolyl hydroxylase activity,tumor progression,metabolic regulation,cellular respiration,warburg effect
ENSG00000106100,NOD1,nf-κb activation,innate immunity,inflammatory response,tumorigenesis regulation,muramyl dipeptide recognition,card4 expression
ENSG00000167553,TUBA1C,microtubule instability,cell division regulation,oncogenic transformation,mitotic spindle assembly,chromosomal instability,cancer cell proliferation
ENSG00000129084,PSMA1,proteasome complex,cell proliferation,tumor progression,anti-apoptotic function,ubiquitin-proteasome pathway,cell cycle regulation
ENSG00000171703,TCEA2,wnt/β-catenin signaling pathway,overexpression,chromatin remodeling,cell proliferation,survival regulation,epigenetic regulation
ENSG00000158796,DEDD,genome stability maintenance,dna repair pathway,cell cycle regulation,tumor suppression role,oncogenic process enhancement,epigenetic alteration involvement
ENSG00000160570,DEDD2,nucleotide metabolism,pi3k/akt pathway activation,cell proliferation enhancement,dna repair regulation,genomic instability contribution,prognostic marker potential
ENSG00000091136,LAMB1,cell adhesion,oncogene activation,tumor progression,metastasis facilitation,poor prognosis marker,angiogenesis promotion
ENSG00000197619,ZNF615,apoptosis regulation,gene expression regulation,tumor suppression,proliferation control,transcriptional modulation,mutation impact
ENSG00000107562,CXCL12,cancer cell migration,chemokine signaling,metastasis promotion,stromal cell interaction,tumor progression,chemotaxis regulation
ENSG00000169925,BRD3,bet family,chromatin remodeling,gene expression regulation,cell cycle progression,oncogenic protein interaction,therapeutic target
ENSG00000132275,RRP8,c-myc interaction,constitutive activation,dna repair mechanism,genomic instability,oncogenic adaptation,transcriptional regulation
ENSG00000140853,NLRC5,nf-kappab inhibition,immune checkpoint regulation,tumor suppression,reduced mhc class i expression,anti-tumor activity,tumor cell growth inhibition
ENSG00000108848,LUC7L3,regulatory function,cellular responses,rna processing,protein interactions,tumor progression,overexpression
ENSG00000136436,CALCOCO2,autophagy regulation,cellular growth modulation,cytoplasmic dynamics control,metabolic regulation,tumor progression contribution,protein degradation regulation
ENSG00000170448,NFXL1,transcriptional regulation,apoptosis inhibition,dna repair suppression,oncogene activation,tumor progression,cell cycle deregulation
ENSG00000135111,TBX3,wnt/β-catenin signaling pathway,oncogenic transcription factor,gain of function mutations,tumor progression,therapeutic target,chromatin remodeling
ENSG00000275730,LILRB4,immune evasion,t-cell suppression,mhc class i interaction,antigen presentation,cancer immunity,cell surface receptor
ENSG00000213024,NUP62,nuclear pore complex regulation,tumor aggressiveness,poor prognosis marker,epithelial-to-mesenchymal transition,oncogenic protein transport,nucleus-targeted transcription factors
ENSG00000125864,BFSP1,cellular proliferation,metabolic regulation,oncogenic signaling,tumor progression,cellular junction disruption,glycolytic enhancement
ENSG00000285049,CPSF1,3' end processing,mrna processing,regulation of gene expression,oncogenesis,dysregulation,cancer biology
ENSG00000188878,FBF1,chromatin remodeling,tumor growth progression,wnt/β-catenin pathway activation,transcription factor regulation,cell proliferation enhancement,dna damage response interaction
ENSG00000162989,KCNJ3,voltage-gated potassium channel,oncogene overexpression,genomic instability,tumor progression,cell proliferation modulation,signaling pathway interaction
ENSG00000157542,KCNJ6,kcnj6 mutations,tumor progression,cellular ion balance regulation,signaling pathway modulation,proliferation and survival enhancement,metastasis promotion
,HIST1H1B,histone modification,epigenetic regulation,chromatin remodeling,genomic instability,cell cycle regulation,apoptosis modulation
,HIST3H2BB,histone modification,chromatin remodeling,tumor progression,epigenetic regulation,transcriptional regulation,genomic instability
ENSG00000140740,UQCRC2,mitochondrial dysfunction,electron transport chain disruption,metabolic reprogramming,ros production increase,apoptosis inhibition,cellular proliferation enhancement
ENSG00000282853,ECH1,metabolic reprogramming,bcaa degradation,oncogenic role,cell proliferation enhancement,therapeutic target,prognostic marker
ENSG00000188042,ARL4C,oncogenic function,pi3k/akt pathway regulation,cell proliferation enhancement,protein-protein interaction,mitotic progression facilitation,tumor metastasis promotion
ENSG00000174137,FAM53A,cell cycle regulation,mitotic spindle formation,oncogene activation,tumor progression,overexpression,cell proliferation
ENSG00000169714,CNBP,regulation of gene expression,interactions with p53,modulation of transcription factors,cell survival and proliferation,aberrant expression or function,tumor suppressor regulation
ENSG00000165732,DDX21,dna repair,chromatin remodeling,transcriptional regulation,genomic instability,protein-protein interaction,helicase activity
ENSG00000143476,DTL,homologous recombination,dna repair,tumor suppressor,genomic instability,cell cycle regulation,emt modulation
,WDR34,cilia formation regulation,gain of function mutations,cellular proliferation enhancement,protein-protein interaction,genetic instability,tumor suppressor dysfunction
ENSG00000130826,DKC1,rna pseudouridylation,cellular homeostasis disruption,aberrant rna accumulation,tumor progression driver,ribonucleic acid biogenesis defect,gene expression dysregulation
ENSG00000083642,PDS5B,genomic instability,chromatin remodeling,dna replication regulation,cell cycle progression modulation,oncogenic potential,tumor aggressiveness marker
ENSG00000165637,VDAC2,mitochondrial regulation,anti-apoptotic activity,oncogenic potential,cell survival pathway,apoptosis regulation,tumor progression
ENSG00000137942,FNBP1L,cellular proliferation,tumor progression,metastasis,actin cytoskeleton regulation,cell migration,protein-protein interactions
ENSG00000068366,ACSL4,fatty acid biosynthesis,tumor progression,cell proliferation,genomic instability,lipid metabolism,cancer driver gene
ENSG00000164062,APEH,lipid metabolism,cell growth regulation,protein-protein interaction,oncogenic signaling pathway,apoptosis modulation,tumor progression
ENSG00000182149,IST1,ifn signaling pathway regulation,apoptosis modulation,tumor suppressor function,jak-stat pathway interaction,genomic instability contribution,cancer immunosurveillance disruption
ENSG00000185187,SIGIRR,tumor progression,tlr signaling inhibition,immune modulation,inflammation regulation,apoptosis induction,gastrointestinal disease
ENSG00000138385,SSB,dna repair,genomic stability,mutations,oncogenic process,tumor microenvironment,cellular interaction
ENSG00000173156,RHOD,oncogenic driver,cell proliferation promoter,cell migration enhancer,apoptosis inhibitor,signaling pathway regulator,cytoskeleton organizer
ENSG00000239306,RBM14,cellular proliferation,epigenetic regulation,transcriptional modulation,apoptosis resistance,tumor aggressiveness,polycomb repressive complex interaction
ENSG00000185615,PDIA2,protein folding regulation,cell proliferation enhancement,erk1/2 signaling pathway involvement,tumor progression facilitation,poor prognosis indicator,cancer cell survival promotion
ENSG00000277334,NCR1,immune modulation,nk cell activation,tumor evasion,cellular interaction,prognostic marker,cancer immunity
ENSG00000145912,NHP2,ribosome biogenesis,dysregulation of ribosomal subunits,gain-of-function mutations,genomic instability,tumor progression,therapeutic target
ENSG00000023902,PLEKHO1,tumor progression,cell proliferation,overexpression,small gtpase interaction,pleiotropic effects,rhoa/rac1 signaling pathway
ENSG00000092621,PHGDH,serine biosynthesis pathway,oncogene overexpression,cell metabolism modulation,cancer cell proliferation,mitochondrial localization,therapeutic target potential
ENSG00000125686,MED1,enhanced transcription regulation,tumor progression,cell proliferation,transcriptional activation,oncogene expression,genomic instability
ENSG00000138279,ANXA7,apoptosis regulation,cell membrane binding,oncogene expression,tumor suppressor interaction,phospholipid interaction,calcium-dependent signaling
ENSG00000143624,INTS3,dna damage response,genomic instability,igas complex,cell cycle regulation,tumor progression,therapeutic target
ENSG00000241794,SPRR2A,pi3k/akt pathway,constitutive activation,genomic instability,cell migration,epithelial-to-mesenchymal transition (emt),tumor progression
ENSG00000187522,HSPA14,cellular homeostasis,molecular chaperone function,protein folding regulation,tumor progression,apoptosis suppression,stress response modulation
ENSG00000106245,BUD31,dna repair,wd repeat domain,cell cycle regulation,oncogene overexpression,tumor growth promotion,genomic instability
ENSG00000100225,FBXO7,tumor suppressor,cell cycle regulation,dna damage response,ubiquitination pathway,protein degradation,cancer prognosis
ENSG00000107833,NPM3,ribosome biogenesis,constitutive activation,cell proliferation,nucleolar localization,tumor progression,therapeutic target
ENSG00000153406,NMRAL1,microtubule dynamics regulation,chromosomal instability,oncogene activation,cell cycle progression,dna repair modulation,kinase activity enhancement
ENSG00000154277,UCHL1,ubiquitination pathway,oncogenic protein stabilization,tumor progression marker,cell cycle regulation,apoptosis inhibition,dna damage response
ENSG00000083896,YTHDC1,mrna degradation,post-transcriptional regulation,nuclear localization,oncogenic pathway interaction,tumor growth promotion,cell proliferation enhancement
ENSG00000151623,NR3C2,glucocorticoid signaling,tumor progression,oncogenic function,cell proliferation regulation,anti-apoptotic signaling,transcriptional activation
ENSG00000165516,KLHDC2,oncogenic driver,tumor progression,cell proliferation,apoptosis regulation,dna repair mechanism,biomarker potential
ENSG00000106554,CHCHD3,mitochondrial outer membrane stability,cell proliferation regulation,p53 interaction,tumor suppressor dysfunction,mitochondrial function maintenance,cancer cell survival enhancement
ENSG00000280680,HHAT,hhat overexpression,oncogene activation,histone modification regulation,tumor suppressor p53 suppression,cell survival promotion,genome instability maintenance
ENSG00000058404,CAMK2B,camk pathway activation,cell cycle regulation,apoptosis inhibition,tumor growth promotion,oncogenic signaling,genomic instability
ENSG00000138646,HERC5,ubiquitination regulation,tumor suppressor function,protein stability modulation,oncogenesis promotion,apoptosis induction,ring finger domain
ENSG00000158445,KCNB1,overexpression,enhanced cell growth,aberrant activation,tumor progression,therapeutic target,cell survival
ENSG00000175497,DPP10,immunomodulation,ca2+ channel regulation,t-cell function,cell signaling,immune cell development,none
ENSG00000127314,RAP1B,cell migration,oncogene activation,gtpase activity,tumor invasion,signaling pathway modulation,protein kinase regulation
ENSG00000115806,GORASP2,pi3k/akt pathway,oncogenic driver,cell proliferation,cell survival,cytoskeletal regulation,membrane trafficking
ENSG00000278129,ZNF8,cell cycle regulation,chromatin remodeling,dna repair mechanisms,tumor suppressor function,metastasis regulator,biomarker significance
ENSG00000137171,KLC4,cellular transport,motor protein function,microtubule interaction,oncogene overexpression,tumor progression,apoptosis regulation
ENSG00000108312,UBTF,histone modification regulation,epigenetic regulator,cell cycle progression,dna replication modulation,transcription factor interaction,oncogenic pathway component
ENSG00000163060,TEKT4,cell adhesion regulation,epithelial-to-mesenchymal transition,overexpression in cancer tissues,diagnostic marker potential,signaling pathway modulation,proliferation and survival enhancement
ENSG00000167858,TEKT1,oncogenic signaling,constitutive activation,pi3k/akt pathway dysregulation,tumor cell proliferation,metastasis promotion,btk family kinase activity
ENSG00000198382,UVRAG,autophagy regulation,genomic instability,tumor suppressor function,cellular degradation,pi3k/akt pathway modulation,ubiquitinated substrate processing
ENSG00000125676,THOC2,mrna export regulation,cell proliferation enhancement,oncogene interaction,poor prognosis association,cancer therapy target,gene expression modulation
ENSG00000187741,FANCA,genomic instability,dna interstrand crosslinks repair,cancer susceptibility,tumor development,dna repair mechanisms disruption,oncogenic process promotion
ENSG00000113368,LMNB1,chromatin organization,enhanced cell proliferation,gene expression regulation,nuclear architecture disruption,prognostic marker,transcriptional regulation
ENSG00000113645,WWC1,ww domain interaction,cell proliferation regulation,apoptosis evasion,oncogenic potential,tumor suppressor regulation,proliferation complex formation
ENSG00000070371,CLTCL1,genomic instability,tumor suppressor function,dna repair regulation,precancerous mutations,oncogenic signaling activation,reduced expression levels
ENSG00000181481,RNF135,**
ring-type e3 ligase activity,protein degradation regulation,ubiquitination,tumor suppressor protein stabilization,cell cycle progression regulation,dna damage response disruption 
**
ENSG00000120457,KCNJ5,gain-of-function mutation,inwardly rectifying potassium channels,cellular proliferation,cellular metabolism regulation,tumor progression,therapeutic target
ENSG00000124171,PARD6B,disrupted cell polarity,apical junction complex component,increased cell migration,tumor progression,cellular integrity disruption,rho gtpase interaction
ENSG00000161940,BCL6B,histone modification,chromatin remodeling,cell cycle progression,oncogenic interaction,tumor metastasis,apoptosis inhibition
ENSG00000160679,CHTOP,chromatin regulation,transcriptional coactivation,cell growth promotion,apoptosis inhibition,angiogenesis facilitation,dna damage repair modulation
ENSG00000101844,ATG4A,autophagy regulation,oncogenic role,tumor progression,cancer cell survival,autophagosome formation,lc3 activation
ENSG00000189403,HMGB1,tumor progression,inflammation,dna-binding protein,nf-κb pathway interaction,pi3k/akt pathway activation,cell proliferation promotion
ENSG00000172236,TPSAB1,proteolytic activity,tumor progression,metastasis,cell migration,angiogenesis,cancer prognosis
ENSG00000119138,KLF9,tumor suppressor function,cell cycle regulation,apoptosis induction,transcription factor activity,poor prognosis indicator,genomic instability
ENSG00000171346,KRT15,cell proliferation,disrupted adhesion,oncogenic transformation,epithelial differentiation,prognostic marker,tumor progression
ENSG00000111321,LTBR,**

* tumor microenvironment,* immune evasion,* nf-κb pathway regulation,* apoptosis inhibition,* lymphoid tissue maintenance disruption,* inflammation promotion 

**
ENSG00000196664,TLR7,tlr7 signaling pathway,innate immune response,recognition of viral rna,tumor immunosuppression,evasion of anti-tumor immunity,genetic overexpression
ENSG00000180182,MED14,transcriptional regulator,chromatin remodeling,cellular proliferation,aberrant gene expression,tumorigenesis promoter,genomic instability
ENSG00000142856,ITGB3BP,cell adhesion regulation,tumor progression,metastasis driver,cell migration promoter,signaling pathway disruption,oncogenic expression upregulation
ENSG00000170776,AKAP13,tumor progression,cell migration,signal transduction pathway,protein-protein interaction,scaffold protein function,chromosomal amplification
ENSG00000101460,MAP1LC3A,autophagy regulation,oncogenesis promotion,cancer progression,metastasis facilitation,cellular survival enhancement,mtor pathway activation
ENSG00000146701,MDH2,glycolytic shift,pdc dysfunction,oncogenic metabolism,tumor cell growth,energy homeostasis disruption,enzyme inactivation
ENSG00000143970,ASXL2,genome instability,dna repair,tumor suppressor,epigenetic regulation,histone modification,cancer initiation
ENSG00000274651,PRPF31,spliceosome regulation,tumor suppression,aberrant gene expression,genomic instability,cellular regulation disruption,oncogenic processes
ENSG00000090621,PABPC4,translational regulation,constitutive activation,oncogenic properties,tumor progression,rna-binding protein,cellular proliferation
ENSG00000141522,ARHGDIA,**

cell migration,cytoskeletal reorganization,oncogenic processes,cell proliferation,prognostic biomarker,signaling pathway regulation 

**
ENSG00000168421,RHOH,genomic instability,epithelial-to-mesenchymal transition,oncogenic process,rac1 activation,cell proliferation,gtpase regulation
ENSG00000182670,TTC3,cellular proliferation,genomic instability,protein-protein interaction,oncogene activation,tumor progression,poor prognosis
ENSG00000103351,CLUAP1,oncogenic signaling,overexpression,cell migration,cytoskeletal regulation,cell adhesion disruption,tumor progression
ENSG00000105492,SIGLEC6,siglec family,sialic acid-binding,oncogenic properties,tumor progression,cell adhesion regulation,immune modulation
ENSG00000116663,FBXO6,tumor suppressor,cell cycle regulation,ubiquitination pathway,protein degradation,scf complex interaction,cancer prognosis
ENSG00000099817,POLR2E,rna polymerase ii activity,anti-apoptotic effects,chromatin remodeling,tumor progression,transcriptional regulation,genomic amplification
ENSG00000189043,NDUFA4,**
mitochondrial dysfunction,tumor aggressiveness,impaired oxidative phosphorylation,enhanced glycolysis,warburg effect,cancer metabolism
**
ENSG00000165588,OTX2,transcription factor activity,promotes cell proliferation,tumor progression,genomic instability,oncogenic function,epithelial-to-mesenchymal transition
ENSG00000108604,SMARCD2,chromatin remodeling,transcription regulation,tumor suppressor loss,cell proliferation,apoptosis suppression,prognostic marker
ENSG00000140743,CDR2,cell cycle regulation,dysregulated cell proliferation,mitotic checkpoint disruption,epithelial-to-mesenchymal transition,protein-protein interaction,biomarker for tumor progression
ENSG00000184743,ATL3,autophagy regulation,cellular stress response,e3 ubiquitin ligase function,cancer cell survival,metastasis promotion,tumor suppressor dysfunction
ENSG00000172346,CSDC2,cell cycle regulation,oncogenic driver,tumor aggressiveness,prognostic marker,cell proliferation enhancement,signaling pathway modulation
ENSG00000119929,CUTC,**

chromatin remodeling,nuclear localization,transcriptional regulation,cellular proliferation,dna damage response,genomic instability

**
ENSG00000105829,BET1,vesicle-mediated transport,protein sorting regulation,cell growth modulation,therapeutic target,cellular proliferation regulation,cancer progression association
ENSG00000179262,RAD23A,protein degradation regulation,p53 targeting,cell cycle progression regulation,tumor growth promotion,oncogene activation,ubiquitin-proteasome pathway involvement
ENSG00000231555,HSPA1B,protein folding regulation,chaperone activity,cell survival enhancement,tumor progression facilitation,cell cycle regulation alteration,apolypotosis modulation
ENSG00000121892,PDS5A,genomic instability,chromatin remodeling,cohesin loading,cell proliferation,dna damage suppression,tumor maintenance
ENSG00000149187,CELF1,spliceosome regulation,mrna processing,cancer cell proliferation,epithelial-to-mesenchymal transition (emt),oncogenic splicing,alternative polyadenylation
ENSG00000135250,SRPK2,regulation of pre-mrna splicing,tumor progression,metastasis promotion,dna damage response modulation,cell proliferation enhancement,serine/arginine protein phosphorylation
ENSG00000102038,SMARCA1,chromatin remodeling,gene expression regulation,tumor suppressor/oncogene dualism,cell cycle progression regulation,dna repair modulation,genomic instability promotion
ENSG00000182199,SHMT2,enhanced glycolysis,cell proliferation,tumor aggressiveness,one-carbon metabolism pathway,mitochondrial localization,therapeutic target
ENSG00000188554,NBR1,autophagy regulation,chromatin modification,ubiquitination pathway,cell survival mechanism,tumor progression modulation,genomic instability
ENSG00000170296,GABARAP,autophagy regulation,cancer cell survival,proliferation adaptation,autophagosome formation,lysosomal degradation,mitochondrial homeostasis
ENSG00000137947,GTF2B,gtfiiib complex,rna polymerase iii transcription,transcriptional dysregulation,oncogenic processes,epithelial-to-mesenchymal transition,genomic instability
,HIST1H2BD,histone modification,tumor suppressor function,chromatin remodeling,transcriptional regulation,genome stability maintenance,cell cycle progression
ENSG00000273575,KIR2DL4,tumor microenvironment modulation,cellular homeostasis regulation,potassium channel subunit function,cancer cell proliferation,therapeutic target potential,immune response modulation
ENSG00000115165,CYTIP,epithelial-to-mesenchymal transition,enhanced translation regulation,tumor progression,apoptosis resistance,prognostic marker,promotes metastasis
ENSG00000143376,SNX27,endocytic trafficking,signaling regulation,cell surface receptor recycling,pi3k/akt pathway modulation,overexpression in cancer tissues,biomarker potential
ENSG00000143549,TPM3,cell migration and invasion,microtubule interaction,oncogenic protein interaction,tumor progression and metastasis,prognostic marker,cytoskeleton regulation
ENSG00000137767,SQOR,detoxification of sulfites,redox balance regulation,tumor suppressor function,pi3k/akt pathway modulation,cancer cell metabolism alteration,sulfur-containing amino acid metabolism
ENSG00000143553,SNAPIN,endosomal regulation,cell survival pathway modulation,protein-protein interaction,tumor progression enhancement,apoptosis inhibition,cancer driver potential
ENSG00000124228,DDX27,genetic reprogramming,cell cycle progression,apoptosis inhibition,oncogenic processes,transcriptional regulation,mirna-dependent regulation
ENSG00000237344,PBX2,transcription regulation,oncogene activity,tumor progression,cell proliferation,emt regulation,dna binding activity
ENSG00000106785,TRIM14,p53 regulation,pi3k/akt pathway modulation,tumor suppressor,genomic stability maintenance,microrna regulation,prognostic marker
ENSG00000112081,SRSF3,splice factor regulation,oncogenic splicing,alternative transcript expression,cell proliferation enhancement,tumor progression facilitation,prognostic marker
ENSG00000072134,EPN2,membrane trafficking regulation,oncogene,endocytic pathway modulation,cell migration enhancement,tumor progression facilitation,amplification in esophageal carcinomas
ENSG00000121653,MAPK8IP1,apoptosis evasion,cell proliferation,cell survival,mitogen-activated protein kinase regulation,scaffolding protein function,tumor aggressiveness
ENSG00000173933,RBM4,cellular response modulation,rna-binding protein function,overexpression in cancer,therapeutic target,signaling pathway regulation,tumor growth promotion
ENSG00000274853,MRM1,microtubule regulation,cellular proliferation,oncogenic mechanism,mitosis regulation,tumor cell survival,microtubule polymerization
ENSG00000138768,USO1,dna damage response,deubiquitinase activity,oncogenic protein stabilization,ubiquitination pathway,tumor progression,cell cycle regulation
ENSG00000070756,PABPC1,translation regulation,oncogenic transformation,cell proliferation,mrna stability,pro-oncogenic mrnas,biomarker identification
ENSG00000100968,NFATC4,oncogenic signaling,constitutive activation,transcriptional regulation,cell cycle progression,proliferation promotion,subcellular localization modulation
ENSG00000149548,CCDC15,mitotic checkpoint regulation,chromosomal instability,cellular proliferation,centrosome integrity disruption,genomic stability impairment,microtubule dynamics regulation
ENSG00000140319,SRP14,protein targeting,cell growth regulation,oncogenic processes,altered expression,cellular stress response,protein folding homeostasis
ENSG00000139197,PEX5,peroxisomal import,pts1 proteins,metabolic reprogramming,tumor proliferation,cancer cell survival,energy metabolism
ENSG00000164251,F2RL1,angiogenesis promotion,tumor progression facilitation,cell invasion enhancement,urokinase-type plasminogen activator inhibition,metastasis association,serine protease inhibitor function
ENSG00000152086,TUBA3E,tumor progression,microtubule stability,cell proliferation,oncogene expression,microtubule dynamics,poor prognosis
ENSG00000163156,SCNM1,splicing regulation,dysregulation of splicing,aberrant protein production,cell growth modulation,proliferation control,rna binding
ENSG00000136147,PHF11,chromatin remodeling,transcriptional regulation,histone modification interaction,tumor suppressor function,cell cycle regulation,genomic stability maintenance
ENSG00000185651,UBE2L3,ubiquitination pathway,constitutive activation,oncogenic protein stabilization,tumor suppressor degradation,cell proliferation promotion,genomic instability promotion
,HIST1H2AH,histone regulation,chromatin structure,epigenetic alterations,gene expression control,cellular proliferation,tumor development
ENSG00000277956,MAPT,cell migration,warburg effect,tau protein regulation,microtubule stability,metabolic reprogramming,protein-protein interaction
ENSG00000131773,KHDRBS3,rna processing regulation,oncogenic transformation,alternative splicing modulation,tumor suppressor inhibition,cell proliferation promotion,poor prognosis association
ENSG00000055118,KCNH2,hyperpolarization activated,ion channel regulation,cardiac rhythm regulation,cell proliferation activation,drug resistance mechanism,tumor suppressor dysregulation
ENSG00000114738,MAPKAPK3,p38 mapk signaling pathway,regulation of gene expression,inflammation regulation,cell survival,transcription factor interaction,immune evasion
ENSG00000136891,TEX10,aberrant splicing,alternative splicing regulation,cell growth regulation,downregulation in cancer cells,oncogenic processes suppression,tumor suppressor gene function
ENSG00000125166,GOT2,mitochondrial localization,metabolic enzyme activation,amino acid metabolism regulation,cellular proliferation promotion,biomarker for diagnosis,energy supply disruption target
ENSG00000116459,ATP5PB,mitochondrial energy production,tumor growth,cell survival,energy metabolism,poor prognosis,amplification mutations
ENSG00000152256,PDK1,pi3k/akt signaling,tumor suppressor modulation,constitutive activation,cell proliferation,metabolic reprogramming,therapeutic target
ENSG00000116977,LGALS8,cell adhesion degradation,epithelial-to-mesenchymal transition,glycoprotein binding,immune evasion,metastasis promotion,pi3k/akt pathway modulation
ENSG00000149968,MMP3,tumor progression,metastasis,extracellular matrix degradation,cell migration,angiogenesis promotion,proteolytic activity
ENSG00000140564,FURIN,tumor-promoting signaling,proteolytic activation,oncogenic pathway modulation,cell proliferation enhancement,angiogenesis facilitation,malignant transformation facilitator
ENSG00000095139,ARCN1,chromosomal instability,aneuploidy promotion,mitotic spindle regulation,cytokinesis modulation,genomic alterations,oncogenic driver
ENSG00000166091,CMTM5,cell signaling regulation,protein-protein interactions,apoptosis modulation,tumor progression,biomarker potential,genomic instability
ENSG00000104894,CD37,tumor progression,tumor cell survival,promoter of oncogenic processes,immune evasion,therapeutic target,dysregulation associated with cancer
ENSG00000231543,C2,cell proliferation,cancer progression,metastasis promotion,phospholipid binding,calcium-dependent membrane targeting,overexpression in cancer
ENSG00000129460,NGDN,transcriptional regulation,nuclear receptor coactivator,cellular proliferation,oncogenesis,cellular survival,genomic instability
ENSG00000106803,SEC61B,protein targeting,er translocon complex,unfolded protein response (upr),oncogene potential,cellular trafficking,regulatory function
ENSG00000163479,SSR2,genome instability,rna splicing regulation,overexpression correlation,tumor progression promoter,biomarker potential,therapeutic target
ENSG00000107872,FBXL15,protein degradation regulation,ubiquitin-proteasome pathway activation,tumorigenesis promotion,cancer progression facilitation,p53 degradation inhibition,aurora kinase b and survivin regulation
ENSG00000102786,INTS6,genomic instability,dna damage response,transcription regulation,poor prognosis,prognostic biomarker,therapeutic target
ENSG00000169599,NFU1,mitochondrial function,dna damage response,reactive oxygen species (ros) production,oncogene overexpression,energy metabolism regulation,cell survival promotion
ENSG00000111615,KRR1,microtubule stabilization,cell cycle progression,oncogene overexpression,genomic instability,therapeutic target,protein-protein interactions
ENSG00000102554,KLF5,transcriptional regulation,oncogenic activation,epithelial-to-mesenchymal transition,cell proliferation,apoptosis suppression,genomic instability
ENSG00000147224,PRPS1,cell growth,dna synthesis,nucleotide biosynthesis,oncogene activation,tumor progression,metabolic regulation
ENSG00000134138,MEIS2,tale-class transcription factor,cell proliferation enhancer,apoptosis evasion,developmental regulator,proliferation inducer,transcriptional coactivator
ENSG00000105193,RPS16,cell proliferation,ribosomal protein regulation,amplification and overexpression,translation initiation,cell cycle progression,tumor progression
ENSG00000126945,HNRNPH2,rna splicing regulation,tumor growth promotion,alternative polyadenylation regulation,cancer metastasis driver,oncogenic pathway interactions,cellular proliferation enhancement
ENSG00000122692,SMU1,cell proliferation,oncogene,genomic instability,ubiquitin ligase interaction,dna repair mechanism,tumor progression
ENSG00000169344,UMOD,tumor progression,cell signaling pathways,biomarker,gene overexpression,protein interaction,tumor growth
ENSG00000108061,SHOC2,pi3k/akt/mtor pathway,overexpression/activation,oncogenic processes,cell survival/proliferation,metastasis promotion,biomarker/therapeutic target
ENSG00000145741,BTF3,transcription factor regulation,cell cycle control,oncogenic function,aberrant gene expression,genome instability,cell proliferation promotion
ENSG00000197785,ATAD3A,mitochondrial dynamics,aaa+ atpases,cellular proliferation,genomic instability,mitophagy regulation,tumor progression
,SEPT4,tumor progression,aberrant expression,cell division regulation,microtubule dynamics,cytoskeletal organization,oncogenic signaling
ENSG00000108671,PSMD11,proteasome activity,tumor progression,metastasis,protein degradation,cellular regulation,prognostic marker
ENSG00000004487,KDM1A,pi3k/akt pathway,histone modification regulation,epigenetic silencing,tumor suppressor gene suppression,cell growth regulation,prognostic marker
ENSG00000104756,KCTD9,cellular proliferation regulation,tumor suppressor function,genomic instability,e3 ubiquitin ligase activity,proteasomal degradation regulation,apoptosis modulation
ENSG00000104687,GSR,apoptosis regulation,cell growth modulation,detoxification role,glutathione conjugation,nf-κb interaction,oxidative stress resistance
ENSG00000153395,LPCAT1,lipid biosynthesis modulation,cancer cell proliferation,genomic alterations,signaling pathway activation,protein-lipid interactions,enzymatic activity changes
ENSG00000277586,NEFL,neurofilament assembly,cell survival pathways,tumor progression,epithelial-to-mesenchymal transition,prognostic marker,neuronal integrity maintenance
ENSG00000124507,PACSIN1,actin polymerization,cell migration,cytoskeletal regulation,protein-protein interaction,signaling pathway modulation,genetic mutation
ENSG00000115317,HTRA2,tumor suppressor,mitochondrial regulation,apoptosis inhibition,genetic alterations,cell death modulation,proteolytic activity
ENSG00000282947,HNRNPL,gene regulatory mechanism,cell proliferation,rna processing,tumor progression,oncogene overexpression,poor prognosis
ENSG00000132849,PATJ,loss of cell polarity,disrupted adherens junctions,increased cell proliferation,tumor aggressiveness,enhanced oncogenic signaling,overexpression profiled
ENSG00000167081,PBX3,oncogene activation,tumor progression,transcriptional regulation,cell proliferation,metastasis promoter,cancer stem cell maintenance
ENSG00000068028,RASSF1,tumor suppressor function,epigenetic silencing,histone demethylation regulation,mitotic spindle assembly disruption,apoptosis resistance,genomic instability promotion
ENSG00000139546,TARBP2,microrna regulation,tumor progression,oncogene regulation,cancer cell proliferation,nuclear protein function,cellular differentiation
ENSG00000114388,NPRL2,pi3k/akt/mtor pathway,constitutive activation,overexpression,tumor growth and metastasis,epithelial-to-mesenchymal transition (emt),therapeutic resistance
ENSG00000106327,TFR2,overexpression,cell proliferation,angiogenesis,anti-apoptosis mechanism,iron homeostasis disruption,oxidative stress promotion
ENSG00000088002,SULT2B1,steroid hormone regulation,cytosolic enzyme activity,cellular metabolism modulation,tumor growth promotion,therapeutic target,genomic amplification
ENSG00000164114,MAP9,microtubule dynamics disruption,spindle assembly deregulation,oncogenic overexpression,tumor growth promotion,cell migration facilitation,chromosomal instability induction
ENSG00000096088,PGC,cellular process regulation,transcriptional regulation,zinc finger protein,cell growth regulation,dna repair,cell cycle regulation
ENSG00000177468,OLIG3,pi3k/akt signaling pathway,transcription factor regulation,tumor cell proliferation,oncogenesis,cell cycle progression,poor prognosis
,SEPT9,oncogene,cell division regulation,mitotic progression disruption,emt regulation,tumor growth promotion,poor prognosis marker
ENSG00000143614,GATAD2B,chromatin remodeling,transcriptional co-activator,oncogene upregulation,cell proliferation,swi/snf complex interaction,aggressive tumor behavior
ENSG00000151923,TIAL1,tumor suppressor function,p53 pathway regulation,apoptosis modulation,oncogenic mutation,genomic instability,biomarker potential
ENSG00000112146,FBXO9,tumor suppressor function loss,cell cycle regulation disruption,protein degradation pathway impairment,myc oncogene stabilization,cyclin e accumulation,cancer driver mutation
ENSG00000197540,GZMM,cell cycle regulation,tumor suppressor activity,loss of function mutations,apoptosis induction,cell proliferation inhibition,epigenetic silencing
ENSG00000124469,CEACAM8,angiogenesis,cell adhesion,cancer stem cells,immune suppression,epithelial-to-mesenchymal transition (emt),vascular endothelial growth factor receptors (vegfrs)
ENSG00000137776,SLTM,transcription factor regulation,cell survival pathways,oncogenic processes,tumor progression,gene expression modulation,apoptosis inhibition
ENSG00000075702,WDR62,cell cycle regulation,aneuploidy,genomic instability,oncogene function,microtubule dynamics,chromosomal instability
ENSG00000090273,NUDC,microtubule dynamics,mitotic progression,cell cycle regulation,centrosome duplication,tumor progression,therapeutic target
ENSG00000125257,ABCC4,drug resistance mechanism,cellular efflux transport,protein-protein interaction,therapeutic target identification,tumor progression regulation,signaling pathway modulation
ENSG00000087087,SRRT,chromatin remodeling,transcription regulation,cell proliferation,survival pathways,prognosis indicator,genome instability
ENSG00000275176,ACACA,acetyl-coa carboxylation,cell membrane synthesis,cholesterol biosynthesis,glycolytic activity,metabolic regulation,therapeutic target
ENSG00000168397,ATG4B,autophagy regulation,constitutive activation,oncogenic process,tumor progression,cancer stem cell maintenance,therapeutic target
ENSG00000160214,RRP1,ribosome maturation,rna binding,oncogene function,cancer progression,tumor growth regulation,cell cycle modulation
ENSG00000135503,ACVR1B,epithelial-to-mesenchymal transition,tgf-β pathway,cell proliferation inhibition,apoptosis regulation,cancer progression driver,signaling pathway dysregulation
ENSG00000114867,EIF4G1,pi3k/akt pathway dysregulation,tumor growth promotion,mrna translation enhancement,cancer cell proliferation,oncogene activation,cell survival regulation
ENSG00000189369,GSPT2,g1-to-s checkpoint regulation,tumor suppressor function,p53 interaction,dna repair modulation,genomic stability maintenance,cell cycle control enhancement
ENSG00000149428,HYOU1,heat shock protein regulation,cellular stress response,apoptosis resistance,angiogenesis promotion,therapeutic resistance,oncogenic driver
ENSG00000181026,AEN,v-type atpase activation,tumor progression,cell proliferation,proton transport regulation,oncogenic role,cancer biomarker
ENSG00000162734,PEA15,apoptosis inhibition,cell survival promotion,growth factor regulation,mapk pathway interaction,p53 regulation,tumor progression association
ENSG00000089234,BRAP,genomic instability,chromatin remodeling,homologous recombination,dna repair mechanism,tumor suppressor function,loss of function mutations
ENSG00000157601,MX1,nf-kappa b activation,cell survival regulation,apoptosis suppression,inflammation modulation,immune response regulation,tumor growth promotion
ENSG00000132313,MRPL35,mitochondrial ribosome assembly,mitochondrial energy metabolism,cellular respiration regulation,tumor progression association,genomic instability link,protein synthesis modulation
ENSG00000092969,TGFB2,tumor progression,epithelial-to-mesenchymal transition,immune suppression,angiogenesis regulation,dysregulated expression,tgf-β signaling pathway activation
ENSG00000277359,RPS9,ribosomal subunit,translation initiation,global translation patterns,oncogenic pathways,cell growth promotion,cellular stress response
ENSG00000100138,SNU13,rna processing dysregulation,genome instability contribution,oncogenic process facilitation,cellular growth promotion,spliceosome component role,genetic predisposition factor
ENSG00000100650,SRSF5,splicing factor regulation,aberrant splicing events,genomic instability,tumor progression,cellular survival,apoptosis regulation
ENSG00000133878,DUSP26,mapk signaling,oncogenic activation,tumor progression,oncogene function,cell proliferation regulation,apoptosis resistance
ENSG00000077312,SNRPA,disrupted splicing regulation,aberrant gene expression,chromatin remodeling,cellular differentiation,altered cell survival,precise rna recognition
ENSG00000198099,ADH4,alcohol metabolism,dysregulated redox balance,oxidative stress,cancer predisposition,enzyme regulation,alcohol-induced toxicity
ENSG00000143106,PSMA5,proteolytic regulation,constitutive activation,cell cycle progression,apoptosis resistance,tumor progression,protein degradation pathway
ENSG00000107816,LZTS2,genomic instability,loss of function mutation,tumor suppressor,cell cycle regulation,apoptosis induction,centrosome interaction
ENSG00000165169,DYNLT3,microtubule stabilization,microtubule dynamics regulation,cell migration and invasion enhancement,pi3k/akt pathway activation,oncogene overexpression,tumor progression promotion
ENSG00000197114,ZGPAT,chromatin regulation,genomic instability,histone modification,oncogenic process,tumor suppressor interaction,biomarker potential
ENSG00000124535,WRNIP1,genomic instability,tumor aggressiveness,increased cell proliferation,dna repair mechanisms,oncogenic process,tumorigenesis
ENSG00000169813,HNRNPF,rna processing,cell proliferation,genomic instability,oncogenic driver,tumor progression,transcriptional regulation
,AARS,mitochondrial function,cellular proliferation,protein synthesis regulation,translation initiation factor interaction,tumor suppressor candidate,mtor pathway modulation
ENSG00000160216,AGPAT3,**
phospholipid biosynthesis,cell membrane fluidity,glycolipid regulation,lipid metabolism alteration,oncogenic processes,cancer therapeutic target
**
ENSG00000006744,ELAC2,rna stability regulation,cell proliferation promotion,oncogene expression,tumor progression driver,therapeutic target identification,genomic instability
ENSG00000008083,JARID2,histone modification,chromatin remodeling,transcriptional regulation,tumor suppressor activity,apoptosis regulation,cellular proliferation
ENSG00000160584,SIK3,pi3k/akt signaling pathway modulation,gene expression regulation,dna repair mechanism alteration,oncogene overexpression,tumor progression enhancement,therapeutic target identification
ENSG00000183010,PYCR1,high glucose metabolism,enhanced biomass production,pyruvate conversion,gluconeogenesis activation,oxaloacetate synthesis,cell growth promotion
ENSG00000137818,RPLP1,ribosome biogenesis,protein synthesis regulation,genomic instability,tumor growth promotion,signaling pathway activation,cell cycle progression facilitation
ENSG00000114125,RNF7,wnt/beta-catenin pathway modulation,cell cycle regulation,ubiquitination and proteasomal degradation,cell proliferation enhancement,apoptosis inhibition,tumor suppressor activity disruption
ENSG00000037474,NSUN2,nucleoside synthetase activity,methyltransferase function,trna methylation,gene expression regulation,cell growth promotion,oncogene overexpression
ENSG00000159189,C1QC,complement activation,tumor growth promotion,cell migration facilitation,apoptosis inhibition,inflammation modulation,proteolytic activity enhancement
ENSG00000167208,SNX20,rtk recycling,cell proliferation,endosomal regulation,receptor tyrosine kinase,signaling pathway activation,genomic instability
ENSG00000176624,MEX3C,microrna regulation,cell cycle progression,oncogene overexpression,apoptosis inhibition,tumorigenesis promotion,genomic instability
ENSG00000131721,RHOXF2,tumor progression,cell proliferation,oncogenic activity,pi3k/akt pathway regulation,therapeutic target,cell migration
ENSG00000276452,LILRB1,immunosuppression,nk cell inhibition,tumor microenvironment modification,angiogenesis promotion,chemotherapy resistance,immune evasion
ENSG00000071626,DAZAP1,ar regulation,cell growth modulation,chromatin remodeling,oncogenesis promotion,transcription factor interaction,tumor aggressiveness enhancement
ENSG00000196470,SIAH1,tumor suppression,cell cycle regulation,apoptosis induction,protein degradation regulation,oncoprotein targeting,genetic instability
ENSG00000084774,CAD,cancer cell proliferation,tumor progression,angiogenesis,metastasis facilitation,protein-protein interaction,hypoxia regulation
ENSG00000135829,DHX9,rna-binding activity,genomic instability,transcription regulation,tumor promoter,prognostic biomarker,cell proliferation
ENSG00000153187,HNRNPU,regulation of rna metabolism,protein-protein interaction,oncogene regulation,tumor progression,cell proliferation modulation,gene expression regulation
ENSG00000077235,GTF3C1,transcription regulation,overexpression,cell proliferation,genetic instability,rna polymerase iii mediation,tumor aggressiveness
ENSG00000071054,MAP4K4,constitutive activation,gain of function mutations,erk/mapk pathway,oncogene,tumor progression,therapeutic target
ENSG00000012232,EXTL3,heparan sulfate biosynthesis,tumor angiogenesis,cell proliferation,wnt/β-catenin pathway interaction,cancer cell invasion,genomic amplification
ENSG00000145088,EAF2,genomic instability,chromatin remodeling,transcriptional elongation,oncogene activation,tumor suppressor regulation,therapeutic resistance
ENSG00000121310,ECHDC2,altered lipid metabolism,oncogenic adaptation,cell proliferation,energy production,lipid biosynthesis regulation,fatty acid elongation
ENSG00000141564,RPTOR,cell growth regulation,mtor signaling pathway activation,metabolic reprogramming,protein synthesis enhancement,therapeutic target identification,integrative signal transduction
ENSG00000101306,MYLK2,pi3k/akt pathway regulation,constitutive activation by genetic mutations,epithelial-to-mesenchymal transition (emt),cell cycle progression regulation,apoptosis inhibition,chemotherapy resistance
ENSG00000197102,DYNC1H1,microtubule-based transport,oncogenic proliferation,tumor progression,cell migration,metastatic niches formation,p53 interaction
ENSG00000101557,USP14,pi3k/akt pathway regulation,oncogenesis promotion,tumor growth facilitation,apoptosis inhibition,proteostasis maintenance,cell survival enhancement
ENSG00000281320,DYRK1B,pi3k/akt pathway regulation,oncogene overexpression,cell cycle progression,apoptosis inhibition,emt regulation,protein kinase activation
ENSG00000120756,PLS1,pi3k/akt signaling,cancer progression,gene amplification,tumor promoting,signaling pathway interaction,cell proliferation enhancement
ENSG00000176171,BNIP3,mitochondrial function regulation,gain of function mutations,tumor progression promotion,anti-apoptotic activity,pro-survival signaling pathway interaction,mitophagy induction
ENSG00000049449,RCN1,microtubule regulation,cell cycle modulation,tumor progression,oncogenic processes,cell migration,protein-protein interactions
ENSG00000128045,RASL11B,oncogenic mutations,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cell signaling
ENSG00000186716,BCR,tyrosine kinase activation,bcr signaling pathway,constitutive activation,cell proliferation,tumor growth,therapeutic target
ENSG00000151694,ADAM17,adam/notch pathway,pro-inflammatory cytokine release,tumor progression,metastasis promotion,cell signaling regulation,oncogenic role
ENSG00000064607,SUGP2,pi3k/akt pathway interaction,oncogene activation,cell proliferation enhancement,tumor progression facilitation,transcription factor modulation,emt regulation
ENSG00000162728,KCNJ9,genomic instability,chromosomal alterations,cellular homeostasis,potassium channel function,tumor progression,therapeutic target
ENSG00000276825,DRD4,constitutive activation,g-protein coupled receptor,oncogenic potential,aberrant expression,therapeutic target,genetic variation
ENSG00000155366,RHOC,metastasis promotion,cell migration enhancement,pi3k/akt pathway activation,tumor progression facilitation,prognostic marker,cell invasion regulation
ENSG00000111913,RIPOR2,regulation of cell growth,cellular trafficking,pi3k/akt pathway regulation,genome stability maintenance,oncogene activation,tumor progression promotion
ENSG00000196839,ADA,dna repair interaction,purine metabolism regulation,tumor suppressor modulation,cell proliferation enhancement,genomic instability protection,therapeutic target consideration
ENSG00000151150,ANK3,epithelial-to-mesenchymal transition,src kinase interaction,adhesion and migration regulation,tumor progression promoter,cell membrane structural component,protein-protein interaction modulation
ENSG00000119402,FBXW2,cell cycle regulation,tumor suppression,ubiquitin-mediated degradation,g1 phase arrest,proliferation dysregulation,cancer progression
ENSG00000169057,MECP2,genomic instability,epigenetic regulation,methylation patterns,chromatin remodeling,tumor suppressor silencing,oncogene activation
ENSG00000151466,SCLT1,cell adhesion disruption,epithelial-to-mesenchymal transition,pi3k/akt pathway modulation,microrna-21 interaction,overexpression,tumor progression
ENSG00000132694,ARHGEF11,rho gtpase regulation,tumor progression,cell migration enhancement,epithelial-to-mesenchymal transition (emt),apoptosis suppression,cell proliferation promotion
ENSG00000166670,MMP10,proteolytic activity,tumor progression,metastasis,cell migration,angiogenesis,immune evasion
ENSG00000178031,ADAMTSL1,ecm regulation,cell migration,tumor progression,biomarker potential,prognostic significance,signaling pathway interaction
ENSG00000173914,RBM4B,cell proliferation,overexpression,apoptosis inhibition,rna processing modulation,gene expression regulation,protein-protein interaction
ENSG00000170485,NPAS2,genomic instability,overexpression,transcriptional regulation,apoptosis inhibition,cell cycle progression,circadian rhythm disruption
ENSG00000081154,PCNP,wnt/β-catenin signaling pathway,constitutive activation,gain of function mutations,tumor progression,protein processing,p53 degradation
ENSG00000149084,HSD17B12,steroid metabolism regulation,tumor progression promotion,cell proliferation enhancement,apoptosis inhibition,metastatic potential increase,chemo-resistance induction
ENSG00000092841,MYL6,oncogene activation,aberrant signaling pathway,cell migration regulation,cytoskeleton dynamics modulation,epithelial-to-mesenchymal transition (emt),prognostic biomarker
ENSG00000115073,ACTR1B,chromatin remodeling,tumor progression,genomic instability,apoptosis suppression,cell cycle regulation,metastasis enhancement
ENSG00000100823,APEX1,genomic instability,dna damage repair,oncogenesis driver,mutational hotspots,cellular response modulation,tumor progression hallmark
ENSG00000188229,TUBB4B,microtubule stability,cellular integrity,enhanced cell proliferation,oncogenic process,apoptosis regulation,therapeutic target
ENSG00000104267,CA2,metabolic adaptation,cellular proliferation,extracellular ph regulation,anabolic processes,tumor metabolism,upregulated expression
ENSG00000113013,HSPA9,oncogene activity,cell survival promotion,tumor progression driver,metabolic reprogramming,chaperone function regulation,stress response pathway modulation
ENSG00000166441,RPL27A,regulation of translation initiation,ribosome biogenesis,cell proliferation,overexpression oncogene,therapeutic target,protein synthesis enhancement
ENSG00000053501,USE1,cell cycle regulation,apoptosis regulation,ubiquitination pathway,cytoplasmic localization,oncogenic process,tumor progression
ENSG00000072501,SMC1A,genomic instability,chromosome segregation defects,cohesin complex regulation,alternative lengthening of telomeres activation,telomere maintenance dysregulation,genome rearrangements
ENSG00000281459,PADI1,histone modification,citrullination,epigenetic regulation,oncogenic activation,nf-κb pathway modulation,tumor suppressor gene dysregulation
ENSG00000182446,NPLOC4,genomic instability,cell cycle regulation,tumor progression,dna damage response,nucleolar protein interaction,replication error tolerance
ENSG00000070087,PFN2,cytoskeleton regulation,oncogene activation,cell migration enhancement,protein-protein interactions,microtubule association,epithelial-to-mesenchymal transition
ENSG00000134899,ERCC5,dna repair dysfunction,genomic instability,mutational signature,poor prognosis,tumor progression,dna damage response pathway
ENSG00000081181,ARG2,metabolic reprogramming,tumor progression,cell proliferation,angiogenesis promotion,oncogenic driver,therapeutic target
ENSG00000215182,MUC5AC,**

mucin overproduction,aberrant promoter methylation,cell adhesion disruption,immune evasion,oncogene expression,tumor microenvironment modulation 

**
ENSG00000122852,SFTPA1,tumor microenvironment modulation,immune response regulation,cell growth promotion,inflammatory process involvement,protein-protein interaction,surface tension reduction
ENSG00000154447,SH3RF1,gain of function mutations,constitutive activation,signaling pathway modulation,cell proliferation regulation,apoptosis inhibition,oncogenic driver gene
ENSG00000161509,GRIN2C,cell proliferation,apoptosis regulation,tumor growth,pi3k/akt pathway interaction,molecular dysregulation,therapeutic target
ENSG00000044090,CUL7,cell cycle regulation,cancer driver,apoptosis evasion,protein degradation,ubiquitination pathway,dna damage response
ENSG00000104321,TRPA1,cell proliferation,calcium channel activity,nf-κb signaling pathway,mapk signaling pathway,tumor marker,therapeutic target
ENSG00000198034,RPS4X,cell proliferation,dna repair mechanism disruption,oncogene overexpression,genomic instability,cancer cell survival pathway activation,ribosomal protein function alteration
ENSG00000111669,TPI1,enhanced glycolytic activity,metabolic regulation,glyceraldehyde-3-phosphate interconversion,tumor growth promotion,energy metabolism modulation,lactate production increase
ENSG00000139722,VPS37B,autophagy regulation,cancer cell growth,escrt complex component,oncogenic role,protein aggregation regulation,tumor suppressor dysfunction
ENSG00000144381,HSPD1,mitochondrial chaperone function,oncoprotein overexpression,cellular stress response modulation,tumor growth promotion,cell survival enhancement,protein misfolding and aggregation
ENSG00000196482,ESRRG,err-γ mediated transcriptional regulation,cell cycle progression,oncogenic function,tumor progression,apoptosis resistance,metabolic reprogramming
ENSG00000169297,NR0B1,cell proliferation suppression,mutations leading to loss of function,affected in adrenal hypoplasia congenita,tissue specific expression,genomic amplification,ahc/cah related transcription factor
ENSG00000186468,RPS23,ribosome biogenesis,genomic instability,protein translation,cell cycle progression,tumor growth,therapeutic target
ENSG00000169564,PCBP1,post-transcriptional regulation,cell proliferation,oncogenic process,gene expression modulation,mrna stability,protein-rna interaction
ENSG00000171345,KRT19,cell proliferation,epithelial differentiation,tumor aggressiveness,signal transduction,apoptosis modulation,cell migration
ENSG00000182809,CRIP2,cellular proliferation,overexpression,rna binding,transcriptional regulation,tumor growth,angiogenesis
ENSG00000204536,CCHCR1,cell cycle regulation,cyclin b1 degradation,g2/m phase progression,anaphase-promoting complex activation,oncogenic function,apoptosis resistance
ENSG00000092208,GEMIN2,cell cycle regulation,chromatin remodeling,dna replication inhibition,genome stability maintenance,tumor suppressor interaction,proliferation promotion
ENSG00000163737,PF4,pro-angiogenic activity,angiogenesis promoter,tumor vascularization,poor prognosis marker,heparin binding protein,vegf interaction
ENSG00000106948,AKNA,regulation of gene expression,cell proliferation driver,transcriptional activity modulation,chromatin structure regulation,oncogene interaction,tumor suppressor protein interaction
ENSG00000198931,APRT,purine metabolism,cellular growth regulation,dna repair enhancement,tumor aggressiveness promotion,cell energy homeostasis modulation,therapeutic target potentialization
ENSG00000154310,TNIK,wnt/β-catenin pathway,oncogene,serine/threonine kinase activity,dna damage response,genomic instability,cell proliferation
ENSG00000188739,RBM34,prc1 complex,tumor suppression,cell cycle regulation,apoptosis modulation,rna processing regulation,microrna interaction
ENSG00000178184,PARD6G,rho gtpase regulation,tumor cell migration,cell polarity disruption,epithelial-to-mesenchymal transition,cancer cell invasion,metastatic potential
ENSG00000139218,SCAF11,genomic instability,dna damage response,cell cycle regulation,dna repair complex assembly,tumor suppressor function,mrn complex interaction
ENSG00000183741,CBX6,histone h3k27me3 binding,chromatin remodeling,polycomb repressive complex,transcriptional regulation,cell proliferation,tumor suppressor repression
ENSG00000125901,MRPS26,mitochondrial translation regulation,cellular energy metabolism modulation,tumor progression association,oxidative phosphorylation regulation,glycolysis pathway involvement,electron transport chain regulation
ENSG00000138100,TRIM54,apoptosis regulation,cell proliferation,genomic instability,microtubule regulation,tumor suppressor function,p53 interaction
ENSG00000082805,ERC1,genetic instability,dna repair deficiency,tumor suppressor function,nucleotide excision repair pathway,genome instability,cancer predisposition
ENSG00000168439,STIP1,tumor progression,genetic amplification,protein degradation regulation,oncogenic signaling interaction,cellular stress response,apoptosis resistance
ENSG00000115816,CEBPZ,pi3k/akt signaling pathway,transcription factor regulation,tumor suppressor function,cancer cell proliferation,cellular differentiation,genomic instability
ENSG00000146007,ZMAT2,oncogene activity,transcriptional regulation,tumor progression,pi3k/akt pathway modulation,cell proliferation enhancement,epigenetic regulation
ENSG00000171860,C3AR1,complement system regulation,oncogene overexpression,immune evasion,angiogenesis modulation,epigenetic regulation,tumor microenvironment interaction
ENSG00000273562,NAP1L4,chromatin remodeling,cell cycle progression,dna replication,oncogenic pathway activation,histone modification regulation,therapeutic resistance
ENSG00000230624,DDX39B,rna helicase activity,cell proliferation,transcription regulation,gene expression,apoptosis resistance,oncogene overexpression
ENSG00000130706,ADRM1,oncogenic role,tumor progression,cell adhesion regulation,metastasis promotion,prognostic biomarker,therapeutic target
ENSG00000160213,CSTB,protease inhibition,tumor suppressor activity,cellular homeostasis regulation,signaling pathway modulation,cell invasion prevention,metastasis suppression
ENSG00000104852,SNRNP70,alternative splicing,spliceosome assembly,tumor progression,cellular transformation,genomic instability,protein overexpression
ENSG00000101916,TLR8,viral rna recognition,inflammatory cytokine regulation,tumor microenvironment modulation,immune evasion mechanism,pro-inflammatory response induction,cell survival promotion
ENSG00000100129,EIF3L,overexpression,cell cycle dysregulation,apoptosis suppression,proliferation enhancement,translation initiation disruption,oncogenic protein overexpression
ENSG00000146676,PURB,genomic instability,tumor suppressor function,cell cycle regulation,dna damage response,replication fork progression,oncogenic signaling activation
ENSG00000086061,DNAJA1,hsp regulation,thermal stress response,cellular survival pathway,protein quality control,chaperone activity,cancer prognosis biomarker
ENSG00000215271,HOMEZ,cellular differentiation,chromatin remodeling,epithelial-to-mesenchymal transition,oncogenesis,transcriptional regulation,tumor progression
ENSG00000109606,DHX15,p53 pathway regulation,rna processing modulation,tumor suppressor function,cell cycle regulation,genomic stability maintenance,biomarker potential
ENSG00000177105,RHOG,rho/rac gtpase pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cancer cell migration
ENSG00000142409,ZNF787,oncogenic transcriptional regulation,tumor suppressive activity,cell cycle progression modulation,transcription factor interaction,apoptosis regulation,genomic instability modulation
ENSG00000172301,COPRS,protein transport regulation,tumor progression contributor,cellular trafficking dysregulation,oncogenic protein modulation,therapeutic target potential,cancer cell survival pathway involvement
ENSG00000101350,KIF3B,microtubule-dependent transport,gene expression regulation,chromosomal segregation,cytokinesis promotion,protein-protein interaction,transcription factor recruitment
ENSG00000167792,NDUFV1,mitochondrial dysfunction,oncogenic potential,cellular respiration,electron transfer,energy metabolism,tumor progression
ENSG00000082175,PGR,progesterone signaling,oncogenic driver,tumor progression,cell proliferation,apoptosis regulation,transcriptional modulation
ENSG00000168286,THAP11,oncogene activation,transcription factor function,cell proliferation enhancement,chromatin remodeling,pi3k/akt pathway activation,tumor progression enhancement
ENSG00000167967,E4F1,transcriptional regulation,tumor progression,oncogene activation,metastasis promotion,apoptosis repression,genomic instability
ENSG00000117650,NEK2,genomic instability,mitotic dysregulation,overexpression,cell cycle progression,pi3k/akt pathway interaction,therapeutic target
ENSG00000076003,MCM6,cell cycle regulation,dna replication,helicase activity,mcm complex interaction,oncogenic transformation,tumor progression
ENSG00000101197,BIRC7,apoptosis inhibition,tumor progression,therapeutic target,cell survival modulation,stress response regulation,prognostic marker
ENSG00000228267,C4B,tumor progression,complement activation regulation,classical pathway dysregulation,immunomodulatory functions,cell survival promotion,prognostic marker
ENSG00000233312,C4B_2,complement activation,immune evasion,tumor progression,protein binding,cell clearance,regulatory function
ENSG00000146063,TRIM41,amplification,cell proliferation,migration invasion,ubiquitination pathway,cell cycle regulation,protein-protein interaction
ENSG00000104388,RAB2A,secretory pathway regulation,gtpase activity,oncogenic properties,tumor progression,cell proliferation regulation,pi3k/akt/mtor signaling
ENSG00000139990,DCAF5,histone modification regulation,cell proliferation enhancement,protein stability modulation,cancer driver mutation,ubiquitin-proteasome system interaction,tumor progression promotion
ENSG00000136111,TBC1D4,rho gtpase regulation,gain-of-function mutation,cell migration,tumor progression,oncogenic signaling,tumorigenesis driver
ENSG00000140299,BNIP2,mitochondrial regulation,angiogenesis promotion,apoptosis suppression,cancer metabolism,cell survival enhancement,hif-1α interaction
ENSG00000142864,SERBP1,transcriptional regulation,cell growth modulation,oncogenic processes,protein interaction,dna damage response,proliferation pathway activation
ENSG00000229314,ORM1,oncogene,overexpression,cell adhesion,metastasis,tumor growth,protein-protein interaction
ENSG00000285258,ATXN7,histone acetyltransferase activity,chromatin remodeling,gene expression regulation,transcriptional activation,dna damage response,cancer progression
ENSG00000111581,NUP107,nuclear pore complex regulation,cell cycle regulation,mitotic spindle assembly,dna repair deficiency,oncogene activation,cancer cell proliferation
ENSG00000187754,SSX7,chromatin remodeling,oncogenic protein,transcriptional regulation,cell growth modulation,yap1 interaction,elevated tumor expression
ENSG00000163736,PPBP,angiogenesis promotion,apoptosis inhibition,immune evasion,integrin interaction,oncogenic driver,protein secretion
ENSG00000188404,SELL,angiogenesis facilitation,immunosuppressive function,tumor progression enhancement,cell adhesion regulation,metastasis promotion,cancer cell recruitment facilitation
ENSG00000152234,ATP5F1A,electron transport chain enhancement,energy production,cellular proliferation,tumor progression,prognostic marker,oncoprotein interaction
ENSG00000162302,RPS6KA4,cellular growth promotion,tumor progression enhancement,mtor signaling pathway activation,cell survival regulation,oncogenic transformation driver,protein kinase function alteration
ENSG00000141551,CSNK1D,wnt/β-catenin pathway activation,tumor progression,cell proliferation modulation,circadian rhythm disruption,oncogenic signaling,inflammatory response regulation
ENSG00000177733,HNRNPA0,mrna splicing regulation,cell proliferation enhancement,oncogene overexpression,tumor metastasis promotion,chemoresistance development,mirna regulation alteration
ENSG00000132182,NUP210,nuclear pore complex,nucleocytoplasmic transport,genomic instability,chromatin remodeling,tumorigenesis driver,cell cycle regulation
ENSG00000065154,OAT,cellular homeostasis disruption,tumor progression promotion,cell growth facilitation,therapeutic target potential,prognostic biomarker candidate,nitrogen metabolism alteration
ENSG00000180228,PRKRA,cell signaling dysregulation,tumor progression,oncogenesis,stress response modulation,protein kinase activation,cell cycle regulation
ENSG00000177169,ULK1,autophagy regulation,cellular stress response,pi3k/akt pathway interaction,tumor progression driver,genomic instability mediator,therapeutic target potential
ENSG00000049540,ELN,elastin degradation,tumor microenvironment disruption,cell adhesion loss,tumor invasiveness enhancement,structural integrity compromise,fibrosis remodeling
ENSG00000087303,NID2,basement membrane remodeling,metastatic potential,tumor progression,cell migration facilitation,protein-protein interaction,overexpression
ENSG00000165861,ZFYVE1,pi3k/akt pathway regulation,ubiquitin ligase activity,e3 ligase function,ring domain involvement,cancer cell survival enhancement,tumor progression promotion
ENSG00000139880,CDH24,tumor suppressor,epithelial-to-mesenchymal transition,pi3k/akt pathway regulation,cell migration and invasion,chemotherapy resistance,loss-of-function mutation
ENSG00000118705,RPN2,erad pathway regulation,tumor cell growth,ubiquitination and degradation,cell cycle progression,apoptosis evasion,cancer metastasis
ENSG00000163939,PBRM1,chromatin remodeling,tumor suppressor function,constitutive activation,genomic instability,histone modification,transcriptional regulation
ENSG00000100220,RTCB,genomic instability,dna repair mechanisms,homologous recombination,cellular proliferation,genome maintenance,oncogenic processes
ENSG00000186010,NDUFA13,mitochondrial dysfunction,ros production,cellular metabolism regulation,tumor progression,oncogenic signaling pathways,dna damage repair
ENSG00000240694,PNMA2,pnma2 expression,tumor progression,cell proliferation,apoptosis evasion,metastasis promotion,immune response modulation
ENSG00000090054,SPTLC1,sphingolipid biosynthesis,oncogenic process,cell proliferation,therapeutic target,signaling pathway regulation,prognostic marker
ENSG00000095627,TDRD1,microrna regulation,transposon silencing,small rna stabilization,protein-protein interaction,molecular diagnosis,genomic instability
ENSG00000099937,SERPIND1,angiogenesis regulation,ovalbumin-like serine protease inhibitor function,proteolytic activity modulation,tumor growth facilitation,cellular damage protection,endothelial cell interaction
ENSG00000081913,PHLPP1,tumor suppressor,dephosphorylation activity,protein kinase regulation,cellular signaling pathway,cancer progression,genomic instability
ENSG00000121410,A1BG,regulatory function,cellular differentiation,apoptosis regulation,gene expression modulation,cancer-related expression changes,cell cycle regulation
ENSG00000108839,ALOX12,tumor progression,pro-inflammatory cytokines,lipid metabolism regulation,cellular redox balance,angiogenesis promotion,metastasis facilitation
ENSG00000164265,SCGB3A2,tumor suppressor/oncogene,cell proliferation regulation,apoptosis modulation,dna repair pathways,epithelial-to-mesenchymal transition,pi3k/akt signaling pathway interaction
ENSG00000019169,MARCO,tumor microenvironment,autophagy modulation,immune surveillance impairment,mannose binding receptor,phagocytosis regulation,innate immunity
ENSG00000056998,GYG2,tight junction regulation,cell adhesion modulation,tumor progression facilitation,epithelial polarity disruption,signaling pathway activation,protein expression alteration
ENSG00000074800,ENO1,oncogenic function,glycolytic reprogramming,epithelial-to-mesenchymal transition (emt),signaling pathway modulation,cell migration and invasion,biomarker potential
ENSG00000167004,PDIA3,oncogenic driver,protein folding regulation,tumor progression facilitation,cell proliferation enhancement,chemotherapy resistance,pi3k/akt pathway interaction
ENSG00000171621,SPSB1,akt pathway activation,emt facilitation,metastatic potential increase,oncogenic signaling enhancement,poor prognosis association,sphingolipid metabolism regulation
ENSG00000111802,TDP2,dna repair,genomic instability,tumor suppressor,oncogene,transcriptional regulation,therapeutic target
ENSG00000133142,TCEAL4,genomic instability,transcription factor activity,overexpression,dna replication and repair enhancement,chromatin remodeling,pi3k/akt pathway interaction
ENSG00000174255,ZNF80,oncogene,transcriptional regulation,cell proliferation,gene overexpression,tumor suppression,wnt/β-catenin interaction
ENSG00000147604,RPL7,ribosome assembly,enhanced translation,tumor progression,cell proliferation,oncogene upregulation,protein synthesis regulation
ENSG00000135625,EGR4,transcription factor regulation,tumor suppressor function,apoptosis induction,cell cycle regulation,prognostic marker,transcriptional repression
ENSG00000263163,SLC27A3,fatty acid transport,lipid metabolism regulation,cell growth promotion,tumor progression marker,metabolic reprogramming,biomarker development
ENSG00000101856,PGRMC1,tumor progression,cell survival,mitochondrial regulation,oncogenic signaling,cell proliferation,progesterone receptor interaction
ENSG00000145012,LPP,rho gtpase regulation,tumor suppressor/ oncogene dual role,cell adhesion modulation,migratory and invasive capacity,prognostic biomarker candidate,cytoskeleton dynamics regulator
ENSG00000153208,MERTK,apoptotic cell clearance,cell survival regulation,dysregulation,impaired engulfment,mutation,tumor suppression
ENSG00000105197,TIMM50,mitochondrial biogenesis,mitochondrial import receptor,energy metabolism adaptation,glycolytic flux integration,tumor progression facilitation,biomarker potential
ENSG00000170759,KIF5B,mitotic spindle formation,chromosomal instability,aneuploidy,driver gene,cell proliferation,mitosis
ENSG00000105372,RPS19,genomic instability,tumor aggressiveness,ribosomal protein synthesis,cell growth regulation,dysregulation,protein production enhancement
ENSG00000067082,KLF6,loss of tumor suppressor activity,dysregulated expression patterns,cell proliferation regulation,apoptosis modulation,transcriptional control,genomic instability
ENSG00000110107,PRPF19,rna splicing,spliceosome regulation,cancer driver mutations,cellular proliferation,therapeutic target,genome stability
ENSG00000205937,RNPS1,rna processing,pre-mrna splicing,regulatory mechanism,cellular differentiation,serine-arginine protein interaction,gene regulation
ENSG00000114316,USP4,deubiquitinating enzyme,stabilizes akt activation,wnt/β-catenin pathway interaction,cell proliferation regulator,tumor progression driver,therapeutic target
ENSG00000162999,DUSP19,erk/mapk pathway regulation,tumor suppressor function,cancer-related mutations,cell proliferation regulation,apoptosis modulation,genetic instability
ENSG00000106344,RBM28,rna-binding protein,nuclear function,cell cycle regulation,apoptosis inhibition,metastasis promotion,biomarker potential
ENSG00000108651,UTP6,**

cell cycle regulation,genomic instability,p53 modulation,dna replication,protein-protein interactions,cancer progression 
**
ENSG00000056736,IL17RB,cancer-promoting signaling pathway,tumor progression facilitation,immune evasion mechanism,genomic amplification hotspot,therapeutic target,inflammation regulation
ENSG00000285433,DEFB4B,apoptosis regulation,epithelial integrity disruption,immune response dysregulation,tumor progression facilitation,microbial invasion promotion,host-microbe interaction disruption
ENSG00000285181,DEFB4A,defensin-like protein activity,antimicrobial defense disruption,apoptosis resistance,cell proliferation enhancement,gene amplification,mapk/erk pathway interaction
ENSG00000131437,KIF3A,genomic instability,cell division regulation,microtubule stability,mitotic checkpoint regulation,oncogenic pathway disruption,chromosomal instability
ENSG00000172943,PHF8,histone demethylation,chromatin remodeling,oncogenic process,tumor progression,genomic instability,protein-protein interaction
ENSG00000008118,CAMK1G,calmodulin-binding activity,cellular signaling pathway,dysregulated expression,genomic instability,increased phosphorylation,oncogenic transformation
ENSG00000157916,RER1,cellular transport,endoplasmic reticulum dynamics,oncogenesis,protein quality control,signaling pathway modulation,tumor progression
ENSG00000145016,RUBCN,mitochondrial dynamics,mitophagy dysfunction,autophagy regulation,tumor progression,therapeutic target,cellular homeostasis
ENSG00000197451,HNRNPAB,alternative splicing,cell proliferation,genome instability,oncogene regulation,rna processing,transcriptional activation
ENSG00000163931,TKT,tyrosine catabolism,cell proliferation,oncogene activation,metabolic reprogramming,tumor growth,upregulation
ENSG00000121741,ZMYM2,chromatin remodeling,transcriptional regulation,histone modification,oncogenesis,cell proliferation,metastasis
,HIST2H2AB,histone modification,chromatin regulation,nucleosome formation,gene expression regulation,tumor suppressor,dna packaging
ENSG00000177189,RPS6KA3,mtor pathway activation,constitutive expression,cell proliferation promotion,protein synthesis enhancement,metastasis facilitation,tumor progression driver
ENSG00000212935,KRTAP10-3,emt process,keratin-associated protein,epithelial-to-mesenchymal transition,cell proliferation regulation,cytoskeletal integrity maintenance,microtubule dynamics modulation
ENSG00000277377,SERPINA1,tumor suppression,protease inhibition,apoptosis regulation,cell proliferation inhibition,angiogenesis inhibition,epithelial-mesenchymal transition
ENSG00000197694,SPTAN1,metastasis,cell migration,signaling pathway regulation,cytoskeleton dynamics,cell invasion,tumor progression
ENSG00000131504,DIAPH1,cellular migration,constitutive activation,oncogenic function,microtubule stability,cell proliferation,pi3k/akt signaling pathway
ENSG00000128739,SNRPN,genomic instability,regulatory mechanism disruption,tumor suppressor function loss,gene expression dysregulation,cellular process modulation,pseudogene dysregulation
ENSG00000105854,PON2,antioxidant properties,cellular redox balance regulation,dna damage protection,lipid peroxidation inhibition,oxidative stress modulation,tumor suppression role
ENSG00000189266,PNRC2,cell cycle regulation,protein degradation,oncogenic potential,tumor growth promotion,cancer metabolism modulation,ubiquitin-proteasome system activation
ENSG00000134014,ELP3,transcription elongation,genomic instability,cell proliferation,dna repair interactions,tumor-promoting,oncogene regulation
ENSG00000125944,HNRNPR,alternative splicing,cell migration,gene regulation,mrna processing,oncogenic function,pre-mrna splicing
ENSG00000163815,CLEC3B,cell surface recognition,immune evasion mechanisms,toll-like receptor interactions,prognostic biomarker,proliferation regulation,cancer cell survival
ENSG00000186395,KRT10,cell proliferation enhancement,tumor progression marker,epithelial differentiation marker,intermediate filament protein,cytoskeletal component,overexpression association
ENSG00000169018,FEM1B,cell cycle regulation,chromatin remodeling,forkhead-associated domain,increased cell proliferation,interacts with tumor suppressors,oncogenic driver
ENSG00000173812,EIF1,oncogene activity,translation initiation factor,enhanced protein synthesis,malignant transformation,tumor aggressiveness,mrna recruitment
ENSG00000078804,TP53INP2,dna repair mechanisms,genomic instability,apoptosis regulation,tumor suppressor function,autophagy regulation,cancer cell survival
ENSG00000128573,FOXP2,oncogenic transcription factor,tumor progression regulator,apoptosis inhibitor,cell cycle regulator,wnt/β-catenin pathway activator,tumor suppressor gene suppressor
ENSG00000096080,MRPS18A,mitochondrial ribosome regulation,metabolic reprogramming,tumor progression,mitochondrial dysfunction,genomic instability,cellular metabolism
ENSG00000131507,NDFIP1,wnt/β-catenin pathway,constitutive activation,ubiquitin ligase activity,protein degradation regulation,tumor progression,cell signaling modulation
ENSG00000119725,ZNF410,zinc finger protein regulation,tumor suppressor activity,cell proliferation regulation,transcriptional modulation,oncogene interaction,apoptosis inhibition
ENSG00000062524,LTK,oncogenic driver,tumor progression,cell proliferation enhancement,migration and invasion promotion,apoptosis resistance,protein kinase activation
ENSG00000177674,AGTRAP,at1r signaling pathway,loss of function mutations,constitutive activation,cell cycle regulation,tumor suppressor function,angiogenesis promotion
ENSG00000127743,IL17B,tumor progression,signaling pathway activation,immune evasion,angiogenesis promotion,cell proliferation enhancement,dysregulated expression
ENSG00000142945,KIF2C,genomic instability,kinetochore regulation,motor protein activity,tumor progression,mitotic spindle assembly,cell division dysregulation
ENSG00000147679,UTP23,pre-mrna splicing regulation,oncogene activation,spliceosome interaction,cell proliferation enhancement,therapeutic target identification,altered expression levels
ENSG00000185825,BCAP31,pi3k/akt pathway regulation,tumor suppressor function,loss of function mutations,cell surface protein trafficking,ubiquitination regulation,apoptosis regulation
ENSG00000109107,ALDOC,glycolysis regulation,oncogenic protein interaction,metabolic adaptation,tumor progression enhancement,poor prognosis marker,therapeutic target candidate
ENSG00000149925,ALDOA,glycolysis,metabolic reprogramming,oncogenic function,apoptosis suppression,dna repair facilitation,poor prognosis
ENSG00000115825,PRKD3,cell proliferation enhancement,tumor progression promoter,signaling pathway modulation,protein kinase activation,cell migration regulator,poor prognosis marker
ENSG00000147130,ZMYM3,tumor suppressor role,transcriptional regulation,cell cycle regulation,apoptosis induction,prognostic marker,pi3k/akt pathway modulation
ENSG00000163132,MSX1,constitutive activation,tumor progression,gain of function mutations,therapeutic target,cell proliferation suppression,apoptosis regulation
ENSG00000276618,RAD17,genomic instability,dna damage response,cell cycle regulation,genetic predisposition,tumor suppressor function,proliferation control
ENSG00000132254,ARFIP2,oncogenic signaling,cell proliferation,metastasis,prognostic marker,pi3k/akt pathway interaction,cell membrane trafficking regulation
ENSG00000159111,MRPL10,mitochondrial function,mitochondrial biogenesis,cell growth,energy metabolism,protein interaction,anticancer target
ENSG00000163221,S100A12,calcium regulation,cell proliferation,tumor progression,inflammatory response,diagnostic biomarker,therapeutic target
ENSG00000181788,SIAH2,tumor suppressor degradation,oncogenic function,protein ubiquitination,cell cycle regulation,apoptosis inhibition,chemosensitivity reduction
ENSG00000111247,RAD51AP1,genomic instability,dna repair dysfunction,enhanced sensitivity to dna-damaging agents,tumor suppressor function,cancer driver mutation,protein-protein interaction
ENSG00000197498,RPF2,cell cycle progression,dna repair,mrna processing,transcriptional regulation,tumor growth,pi3k/akt pathway
ENSG00000117395,EBNA1BP2,epstein-barr virus transcriptional regulation,cell proliferation regulation,immune evasion mechanism,oncogenic factor association,viral protein interaction,transcriptional activation
ENSG00000143742,SRP9,cellular protein synthesis,mirna processing,oncogenic signaling pathway,tumor development,biomarker potential,therapeutic target
ENSG00000142168,SOD1,oxidative stress,redox balance disruption,tumor progression driver,therapeutic target candidate,cell survival enhancement,signaling pathway activation
ENSG00000152214,RIT2,rho gtpase activation,mitogen-activated protein kinase pathway interaction,cell migration promotion,oncogenic signaling facilitation,tumor progression enhancement,guanine nucleotide exchange factor activity
ENSG00000120800,UTP20,ribosomal rna processing,genomic instability,cell proliferation,tumorigenicity,therapeutic target,genomic stability
ENSG00000011007,ELOA,fatty acid metabolism,lipid regulation,cell proliferation,oncogenesis,peroxisomal function,metabolic imbalance
ENSG00000140988,RPS2,protein synthesis regulation,tumor growth promotion,ribosomal subunit assembly,dysregulated signaling pathways,cell proliferation enhancement,akt pathway activation
ENSG00000067596,DHX8,cell proliferation,genomic instability,dna helicase activity,rna degradation,transcription regulation,metastasis promotion
ENSG00000176783,RUFY1,mitotic checkpoint regulation,cell cycle control,oncogenic activity,ubiquitination target,dna repair regulation,genomic instability promotion
ENSG00000107625,DDX50,rna helicase function,oncogenic potential,tumor progression,cell proliferation,apoptosis regulation,gene expression modulation
ENSG00000137804,NUSAP1,microtubule stabilization,mitotic checkpoint control,cell cycle progression,tumor suppressor protein interaction,prognostic marker candidate,cancer cell proliferation
ENSG00000131018,SYNE1,epithelial tumor progression,cell proliferation,nuclear envelope integrity,protein-protein interactions,tumor invasion and metastasis,cancer cell survival
ENSG00000141644,MBD1,epigenetic regulation,gene expression modulation,tumor suppressor function,dna repair mechanism,oncogene silencing,cell cycle regulation
ENSG00000115234,SNX17,pi3k/akt pathway regulation,oncogenic potential,endosomal trafficking modulation,cell growth promotion,survival signaling enhancement,regulatory subunit function
ENSG00000278741,ABR,multidrug resistance,tumor chemoresistance,atp-binding cassette transporter,cellular efflux mechanism,chemotherapy response,protein-protein interaction
ENSG00000165006,UBAP1,escrt pathway dysfunction,oncogene activation,tumor suppressor degradation,cell proliferation enhancement,autophagy dysregulation,apoptosis resistance
ENSG00000102908,NFAT5,oncogenic transcription factor,epithelial-to-mesenchymal transition,cell proliferation regulation,apoptosis resistance,genomic instability,tumor progression
ENSG00000169692,AGPAT2,lipid biosynthesis,tumor cell growth,insulin resistance,apoptosis regulation,metabolic dysfunction,oncogenic pathway modulation
ENSG00000196581,AJAP1,tumor suppressor regulation,p53 modulation,cell adhesion regulation,oncogene overexpression,pi3k/akt pathway activation,metastasis promotion
ENSG00000108700,CCL8,tumor microenvironment modification,immune suppressive cells recruitment,tumor progression promotion,cancer metastasis facilitation,immune evasion enhancement,cancer prognosis association
ENSG00000175183,CSRP2,oncogene,tumor growth regulation,cell differentiation modulation,apoptosis suppression,transcription factor interaction,metastasis promotion
,H2AFY,chromatin remodeling,proliferation regulation,epigenetic modification,protein-protein interactions,oncogenic signaling pathway,tumor suppressor silencing
ENSG00000130830,MPP1,cell migration,cell invasion,cytoskeletal organization,transcription factor regulation,apoptosis suppression,prognostic marker
ENSG00000230456,DDR1,ecm remodeling,tumor invasion,metastasis promotion,pi3k/akt pathway,collagen fiber interaction,gain-of-function mutations
ENSG00000150594,ADRA2A,g protein-coupled receptor,regulatory signaling pathways,cell proliferation regulation,apoptosis modulation,angiogenesis promotion,prognostic biomarker
ENSG00000104327,CALB1,calcium-binding protein,cell proliferation enhancement,cell survival promotion,calmodulin interaction,pi3k/akt pathway activation,tumor progression facilitation
ENSG00000079332,SAR1A,retrograde transport regulation,cell survival promotion,oncogenic protein trafficking,mapk/erk pathway modulation,microtubule interaction,tumor progression driver
ENSG00000274442,PRPF8,alternative splicing,cell cycle regulation,dna repair disruption,oncogenic transcript expression,spliceosome dysregulation,tumor progression
ENSG00000196154,S100A4,emt induction,cell migration,metastasis promotion,calcium-binding protein function,protein-protein interactions,signal transduction modulation
ENSG00000073803,MAP3K13,mapk signaling pathway,constitutive activation,oncogene,tumor progression,mitogen-activated protein kinase signaling,mutational activation
ENSG00000130656,HBZ,transcriptional regulation,cell proliferation,oncogenesis,tumor progression,epigenetic regulation,protein-protein interactions
ENSG00000100410,PHF5A,chromatin remodeling,dna repair,cell cycle progression,transcriptional regulation,protein-protein interactions,altered gene expression
ENSG00000102531,FNDC3A,cell growth regulation,tumor suppression,metastasis modulation,cancer cell regulation,proliferation inhibition,environmental response modulation
ENSG00000164506,STXBP5,pkr pathway regulation,apoptosis resistance,cell proliferation enhancement,tumor aggressiveness promoter,prognostic marker alteration,cancer cell survival enhancer
ENSG00000076944,STXBP2,mapk signaling pathway alteration,cell proliferation enhancement,survival pathway regulation,apoptosis modulation,autophagy involvement,vesicle transport regulation
ENSG00000198258,UBL5,ubiquitination pathway regulation,cancer cell proliferation,apoptosis regulation,pi3k/akt signaling interaction,tumor aggressiveness promoter,genomic instability contributor
ENSG00000102879,CORO1A,actin cytoskeleton regulation,cell migration promotion,cancer progression facilitation,rho gtpase modulation,poor prognosis indicator,metastasis promoter
ENSG00000120948,TARDBP,tdp-43 dysregulation,oncogenesis,cell proliferation,metastasis promotion,rna processing regulation,nuclear localization
ENSG00000148337,CIZ1,coiled-coil domain-containing protein,cell cycle regulation,dna replication,transcriptional control,oncogene,tumor progression
ENSG00000103507,BCKDK,bcaa metabolism dysregulation,substrate accumulation,metabolic reprogramming,oncogenic signaling,prognostic marker,tumor progression
ENSG00000104903,LYL1,cellular regulation,interprotein interaction,oncogenic pathway activation,tumor progression,metastatic potential,adhesion molecule regulation
ENSG00000141127,PRPSAP2,prpp synthetase regulation,cell proliferation enhancement,oncogenic driver,mutational hotspot,purine biosynthesis modulation,cell cycle regulation
ENSG00000163938,GNL3,cell proliferation,transcriptional regulation,gain of function mutations,oncogene activation,constitutive expression,protein-protein interaction
ENSG00000111907,TPD52L1,tumor suppressor loss,microtubule regulation,cell cycle dysregulation,apoptosis inhibition,oncogene overexpression,tumor progression
ENSG00000108433,GOSR2,**

golgi apparatus,protein trafficking,endoplasmic reticulum,secretory pathway,cancer cell metabolism,tumor progression

**
ENSG00000269858,EGLN2,hypoxia regulation,prolyl hydroxylase activity,angiogenesis promotion,cell proliferation enhancement,tumor metastasis facilitation,oncogene activation
ENSG00000142794,NBPF3,centrosome regulation,tumor suppressor function,cell cycle regulation,genomic instability,protein-protein interaction,aneuploidy
ENSG00000126752,SSX1,genomic instability,oncogene activation,tumor progression,dna repair disruption,cell cycle dysregulation,apoptosis inhibition
ENSG00000196998,WDR45,fanconi anemia pathway regulation,dna repair mechanism,tumor progression,cell cycle modulation,genomic instability,protein-protein interaction
ENSG00000182901,RGS7,g-protein regulation,regulator of g-proteins,camp/pka pathway modulation,oncogene potential,cell survival enhancement,signal transduction interaction
ENSG00000145191,EIF2B5,protein synthesis regulation,cell growth promotion,oncogenesis facilitation,translation initiation complex component,therapeutic target identification,stress response modulation
ENSG00000130037,KCNA5,cellular excitability,constitutive activation,dysregulated ion channels,enhanced cell survival,epithelial-to-mesenchymal transition,potential cancer driver gene
ENSG00000169504,CLIC4,overexpression,tumor progression,cellular proliferation,signaling pathway activation,prognosis,chloride channel regulation
ENSG00000125898,FAM110A,oncogenic transformation,cell proliferation,cell survival,dna damage response,cell cycle regulation,protein-protein interactions
ENSG00000174891,RSRC1,p53 regulation,cell cycle progression,ubiquitination machinery,apoptosis evasion,tumor suppressor protein regulation,dna repair regulation
ENSG00000133574,GIMAP4,tumor progression,immune evasion,signaling pathway activation,oncogenic driver,biomarker potential,immunosuppression
ENSG00000119408,NEK6,mitotic checkpoint regulation,genomic instability,kinase activity,cell cycle progression,metastasis promotion,epithelial-to-mesenchymal transition
ENSG00000133818,RRAS2,**
ras signaling pathway activation,constitutive gtpase activity,gain of function mutations,tumor cell proliferation,metastasis promotion,genomic mutation hotspot 
**
ENSG00000170748,RBMXL2,cell cycle regulation,apoptosis evasion,oncogenic mutations,tumor growth promotion,transcriptional regulation,nuclear localization
ENSG00000153914,SREK1,spliceosome regulation,prognostic biomarker,alternative splicing,oncogenic function,tumor progression,cell proliferation enhancement
ENSG00000166634,SERPINB12,proteolytic regulation,apoptosis inhibition,cell cycle modulation,oncogene expression,ubiquitin-proteasome pathway,tumor aggressiveness
ENSG00000105281,SLC1A5,gene expression modulation,amino acid transport,cell proliferation promotion,tumor progression facilitation,downstream signaling activation,poor prognosis association
ENSG00000123405,NFE2,keap1-nfe2l pathway,stabilization and activation,anti-apoptotic signaling,cell survival,genome stability maintenance,apoptosis evasion
ENSG00000110057,UNC93B1,tlr regulation,immunoregulation,innate immunity activation,endosomal trafficking modulation,anti-tumor immune suppression,genomic instability
ENSG00000099901,RANBP1,nucleocytoplasmic transport,cell proliferation,oncogenic signaling,tumor aggressiveness,genomic instability,therapeutic target
ENSG00000100714,MTHFD1,dna synthesis regulation,folate metabolism pathway,methionine cycle interaction,homologous recombination repair,genomic instability induction,oncogenic driver mutation
ENSG00000107537,PHYH,mitochondrial function,cellular metabolism,oncogenic pathway activation,pi3k/akt/mtor signaling,unfolded protein response regulation,genomic instability
ENSG00000099624,ATP5F1D,mitochondrial function,energy metabolism,oncogenic transformation,cellular proliferation,glycolytic shift,reactive oxygen species production
ENSG00000157087,ATP2B2,cancer driver gene,cell migration,calcium-dependent signaling,ion transport regulation,protein-protein interactions,amplified expression
ENSG00000161647,MPP3,tumor suppressor,cell-cell adhesion regulation,epithelial-to-mesenchymal transition,metastatic potential enhancement,protein interaction,signaling pathway modulation
ENSG00000069275,NUCKS1,genomic instability,cell proliferation,constitutive activation,dna replication regulation,serine/threonine kinase activity,tumor progression
ENSG00000089775,ZBTB25,chromatin remodeling,transcriptional repression,tumor suppressor function,apoptosis regulation,prognostic biomarker,genetic regulation
ENSG00000162231,NXF1,tumor suppressor,rna export regulation,genomic instability prevention,molecular marker,protein-protein interaction,oncogenesis suppression
ENSG00000145979,TBC1D7,mapk signaling,cell migration and invasion,gtpase regulation,tumor progression,rac1 interaction,dysregulated expression
ENSG00000134686,PHC2,genome instability,loss of histone h2a ubiquitination,derepression of target genes,tumor suppressor dysfunction,cell cycle dysregulation,pi3k/akt pathway interaction
ENSG00000063177,RPL18,ribosomal protein,cell proliferation,tumor progression,genetic mutations,protein synthesis regulation,cancer-related alterations
ENSG00000197111,PCBP2,oncogenic mrnas stabilization,cell proliferation promotion,multifunctional protein,rna binding activity,tumor growth facilitation,dna repair enhancement
ENSG00000105141,CASP14,apoptosis regulation,inflammatory response modulation,tumor suppression deficiency,cancer cell survival enhancement,oncogenic driver mutation,proteolytic activity maintenance
ENSG00000275700,AATF,apoptosis regulation,cell cycle progression,tumor suppressor inhibition,p53 regulation,transcription factor activity,poor prognosis marker
ENSG00000136929,HEMGN,histone modification,epigenetic alterations,chromatin remodeling,genomic instability,nucleosome formation,transcriptional control
ENSG00000160299,PCNT,microtubule regulation,tumor progression,cytokinesis regulation,mitotic spindle formation,cell proliferation enhancement,genomic instability promotion
ENSG00000163468,CCT3,cellular chaperoning,oncoprotein stabilization,tumor progression,protein synthesis regulation,stress response modulation,ap-1 activation
ENSG00000131626,PPFIA1,erbb4 interaction,oncogenic activity,cell proliferation regulation,pi3k/akt/mtor pathway activation,cell adhesion modulation,tumor progression promotion
ENSG00000112640,PPP2R5D,akt signaling,regulatory subunit inhibition,overexpression,cell cycle regulation,oncogenic transformation,gene expression regulation
ENSG00000123136,DDX39A,transcription regulation,nuclear localization,alternative splicing,oncogene expression,cell survival pathway,poor prognosis biomarker
ENSG00000163702,IL17RC,il-17a/il-17rc interaction,nf-kappab signaling activation,tumor progression,metastasis promotion,cell proliferation enhancement,immune evasion mechanism
ENSG00000134545,KLRC1,tumor immune evasion,reduced immune surveillance,downregulated expression,biomarker potential,cell signaling regulation,immune checkpoint modulation
ENSG00000147378,FATE1,cell migration,focal adhesion turnover,epithelial-to-mesenchymal transition,pi3k/akt pathway modulation,actin dynamics regulation,poor prognosis marker
,H1FX,chromatin remodeling,histone modification,gene expression regulation,cell cycle progression,oncogenesis,therapeutic target
ENSG00000101882,NKAP,nf-κb signaling pathway,tumor suppressor function,tumor cell survival,transcriptional regulation,somatic mutations,cell cycle regulation
ENSG00000008735,MAPK8IP2,mapk8ip2 interactions,dysregulation oncogene,cell survival resistance apoptosis,pi3k/akt pathway activation,cell growth proliferation promotion,stress inflammatory stimuli modulation
ENSG00000119599,DCAF4,ubiquitin ligase activity,protein degradation regulation,tumor suppressor protein regulation,epigenetic modification,cell cycle control,dna repair pathway
ENSG00000168542,COL3A1,type iii collagen expression,cell migration,ecm remodeling,angiogenesis promotion,tumor microenvironment modulation,chemo-resistance enhancement
ENSG00000083720,OXCT1,tumor metabolomics,metabolic reprogramming,histone deacetylase inhibition,cell growth promotion,antitumor gene expression,mitochondrial regulation
ENSG00000075415,SLC25A3,mitochondrial carrier protein,succinate transport,metabolic regulation,oncogenic process,energy metabolism,reactive oxygen species generation
ENSG00000138442,WDR12,chromatin remodeling,cell cycle regulation,overexpression,gene expression modulation,oncogene,cell growth promotion
ENSG00000138160,KIF11,mitotic spindle formation,chromosome segregation,genomic instability,cell proliferation,therapeutic target,epithelial-to-mesenchymal transition (emt)
ENSG00000017260,ATP2C1,calcium signaling,tumor progression,cell migration,epithelial-to-mesenchymal transition (emt),overexpression,prognostic marker
ENSG00000176887,SOX11,transcription factor regulation,cell cycle progression,oncogene activation,tumor progression,apoptosis inhibition,prognostic marker
ENSG00000175216,CKAP5,microtubule regulation,tumor suppressor inhibition,cell proliferation promotion,oncogene overexpression,genomic instability induction,mitosis regulation
ENSG00000120158,RCL1,ribosome assembly,cell proliferation,protein synthesis regulation,translation initiation enhancement,oncogenic process facilitation,genomic instability
ENSG00000111605,CPSF6,post-transcriptional regulation,alternative polyadenylation sites,tumor progression,cell proliferation,rna processing,genomic instability
ENSG00000214022,REPIN1,genomic instability,tumor progression,dna replication regulation,cellular proliferation enhancement,oncogenic pathway modulation,pi3k/akt signaling activation
ENSG00000175390,EIF3F,oncogenic translation,tumor progression,translation initiation factor,gene expression regulation,protein synthesis enhancement,cell proliferation promotion
ENSG00000164934,DCAF13,tumor suppressor downregulation,cell proliferation enhancement,ubiquitination regulation,cell cycle control disruption,poor prognosis indicator,dna damage response modulation
ENSG00000197635,DPP4,cell proliferation,tumor progression,enzymatic activity,oncogenic processes,biomarker,regulatory mechanisms
ENSG00000171385,KCND3,calcium signaling,cell proliferation,oncogenic processes,epithelial-to-mesenchymal transition,potassium channel regulation,voltage-gated potassium channels
ENSG00000134365,CFHR4,complement regulation,tumor progression,angiogenesis promotion,metastasis enhancement,immune evasion,signaling pathway interaction
ENSG00000150768,DLAT,lipid metabolism regulation,oncogenic signaling pathway modulation,cell survival promotion,tumor progression correlation,therapeutic target potential,lipid synthesis enzyme interaction
ENSG00000078018,MAP2,microtubule regulation,cell proliferation,metastatic potential,prognostic marker,oncogenic signaling,cytoskeletal dynamics
ENSG00000183765,CHEK2,genomic instability,tumor suppressor function,checkpoint regulation,cell cycle arrest,dna damage response,cancer predisposition gene
ENSG00000244038,DDOST,altered glycosylation,protein misfolding,cancer cell survival,cell proliferation regulation,glycoprotein modification,tumor microenvironment interaction
ENSG00000064547,LPAR2,lysophosphatidic acid receptor activation,g protein-coupled receptor signaling,cell proliferation promotion,tumor progression involvement,pi3k/akt pathway activation,mapk/erk pathway activation
ENSG00000182134,TDRKH,genomic instability,chromatin remodeling,transcriptional regulation,pi3k/akt signaling pathway,dna damage response,oncogenic driver
ENSG00000140382,HMG20A,aberrant chromatin remodeling,apoptosis inhibition,cell cycle progression,dna damage response,g2/m phase transition regulation,transcriptional regulation
ENSG00000066322,ELOVL1,regulation of fatty acid biosynthesis,oncogenic process promotion,cell growth and proliferation regulation,lipid metabolism dysregulation,tumor aggressiveness association,cell signaling pathway interaction
ENSG00000174827,PDZK1,egf receptor activation,cell-cell interaction regulation,tumor cell invasiveness,scaffolding protein function,protein-protein interaction regulation,cancer-related pathway modulation
ENSG00000280987,MATR3,rna metabolism regulation,oncogenic protein,cell proliferation enhancement,chemoresistance induction,tumor aggressiveness promotion,prognostic marker expression
ENSG00000143006,DMRTB1,wnt/β-catenin signaling pathway,epigenetic regulation,oncogene potential,cell proliferation modulation,chromatin remodeling,tumor suppressor regulation
ENSG00000174547,MRPL11,mitochondrial translation,oncogenic mutations,glycolytic shift,apoptosis suppression,cancer metabolism,tumor progression
ENSG00000100916,BRMS1L,genomic instability,dna damage response,tumor suppressor function,cell cycle regulation,oncogenic processes,cancer driver gene
ENSG00000143537,ADAM15,cell adhesion disruption,cell migration facilitation,tumor progression promotion,extracellular matrix degradation,protein-protein interaction modulation,notch-wnt signaling pathway activation
ENSG00000117139,KDM5B,epigenetic regulation,tumorigenesis,proliferation,cellular homeostasis,histone demethylation,oncogenic processes
ENSG00000148572,NRBF2,**

dna repair mechanisms,cell cycle regulation,genomic instability,tumor suppressor protein regulation,p53 modulation,protein-protein interactions 

**
,HIST1H2BB,histone modification,chromatin remodeling,tumor progression,cell proliferation,survival pathway,therapeutic target
ENSG00000174437,ATP2A2,calcium regulation,cell proliferation,pi3k/akt pathway interaction,oncogenic process,calcium influx,therapeutic target
ENSG00000119285,HEATR1,genomic instability,pi3k/akt signaling pathway,cell cycle regulation,dna repair mechanisms,protein-protein interactions,therapeutic target
ENSG00000171953,ATPAF2,regulation of cell cycle,microrna processing,pi3k/akt pathway interaction,enhanced cell proliferation,resistance to apoptosis,genomic stability maintenance
ENSG00000163625,WDFY3,genomic instability,oncogene overexpression,cell proliferation,pi3k/akt pathway regulation,dna repair facilitation,tumor progression enhancement
ENSG00000139112,GABARAPL1,autophagy regulation,cell survival promotion,tumor progression association,poor prognosis marker,vesicular trafficking involvement,genomic instability link
ENSG00000113790,EHHADH,fatty acid metabolism,oncogenesis,cellular energy regulation,signaling pathway activation,tumor progression,genomic amplification
ENSG00000215375,MYL5,myosin contraction regulation,oncogenic properties,tumor progression driver,cell proliferation enhancement,signaling pathway interaction,protein-protein interaction
ENSG00000108819,PPP1R9B,pi3k/akt pathway,pp1 regulatory subunit,cell survival enhancement,oncogenic transformation promotion,cell proliferation and differentiation regulation,metastasis promotion
ENSG00000145349,CAMK2D,calcium-calmodulin dependent kinase signaling,oncogenic signaling pathway,cell cycle progression regulator,tumor suppressor gene dysregulation,metastasis promoter,cellular growth and proliferation enhancer
ENSG00000004142,POLDIP2,cell cycle regulation,dna replication,genomic stability,telomere maintenance,cancer suppression,tumor suppressor function
ENSG00000124193,SRSF6,altered alternative splicing,dysregulated gene expression,epigenetic regulation,oncogenic potential,tumor suppressor activity,enhanced transcription levels
ENSG00000108852,MPP2,autophagy regulation,tumor progression,cell cycle modulation,oncogenic transformation,rna/dna degradation,protein-protein interaction
ENSG00000116584,ARHGEF2,rho-gef activation,cell migration,tumor progression,protein interaction,downstream signaling,ubiquitination
ENSG00000104969,SGTA,cell proliferation,hypoxia-induced gene expression,angiogenesis regulation,therapeutic target,protein stability modulation,tumor microenvironment adaptation
ENSG00000175029,CTBP2,transcriptional co-repressor,oncogenesis promotion,cell proliferation enhancement,tumor suppressor gene repression,prognostic marker association,metabolic regulation involvement
ENSG00000178035,IMPDH2,purine biosynthesis regulation,cell growth modulation,tumor progression association,prognostic marker,genomic instability promotion,metabolic reprogramming
ENSG00000076928,ARHGEF1,rhoa activation,cell migration promotion,cancer cell invasion,prognostic biomarker,tumor progression regulation,gef function
ENSG00000007314,SCN4A,ion channel function,oncogene activation,overexpression levels,protein-protein interactions,therapeutic target,genomic profiling
ENSG00000103222,ABCC1,multidrug resistance,protein transport,cancer progression,tumor microenvironment modulation,chemotherapy evasion,poor prognosis marker
ENSG00000169727,GPS1,glycosylation pathway,tumor progression,protein interaction,lipid metabolism regulation,cellular growth regulation,poor prognosis predictor
ENSG00000100664,EIF5,translation initiation factor,mtor pathway modulation,cell growth regulation,ribosome biogenesis,tumor suppressor interaction,cancer driver mutation
ENSG00000115694,STK25,**

stk25 overexpression,constitutive activation,cell cycle progression,dna damage response,oncogene function,chemoresistance development
ENSG00000108106,UBE2S,cell cycle regulation,tumor growth promotion,dna damage response,oncogene activation,apoptosis resistance,ubiquitination pathway
ENSG00000174989,FBXW8,loss of function mutations,constitutive activation of downstream targets,cell cycle regulation,oncogenic substrate degradation,tumor suppressor activity,tumor progression
ENSG00000166135,HIF1AN,hypoxia response,transcription regulation,cell proliferation,angiogenesis promotion,tumor adaptation,oxygen sensing
ENSG00000164946,FREM1,cell invasion,metastasis promotion,wnt/pcp pathway interaction,transcriptional regulation,epigenetic modification,oncogene overexpression
ENSG00000256235,SMIM3,tumor suppressor function,cell growth regulation,aberrant cell division inhibition,apoptosis promotion,genomic deletion,therapeutic target
ENSG00000213585,VDAC1,regulation of apoptosis,mitochondrial dynamics,therapeutic target,cellular energy homeostasis,prognostic marker,cancer metabolism
ENSG00000168496,FEN1,genomic instability,tumor suppressor function,dna repair mechanism,replication regulation,unwinding activity,biomarker potential
ENSG00000165934,CPSF2,oncogene activity,poly(a) tail regulation,cancer-promoting effects,mrna processing complex formation,tumor progression contribution,signaling pathway interaction
ENSG00000115355,CCDC88A,cell migration,wnt/pcp signaling pathway,coiled-coil domain interactions,oncogenic transformation,epithelial polarity loss,microtubule dynamics regulation
ENSG00000166681,BEX3,cell cycle progression,apoptosis inhibition,oncogene,microrna regulation,tumor suppressor dysregulation,growth factor interaction
ENSG00000113810,SMC4,chromosome segregation,genomic instability,cell division regulation,cohesin complex interaction,dna repair disruption,epigenetic regulation
ENSG00000175581,MRPL48,mitochondrial function regulation,tumor aggressiveness,oncogene addiction,cell proliferation regulation,ribosomal protein mutations,therapeutic target
ENSG00000021776,AQR,autophagy regulation,protein degradation regulation,cellular stress response,oncogenic adaptation,tumor progression promotion,aaa+ atpase function
ENSG00000155974,GRIP1,nuclear import regulation,tumor progression,cell proliferation enhancement,apoptosis resistance,cell cycle modulation,protein interaction alteration
,SPERT,cellular regulation,tumor suppressor function,genomic stability,apoptosis regulation,cell proliferation control,oncogenesis suppression
ENSG00000132716,DCAF8,genomic instability,cell cycle regulation,protein degradation pathways,dna damage response,ubiquitin ligase complex component,cancer predisposition
ENSG00000205846,CLEC6A,tumor cell regulation,immune system modulation,apoptosis regulation,proliferation enhancement,cell migration facilitation,cancer metastasis promotion
ENSG00000166527,CLEC4D,tumor-associated macrophage modulation,immunosuppressive microenvironment,cell adhesion regulation,tumor progression promotion,immune response modulation,protein interaction
ENSG00000160201,U2AF1,alternative splicing,cancer driver mutation,cell proliferation,disrupted gene regulation,genome instability,splice site mutation
ENSG00000137154,RPS6,translation regulation,mtor pathway activation,cell cycle progression,oncogenic transformation,protein synthesis modulation,ribosomal biogenesis
ENSG00000015153,YAF2,ubiquitin-proteasome pathway,cell proliferation,apoptosis inhibition,tumor suppressor regulation,oncogenic driver,tumor aggressiveness
ENSG00000125457,MIF4GD,mitochondrial dysfunction,energy metabolism regulation,cancer biology insight,cellular respiration maintenance,iron-sulfur cluster assembly,genomic stability maintenance
ENSG00000129988,LBP,tumor microenvironment modulation,tumor progression enhancement,inflammation promotion,immune response regulation,cell proliferation modulation,genomic instability facilitation
ENSG00000123131,PRDX4,redox regulation,cancer cell proliferation,antioxidant function,cell signaling,apoptosis inhibition,tumor progression
ENSG00000142748,FCN3,tumor progression,immune modulation,therapeutic target,cell migration,prognostic biomarker,cell growth and survival
ENSG00000140632,GLYR1,cell growth regulation,differentiation regulation,apoptosis inhibition,tumor promotion,metastasis facilitation,pi3k/akt pathway interaction
ENSG00000135404,CD63,tumor microenvironment modulation,lysosomal regulation dysfunction,tetraspanin interaction,epithelial-to-mesenchymal transition,immune evasion mechanism,overexpression association
ENSG00000112742,TTK,genome stability regulation,oncogenic signaling,cell proliferation enhancement,dna repair complex activation,poor prognosis association,high expression levels
ENSG00000105404,RABAC1,receptor recycling,cell surface modulation,tumor microenvironment,immune evasion,signaling pathway regulation,protein-protein interaction
ENSG00000161265,U2AF1L4,aberrant splicing,disrupted gene expression,oncogenic processes,pre-mrna splicing,spliceosome regulation,none
ENSG00000130816,DNMT1,epigenetic regulation,dna methylation,tumor suppressor gene silencing,oncogenic process,epigenetic reprogramming,cell proliferation enhancement
ENSG00000162946,DISC1,pi3k/akt pathway modulation,growth factor regulation,aneuploidy promotion,genomic instability,cell cycle disruption,tumor progression
ENSG00000100813,ACIN1,regulation of proteasome function,p53 pathway modulation,cell cycle progression,apoptosis regulation,dna repair mechanism interaction,oncogenic signaling modulation
ENSG00000123395,ATG101,autophagy regulation,dna damage response,genomic instability,tumor progression,tumor suppressor function,cellular stress adaptation
ENSG00000151651,ADAM8,emt induction,cellular adhesion modulation,growth factor regulation,signal transduction activation,proteolytic activity enhancement,oncogenic pathway activation
ENSG00000100227,POLDIP3,dna replication regulation,genomic instability,cell proliferation enhancement,oncogene function,polymerase interaction,cell survival promotion
ENSG00000147416,ATP6V1B2,**

cellular ph regulation,glycolytic activation,glucose metabolism,tumor growth promotion,signaling pathway activation,proton pumping activity
ENSG00000262327,AGK,lipid metabolism alteration,oncogenic potential,enhanced cellular proliferation,resistance to therapy,phospholipid synthesis increase,signaling pathway interaction
ENSG00000165283,STOML2,scaffold protein function,oncogene activation,tumor progression,metastasis driver,apoptosis resistance,angiogenesis facilitation
ENSG00000239713,APOBEC3G,apobec mediated mutagenesis,gene mutation induction,genomic instability promoter,increased dna damage,immune system regulator,cytosine deamination activity
ENSG00000155363,MOV10,tumor suppressor,rna stability regulation,cell proliferation inhibition,oncogenic pathway regulation,transcriptional regulation,metastasis suppression
ENSG00000102738,MRPS31,mitochondrial ribosome function,impaired energy production,cellular metabolism regulation,tumorigenesis contribution,genetic alterations impact,protein synthesis disruption
ENSG00000100450,GZMH,apoptosis regulation,immune evasion,cell death pathways,proteolytic activity,tumor cell killing,cancer progression
ENSG00000115414,FN1,tumor progression,cell adhesion,extracellular matrix interaction,signaling pathway modulation,poor prognosis marker,cell migration and invasion
ENSG00000143842,SOX13,transcription factor regulation,emt modulation,tumor suppressor interaction,cellular proliferation,apoptosis regulation,epithelial cell differentiation
ENSG00000124253,PCK1,enhanced glucose metabolism,warburg effect promotion,lipid biosynthesis interaction,therapeutic target,upregulation in cancer cells,promoted glycolysis
ENSG00000164587,RPS14,ribosome biogenesis,cell cycle regulation,constitutive activation,oncogenic pathway activation,tumor progression,metastasis promotion
ENSG00000040199,PHLPP2,loss-of-function mutations,tumor suppressor activity,akt/mtor pathway regulation,cell proliferation inhibition,phosphatase function,dephosphorylation activity
ENSG00000148660,CAMK2G,cellular regulation,calcium-dependent signaling,oncogenesis,therapeutic target,cell cycle regulation,apoptosis inhibition
ENSG00000134759,ELP2,histone modification,chromatin relaxation,transcriptional regulation,cell cycle progression,dna damage response,oncogene activation
ENSG00000143412,ANXA9,tumor progression,apoptosis modulation,cell survival enhancement,metastasis promotion,signaling pathway interaction,prognostic biomarker
ENSG00000170542,SERPINB9,tumor progression,anti-apoptotic function,protease inhibition,angiogenesis promotion,epithelial-to-mesenchymal transition (emt),poor prognosis biomarker
ENSG00000262145,ATP23,mitochondrial complex i assembly,energy metabolism reprogramming,oxidative stress induction,cellular reprogramming,tumor progression facilitation,cancer cell metabolic shift
ENSG00000005810,MYCBP2,transcriptional co-regulation,cell cycle control,oncogene overexpression,apoptosis resistance,cell proliferation promotion,genetic instability
ENSG00000203690,TCP10,cellular proliferation enhancement,constitutive activation,cell survival regulation,gene expression modulation,tumor progression association,protein folding homeostasis maintenance
ENSG00000147509,RGS20,g-protein regulation,mapk/erk pathway inhibition,pi3k/akt pathway modulation,cell proliferation regulation,tumor suppressor function,gpcr interaction
ENSG00000067048,DDX3Y,rna helicase function,oncogene overexpression,transcription regulation,cell cycle progression,tumorigenesis driver,metastasis facilitation
,HIST1H3A,histone modifications,chromatin regulation,cell cycle progression,transcriptional control,tumor development,cancer biology
,HIST1H3B,histone modification,chromatin regulation,epigenetic alterations,gene expression modulation,transcription factor recruitment,tumor progression
,HIST1H3C,histone regulation,chromatin remodeling,epigenetic reprogramming,genomic instability,tumor suppressor gene repression,oncogene activation
,HIST1H3I,histone modification,chromatin remodeling,epigenetic regulation,tumor progression,cell proliferation,protein interaction
,HIST1H3H,histone modification,oncogene activation,epigenetic regulation,cell proliferation,dna repair mechanisms,chromatin structure
,HIST1H3G,histone regulation,dna packaging,chromatin remodeling,epigenetic regulation,cell proliferation,cancer progression
,HIST1H3F,histone modification,chromatin regulation,gene expression modulation,tumor development promotion,cell proliferation enhancement,oncogenic protein interaction
,HIST1H3E,histone modification,chromatin remodeling,epigenetic regulation,transcriptional control,genome stability,tumorigenesis
,HIST1H3J,histone modification,epigenetic regulation,cell cycle regulation,tumor suppression,chromatin remodeling,gene silencing
,HIST1H3D,histone regulation,tumor suppressor silencing,epigenetic dysregulation,genome instability,cell cycle progression,chromatin remodeling
ENSG00000100422,CERK,inflammatory response modulation,cell adhesion regulation,tumor progression,enhanced cell migration,metastasis promotion,cytokine signaling pathway
ENSG00000129195,PIMREG,oncogene regulation,genomic instability,cellular proliferation,transcriptional modulation,signaling pathway activation,protein-protein interaction
ENSG00000137745,MMP13,tumor progression,cell migration,metastasis facilitation,extracellular matrix degradation,proteolytic activity regulation,transcription factor interaction
ENSG00000172059,KLF11,tumor suppressor,genomic stability maintenance,dna repair regulation,apoptosis modulation,cell cycle progression regulation,oncogenesis suppression
ENSG00000135316,SYNCRIP,rna processing,oncogenesis,cell proliferation,transcriptional regulation,stress granule formation,cell cycle progression
ENSG00000095002,MSH2,dna repair deficiency,genomic instability,microsatellite instability,mismatch repair pathway,tumor progression,hypermutated phenotype
ENSG00000067191,CACNB1,calcium channel regulation,cell cycle modulation,pi3k/akt pathway interaction,oncogene activation,therapeutic target,signaling pathway regulation
ENSG00000196504,PRPF40A,rnp complex biogenesis,pre-mrna splicing regulation,cellular growth and differentiation,oncogenic splicing aberrations,cancer-associated protein interactions,therapeutic target candidate
,HIST1H2BC,chromatin remodeling,histone modification,transcriptional regulation,oncogene activation,tumor suppressor suppression,cancer development
,HIST1H2BE,histone modification,chromatin organization,gene regulation,cell proliferation,tumor suppressor,epigenetic regulation
,HIST1H2BG,histone modification,chromatin remodeling,dna repair,epigenetic regulation,oncogene/tumor suppressor,transcriptional regulation
,HIST1H2BF,histone modification,chromatin remodeling,genomic instability,tumor suppressor dysregulation,cellular proliferation enhancement,epigenetic regulation
,HIST1H2BI,histone modification,chromatin structure,gene regulation,cell cycle progression,dna repair,transcriptional regulation
ENSG00000100083,GGA1,overexpression,cell growth promotion,oncogene activation,tumor progression,signaling pathway modulation,poor prognosis association
ENSG00000125445,MRPS7,mitochondrial function regulation,tumor development,cell proliferation,survival promotion,energy metabolism regulation,apoptosis regulation
ENSG00000116560,SFPQ,spliceosome regulation,alternative splicing,transcriptional regulation,nucleosome organization,chromatin remodeling,tumor progression
ENSG00000173482,PTPRM,pi3k/akt/mtor signaling,tumor progression,oncogene function,stat3 activation,cell proliferation,metastasis
ENSG00000164610,RP9,rna processing,dysregulation of nmd,oncogenesis,cell proliferation,apoptosis,tumor suppression
ENSG00000173545,ZNF622,tumor suppressor function,chromatin regulation,transcriptional repression,genomic stability maintenance,epigenetic modulation,apoptosis induction
ENSG00000105393,BABAM1,genomic instability,tumor suppressor function,cell growth regulation,chromosomal abnormalities,protein interaction partner,genetic alterations
ENSG00000100354,TNRC6B,microrna-mediated regulation,tumor suppressor regulation,rna degradation pathways,oncogene activation,gene expression modulation,therapeutic target
ENSG00000124160,NCOA5,epithelial-to-mesenchymal transition (emt),nuclear receptor coactivator function,tumor progression enhancement,cell proliferation promotion,therapeutic target identification,oncogene interaction modulation
ENSG00000198755,RPL10A,ribosomal protein regulation,tumor progression,cell growth promotion,diagnostic marker overexpression,poor prognosis indicator,apoptosis inhibition
ENSG00000102931,ARL2BP,arl2 regulation,oncogenic pathway activation,cell cycle progression,apoptosis suppression,tumor growth promotion,genomic instability
ENSG00000121058,COIL,cell cycle regulation,mutations leading to oncogenesis,protein interaction and modulation,tumor growth and progression,biomarker potential,genetic alterations
ENSG00000160789,LMNA,nuclear lamina disruption,gain of function mutations,genomic instability,tumor suppressor function,loss of heterozygosity,constitutive activation
ENSG00000135083,CCNJL,calcium signaling pathway,cell cycle regulation,genomic instability,oncogenic mutation,apoptosis dysregulation,tumor progression
ENSG00000142186,SCYL1,microtubule regulation,chromosomal instability,oncogene activation,pi3k/akt signaling,cell cycle disruption,protein phosphorylation
ENSG00000119403,PHF19,histone modification,p53 pathway suppression,chromosomal instability,cell proliferation enhancement,transcriptional regulation,apoptosis inhibition
ENSG00000038945,MSR1,immune suppression,tumor microenvironment regulation,pro-tumorigenic signaling,cancer progression enhancement,lipid metabolism dysregulation,apoptotic cell clearance modulation
ENSG00000226033,STK19,genomic instability,cell cycle regulation,dna damage response,checkpoint activation,cell proliferation enhancement,tumor suppressor function
ENSG00000198856,OSTC,osteoclast activity,bone resorption regulation,tumor invasion promotion,apoptosis resistance,angiogenesis modulation,epithelial-to-mesenchymal transition
ENSG00000107937,GTPBP4,g-protein coupled receptor regulation,cell proliferation modulation,signal transduction pathway,guanylate cyclase activation,subunit interaction,gene expression regulation
ENSG00000184408,KCND2,electrogenic regulation,oncogene overexpression,ion channel dysfunction,tumor progression,prognostic marker,therapeutic target
ENSG00000100346,CACNA1I,calcium channel regulation,cell proliferation,tumor progression,calcium influx modulation,signaling pathway activation,voltage-gated ion channel function
ENSG00000110429,FBXO3,cell cycle regulation,tumor suppressor function,ubiquitination and proteasomal degradation,mdm2-p53 pathway regulation,apoptosis modulation,oncoprotein targeting
ENSG00000198830,HMGN2,chromatin remodeling,epigenetic regulation,tumor progression,metastasis promoter,pi3k/akt pathway modulation,transcriptional regulator
ENSG00000183751,TBL3,chromatin remodeling,oncogene activation,tumor growth,apoptosis inhibition,dna repair dysregulation,signaling pathway modulation
ENSG00000092847,AGO1,ago1 overexpression,tumor suppressor silencing,oncogene activation,rna regulation,metastasis promotion,therapeutic target
ENSG00000247077,PGAM5,cellular metabolism,tumor growth,glycolytic flux,energy metabolism,biomarker potential,protein-protein interactions
ENSG00000134086,VHL,tumor suppressor function,hypoxia-inducible factor-alpha (hif-α) degradation,ubiquitination pathway disruption,cell proliferation regulation,vascular endothelial growth factor (vegf) expression,angiogenesis and metastasis promotion
ENSG00000132109,TRIM21,tumor suppressor,oncogenic signaling pathways,genomic instability,apoptosis inhibition,cell growth regulation,immune response modulation
ENSG00000167283,ATP5MG,mitochondrial dysfunction,energy metabolism alterations,cellular growth promotion,therapeutic target potential,cancer cell survival enhancement,oxidative phosphorylation reduction
ENSG00000088992,TESC,cancer progression,cell migration regulation,oncogene activation,actin cytoskeleton modulation,protein-protein interactions,tumor growth promotion
ENSG00000124126,PREX1,ph domain,rhogap domain,cancer driver,rac1 activation,cell migration,protein-protein interactions
ENSG00000197769,MAP1LC3C,autophagy regulation,cell survival enhancement,tumor progression promotion,potential therapeutic target,protein-protein interaction modulation,aberrant expression contributing to oncogenesis
ENSG00000111445,RFC5,genomic instability,tumor progression,cell cycle regulation,dna damage response,replication factor activation,protein-protein interaction
ENSG00000104413,ESRP1,esrp1 upregulation,alternative splicing regulation,tumor progression,cell migration and invasion,oncogene role,prognostic marker
ENSG00000100503,NIN,ubiquitination regulation,cellular proliferation,tumorigenesis driver,protein-protein interaction,e3 ligase function,pi3k/akt signaling modulation
ENSG00000093010,COMT,oxidative stress regulation,apoptosis regulation,tumor progression,cell survival pathway,gene expression modulation,inflammation modulation
ENSG00000273772,SMN2,rna splicing regulation,aberrant splicing mechanisms,cellular integrity preservation,protein interaction networks,cancer-related rna processing,oncogenic pathways involvement
ENSG00000172062,SMN1,splicing regulation,rna stability,neurodevelopmental disorder,spliceosome assembly,cellular maintenance,polymerase recruitment
ENSG00000156299,TIAM1,cell migration promotion,wnt/β-catenin pathway interaction,pi3k/akt signaling activation,tumor progression,metastasis facilitation,emt regulation
ENSG00000197381,ADARB1,adar enzyme activity,oncogenic signaling pathways,rna editing,microrna regulation,tumor suppressor gene silencing,cancer driver mutation
ENSG00000124207,CSE1L,chromatin remodeling,nuclear transport regulation,nuclear pore complex assembly,cell proliferation promotion,oncogenic signaling enhancement,genetic mutation occurrence
ENSG00000167863,ATP5PD,mitochondrial respiration,tumor growth promotion,cellular energy production regulation,protein-protein interactions,cancer prognosis impact,therapeutic target potential
ENSG00000136527,TRA2B,oncogenic function,alternative splicing regulator,cell proliferation promotion,apoptosis evasion,microrna regulation,splicing machinery interaction
ENSG00000114391,RPL24,rpl24 mutations,aberrant protein synthesis,cell cycle regulation,tumor growth promotion,resistance to chemotherapy,dysregulation of gene expression
ENSG00000111752,PHC1,e3 ligase activity,cell cycle regulation,dna repair mechanism,protein degradation pathway,oncoprotein stabilization,transcriptional regulation
ENSG00000144713,RPL32,ribosomal function,cell proliferation,oncogene activation,protein synthesis regulation,tumor growth promotion,genomic instability
ENSG00000131263,RLIM,p53 regulation,chromatin remodeling,tumor suppressor function,genome stability maintenance,transcriptional regulation,ubiquitination regulation
ENSG00000079785,DDX1,genomic instability,transcription regulation,oncogene activation,cell proliferation,dna repair,chromatin remodeling
ENSG00000241553,ARPC4,actin cytoskeleton regulation,oncogenic mutations,cell migration enhancement,tumor progression facilitation,genomic instability induction,therapeutic target potential
ENSG00000163644,PPM1K,tumor suppressor function,dephosphorylation activity,pi3k/akt pathway regulation,cell growth regulation,therapeutic target,genomic instability modulation
ENSG00000100519,PSMC6,proteasome regulation,ubiquitin-proteasome pathway,protein degradation,tumor growth,metastasis,poor prognosis
ENSG00000152291,TGOLN2,pi3k/akt pathway interaction,tumor progression regulation,protein transport regulation,oncogenic properties enhancement,therapeutic target potential,genomic overexpression association
ENSG00000088179,PTPN4,constitutive activation,loss-of-function mutations,tumor suppressor function,pi3k/akt pathway regulation,protein-protein interactions,therapeutic target
ENSG00000108349,CASC3,enhanced cell proliferation,oncogenic driver,integrin interaction,cell migration and invasion,chemoresistance facilitation,biomarker for cancer aggressiveness
ENSG00000124614,RPS10,tumor promotion,protein synthesis regulation,cell proliferation enhancement,oncogene overexpression,poor prognosis indicator,therapeutic target
ENSG00000114446,IFT57,hedgehog signaling,ciliogenesis disruption,tumor suppressor function,cell growth regulation,dna damage response,therapeutic target
ENSG00000081320,STK17B,mitotic checkpoint regulation,serine/threonine kinase activity,cell cycle progression,p53 activation,genomic instability,tumor suppressor function
,HIST1H1C,chromatin remodeling,tumor suppressor regulation,genomic instability,gene expression modification,histone modifications,epigenetic alteration
ENSG00000005007,UPF1,cell survival,genome instability,mrna stability regulation,oncogenic processes,proliferation promotion,tumor development
ENSG00000125388,GRK4,cell proliferation,g protein-coupled receptor phosphorylation,tumor progression,dysregulated expression,protein kinase activation,cell signaling pathway modulation
ENSG00000093144,ECHDC1,mevalonate pathway,cholesterol biosynthesis,gene amplification,mutation hotspot,cell survival modulation,tumor suppressor dysregulation
ENSG00000166855,CLPX,genomic instability,cell cycle dysregulation,dna damage tolerance,chromosomal instability,replication stress response,protein homeostasis regulation
ENSG00000141867,BRD4,cellular proliferation,transcriptional regulation,chromatin remodeling,oncogenic processes,therapeutic target,apoptosis evasion
ENSG00000110958,PTGES3,prostaglandin e synthase function,inflammation mediator production,tumor progression promoter,immune evasion mechanism,poor prognosis indicator,cell proliferation enhancer
ENSG00000119950,MXI1,cell cycle regulation,transcription factor activity,tumor suppressor function,apoptosis modulation,protein-protein interaction,gene expression regulation
ENSG00000172232,AZU1,genomic instability,cell cycle regulation,proliferation promotion,dna replication facilitation,mutational hotspot,protein-protein interaction
ENSG00000107859,PITX3,emt induction,transcription factor activation,cell proliferation promotion,chemotherapy resistance,tumor recurrence,poor prognosis
ENSG00000105538,RASIP1,rhoa/rac1 pathway,oncogenic signaling,cell migration regulation,pak interactions,tumor progression,metastasis promotion
ENSG00000213516,RBMXL1,aberrant splicing,alternative splicing regulator,cell cycle progression,nucleic acid processing,rna binding,therapeutic target
ENSG00000285301,BOP1,genomic instability,cell cycle regulation,tumor suppressor function,dna repair mechanism,chromatin modification,espigenetic regulation
ENSG00000137193,PIM1,phosphorylation regulation,apoptosis inhibition,cell proliferation,transcription factor modulation,oncogene activation,tumor suppressor interaction
ENSG00000086504,MRPL28,metabolic regulation,energy homeostasis disruption,tumor progression,cell proliferation,aberrant expression,translation initiation complex
ENSG00000281763,DHX36,alternative splicing regulation,genome instability maintenance,transcriptional regulation,rna processing dysfunction,oncogenic pathway activation,tumor suppressor gene silencing
ENSG00000165209,STRBP,regulation of skp2 activity,overexpression in esophageal carcinoma,ubiquitination of p27,enhanced cell proliferation,interaction with transcription factors,tumor aggressiveness
ENSG00000171560,FGA,angiogenesis,inflammation modulation,tumor growth promotion,extracellular matrix remodeling,microenvironment regulation,blood coagulation dysregulation
ENSG00000185515,BRCC3,genomic instability,dna damage response,tumor suppressor function,homologous recombination repair,nucleotide excision repair,base excision repair
ENSG00000174243,DDX23,aberrant splicing,alternative splicing regulation,cancer driver genes,cell proliferation regulation,mrna degradation modulation,tumor suppressor regulation
ENSG00000179271,GADD45GIP1,pi3k/akt pathway regulation,tumor suppressor function,cell cycle regulation,apoptosis induction,dna damage response,genomic stability maintenance
ENSG00000099875,MKNK2,translation initiation,mapk/erk pathway activation,proliferation enhancement,cell survival promotion,tumor progression facilitation,oncogenic driver protein expression
,HIST2H2BE,histone modification,chromatin regulation,gene expression alterations,tumorigenesis,cancer development,epigenetic changes
ENSG00000137270,GCM1,cell proliferation,transcriptional regulation,emt program,metastatic potential,tumor aggressiveness,apoptosis resistance
ENSG00000101695,RNF125,cell cycle regulation,cancer progression,protein degradation,oncogenic pathways,tumor suppressor regulation,immune evasion
ENSG00000170248,PDCD6IP,pi3k regulation,cell migration regulation,signaling pathway interaction,oncogenic function promotion,tumor progression facilitation,metastasis enhancement
ENSG00000127511,SIN3B,histone deacetylation,chromatin remodeling,transcriptional repression,tumor progression,oncogene activation,cell survival
ENSG00000089280,FUS,fus overexpression,transcription factor activity,cell proliferation regulation,chromatin remodeling,oncogenic process promotion,epigenetic changes regulation
,HIST1H1D,histone modification,tumor suppressor,chromatin compaction,transcriptional regulation,cancer associated mutations,epigenetic regulation
ENSG00000173272,MZT2A,epigenetic regulation,polycomb repressive complex 1 (prc1),cell cycle progression,tumorigenesis,genomic instability,aberrant gene expression
ENSG00000166130,IKBIP,nf-κb pathway,tumor suppressor function,loss of function mutations,cell survival promotion,pro-inflammatory gene expression,oncogenic signaling
ENSG00000169710,FASN,lipid metabolism,oncogenesis,metabolic reprogramming,therapeutic target,enzyme activity,cell cycle progression
ENSG00000100109,TFIP11,overexpression,cell proliferation,apoptosis evasion,tumor growth,metastasis,transcription regulation
ENSG00000074201,CLNS1A,genomic instability,cell cycle regulation,dna repair mechanisms,chromatin remodeling complex,protein-protein interactions,tumor aggressiveness
ENSG00000000003,TSPAN6,tumor microenvironment modulation,cell migration and adhesion regulation,metastasis promotion,apoptosis inhibition,immune response modulation,cell proliferation enhancement
ENSG00000189067,LITAF,cell growth regulation,apoptosis evasion,epithelial-to-mesenchymal transition,metastasis promotion,tumor aggressiveness,prognostic marker
ENSG00000273594,EEF1D,oncogenic process,protein synthesis regulation,cell proliferation promotion,tumor progression facilitation,therapeutic target potential,translation initiation factor subunit
ENSG00000102030,NAA10,protein modification,cancer driver mutation,cell growth promotion,therapeutic target,chromatin remodeling,protein stability alteration
ENSG00000172399,MYOZ2,actin cytoskeleton regulation,cellular integrity maintenance,oncogene overexpression,tumor progression,cell migration and invasion,protein-protein interaction
ENSG00000133398,MED10,transcriptional regulation,oncogene overexpression,cellular proliferation,chromatin remodeling complex interaction,tumor progression facilitation,gene expression enhancement
ENSG00000163811,WDR43,genomic instability,dna damage response,tumor suppressor,chromatin remodeling,histone modifications,set complex
ENSG00000143321,HDGF,cell cycle regulation,apoptosis inhibition,tumor progression,protein-protein interaction,biomarker expression,growth factor signaling
ENSG00000180628,PCGF5,epigenetic regulation,polycomb group protein function,tumor suppressor gene repression,cellular proliferation modulation,apoptosis inhibition,chromatin structure modulation
ENSG00000198642,KLHL9,ubiquitination regulation,gene expression modulation,tumor progression promotion,ubiquitin ligase complex component,cell growth regulation,metastasis facilitation
ENSG00000097033,SH3GLB1,**

egf receptor signaling,endocytic regulation,negative regulatory functions,cell surface receptor dynamics,trafficking modulation,cancer-related signaling 
**
ENSG00000176444,CLK2,protein kinase activation,splicing regulation,tumor progression,metastasis promotion,cancer cell growth,oncogene interaction
ENSG00000196975,ANXA4,cell proliferation,protein binding,focal adhesion complex formation,cytoskeleton regulation,tumor progression,metastasis promotion
ENSG00000280908,PADI4,proliferation regulation,histone modification,cancer prognosis,apoptosis suppression,cell cycle regulation,tumor suppressor interaction
ENSG00000125735,TNFSF14,apoptosis induction,immunomodulatory function,t cell activation,oncogenesis promotion,angiogenesis regulation,genetic dysregulation
ENSG00000198373,WWP2,cell cycle regulation,ubiquitin-proteasome pathway regulation,tumor suppressor activity,protein degradation modulation,oncogenic protein accumulation,poor prognosis biomarker
ENSG00000137941,TTLL7,microtubule regulation,cell proliferation,oncogenesis,tumor progression,protein-protein interaction,cancer cell invasion
ENSG00000143164,DCAF6,cell cycle regulation,dna damage response,ubiquitin ligase complex,protein degradation pathway,overexpression,tumor progression
ENSG00000060688,SNRNP40,spliceosome regulation,aberrant splicing,gene expression dysregulation,cellular proliferation,rna processing,oncogenic mutations
ENSG00000143815,LBR,genomic stability,chromatin organization,transcription regulation,dna repair,genome instability,tumor progression marker
ENSG00000115289,PCGF1,polycomb group function,chromatin remodeling,epigenetic regulation,tumor suppressor suppression,oncogenic signaling pathway,dysregulated gene expression
ENSG00000131473,ACLY,enhanced glycolysis,lipogenesis promotion,metabolic reprogramming,pentose phosphate pathway modulation,therapeutic target,tumor growth facilitation
ENSG00000174996,KLC2,microtubule binding,chromosomal instability,mitotic spindle formation,cell division regulation,oncogenic signaling pathway,pro-oncogenic role in esca
ENSG00000183943,PRKX,pi3k/akt signaling,constitutive activation,gain of function mutations,oncogenic transformation,therapeutic target,genomic amplification
ENSG00000132382,MYBBP1A,tumor suppressor,g1-s transition regulation,cell cycle control disruption,dna repair pathway interaction,telomere length regulation,prognostic significance
ENSG00000134318,ROCK2,cell migration,protein kinase activation,cytoskeleton reorganization,apoptosis regulation,epithelial-to-mesenchymal transition,tumor progression
ENSG00000055917,PUM2,post-transcriptional regulation,microrna interaction,cell cycle progression,apoptosis inhibition,tumor progression,gene expression modulation
ENSG00000107863,ARHGAP21,rho gtpase activation,cell migration,tumor progression,metastasis,epithelial-to-mesenchymal transition,rac1/rhoa interaction
ENSG00000109111,SUPT6H,chromatin remodeling,tumor progression,poor prognosis marker,epigenetic modulation,cell proliferation promotion,maintenance of genome stability
ENSG00000186197,EDARADD,notch receptor activation,oncogenic behavior,cell proliferation,tumor progression,dna repair regulation,epithelial differentiation
ENSG00000187796,CARD9,tumor progression,enhanced inflammation,oncogene activation,nf-κb pathway activation,cell survival signaling,fungal pathogen recognition
ENSG00000170142,UBE2E1,ubiquitination regulation,protein stabilization,cell cycle progression,apoptosis evasion,signaling molecule interaction,oncogenic function
ENSG00000132334,PTPRE,dephosphorylation,oncogenic driver,cell proliferation,protein kinase b activation,receptor tyrosine kinase regulation,signal transduction
ENSG00000028839,TBPL1,tata-binding protein-like 1,transcription factor activity,cell proliferation regulation,apoptosis inhibition,gene expression modulation,pi3k/akt signaling pathway interaction
ENSG00000163904,SENP2,oncogenic regulation,ubiquitin-proteasome pathway,protein acetylation regulation,tumor progression,metastasis promotion,cell cycle regulation
ENSG00000131469,RPL27,enhanced translation,cell proliferation,tumor progression,protein synthesis,oncogene activation,ribosomal subunit assembly
ENSG00000167005,NUDT21,genomic instability,oncogene activation,cellular pool dysregulation,dna replication enhancement,apoptosis suppression,tumor progression facilitation
ENSG00000102098,SCML2,chromatin remodeling,tumor suppressor function,transcriptional regulation,dna repair,genomic instability,oncogenic process
ENSG00000130935,NOL11,dna repair defects,genomic instability,telomere maintenance,oncogene potential,chromatin remodeling,dna damage response
ENSG00000251322,SHANK3,shank3-overexpressed tumors,cell proliferation,cell survival pathways,cytoskeleton regulation,neurodevelopmental disorder,signaling pathway modulation
ENSG00000108448,TRIM16L,tumor suppressor function,loss of expression,cell cycle regulation,dna damage response,apoptosis induction,mitotic checkpoint control
ENSG00000133661,SFTPD,tumor suppression,immune evasion,cellular defense mechanisms,protein-protein interactions,genetic predisposition,lung defense mechanism
ENSG00000125124,BBS2,cilia dysfunction,cell proliferation,signaling pathway disruption,hippo signaling pathway activation,tumor progression,cancer-related protein interactions
ENSG00000131467,PSME3,ubiquitin-proteasome pathway,overexpression,protein degradation,tumor suppressor regulation,immune evasion,antigen presentation
ENSG00000183496,MEX3B,tumor suppressor function,cell proliferation regulation,apoptosis modulation,epithelial-to-mesenchymal transition (emt) inhibition,pi3k/akt pathway regulation,protein-protein interaction with tp53 and pten
ENSG00000102837,OLFM4,oncogene,tumor progression,epithelial-to-mesenchymal transition,cell adhesion modulation,cancer marker potential,overexpression in cancer
ENSG00000105245,NUMBL,notch pathway regulation,tumor suppressor activity,cell fate decision regulation,anti-tumorigenic effects,cancer stem cell inhibition,protein-protein interaction modulation
ENSG00000101210,EEF1A2,enhanced protein synthesis,cell proliferation,oncogene activation,tumor progression,therapeutic target,signaling pathway interaction
ENSG00000181163,NPM1,genomic instability,dna repair disruption,cell proliferation promotion,aberrant protein expression,signaling pathway dysregulation,cell cycle regulation alteration
ENSG00000071655,MBD3,epigenetic regulation,tumor suppressor function,histone modification,chromatin remodeling,transcriptional repression,genomic stability
ENSG00000187778,MCRS1,protein stabilization,tumor progression,pi3k/akt pathway modulation,proteasome regulation,cell proliferation enhancement,molecular chaperone function
ENSG00000164104,HMGB2,hmgb2 binding,chromatin remodeling,tumor progression,immune evasion,metastasis facilitation,oncogenic signaling
ENSG00000266472,MRPS21,mitochondrial biogenesis,cellular metabolism regulation,glycolytic shift,cell proliferation enhancement,survival pathway stabilization,mitochondrial ribosomal assembly
ENSG00000063046,EIF4B,genomic instability,constitutive activation,protein synthesis regulation,oncogenic protein expression,cell proliferation enhancement,translation initiation complex component
ENSG00000135945,REV1,genomic instability,dna repair pathway,tumor progression,polymerase activity,error-prone repair,oncogenesis
ENSG00000130758,MAP3K10,apoptosis regulation,dna damage response,cell proliferation modulation,oncogene interaction,tumor suppressor interaction,genetic aberration
ENSG00000171873,ADRA1D,g protein-coupled receptor,tumor growth promotion,wnt/β-catenin pathway activation,cell proliferation enhancement,apoptosis inhibition,oncogenic protein interaction
ENSG00000170525,PFKFB3,glucose metabolism,oncogenic activation,hypoxia-inducible factor 1-alpha regulation,vascular endothelial growth factor upregulation,angiogenesis promotion,glycolytic enzyme overexpression
ENSG00000119041,GTF3C3,microtubule dynamics regulation,cell division regulation,centrosome organization,oncogenic function,cell proliferation enhancement,tumorigenesis promotion
ENSG00000196557,CACNA1H,calcium channel regulation,cancer cell survival,cell proliferation signaling,pi3k/akt pathway activation,tumor progression,chemotherapy resistance
ENSG00000100941,PNN,immunomodulatory function,tumor progression,metastasis promotion,oncogene interaction,inflammation regulation,cancer cell proliferation
ENSG00000198363,ASPH,histone modification,chromatin remodeling,cell proliferation,oncogenic pathway activation,genomic instability,protein-protein interaction
,ASNA1,sigma factor regulation,transcriptional modulation,oncogenic drivers,cell proliferation,transcription initiation,genomic instability
ENSG00000096063,SRPK1,regulation of alternative splicing,constitutive activation of signaling pathways,overexpression in cancer,modulation of apoptosis,interaction with pi3k/akt pathway,pre-mrna splicing and processing
ENSG00000104081,BMF,protein ubiquitination,anti-apoptotic signaling,cell cycle regulation,tumor progression,poor prognosis,apoptosis inhibition
ENSG00000139921,TMX1,emt process,transcription factor activity,cell migration,enhanced metastatic potential,poor prognosis,increased proliferation
,HIST1H2BM,chromatin remodeling,histone modifications,gene expression regulation,cell proliferation promotion,apoptosis suppression,tumor progression facilitation
ENSG00000115484,CCT4,cell cycle regulation,chaperone function,cell proliferation,oncogenic process,protein misfolding,signal transduction
ENSG00000112365,ZBTB24,transcription regulation,oncogenic properties,cell cycle progression,epigenetic modification,protein-protein interactions,none
ENSG00000131876,SNRPA1,rna splicing regulation,alternative splicing,oncogene expression,tumor suppressor gene dysregulation,spliceosome component,gene expression modulation
ENSG00000149452,SLC22A8,oncogene upregulation,chemotherapy resistance,drug transport modulation,cell proliferation influence,poor prognosis marker,therapeutic target
ENSG00000107957,SH3PXD2A,egfr signaling,oncogenic potential,overexpression associated with poor prognosis,tumor cell growth promotion,therapeutic target,cell surface receptor regulation
ENSG00000215474,SKOR2,cell cycle regulation,dna damage response,spindle checkpoint dysregulation,transcriptional control,oncogenic potential,tumor progression
ENSG00000160224,AIRE,tissue-specific antigen regulation,immune tolerance modulation,oncogene interaction,tumor microenvironment regulation,cell growth regulation,aberrant expression association
ENSG00000134371,CDC73,genomic instability,tumor suppression,rna polymerase ii-dependent transcription,dna repair mechanisms,cell cycle regulation,oncogenic pathway activation
ENSG00000135521,LTV1,cell cycle regulation,epigenetic modification,apoptosis inhibition,proliferation promotion,metastasis facilitation,oncogenic overexpression
ENSG00000062038,CDH3,pi3k/akt pathway,epithelial-to-mesenchymal transition,cell-cell adhesion disruption,downregulation,tumor progression,oncogenic process
ENSG00000168763,CNNM3,metabolic regulation,ion homeostasis,angiogenesis promotion,cellular survival enhancement,therapeutic target,redox status modulation
ENSG00000149792,MRPL49,mitochondrial biogenesis,cell proliferation,apoptosis inhibition,therapeutic target,regulatory function,cell cycle progression
ENSG00000010030,ETV7,tumor suppressor,downregulation mutations,epithelial integrity maintenance,cell cycle regulation,apoptosis induction,oncogene suppression
ENSG00000179639,FCER1A,cell migration,immune evasion,protein-protein interaction,signaling pathway activation,tumor progression,metastasis
ENSG00000244537,KRTAP4-2,cell proliferation,overexpression,poor prognosis,advanced stage,signaling pathway alteration,epithelial integrity disruption
ENSG00000185650,ZFP36L1,tumor suppressor function,mrna stability regulation,cell proliferation inhibition,vegf repression,p53 modulation,metastatic potential increase
ENSG00000151702,FLI1,tumor suppressor,transcription factor activity,cell proliferation,oncogene activation,growth regulation,cancer stem cell maintenance
ENSG00000079277,MKNK1,enhanced cell proliferation,protein kinase activation,oncogenic transformation,signaling pathway regulation,tumor progression marker,cell survival promotion
ENSG00000159023,EPB41,cancer progression,cell migration,metastatic potential,epithelial-to-mesenchymal transition (emt),fak activation,signaling pathway interaction
ENSG00000047579,DTNBP1,cellular trafficking disruption,genomic instability,oncogene activation,autophagy pathway modulation,microtubule regulation,cell cycle progression alteration
ENSG00000161970,RPL26,cellular proliferation,protein-protein interaction,translation regulation,tumor suppressor function,oncogenic potential,anti-apoptotic activity
ENSG00000108669,CYTH1,methylation regulation,tumor progression,cell growth promotion,apoptosis resistance,signaling pathway modulation,prognostic marker
ENSG00000129245,FXR2,rna-binding protein function,alternative splicing regulation,tumor promoter,oncogene expression,genomic instability,cancer-specific transcriptome
ENSG00000184363,PKP3,cell adhesion disruption,signaling pathway activation,tumor progression,metastasis promotion,oncogene overexpression,cell-cell interaction disruption
ENSG00000120437,ACAT2,cholesterol biosynthesis,tumor progression,cell proliferation,protein kinase regulation,lipid metabolism,genomic amplification
ENSG00000075785,RAB7A,late endosomal regulation,gtpase activity,lysosomal function,autophagy regulation,cell migration,protein recycling
ENSG00000108064,TFAM,mitochondrial biogenesis,oxidative phosphorylation enhancement,energy production modulation,tumor growth promotion,cell proliferation regulation,protein complex formation
ENSG00000007392,LUC7L,chromatin remodeling,dna repair regulation,cell cycle progression modulation,tumor suppressor p53 regulation,prognostic biomarker candidate,transcriptional control facilitation
ENSG00000133243,BTBD2,tumor suppressor function,dna repair regulation,cell cycle arrest,apoptosis induction,epithelial-to-mesenchymal transition regulation,methylation silencing
ENSG00000143622,RIT1,gain of function mutations,constitutive activation,cell proliferation,cell migration,oncogenic signaling,ras-like gtpase activity
ENSG00000133835,HSD17B4,steroid hormone regulation,tumor growth promotion,cell signaling pathway interaction,oncogenic role in esophageal carcinoma,therapeutic target,metabolic regulation
ENSG00000148335,NTMT1,epigenetic regulation,oncogenic transcription factors,histone modification,chromatin remodeling,cell cycle progression,apoptosis suppression
ENSG00000106397,PLOD3,post-translational modification,cell migration,extracellular matrix regulation,tumor aggressiveness,molecular interaction,cellular signaling
ENSG00000088205,DDX18,pi3k/akt signaling pathway modulation,rna stability regulation,mrna translation efficiency,dead-box helicase activity,cell growth regulation,tumor suppressor function
ENSG00000089818,NECAP1,cellular recycling,egfr signaling pathway activation,metabolic regulation,glycolysis enhancement,tumor progression,oncogene
ENSG00000156697,UTP14A,rnp complex assembly,rna processing regulation,tumor suppressor function loss,cellular growth promotion,nuclear export modulation,dna damage response alteration
ENSG00000130255,RPL36,ribosome biogenesis,oncogenic mutation,cell growth promotion,protein synthesis enhancement,tumor microenvironment modulation,angiogenesis regulation
ENSG00000164675,IQUB,dysregulation of protein stability,cell cycle regulation,apoptosis modulation,ubiquitin-proteasome pathway,protein degradation regulation,tumor progression
ENSG00000138443,ABI2,wnt/β-catenin pathway activation,tumor progression promoter,cell proliferation regulator,oncogene candidate,prognostic marker,genomic amplification
ENSG00000112282,MED23,transcriptional regulation,mediator complex function,epigenetic regulation,tumor progression,poor prognosis,oncogenesis
ENSG00000243943,ZNF512,genomic instability,krab domain-containing protein family,cell growth regulation,transcriptional repression,tumor suppressor function,chromatin remodeling interactions
ENSG00000122180,MYOG,oncogene activity,transcription factor regulation,cell proliferation enhancement,tumor progression,therapeutic target,genomic overexpression
ENSG00000140463,BBS4,primary cilia dysfunction,oncogenic transformation,cell proliferation,cell survival,metastasis,therapeutic target
ENSG00000167306,MYO5B,invasive cell clusters formation,cellular membrane integrity,organelle transport regulation,tumor progression driver,membrane trafficking regulation,protein-protein interaction mediator
ENSG00000105501,SIGLEC5,tumor-associated immune suppression,immune cell activation,myeloid cell expression,cell surface receptor,pro-tumorigenic signaling,molecular interaction
ENSG00000198646,NCOA6,oncogenic transcriptional regulator,chromatin remodeling,dna repair pathway,gene expression regulation,transcription factor interaction,coactivator function
ENSG00000231370,PRRC2A,cell proliferation,angiogenesis,tumor progression,oncogene overexpression,cell survival,pi3k/akt signaling pathway interaction
ENSG00000081277,PKP1,cell-cell adhesion,tumor progression,metastasis,epithelial integrity loss,prognostic marker,adhesion complex disruption
ENSG00000145908,ZNF300,transcription factor activity,overexpression in cancer,cell proliferation regulation,apoptosis evasion pathways,target gene regulation,protein-protein interaction
ENSG00000169020,ATP5ME,mitochondrial function,energy metabolism regulation,oxidative phosphorylation,cellular respiration,tumor progression support,genomic instability
ENSG00000125484,GTF3C4,chromatin remodeling,constitutive activation,epigenetic regulation,gene expression regulation,mutational hotspot,transcriptional dysregulation
ENSG00000128951,DUT,dna synthesis,genomic instability,mutagenesis,tumor progression,oncogene activation,microsatellite instability
ENSG00000185532,PRKG1,gain of function mutations,overexpression,signaling pathway activation,cell proliferation regulation,tumor progression facilitation,therapeutic target identification
ENSG00000141385,AFG3L2,mitochondrial regulation,gain of function mutations,cell survival mechanism,oncogenic pathway activation,cellular adaptation,therapeutic target
ENSG00000169045,HNRNPH1,heterogeneous nuclear ribonucleoprotein regulation,rna processing modulation,oncogenic function implicated,cell survival promotion,tumor progression enhancement,therapeutic target candidate
ENSG00000177600,RPLP2,cell proliferation,genomic instability,tumor progression,protein synthesis regulation,oncogenic protein expression,chemotherapy resistance
ENSG00000067715,SYT1,calcium-dependent exocytosis,tumor biomarker,overexpression,cell proliferation,neurotransmitter release regulation,vesicle fusion modulation
ENSG00000273761,DDX24,rna helicase activity,regulation of gene expression,stress response modulation,cellular proliferation regulation,transcriptional control,oncogene activation
ENSG00000143226,FCGR2A,fc gamma receptor iia,immune evasion,tumor progression,biomarker candidate,prognostic significance,immunotherapy resistance
ENSG00000110876,SELPLG,tumor progression,angiogenesis promotion,epithelial-to-mesenchymal transition (emt) facilitation,leukocyte adhesion regulation,platelet activation mediation,prognostic marker
ENSG00000143442,POGZ,genomic instability,chromatin remodeling,tumor suppressor function,epigenetic regulation,histone modification,oncogenic mechanism
ENSG00000100600,LGMN,rho gtpase activation,cytoplasmic signaling pathway disruption,genomic instability contribution,microtubule dynamics regulation,rhogap function loss,cellular cytoskeleton reorganization
ENSG00000154556,SORBS2,cell migration,adhesion regulation,tumor suppression,cytoplasmic organization,protein interaction networks,genetic mutation
ENSG00000109171,SLAIN2,microtubule stability regulation,chromosomal instability facilitation,tumor progression promotion,cell cycle regulation modulation,apoptosis resistance induction,genomic alteration contribution
ENSG00000130956,HABP4,hyaluronan-binding,oncogenic,epigenetic regulation,tumor progression,cell adhesion,pi3k/akt pathway
ENSG00000123700,KCNJ2,ion channel regulation,tumor progression,cellular metabolism,cancer cell proliferation,sodium-potassium pump interaction,apoptosis inhibition
ENSG00000115268,RPS15,cellular proliferation,ribosome biogenesis,transcriptional regulation,protein synthesis regulation,apoptosis disruption,oncogenic transformation
ENSG00000183495,EP400,epigenetic regulation,histone modification,tumor suppressor function,chromatin remodeling,apoptosis evasion,cell proliferation
ENSG00000057608,GDI2,gtpase regulation,cell migration,apoptosis resistance,cell proliferation,signaling pathway modulation,cancer progression
ENSG00000094880,CDC23,cell cycle regulation,aneuploidy,genomic instability,dna damage tolerance,tumor progression,prognostic marker
ENSG00000073350,LLGL2,wnt/β-catenin pathway activation,genomic instability,chromosomal alterations,cell proliferation,centrosome regulation,loss-of-function mutations
ENSG00000096433,ITPR3,constitutive activation,aberrant calcium signaling,tumor progression,cellular reprogramming,metabolic adaptation,resistance to chemotherapy
ENSG00000137815,RTF1,genomic instability,aberrant transcriptional regulation,dna repair deficiency,cell survival promotion,genome maintenance disruption,tumor suppressor dysfunction
ENSG00000050130,JKAMP,cellular regulation,ubiquitination pathway,oncogenic mutations,apoptosis suppression,tumor aggressiveness,metastasis promotion
ENSG00000182952,HMGN4,chromatin remodeling,tumor progression,cell proliferation,transcription regulation,gene overexpression,epigenetic dysregulation
ENSG00000164134,NAA15,mtor pathway interaction,cell cycle regulation,tumor growth enhancement,oncogene potential,ribosome biogenesis,apoptosis inhibition
ENSG00000244234,GMCL2,microtubule stability,cell division regulation,genomic instability prevention,tumor progression,oncogenic function,kinase activity
ENSG00000103569,AQP9,tumor progression,metastasis,chemotherapy resistance,glycerol transport,cell proliferation,ion channel function
ENSG00000134001,EIF2S1,eif2 alpha subunit,protein synthesis regulation,oncogenesis promotion,cell proliferation enhancement,apoptosis resistance,upr pathway modulation
ENSG00000117707,PROX1,oncogene activation,transcription factor regulation,tumor progression,cell proliferation,stemness maintenance,cancer stem cell regulation
ENSG00000124198,ARFGEF2,pi3k/akt pathway interaction,phosphoinositide regulation,rho gtpase activation,membrane trafficking dysregulation,tumor progression promotion,antitumor activity
ENSG00000121211,MND1,chromosomal instability,genomic alterations,dna repair mechanism,sister chromatid cohesion,mitotic fidelity disruption,tumor progression
ENSG00000123562,MORF4L2,transcription regulation,tumor suppressor function,genomic instability,cell cycle modulation,chromatin remodeling interaction,oncogenesis driver
ENSG00000108395,TRIM37,apoptosis regulation,cell survival enhancement,oncogene interaction,tumor suppressor modulation,ubiquitin ligase activity,cell cycle regulation
ENSG00000116750,UCHL5,deubiquitinating enzyme activity,oncogenic pathway regulation,pi3k/akt signaling modulation,cell cycle progression promotion,tumor progression enhancement,poor prognosis marker
ENSG00000170144,HNRNPA3,rna-binding activity,pre-mrna processing,gene expression regulation,oncogenic pathway activation,poor prognosis marker,post-transcriptional regulation
ENSG00000106305,AIMP2,autophagy,cancer progression,prognostic marker,tumor microenvironment,cytoplasmic localization,apoptosis regulation
ENSG00000138398,PPIG,genomic instability,cell cycle progression,dna repair mechanisms,protein phosphatase activity,apoptosis inhibition,tumor growth promotion
ENSG00000152936,LMNTD1,chromatin remodeling,genomic instability,aneuploidy,transcriptional regulation,cancer driver gene,tumor progression
ENSG00000196408,NOXO1,genomic instability,oncogenic transformation,tumor progression,reactive oxygen species generation,cellular proliferation,protein-protein interaction
ENSG00000182196,ARL6IP4,cell migration,golgi apparatus function,apoptosis resistance,prognostic marker,cancer cell invasion,epithelial-to-mesenchymal transition
ENSG00000153207,AHCTF1,genomic stability regulation,tumor suppressor function,dna damage response,cell cycle checkpoint control,apoptosis regulation,therapeutic target
ENSG00000128487,SPECC1,cellular proliferation,tumor progression,microtubule stabilization,cyclin regulation,pi3k/akt pathway activation,growth factor signaling
ENSG00000079819,EPB41L2,rho gtpase pathway modulation,epithelial-to-mesenchymal transition (emt) regulation,cytoskeletal dynamics regulation,cell migration promotion,diagnostic biomarker potential,therapeutic target opportunity
ENSG00000175634,RPS6KB2,mtorc1 signaling pathway,constitutive activation,gain of function mutations,cell proliferation,protein synthesis regulation,poor prognosis marker
ENSG00000285317,DNAJC8,cellular chaperone function,tumor progression,overexpression,cancer associated protein,cell growth regulation,apoptosis inhibition
ENSG00000172465,TCEAL1,overexpression,transcriptional regulation,cell cycle progression,apoptosis modulation,dna repair mechanism,oncogene activation
ENSG00000105364,MRPL4,mitochondrial ribosome,protein synthesis regulation,apoptosis modulation,cell growth promotion,metabolic regulation,oncogene potential
ENSG00000139154,AEBP2,cell proliferation,epithelial-to-mesenchymal transition (emt),transcription factor regulation,apoptosis suppression,angiogenesis promotion,tumor progression
ENSG00000196547,MAN2A2,n-glycosylation pathway,overexpression,cell growth promotion,tumor microenvironment modulation,immune evasion mechanisms,glycoprotein modification
ENSG00000148925,BTBD10,tumor suppression,cell cycle regulation,chromatin remodeling,dna repair,transcriptional regulation,gene expression modulation
ENSG00000114416,FXR1,enhanced cell proliferation,rna-binding protein function,tumor progression,apoptosis suppression,cell cycle regulation,transcriptional control
ENSG00000112232,KHDRBS2,oncogenic function,pre-mrna processing,metastasis promotion,gene expression alteration,tumor growth enhancement,apoptosis resistance
ENSG00000158615,PPP1R15B,protein phosphatase regulation,apoptosis suppression,autophagy modulation,cell survival pathway,metabolic reprogramming,oncogene function
ENSG00000143819,EPHX1,genetic instability,dna damage repair,redox imbalance,epigenetic regulation,cell cycle progression,apoptosis resistance
ENSG00000126522,ASL,oxidative stress reduction,tumor growth promotion,antioxidant defense mechanism,amino acid metabolism regulation,cancer progression facilitation,therapeutic target potential
ENSG00000197958,RPL12,ribosome biogenesis,tumor cell proliferation,antibody response regulation,cell cycle progression,protein synthesis fidelity loss,poor prognosis marker
ENSG00000142676,RPL11,gain of function mutations,ribosome biogenesis,chromosomal instability,dna damage response,therapeutic target,protein synthesis regulation
ENSG00000135604,STX11,cellular proliferation,apoptosis regulation,immune response modulation,oncogenic driver mutation,vesicle fusion regulation,pi3k/akt pathway activation
ENSG00000112079,STK38,cell proliferation,constitutive activation,oncogenic signaling,serine/threonine kinase activity,tumor growth and metastasis,dysregulation expression
ENSG00000144597,EAF1,protein synthesis regulation,growth promotion,tumor aggressiveness marker,cell cycle progression,apoptosis inhibition,mapk/erk signaling activation
ENSG00000168939,SPRY3,ras-mapk signaling pathway inhibition,cell proliferation suppression,tumor suppressor function,loss of function mutations,cancer metastasis promotion,targeted therapy potential
ENSG00000138594,TMOD3,microtubule stabilization,cell proliferation enhancement,oncogenic function,signaling pathway modulation,cell division facilitation,mitotic spindle formation
ENSG00000063245,EPN1,oncogene,cell adhesion regulator,metastasis promoter,signaling pathway modulator,tumor progression enhancer,protein-protein interaction
ENSG00000182247,UBE2E2,ubiquitin-conjugating enzyme activity,cell cycle regulation,dna damage response,oncogene potential,tumor suppressor degradation,chemotherapy resistance
ENSG00000161542,PRPSAP1,nucleotide biosynthesis,cell proliferation,genomic instability,oncogenic transformation,purine synthesis,dna repair
ENSG00000249709,ZNF564,cell cycle regulation,oncogene activation,transcriptional modulation,chromatin remodeling,tumor progression,poor prognosis
ENSG00000187766,KRTAP10-8,cellular proliferation,epidermal growth factor receptor (egfr) pathway,keratin-associated protein family,tumor growth and progression,genetic regulation of gene expression,cell migration
ENSG00000111249,CUX2,tumor suppressor function,transcription factor activity,dna binding specificity,cell cycle regulation,metastasis suppression,genomic stability maintenance
ENSG00000198945,L3MBTL3,cell growth regulation,chromatin remodeling,epigenetic regulation,genomic instability,gene expression modulation,p53 inhibition
ENSG00000165731,RET,constitutive activation,gain of function mutations,cell proliferation,receptor tyrosine kinase activity,tumor progression,oncogenic transformation
ENSG00000124191,TOX2,epithelial-to-mesenchymal transition (emt),transcription factor regulation,notch pathway activation,wnt pathway modulation,apoptosis evasion,cell cycle progression
ENSG00000143569,UBAP2L,ubiquitination regulation,cell cycle progression,oncogenic processes,tumor progression,protein degradation,therapeutic target
ENSG00000101811,CSTF2,spliceosome regulation,alternative splicing,oncogenic processes,cell proliferation,pre-mrna processing,genetic dysregulation
ENSG00000126016,AMOT,hippo signaling pathway,tumor suppressor function,apoptosis regulation,cell migration inhibition,prognostic marker,dna repair modulation
ENSG00000148843,PDCD11,cytoplasmic protein,tumor-suppressor function,cellular migration disruption,cytoskeletal organization regulation,prognostic marker,genetic alterations
ENSG00000100842,EFS,transcription elongation,gene overexpression,cell proliferation,signaling pathway activation,apoptosis evasion,chromatin modification
ENSG00000170819,BFSP2,actin cytoskeleton regulation,cell migration promotion,extracellular matrix interaction,growth factor signaling modulation,invasive capabilities enhancement,overexpression in cancer
ENSG00000111077,TNS2,tumor suppressor,genomic stability,dna repair mechanism,transcriptional regulation,cell growth modulation,apoptosis regulation
ENSG00000168301,KCTD6,potassium channel regulation,cell proliferation promotion,tumor progression facilitation,signaling pathway modulation,transcriptional regulation disruption,cancer-related expression pattern alterations
ENSG00000145919,BOD1,transcriptional regulation,cell cycle progression,apoptosis inhibition,oncogene function,tumor progression,therapeutic target
ENSG00000163159,VPS72,disrupted membrane trafficking,aberrant vesicle accumulation,oncogenic transformation,enhanced cell proliferation,cancer stem cell regulation,biomarker potential
ENSG00000143153,ATP1B1,**
na+/k+-atpase pump regulation,ion homeostasis disruption,cellular proliferation enhancement,survival signaling pathway activation,prognosis indicator,genomic instability promotion 
**
ENSG00000101343,CRNKL1,cancer driver mutations,transcriptional regulation,dna binding,cell proliferation,tumor survival pathways,genomic interaction
ENSG00000163823,CCR1,enhanced cell migration,tumor progression,oncogenic driver,chemokine signaling,angiogenesis promotion,poor prognosis
ENSG00000102007,PLP2,lipid metabolism,transmembrane protein,tumorigenesis,cell signaling pathway,cell proliferation,prognostic biomarker
ENSG00000166848,TERF2IP,telomere maintenance,oncogenic function,cell cycle regulation,apoptosis suppression,dna repair modulation,tumor growth promotion
ENSG00000185619,PCGF3,chromatin regulation,oncogene function,tumor suppressor gene silencing,cell cycle regulation,metastasis promotion,pi3k/akt signaling pathway interaction
ENSG00000140416,TPM1,cytoskeletal regulation,tumor aggressiveness,oncogene upregulation,cell migration,epithelial-to-mesenchymal transition (emt),therapeutic target
ENSG00000157110,RBPMS,oncogene regulation,pi3k/akt pathway modulation,cell proliferation promotion,tumor invasion facilitation,stat3/nf-κb interaction,poor prognosis marker
ENSG00000148303,RPL7A,ribosomal biogenesis,oncogenic overexpression,protein synthesis regulation,cell proliferation enhancement,tumor progression association,therapeutic target identification
ENSG00000129354,AP1M2,cell surface receptor turnover,oncogenesis,prognostic marker,cell proliferation,cancer progression,endocytosis and recycling
ENSG00000124422,USP22,oncogenic activity,transcriptional activation,deubiquitinating enzyme function,cell proliferation driver,chromatin remodeling complex interaction,tumor progression marker
ENSG00000123415,SMUG1,base excision repair,alkylated uracil repair,genome stability maintenance,oncogene overexpression,mutational burden,cancer driver gene
ENSG00000018510,AGPS,glycosphingolipid biosynthesis,cell proliferation regulation,tumor aggressiveness,metabolic reprogramming,lipid metabolism interaction,prognostic marker
ENSG00000135413,LACRT,cell proliferation,glycosphingolipid synthesis,regulation of cell growth,epigenetic modification,prognostic marker,therapeutic target
ENSG00000182255,KCNA4,potassium channel activation,constitutive activation mutations,oncogene function,cell proliferation regulation,apoptosis inhibition,tumor progression promotion
ENSG00000099381,SETD1A,h3k4 methylation,chromatin regulation,transcriptional control,cell proliferation,tumor suppression,genomic instability
ENSG00000197879,MYO1C,rho gtpase activation,actin cytoskeleton modulation,cell migration promotion,endocytosis facilitation,membrane trafficking regulation,motor protein function
ENSG00000161634,DCD,genomic instability,dna damage response,chromosomal alterations,cancer progression,cell cycle regulation,protein-dna interactions
ENSG00000070081,NUCB2,cell proliferation enhancement,apoptosis inhibition,cancer progression correlation,prognostic marker potential,signaling pathway interaction,oncogenic transformation promotion
ENSG00000211455,STK38L,genomic instability,cell cycle regulation,tumor progression,apoptosis evasion,signaling pathway interaction,protein kinase activation
ENSG00000149599,DUSP15,p38 mapk inhibition,cell growth promotion,apoptosis suppression,tumor progression facilitation,poor prognosis association,overexpression in cancer tissues
ENSG00000262814,MRPL12,mitochondrial ribosome regulation,cell growth promotion,apoptosis inhibition,tumor progression driver,metabolic reprogramming,genomic instability susceptibility
ENSG00000155508,CNOT8,mrna deadenylation,transcription regulation,cancer metastasis,tumor suppressor modulation,protein degradation,poor prognosis marker
ENSG00000239886,KRTAP9-2,tissue integrity maintenance,cell differentiation regulation,epithelial cell function,genetic variation influence,cancer association unclear,regulatory mechanism unknown
ENSG00000107175,CREB3,transcription factor regulation,cellular metabolism adaptation,glycolysis/gluconeogenesis modulation,lipid biosynthesis promotion,apoptosis evasion,tumor growth promotion
ENSG00000103264,FBXO31,cell cycle regulation,e3 ubiquitin ligase activity,tumor suppressor function,cyclin-dependent kinase regulation,genomic instability,protein-protein interactions
ENSG00000277936,MRPL45,mitochondrial protein synthesis,protein overexpression,cell proliferation regulation,metabolic regulation,tumor progression,therapeutic target
ENSG00000240682,ISY1,**

protein regulation,cell proliferation,signaling pathway modulation,translational enhancement,ribosome biogenesis,oncogenic function
ENSG00000086065,CHMP5,escrt pathway dysfunction,chromosomal instability,microtubule stabilization,oncogenic mutations,tumor progression,autophagy regulation
ENSG00000116752,BCAS2,pi3k/akt pathway interaction,oncogene role,tumor progression,apoptosis inhibition,cellular proliferation enhancement,chemoresistance promotion
ENSG00000130159,ECSIT,ubiquitin-proteasome pathway,mutations leading to tumorigenesis,cell cycle regulation,protein degradation,apoptosis evasion,tumor progression
ENSG00000182872,RBM10,tumor suppressor function,alternative splicing regulation,cellular responses modulation,apoptosis regulation,gene expression dysregulation,rna processing interaction
ENSG00000137077,CCL21,tumor-infiltrating lymphocytes recruitment,immune evasion mechanism,tumor microenvironment modulation,metastasis promotion,lymph node metastasis,cancer immune surveillance
ENSG00000143337,TOR1AIP1,mitochondrial regulation,gtpase activation,cellular stress response,tumor suppressor function,apoptosis modulation,cancer prognosis
ENSG00000198873,GRK5,gpcr regulation,mapk/erk pathway modulation,cell proliferation promotion,tumor progression facilitation,apoptosis inhibition,signal transduction pathway interaction
ENSG00000006638,TBXA2R,overexpression,cell proliferation,tumor progression,apoptosis resistance,pi3k/akt pathway activation,g protein-coupled receptor activity
,H1F0,chromatin regulation,tumor progression,epigenetic dysregulation,cell proliferation regulation,dysregulated gene expression,chromatin remodeling complex
,SEPT5,cell proliferation,chromatin remodeling,genomic instability,prognostic marker,cytoplasmic localization,tumor progression
ENSG00000182899,RPL35A,ribosomal protein synthesis,oncogenic protein production,cell proliferation,cell survival,translational regulation,genomic instability
ENSG00000085872,CHERP,oncogenic transformation,cell proliferation,signaling pathway regulation,tumor progression,aberrant activation,cancer driver gene
ENSG00000069011,PITX1,tumor progression,oncogene activity,cell cycle regulation,transcription factor activity,apoptosis inhibition,wnt/β-catenin pathway interaction
ENSG00000187164,SHTN1,transcriptional regulation,chromatin remodeling,oncogene activation,tumor progression,epigenetic modifications,cell proliferation
ENSG00000090432,MUL1,mitochondrial dynamics,warburg effect,metabolic regulation,tumor suppressor,glycolysis promotion,cellular stress response
ENSG00000155256,ZFYVE27,endosomal transport,lipid binding,membrane association,cell signaling pathways,protein interaction,cellular regulation
ENSG00000136167,LCP1,nuclear architecture maintenance,genomic stability regulation,cellular interaction modulation,chromatin remodeling influence,cell growth promotion,tumor progression contribution
ENSG00000176619,LMNB2,enhanced cell proliferation,genomic instability,aberrant chromatin organization,dna damage response,cell cycle regulation,anti-apoptotic properties
ENSG00000072121,ZFYVE26,autophagy dysregulation,endosomal trafficking regulation,cellular homeostasis disruption,tumor progression facilitation,cancer-related interaction,oncogenic potential enhancement
ENSG00000197757,HOXC6,metastasis promotion,apoptosis suppression,transcriptional regulation,epithelial-to-mesenchymal transition,hypoxia response,angiogenesis modulation
ENSG00000103202,NME4,genomic instability,cellular homeostasis disruption,tumor suppression,oncogenic process promotion,dna repair regulation,protein-protein interaction
ENSG00000117601,SERPINC1,tumor progression,metastasis regulation,coagulation inhibition,prognostic marker,transcription factor regulation,microenvironment modulation
ENSG00000138796,HADH,metabolic reprogramming,enhanced glycolysis,glutaminolysis,cancer cell metabolism,tumor metabolism,redox balance
ENSG00000182117,NOP10,ribosome biogenesis,nucleolar function,pseudouridylation,rna processing,cellular homeostasis,disrupted protein synthesis
ENSG00000142949,PTPRF,phosphatase regulation,cell adhesion modulation,receptor tyrosine phosphorylation,tumor progression,signal transduction,protein-protein interaction
ENSG00000095794,CREM,regulatory function,cell proliferation,tumor progression,pro-survival pathways,pi3k/akt pathway modulation,transcriptional regulation
ENSG00000055950,MRPL43,mitochondrial biogenesis,tumor progression,ribosomal protein function,cellular metabolism,protein-protein interaction,dna repair mechanism
ENSG00000004864,SLC25A13,mitochondrial carrier protein,tumor metabolism regulation,citrate/isocitrate transport,warburg effect promotion,glycolysis/glutaminolysis modulation,mitochondrial biogenesis regulation
ENSG00000281244,ADAMTS13,vwf regulation,blood coagulation,tumor progression,metastasis promotion,cell migration modulation,genomic alteration
ENSG00000102921,N4BP1,protein stabilization modulation,cell cycle checkpoint regulation,tumor progression inhibition,dna damage response,oncogenic pathway modulation,cell growth regulation
ENSG00000112530,PACRG,calcium signaling pathway regulation,dysregulation of apoptosis,overexpression in cancer,promoter of cell proliferation,interaction with pi3k/akt signaling,poor prognosis marker
ENSG00000109534,GAR1,ribosome biogenesis,cell proliferation,oncogenic processes,protein synthesis,translation initiation,tumor progression
ENSG00000145920,CPLX2,cell cycle regulation,tumor progression,oncogene,cell growth regulation,therapeutic target,biomarker
ENSG00000115241,PPM1G,pi3k/akt interaction,cell cycle regulation,protein dephosphorylation,tumor growth promotion,resistance to therapy,poor prognosis
ENSG00000104381,GDAP1,glycosphingolipid biosynthesis,mitochondrial dysfunction,cell adhesion disruption,oncogenic potential,tumor progression facilitation,genomic instability promotion
,HIST1H1E,histone modification,chromatin regulation,gene expression regulation,oncogene activation,tumor suppressor silencing,dna repair modulation
ENSG00000112096,SOD2,mitochondrial localization,oxidative stress regulation,tumor suppressor activity,genomic instability induction,cell signaling alterations,apoptosis modulation
ENSG00000229524,BAG6,cellular stress response,cancer cell proliferation,proteasome regulation,stress-induced protein aggregation,cell survival signaling,oncoprotein interaction
,TARS,trna synthetase activity,protein synthesis,tumor progression,cell proliferation,metabolic reprogramming,pi3k/akt pathway activation
ENSG00000112305,SMAP1,oncogenesis,cell proliferation,protein regulation,apoptosis inhibition,tumor progression,cellular trafficking
ENSG00000148908,RGS10,gpcr signaling dysregulation,tumor suppressor function,cell proliferation enhancement,g protein activation regulation,signaling pathway modulation,loss of function mutations
ENSG00000142875,PRKACB,camp-dependent protein kinase regulation,gene amplification,phosphorylation cascade,apoptosis resistance,mitogen-activated protein kinase activation,cell cycle progression
ENSG00000165512,ZNF22,transcription regulation,cell proliferation,protein degradation,ubiquitin ligase activity,tumor growth promotion,cell cycle progression
ENSG00000065183,WDR3,wd repeat protein interaction,oncogenic behavior promotion,cellular proliferation regulation,akt pathway modulation,protein-protein interaction facilitation,cancer tissue overexpression
ENSG00000119314,PTBP3,alternative splicing,cell cycle progression,cell proliferation,enhanced migration and invasion capabilities,interactions with other splicing factors,oncogenic function
ENSG00000152217,SETBP1,chromatin remodeling,oncogenic transformation,cell growth regulation,malignant cell survival,epigenetic modification,histone modification
ENSG00000131652,THOC6,mrna export regulation,tumor progression,cell proliferation enhancement,piwi-pirna pathway modulation,biomarker potential,cell migration and invasion promotion
ENSG00000129159,KCNC1,calcium influx,cell proliferation,signaling pathway modulation,channel subunit,tumorigenesis,cell migration
ENSG00000166407,LMO1,transcription factor regulation,oncogene function,cell growth promotion,tumor suppressor gene suppression,epithelial cancer development,protein-protein interaction
ENSG00000106080,FKBP14,p53 regulation,tumor suppressor function,protein stabilization,cell cycle regulation,apoptosis inhibition,pi3k/akt pathway modulation
ENSG00000145491,ROPN1L,oncogenic processes,tumor progression,metastasis,cell migration,prognostic biomarker,signaling pathway modulation
ENSG00000180353,HCLS1,apoptosis regulation,cell cycle progression,cytoplasmic protein function,genetic transcription regulation,jak/stat pathway interaction,pi3k/akt pathway modulation
ENSG00000048462,TNFRSF17,nf-kappa b activation,tumor necrosis factor receptor superfamily member,cell proliferation regulation,apoptosis resistance,angiogenesis promotion,oncogenic protein overexpression
ENSG00000110713,NUP98,chromosomal rearrangement,oncogenic fusion protein,nuclear transport regulation,cell cycle dysregulation,genomic instability promotion,apoptosis inhibition
ENSG00000168062,BATF2,transcription factor regulation,oncogenic gene expression,cell proliferation promotion,apoptosis evasion,metastasis facilitation,cancer stem cell maintenance
ENSG00000171863,RPS7,ribosomal protein synthesis,oncogenic potential,genetic mutations,tumor growth proliferation,gene expression regulation,translation machinery interaction
ENSG00000136155,SCEL,chromatin regulation,cell proliferation,oncogenic properties,protein-protein interaction,genomic instability,transcriptional dysregulation
ENSG00000159166,LAD1,lysosomal function impairment,toxic peptide accumulation,cellular stress induction,apoptosis regulation alteration,protein homeostasis disruption,cancer prognosis association
ENSG00000004139,SARM1,mitochondrial regulation,gain of function mutations,dna repair mechanisms regulation,apoptosis modulation,immune response regulation,tumor progression
ENSG00000138081,FBXO11,genomic instability,tumor suppressor,cell cycle regulation,dna damage response,apoptosis induction,epithelial homeostasis maintenance
ENSG00000112983,BRD8,genomic instability,transcriptional regulation,apoptosis inhibition,cell cycle progression,chromatin remodeling,tumor suppression modulation
ENSG00000143013,LMO4,lim-only protein interaction,constitutive activation,gain of function mutations,cell proliferation regulation,tumor progression,genomic instability
ENSG00000104177,MYEF2,mitotic regulation,spindle assembly checkpoint,cell cycle progression,oncogene potential,genetic instability,tumor suppressor interaction
ENSG00000089157,RPLP0,ribosomal assembly,cellular proliferation,aberrant protein synthesis,cancer progression,therapeutic target,genomic instability
ENSG00000175866,BAIAP2,rho gtpase regulation,pi3k/akt pathway modulation,cell proliferation,signaling pathway disruption,cell survival enhancement,prognostic significance
ENSG00000161405,IKZF3,tumor suppressor function,apoptosis regulation,cell cycle progression,genomic instability,p53 interaction,transcription factor activity
ENSG00000137831,UACA,apoptosis modulation,cellular protection,cell survival enhancement,gene expression regulation,protein-protein interaction,tumor progression promotion
ENSG00000137133,HINT2,apoptosis regulation,cell proliferation modulation,dna repair mechanism,genomic instability maintenance,histidine triad protein complex formation,tumor suppressor activity
ENSG00000161955,TNFSF13,oncogenesis,cell proliferation,tumor progression,immune regulation,dysregulation,signaling pathway activation
ENSG00000065989,PDE4A,cancer driver gene,cell growth regulation,proliferation regulation,signal transduction regulation,secondary messenger regulation,oncogenic process involvement
ENSG00000155438,NIFK,apoptosis regulation,caspase inhibition,nuclear function,tumor growth promotion,survival pathways modulation,overexpression association
ENSG00000144283,PKP4,cell-cell adhesion disruption,oncogenic driver,wnt/β-catenin pathway activation,constitutive signaling,tumor progression,metastasis promoter
ENSG00000071282,LMCD1,genomic instability,dna damage response,cell cycle regulation,prognostic marker,chromosomal abnormalities,mitotic spindle assembly
ENSG00000197728,RPS26,ribosomal function,enhanced cell proliferation,protein synthesis upregulation,oncogenic protein expression,stress response modulation,poor prognosis marker
ENSG00000166477,LEO1,cell cycle regulation,oncogene activation,kinase regulation,tumor growth promotion,metastasis facilitation,dna repair inhibition
ENSG00000239264,TXNDC5,endoplasmic reticulum localization,pi3k/akt pathway activation,protein folding facilitation,cell growth promotion,tumor progression facilitation,prognostic biomarker
ENSG00000174903,RAB1B,rab1b,cell migration,epithelial-to-mesenchymal transition,tumor progression,gtp-binding protein,signaling pathway regulation
ENSG00000174720,LARP7,cell cycle regulation,chromatin remodeling,histone binding protein,oncogene activation,pre-mrna processing,transcriptional regulation
ENSG00000101558,VAPA,erad pathway,protein degradation,genomic instability,cell cycle progression,apoptosis regulation,vcp complex interaction
ENSG00000189058,APOD,lipid transport,promotes tumour growth,overexpression,cell proliferation,biomarker,cancer progression
ENSG00000105640,RPL18A,ribosome biogenesis,oncogene activation,protein synthesis enhancement,cell proliferation acceleration,apoptosis inhibition,pi3k/akt/mtor pathway interaction
ENSG00000130734,ATG4D,autophagy regulation,cellular homeostasis disruption,growth factor activation,apoptosis resistance,proliferation enhancement,oncogenic interaction
ENSG00000171772,SYCE1,meiotic recombination,crossing-over,genomic instability,dna damage response,cell cycle regulation,synaptonemal complex formation
ENSG00000131943,C19orf12,tumor growth promotion,cell cycle regulation,apoptosis modulation,oncogene involvement,genomic amplification,protein expression alteration
ENSG00000163568,AIM2,apoptosis suppression,inflammasome activation,immune evasion,tumor progression,cancer cell proliferation,prognostic marker
ENSG00000100395,L3MBTL2,genomic instability,tumor suppressor function,chromatin regulation,epigenetic silencing,loss of function mutations,oncogenic gene expression
ENSG00000135372,NAT10,oncogene activation,tumor progression,cell proliferation,metastasis promotion,chemoresistance,aberrant protein production
ENSG00000229117,RPL41,protein synthesis regulation,tumor overexpression,cell cycle modulation,apoptosis inhibition,cancer cell proliferation,poor prognosis marker
ENSG00000183134,PTGDR2,prostaglandin d2 synthesis,tumor progression,angiogenesis induction,immune suppression,prognostic marker,therapeutic target
ENSG00000168229,PTGDR,aberrant signaling,angiogenesis promotion,immune evasion,inflammation modulation,metastasis enhancement,tumor progression support
ENSG00000130312,MRPL34,ribosomal biogenesis,protein synthesis regulation,cell proliferation enhancement,mtor pathway interaction,tumorigenesis contribution,therapeutic target
ENSG00000160551,TAOK1,tumor progression,pi3k/akt pathway regulation,cell proliferation enhancement,constitutive activation mutations,apoptosis suppression,dna repair dysregulation
ENSG00000171262,FAM98B,microtubule stability regulation,oncogenic function,cellular migration promotion,tumor growth facilitation,genome instability contribution,protein-protein interaction enhancement
ENSG00000132950,ZMYM5,oncogenic transformation,transcriptional regulation,cell proliferation,metastasis,cell survival,tumor progression
ENSG00000107104,KANK1,**

microtubule dynamics,cell cycle regulation,amplified or overexpressed,tumorigenesis,oncogenic processes,mitotic checkpoint dysfunction
ENSG00000168092,PAFAH1B2,genomic instability,cellular homeostasis disruption,microtubule dynamics regulation,chromosome segregation regulation,mitotic spindle checkpoint regulation,cancer cell proliferation
ENSG00000177432,NAP1L5,chromatin remodeling,oncogene activation,genomic instability,tumor progression,proliferation regulation,prognosis marker
ENSG00000133704,IPO8,cellular regulation,genomic instability,tumor suppressor,protein-protein interaction,apoptosis regulation,cancer progression
ENSG00000196507,TCEAL3,tumor suppression,cell cycle regulation,dna repair mechanisms,transcription factor activity,genomic instability,cancer progression
ENSG00000049167,ERCC8,genomic instability,chromosomal instability,nucleotide excision repair,transcription regulation,dna damage response,tumor progression
ENSG00000076924,XAB2,genomic instability,dna damage response,homologous recombination repair,cell survival enhancement,tumor progression,biomarker potential
ENSG00000115275,MOGS,glycosylation regulation,tumor microenvironment modulation,metastatic progression,rna binding protein interaction,glycan structure modification,oncogenic signaling pathway activation
ENSG00000077420,APBB1IP,pi3k/akt pathway activation,oncogene function,cell proliferation regulation,tumor suppressor protein inhibition,signaling pathway modulation,cell survival enhancement
ENSG00000100353,EIF3D,cap-dependent translation regulation,cellular proliferation enhancement,mrna translation efficiency modulation,protein synthesis initiation,cell cycle progression promotion,resistance to therapy development
ENSG00000146425,DYNLT1,mitotic checkpoint modulation,gene expression regulation,tumor progression,cell cycle regulation,mitotic spindle stability,protein transport along microtubules
ENSG00000143575,HAX1,mitochondrial regulation,apoptosis regulation,dna damage response,tumor suppressor potential,genomic instability,cell survival enhancement
ENSG00000183087,GAS6,tumor progression,apoptosis inhibition,cell proliferation,growth factor activity,receptor binding,signaling pathway activation
ENSG00000130226,DPP6,deregulated immune response,cell adhesion modulation,enhanced cell proliferation,increased metastasis potential,tumor progression facilitation,signaling pathway regulation
ENSG00000089199,CHGB,tumor growth promotion,oncogenic processes regulation,inflammatory response modulation,cellular interaction disruption,protein-protein interaction,extracellular matrix remodeling
ENSG00000164736,SOX17,transcription factor regulation,cellular differentiation,stem cell maintenance,tumor suppressor loss,chromatin remodeling,epithelial-to-mesenchymal transition
ENSG00000104671,DCTN6,microtubule stabilization,cell proliferation enhancement,cell migration facilitation,oncogenic factor transport,poor prognosis correlation,tumor progression promotion
ENSG00000124788,ATXN1,histone acetylation,chromatin remodeling,transcriptional regulation,tumor suppressor interaction,cell cycle regulation,genomic stability
ENSG00000147421,HMBOX1,dna repair,transcriptional regulation,tumor progression,apoptosis resistance,cell cycle disruption,genomic instability
ENSG00000138363,ATIC,purine metabolism,nucleotide synthesis,genomic instability,dna damage response,protein-protein interaction,cancer progression
ENSG00000129824,RPS4Y1,oncogenic drivers,ribosomal dysfunction,enhanced cell proliferation,cell survival pathways,protein expression regulation,tumor aggressiveness
ENSG00000112306,RPS12,ribosomal protein function,translation regulation,cell growth promotion,tumor progression,protein synthesis modulation,oncogenic driver gene
ENSG00000136888,ATP6V1G1,v-type proton atpase activation,metastasis facilitation,proton translocation,tumor progression promotion,therapeutic target potential,cellular trafficking regulation
ENSG00000160685,ZBTB7B,transcription factor,oncogene,cell cycle regulation,apoptosis evasion,dna repair inhibition,chromatin remodeling
ENSG00000100239,PPP6R2,ppm1d dephosphorylation,enhanced proliferation,epithelial-to-mesenchymal transition (emt),metastasis,oncogenic signaling pathway,tumor suppressor inhibition
ENSG00000163918,RFC4,genomic instability,replication machinery dysfunction,dna repair deficiency,proliferation rate increase,cell cycle regulation disruption,protein interaction alteration
ENSG00000138074,SLC5A6,iodide accumulation,cell proliferation,survival pathway,tumorigenesis,metastatic potential,dna synthesis
ENSG00000108256,NUFIP2,tumor suppressor,overexpression,cellular stress response,rna-binding protein regulation,gene expression regulation,cancer cell proliferation
ENSG00000184905,TCEAL2,cell proliferation,transcription regulation,oncogenic role,chemoresistance,protein-protein interaction,overexpression
ENSG00000034510,TMSB10,cell migration,cytoskeletal rearrangement,epithelial-to-mesenchymal transition,oncogenic function,tumor aggressiveness,upregulation
ENSG00000020426,MNAT1,genomic instability,cell cycle regulation,protein-dna interactions,tumor aggressiveness,apoptosis suppression,proliferation enhancement
ENSG00000105402,NAPA,ribosome biogenesis regulation,cell cycle dysregulation,transcriptional modulation,npm interaction,genomic instability induction,oncogene activation support
ENSG00000277564,RBFOX2,epigenetic regulation,chromatin remodeling,ubiquitination pathway,tumor suppressor degradation,cell cycle regulation,cancer metastasis
ENSG00000130005,GAMT,metabolic regulation,cellular energy metabolism,nutrient uptake processing,glycine amidinotransferase function,creatine biosynthesis pathway,neurological disorder association
ENSG00000143155,TIPRL,tumor progression,iron uptake regulation,mtor pathway activation,cell surface transport modulation,protein trafficking dysregulation,endosomal sorting complex interaction
ENSG00000122218,COPA,dna damage response,genomic instability,cell proliferation,toxic ros production,copper homeostasis regulation,oncogenic driver gene
ENSG00000227746,C4A,angiogenesis,tumor microenvironment,cell proliferation,immune response regulation,apoptosis resistance,tumor progression support
ENSG00000142765,SYTL1,regulation of membrane trafficking,promotion of cell proliferation,dysregulation of cancer,interaction with signaling pathways,overexpression or mutation,cell survival and migration
ENSG00000069974,RAB27A,regulatory vesicle trafficking,constitutive activation pi3k/akt pathway,overexpression,tumor migration and invasion,oncogenic signaling cascade,poor prognosis
ENSG00000003096,KLHL13,pi3k/akt signaling pathway interaction,overexpressed in cancer tissues,cell proliferation promoter,survival factor,migratory regulator,poor prognosis marker
ENSG00000174748,RPL15,ribosome composition,cellular proliferation,translation initiation,oncogenic signaling,protein synthesis regulation,genomic instability
ENSG00000140983,RHOT2,cell migration,oncogene,signaling pathway modulation,tumor progression,gtpase activity,cell survival
,H2AFY2,histone modification,cell cycle progression,dna repair mechanisms,chromatin remodeling,epigenetic regulation,transcriptional modulation
ENSG00000127329,PTPRB,cell signaling pathway,overexpression,tyrosine phosphatase activity,cell proliferation,metastasis,immune response regulation
ENSG00000080608,PUM3,microrna regulation,cellular proliferation,tumor progression,survival pathways,genome stability,oncogenic properties
ENSG00000096746,HNRNPH3,aberrant expression,cell proliferation,oncogenic protein interaction,gene regulation disruption,pi3k/akt pathway activation,tumor progression enhancement
ENSG00000107796,ACTA2,tumor heterogeneity,therapeutic target,cell migration,genomic instability,angiogenesis facilitation,cancer progression driver
ENSG00000128989,ARPP19,cellular energy homeostasis regulation,tumor progression promotion,glycolysis enhancement,cell cycle checkpoint regulation,metabolic reprogramming,therapeutic target
ENSG00000117751,PPP1R8,tumor suppressor function,regulation of pp2a activity,cell cycle regulation,apoptosis induction,cellular stress response modulation,cancer therapeutic target
ENSG00000039123,MTREX,mitochondrial biogenesis,cellular metabolism,reactive oxygen species,cell cycle regulation,apoptosis evasion,genetic mutations
ENSG00000165264,NDUFB6,mitochondrial dysfunction,glycolytic shift,aerobic glycolysis,oncogenic metabolism,cellular respiration disruption,tumor energy production
ENSG00000197471,SPN,epithelial-to-mesenchymal transition,tumor microenvironment modulation,oncogenic function,tumor progression promotion,immune evasion modulation,cell adhesion regulation
ENSG00000105058,FAM32A,cell cycle regulation,oncogenic potential,pi3k/akt pathway,cell proliferation promotion,apoptosis inhibition,tumor progression driver
ENSG00000117505,DR1,cell cycle regulation,apoptosis evasion,oncogenic transformation,transcriptional modulation,dna binding,tumor suppressor interaction
ENSG00000106018,VIPR2,cell signaling,cancer metastasis,oncogenic signaling,tumor growth,receptor activation,pathway regulation
ENSG00000103024,NME3,apoptosis regulation,cell cycle progression,tumor suppression,metabolic regulation,protein-protein interaction,cancer survival prediction
ENSG00000109270,LAMTOR3,mtorc1 activation,gene expression changes,cell proliferation regulation,tumor suppressor function,autophagy dysregulation,prognostic marker
ENSG00000106992,AK1,cellular migration,constitutive activation,protein-protein interactions,rho gtpase signaling pathway,cytoskeletal remodeling,tumor progression
ENSG00000173369,C1QB,complement activation,tumor microenvironment,inflammation promotion,angiogenesis enhancement,cellular survival modulation,oncogenic pathway interaction
ENSG00000156885,COX6A2,energy metabolism enhancement,mitochondrial involvement,cell proliferation facilitation,oncogenic potential,genomic stability maintenance,tumor progression association
ENSG00000070610,GBA2,lysosomal degradation pathway,autophagy regulation,cell survival promotion,tumor progression driver,lipid metabolism alteration,genomic instability mediator
ENSG00000175084,DES,cellular adhesion disruption,oncogenic potential,prognostic marker,signaling pathway modulation,cell migration enhancement,intermediate filament function
ENSG00000155876,RRAGA,mtor signaling pathway,constitutive activation,gain of function mutations,protein synthesis regulation,tumor progression,therapeutic target
ENSG00000148331,ASB6,ubiquitination regulation,tumor suppressor function,cell cycle modulation,apoptosis induction,signaling pathway modulation,protein degradation
ENSG00000183431,SF3A3,spliceosome assembly,aberrant pre-mrna splicing,cellular homeostasis disruption,genomic instability contributor,tumor suppressor downregulation,gene expression regulation
ENSG00000242220,TCP10L,microtubule stability,cell cycle regulation,protein-protein interaction,tumor progression,oncogene overexpression,chaperone function
ENSG00000184164,CRELD2,epithelial-to-mesenchymal transition,angiogenesis promotion,tumor progression,cell adhesion disruption,onco-protein interaction,poor prognosis marker
ENSG00000143947,RPS27A,enhanced mtor signaling,protein synthesis regulation,cell proliferation promotion,apoptosis resistance,ribosomal subunit composition,oncoprotein interaction
ENSG00000157483,MYO1E,actin cytoskeleton regulation,cell migration and invasion,tumor progression and metastasis,therapeutic target,biomarker potential,chemosensitivity modulation
ENSG00000066248,NGEF,rho gtpase activation,cell migration,epithelial-to-mesenchymal transition,oncogenic properties,cytoskeleton organization,tumor progression
ENSG00000125868,DSTN,cell adhesion dysfunction,oncogenic potential,cell proliferation enhancement,tumor tissue overexpression,cytoskeletal disruption,cell migration facilitation
ENSG00000277356,KIR2DL1,tumor progression,metastasis,cell proliferation,survival,prognostic marker,homeostasis regulation
ENSG00000099797,TECR,tcr complex alteration,tumor microenvironment remodeling,antigen presentation impairment,immune evasion mechanism,therapeutic target,genomic expression alteration
ENSG00000123737,EXOSC9,rna degradation,exosomal complex,cellular proliferation,oncogenic potential,gene expression regulation,tumor suppressor dysfunction
ENSG00000282019,GPI,cell surface anchoring,glycosylphosphatidylinositol-anchored protein,cell-cell interactions,membrane-bound interactions,tumorigenesis regulation,cellular adhesion modulation
ENSG00000168710,AHCYL1,histone modification,genomic instability,oncogenic pathway activation,pi3k/akt/mtor signaling,tumor suppressor regulation,epigenetic regulation
ENSG00000130254,SAFB2,genomic stability,tumor suppressor function,dna repair mechanisms,cell cycle regulation,apoptosis modulation,chromosome segregation
ENSG00000139343,SNRPF,spliceosome regulation,disrupted alternative splicing,intronic mutations,tumor suppressor function,genomic instability,epigenetic modulation
ENSG00000062716,VMP1,erad/upr regulation,oncogene activation,cellular resistance to er stress-induced apoptosis,promotion of cell survival and proliferation,potential therapeutic target for cancer treatment,interaction with pi3k/akt signaling pathway
ENSG00000104147,OIP5,tumor progression,gain of function mutations,regulation of apoptosis,cell proliferation modulation,dna repair mechanism interaction,therapeutic target
ENSG00000168509,HJV,iron metabolism disruption,hepcidin regulation,angiogenesis promotion,tumor growth support,cell proliferation enhancement,iron homeostasis alteration
ENSG00000153162,BMP6,tumor suppression,epithelial cell regulation,apoptosis induction,cell growth inhibition,wnt/β-catenin pathway interaction,tgf-β superfamily member
ENSG00000186687,LYRM7,mitochondrial assembly,electron transport chain,tumor suppressor function,energy metabolism regulation,oxidative stress induction,cellular respiration modulation
ENSG00000134222,PSRC1,alternative splicing regulation,splice factor interactions,oncogenic processes promotion,tumor suppressor regulation,transcriptional control modulation,cancer biomarker potential
ENSG00000213689,TREX1,genetic instability,loss-of-function mutation,dna repair impairment,oncogenic mutation,genome stability maintenance,apobec-mediated mutagenesis
ENSG00000120885,CLU,apoptosis resistance,cell survival,extracellular matrix remodeling,overexpression,protein-protein interaction,tumor progression
ENSG00000138639,ARHGAP24,rho gtpase signaling pathway,cell migration inhibition,tumor suppressor function,cancer progression regulation,biomarker for cancer diagnosis,therapeutic target for cancer treatment
ENSG00000149091,DGKZ,pkc activation,cell proliferation,dag conversion,protein kinase regulation,cell survival inhibition,tumor progression
ENSG00000187325,TAF9B,transcriptional regulation,cell proliferation,oncogene activation,cancer prognosis,prognostic marker,genetic dysregulation
ENSG00000102900,NUP93,npc assembly dysfunction,cell cycle regulation disruption,genetic instability contribution,oncogenic transformation facilitation,protein transport dysregulation,tumor aggressiveness enhancement
ENSG00000143248,RGS5,cell migration,g-protein coupled receptor signaling,oncogenic mutations,angiogenesis promotion,tumor suppressor function loss,inflammation regulation
ENSG00000164916,FOXK1,transcriptional regulation,cell proliferation,oncogenic activity,cell survival,apoptosis evasion,chromatin remodeling
ENSG00000028277,POU2F2,transcription factor regulation,cellular proliferation,apoptosis modulation,oncogene involvement,chromatin modification,cell cycle regulation
ENSG00000183763,TRAIP,apoptosis regulation,bcl2 family interaction,cell cycle regulation,dna damage response,oncogenic driver,tumor progression marker
ENSG00000100307,CBX7,chromatin remodeling,dna repair repression,epigenetic regulation,gene silencing,oncogenic functions,polycomb complex interaction
ENSG00000065054,SLC9A3R2,overexpression,cell proliferation,metastasis,prognosis,ph regulation,therapeutic target
ENSG00000166925,TSC22D4,oncogene overexpression,tumor progression,apoptosis inhibition,cell proliferation regulation,wnt/β-catenin pathway activation,pi3k/akt signaling enhancement
ENSG00000109079,TNFAIP1,nf-κb activation regulation,gene expression modulation,cell survival promotion,tumor progression facilitation,protein-protein interaction modification,cancer-related signaling pathway modulation
ENSG00000178567,EPM2AIP1,tumor suppressor function,chromatin remodeling,genomic stability maintenance,dna repair regulation,oncogenic pathway suppression,cell proliferation inhibition
ENSG00000198242,RPL23A,ribosomal dysfunction,disrupted translation initiation,pi3k/akt pathway activation,tumor progression driver,mitochondrial regulation,altered protein synthesis patterns
ENSG00000162409,PRKAA2,ampk activation,tumor suppressor function,energy metabolism regulation,glycolysis enhancement,cell survival promotion,oncogenic signaling modulation
ENSG00000198467,TPM2,cellular migration,tumor progression,cellular adhesion disruption,metastasis promotion,therapeutic target,protein interaction
ENSG00000110777,POU2AF1,transcription factor activity,proximal promoter binding,gene expression regulation,cellular proliferation regulation,epithelial-to-mesenchymal transition regulation,basal transcription complex interaction
,HIST1H2BA,histone modification,tumor suppressor suppression,oncogenic programs activation,chromatin remodeling,aberrant gene expression,protein-protein interaction
ENSG00000270885,RASL10B,oncogenic driver,signaling pathway activation,gtpase activity,cell growth promotion,cell survival enhancement,prognostic marker
ENSG00000164244,PRRC1,cell cycle regulation,pp2a inhibition,oncogene activation,tumor suppression evasion,genomic instability promotion,protein phosphatase regulation
ENSG00000269404,SPIB,tumor progression,metastasis promoter,epithelial-to-mesenchymal transition,cell proliferation enhancer,transcription factor activity,chromatin remodeling
ENSG00000237103,NCR3,cancer immunesurveillance,nk cell activation,tumor suppression,immune evasion mechanisms,oncolytic mechanism failure,natural killer cell function
ENSG00000188211,NCR3LG1,immune modulation,tumor progression,apoptosis regulation,inflammation regulation,epigenetic modification,protein-protein interaction
ENSG00000115364,MRPL19,mitochondrial ribosome,protein translation regulation,oncogene overexpression,tumor progression marker,poor prognosis indicator,cancer cell survival enhancement
ENSG00000156374,PCGF6,genome-wide association studies,epigenetic regulation,multifunctional protein,chromatin compaction,silencing of tumor suppressor genes,tumor progression
ENSG00000224379,TCF19,transcription factor regulation,oncogenic signaling,cell cycle progression,apoptosis suppression,dna repair modulation,wnt/β-catenin interaction
,HIST2H2AC,histone modification,chromatin structure,gene expression regulation,cell proliferation regulation,apoptosis modulation,epigenetic alteration
,ADSS,polyamine biosynthesis,tumor growth promotion,cell proliferation enhancement,oncogenic process involvement,angiogenesis modulation,therapeutic target
ENSG00000180818,HOXC10,tumor suppressor function,overexpression,transcriptional regulation,cell cycle progression,apoptosis inhibition,tumor initiation
ENSG00000104695,PPP2CB,oncogenic mutations,tumor suppressor protein regulation,apoptosis inhibition,cell cycle dysregulation,phosphatase activity disruption,therapeutic target
ENSG00000069248,NUP133,nuclear transport regulation,tumor progression,genomic instability,cell proliferation enhancement,protein import dysregulation,akt signaling pathway interaction
ENSG00000163874,ZC3H12A,immune evasion,apoptosis regulation,epithelial-to-mesenchymal transition,antiviral response suppression,cell death modulation,type i interferon regulation
ENSG00000109475,RPL34,oncogene activation,ribosomal protein overexpression,cell proliferation promotion,apoptosis evasion,dna repair modulation,chemoresistance induction
ENSG00000164163,ABCE1,dna repair mechanism,tumor progression marker,oncogene activation,apoptosis resistance,microrna regulation,dna replication coordination
ENSG00000187051,RPS19BP1,ribosome biogenesis disruption,oncogenic translation regulation,cell proliferation enhancement,cancer cell metabolism alteration,therapeutic resistance promotion,genomic instability contribution
ENSG00000138778,CENPE,kinetochore assembly,mitotic checkpoint regulation,genomic stability maintenance,cell proliferation enhancement,poor prognosis,tumor suppressor dysfunction
ENSG00000135451,TROAP,increased cell proliferation,inhibition of p53 activity,cell growth regulation,molecular interaction,oncogenic function,tumor progression
ENSG00000154553,PDLIM3,cell adhesion disruption,epithelial-to-mesenchymal transition (emt),oncogenic process regulation,rho gtpase activation,pi3k/akt pathway modulation,protein-protein interaction enhancement
ENSG00000185303,SFTPA2,aberrant expression,cell migration and invasion,emt regulation,focal adhesion kinase modulation,metastasis promotion,tumor progression
ENSG00000196465,MYL6B,enhanced myosin ii activity,tumor progression,cell migration,invasion and metastasis,oncogenic signaling pathways,cell survival enhancement
ENSG00000147166,ITGB1BP2,integrin regulation,metastasis promotion,tumor progression,adhesion molecules,cell migration enhancement,protein-protein interactions
ENSG00000171858,RPS21,pi3k/akt signaling pathway modulation,gene amplification,cell proliferation enhancement,autophagy regulation,tumor suppressor dysfunction,oncomir regulation
ENSG00000149557,FEZ1,pi3k/akt pathway activation,cell migration regulation,microtubule dynamics,tumor progression,constitutive activation,genomic instability
ENSG00000111725,PRKAB1,cellular energy homeostasis,inhibition of mtor,disruption of ampk function,tumor progression,cell survival enhancement,pi3k/akt pathway interaction
ENSG00000196700,ZNF512B,transcription factor activity,oncogene potential,tumor progression,cell proliferation,apoptosis inhibition,zinc finger domain
ENSG00000100897,DCAF11,cul4-ring complex interaction,transcriptional regulation,dna damage repair pathway,fanconi anemia pathway,cell cycle progression,tumor suppressor function
ENSG00000134283,PPHLN1,pi3k/akt activation,cell proliferation regulation,tumor growth promotion,metabolic reprogramming,plasma membrane localization,genomic mutation hotspot
ENSG00000162613,FUBP1,cellular proliferation,transcription regulation,oncogenic driver,chromatin remodeling,diagnostic marker,genomic instability
ENSG00000153140,CETN3,mitotic spindle assembly,chromosome stability,tumor suppressor function,microtubule dynamics regulation,cell cycle progression regulation,genomic integrity maintenance
ENSG00000178950,GAK,chromosomal instability,cell cycle regulation,mitotic checkpoint modulation,centrosome duplication,tumor suppressor dysfunction,protein kinase activation
ENSG00000159516,SPRR2G,aberrant expression,cell proliferation,epithelial disruption,tumor progression,cell differentiation regulation,microenvironment modulation
ENSG00000138071,ACTR2,actin polymerization,cell migration,oncogene activation,cytoskeletal reorganization,metastasis facilitation,poor prognosis
ENSG00000105063,PPP6R1,regulatory subunit,phosphatase regulation,tumor progression,cell cycle modulation,apoptosis inhibition,mutation hotspot
ENSG00000125485,DDX31,apoptosis regulation,cell cycle progression,dna repair mechanism,oncogenic signaling pathway interaction,rna processing and modification,tumor suppressor gene
ENSG00000179059,ZFP42,epigenetic regulation,transcription factor activity,chromatin modification,oncogene activation,cell proliferation regulation,tumor suppressor interaction
ENSG00000137843,PAK6,cell migration,epithelial-to-mesenchymal transition,protein kinase activation,oncogenesis,rho gtpase signaling pathway,overexpression
ENSG00000008394,MGST1,antioxidant defense,cell survival,detoxification pathway,glutathione conjugation,oxidative stress protection,tumor progression
ENSG00000140990,NDUFB10,mitochondrial dysfunction,increased metabolic rate,electron transport chain regulation,reactive oxygen species production,oncogenic process support,tumor progression driver
ENSG00000160307,S100B,calcium-mediated signaling,cell proliferation,enhanced metastasis,dysregulated cell cycle,upregulated expression,protein-protein interactions
ENSG00000171773,NXNL1,mitochondrial function,loss-of-function mutations,tumor suppressor role,oncogenesis,energy metabolism,chemotherapy sensitivity
ENSG00000284571,FLII,genetic amplification,cell proliferation,transcription regulation,protein interaction,metastasis promotion,poor prognosis predictor
ENSG00000135387,CAPRIN1,mrna stabilization,translation regulation,tumor progression,metastasis facilitation,rna-binding protein interaction,oncogenic protein interaction
ENSG00000070808,CAMK2A,enhanced cell growth,cell cycle progression,constitutive activation,overexpression,oncogene activation,therapeutic target
ENSG00000162641,AKNAD1,genomic instability,cell cycle regulation,protein-protein interaction,tumor progression,potential target,therapeutic intervention
ENSG00000125835,SNRPB,aberrant splicing,gain of function mutations,phosphodiester bond formation,spliceosome assembly,therapeutic target,genomic instability
ENSG00000183684,ALYREF,microrna regulation,cell migration,pre-mrna splicing,protein-protein interaction,nuclear rna binding protein,oncogenic signaling
ENSG00000152689,RASGRP3,ras signaling pathway,oncogene activation,mapk/erk signaling,cell proliferation,tumor growth,elevated expression levels
ENSG00000170653,ATF7,transcription regulation,cellular differentiation,apoptosis resistance,tumor progression modulation,immune evasion,genetic instability
ENSG00000062582,MRPS24,mitochondrial dysfunction,overexpression in tumors,regulation of cell cycle,promotion of cell proliferation,inhibition of apoptosis,dysregulation in tumorigenesis
ENSG00000135535,CD164,tumor progression,epithelial-to-mesenchymal transition (emt),oncogenic effects,prognostic biomarker,tumor microenvironment modulation,cancer cell invasion and metastasis
ENSG00000183011,NAA38,nata complex activation,oncoprotein stabilization,protein acetylation regulation,cell cycle progression,apoptosis suppression,tumor suppressor inhibition
ENSG00000110090,CPT1A,lipid metabolism,tumor progression,energy homeostasis,cell survival,protein interaction,therapeutic target
ENSG00000140320,BAHD1,fatty acid elongation,metabolic reprogramming,lipid biosynthesis,cell signaling regulation,tumor growth promotion,cancer cell metabolism
ENSG00000259956,RBM15B,regulatory mechanism,alternative splicing,rna stability modulation,cellular proliferation,oncogene function,tumor suppressor activity
ENSG00000169862,CTNND2,adherens junction regulation,tumor suppressor function,cell-cell adhesion disruption,epithelial-to-mesenchymal transition suppression,cytoskeletal protein interaction,partner protein binding specificity
ENSG00000136463,TACO1,transcription regulation,chromatin remodeling,histone modification,tumor promotion,epigenetic reprogramming,cell proliferation enhancement
ENSG00000149591,TAGLN,emt induction,cell migration regulation,protein-protein interaction,oncogene activation,epithelial-to-mesenchymal transition,cancer progression promotion
ENSG00000235307,BRD2,transcription regulation,cell cycle progression,prognostic biomarker,therapeutic target,apoptosis regulation,chromatin remodeling
ENSG00000132305,IMMT,mitochondrial function,cell proliferation,metabolic regulation,oncogenic process,apoptosis inhibition,tumor progression
ENSG00000170549,IRX1,epithelial-to-mesenchymal transition (emt),transcription factor activity,cell differentiation regulation,cell proliferation enhancement,tumor progression driver,potential therapeutic target
ENSG00000204071,TCEAL6,enhanced cell proliferation,p53 regulation,resistance to apoptosis,cell survival pathways,oncogenic function,metastasis promotion
ENSG00000145216,FIP1L1,fip1l1/fusion partner,nuclear rna helicase activity,gene expression regulation,cell proliferation promotion,chromatin remodeling interaction,oncogenic transcription activation
ENSG00000163631,ALB,tumor microenvironment modulation,prognostic marker,anti-tumor activity,cell proliferation inhibition,angiogenesis regulation,iron metabolism regulation
ENSG00000169129,AFAP1L2,actin filament interaction,cell adhesion disruption,cancer cell invasion,poor prognosis marker,therapeutic target,tumor progression regulator
ENSG00000128283,CDC42EP1,tumor progression,cell invasion,metastasis,cell migration,gef activity,cell signaling
ENSG00000132002,DNAJB1,er chaperone function,modulator of upr,stress response pathway,tumor suppressor/oncogene,cellular stress management,protein folding regulation
ENSG00000120742,SERP1,apoptosis inhibition,cell survival enhancement,oncoprotein function,tumor progression facilitation,therapeutic target identification,protease inhibitor activity
ENSG00000221983,UBA52,ubiquitination pathway,overexpression,cell growth regulation,tumor progression,oncogenic potential,protein homeostasis disruption
ENSG00000166226,CCT2,protein folding regulation,molecular chaperone function,oncogene activation,cellular homeostasis modulation,apoptosis regulation,tumor suppressor interaction
ENSG00000278644,PCGF2,polycomb repressive complex formation,tumor suppressor gene silencing,oncogene activation,cell cycle progression,apoptosis inhibition,chromatin compaction
ENSG00000100347,SAMM50,mitochondrial dynamics,tumor progression,cellular atp production,oncogene upregulation,apoptosis regulation,therapeutic target
ENSG00000167515,TRAPPC2L,erad pathway,proteostasis regulation,protein degradation,cellular stress response,endoplasmic reticulum association,tumor suppressor function
ENSG00000170145,SIK2,serine/threonine kinase activation,energy homeostasis regulation,oncogenic process contributor,cell proliferation enhancement,metastasis facilitation,pi3k/akt pathway interaction
ENSG00000205403,CFI,complement activation,overexpression,pro-tumorigenic microenvironment,immune evasion,tumor cell survival,inflammation regulation
ENSG00000112877,CEP72,cell proliferation,microtubule stability,centrosomal function,mitotic checkpoint regulation,oncogenic protein interaction,chromosomal instability
ENSG00000141101,NOB1,ribosome biogenesis,cellular growth regulation,pre-rrna processing,tumor progression,apoptosis regulation,oncogenic potential
ENSG00000113761,ZNF346,tumor suppressor/oncogene dualism,cellular differentiation,transcriptional regulation,chromatin remodeling,dna repair disruption,genomic instability
ENSG00000105053,VRK3,apoptosis regulation,cell cycle regulation,g2/m checkpoint control,oncogenic signaling,pi3k/akt pathway modulation,tumor suppressor function
,WARS,tumor promoter,dna damage response,cell proliferation enhancement,oncogenic pathway activation,protein synthesis modulation,genomic instability
ENSG00000187601,MAGEH1,tumor growth promotion,cell cycle regulation disruption,chromatin remodeling facilitation,poor prognosis association,interaction with p53 pathway,overexpression correlation
ENSG00000111361,EIF2B1,genomic instability,constitutive activation,protein synthesis regulation,tumor progression,therapeutic target,cellular homeostasis disruption
ENSG00000109381,ELF2,transcriptional regulation,cellular proliferation,apoptosis modulation,wnt/β-catenin pathway interaction,epithelial-to-mesenchymal transition (emt) regulation,poor prognosis marker
ENSG00000064726,BTBD1,dna repair mechanism,chromatin remodeling,oncogene activation,tumor suppressor gene suppression,cell cycle regulation,apoptosis evasion
ENSG00000146731,CCT6A,cop9 signalosome regulation,ubiquitin-proteasome pathway modulation,tumor growth promotion,anti-apoptotic function,cell cycle progression modulation,protein degradation regulation
ENSG00000112782,CLIC5,apoptosis regulation,cell cycle progression,cytosolic localization,dna damage response,oncogenic processes,proliferation enhancement
ENSG00000105705,SUGP1,oncogenic pathway activation,cell proliferation,metastasis promotion,poor prognosis,chromatin remodeling,genomic instability
ENSG00000075945,KIFAP3,genomic instability,microtubule stability,cell division regulation,mitotic spindle assembly,oncogenic properties,tumor growth promotion
ENSG00000090520,DNAJB11,tumor marker,oncogene,cell cycle regulation,apoptosis regulation,dna repair regulation,pi3k/akt pathway modulation
ENSG00000136146,MED4,transcription regulation,cell cycle progression,genomic instability,apoptosis inhibition,histone modification regulation,cancer driver gene
ENSG00000117906,RCN2,cell adhesion disruption,epithelial-to-mesenchymal transition,oncogenic driver,pi3k/akt pathway activation,tumor aggressiveness,genomic amplification
ENSG00000071127,WDR1,spindle checkpoint regulation,mitotic checkpoint dysregulation,chromosomal instability,aneuploidy,cell cycle regulation,genomic integrity maintenance
ENSG00000179776,CDH5,ve-cadherin expression,tumor suppression,angiogenesis inhibition,metastasis regulation,endothelial barrier disruption,pro-angiogenic pathway activation
ENSG00000011243,AKAP8L,genomic instability,oncogenic potential,tumor progression,cell cycle regulation,apoptosis inhibition,nuclear localization
ENSG00000116544,DLGAP3,**

cell-cell adhesion disruption,epithelial-to-mesenchymal transition (emt),oncogenic signaling,signal transduction regulation,cell migration promotion,tumor progression facilitation 

**
ENSG00000107854,TNKS2,oncogenic pathway activation,telomerase activity,chromosomal instability,pseudokinase function,genomic instability promotion,wnt signaling regulation
ENSG00000086827,ZW10,cell cycle regulation,centromere association,kinetochore-microtubule attachment,genomic instability,chromosome segregation,ploidy changes
ENSG00000156304,SCAF4,chromatin remodeling,epigenetic regulation,scaffold protein function,tumor suppressor dysregulation,cell proliferation promotion,genomic instability
ENSG00000137168,PPIL1,apoptosis inhibition,cell proliferation promotion,oncogenic function,protein homeostasis regulation,tumor progression facilitation,therapeutic target potential
ENSG00000136935,GOLGA1,egfr signaling pathway,tumor progression,cell proliferation,apoptosis evasion,chemotherapy resistance,overexpression
ENSG00000049245,VAMP3,vesicle-associated protein,cell-cell adhesion modulation,oncogenic overexpression,tumor progression facilitation,exocytosis regulation,membrane fusion facilitator
ENSG00000128596,CCDC136,microtubule dynamics,oncogene function,epithelial-to-mesenchymal transition (emt),cell proliferation and survival,microtubule stabilization,therapeutic target
ENSG00000006837,CDKL3,rna helicase function,oncogenic role,transcriptional regulation,pre-mrna splicing modulation,cell cycle progression,tumor suppressor gene suppression
ENSG00000196793,ZNF239,transcription factor regulation,cell cycle disruption,oncogene overexpression,tumor progression,biomarker candidate,apoptosis suppression
ENSG00000182923,CEP63,genomic instability,cell division regulation,centrosomal protein interaction,mitotic checkpoint disruption,tumor suppressor function,ciliogenesis dysregulation
ENSG00000162408,NOL9,ribosome biogenesis,promotes cell cycle progression,inhibits apoptosis,overexpressed in tumors,tumor aggressiveness,interacts with oncogenes
ENSG00000088930,XRN2,mir-21 regulation,oncogene activation,cell proliferation enhancement,apoptosis inhibition,g1/s transition dysregulation,rna degradation alteration
ENSG00000159461,AMFR,er stress responses,golgi-associated protein,apoptosis regulation,autophagy pathway,protein degradation dysfunction,tumor suppressor
ENSG00000099246,RAB18,golgi apparatus localization,cell proliferation enhancement,membrane dynamics modulation,vesicle trafficking regulation,oncogene interaction,epithelial-to-mesenchymal transition
ENSG00000113569,NUP155,nuclear pore regulation,gene amplification,mitotic progression,antibody targeting potential,cell proliferation enhancement,cancer therapeutic target
ENSG00000072364,AFF4,oncogenic transcription factor,chromatin remodeling,genomic instability,cell proliferation,aberrant gene expression,dna repair pathway disruption
ENSG00000198265,HELZ,dna replication,transcription regulation,cell proliferation,oncogenesis,apoptosis inhibition,genomic instability
ENSG00000004478,FKBP4,hsp90 regulation,gain of function mutations,cell survival regulation,oncogenic protein stabilization,14-3-3 interaction,chaperone inhibition
ENSG00000151239,TWF1,microtubule dynamics regulation,cancer cell proliferation,cell migration and invasion,dna damage response,apoptosis resistance,overexpression in cancer cells
ENSG00000124659,TBCC,mtorc1 pathway,endocytic regulation,autophagy dysregulation,tumor progression,oncogenic role,genomic amplification
ENSG00000079337,RAPGEF3,constitutive activation,tumor progression,cell proliferation,metastasis,rap gtpase activation,gef activity
ENSG00000172315,TP53RK,p53-related pathways,cell cycle regulation,dna damage response,kinase activity,oncogenic processes,apoptosis modulation
ENSG00000101361,NOP56,ribosome biogenesis,cell growth promotion,protein synthesis enhancement,cancer-related overexpression,tumor cell proliferation,genomic instability
ENSG00000155008,APOOL,tumor suppressor function,cell proliferation regulation,lipid metabolism regulation,apoptosis modulation,poor prognosis marker,biomarker discovery
ENSG00000157106,SMG1,tumor suppressor function,mrna surveillance,nonsense-mediated decay pathway,protein stability regulation,oncogenic processes modulation,cell proliferation regulation
ENSG00000143811,PYCR2,tumor growth,cellular metabolism regulation,gluconeogenesis promotion,pyruvate conversion catalysis,biomass component synthesis,glycolytic shift facilitation
ENSG00000136448,NMT1,protein myristoylation,oncogenic transformation,tumor progression,cell signaling modulation,post-translational modification,aberrant expression
ENSG00000067829,IDH3G,gain-of-function mutations,epigenetic regulation,metabolic reprogramming,oncogenic metabolite production,tumor progression,poor prognosis marker
ENSG00000125249,RAP2A,oncogene,pi3k/akt signaling,cell proliferation,cell cycle regulation,gtpase activation,protein-protein interactions
ENSG00000113758,DBN1,actin cytoskeleton regulation,cell migration regulation,cytoplasmic protein interaction,metastasis promotion,prognostic marker,tumor progression
ENSG00000105398,SULT2A1,tumor suppressor,metabolic regulation,sulfation activity,cell cycle regulation,apoptosis promotion,dna repair interaction
ENSG00000126856,PRDM7,tumor suppressor gene silencing,constitutive activation,chromatin-modifying complexes,transcription factor interactions,cell growth promotion,apoptosis inhibition
ENSG00000152465,NMT2,protein n-myristoylation,signaling pathway modulation,tumor suppressor protein,cellular localization regulation,mitotic regulation,protein-protein interaction
ENSG00000153814,JAZF1,cell proliferation suppression,epigenetic regulation,tumor suppressor function,anti-apoptotic activity,transcriptional modulation,genomic instability prevention
ENSG00000213463,SYNJ2BP,regulation of lipid metabolism,cell membrane dynamics,oncogenic activity,cell proliferation enhancement,signaling pathway modulation,protein-protein interaction
ENSG00000113356,POLR3G,transcriptional regulation,cell proliferation,epigenetic modification,oncogenic activity,therapeutic target,prognostic biomarker
ENSG00000132664,POLR3F,tumor progression,metastasis driver,transcription regulation,cell proliferation,biomarker,oncogene expression
ENSG00000136271,DDX56,oncogene activation,aberrant splicing patterns,enhanced cell proliferation,apoptosis resistance,cell cycle dysregulation,tumor growth promotion
ENSG00000145824,CXCL14,angiogenesis promotion,cancer cell migration,chemokine signaling pathway,immune evasion mechanisms,metastasis facilitation,pro-inflammatory response
ENSG00000172893,DHCR7,loss of function mutations,cholesterol biosynthesis regulation,cell proliferation promotion,angiogenesis modulation,stress response activation,metabolic dysregulation
ENSG00000149485,FADS1,**

cellular growth regulation,lipid metabolism alteration,pro-inflammatory mediator production,reactive oxygen species generation,gene expression dysregulation,signaling pathway interaction

**
ENSG00000171109,MFN1,mitochondrial dynamics regulation,metabolic reprogramming,cellular adaptation,protein-protein interaction,apoptosis modulation,tumorigenesis facilitation
ENSG00000163110,PDLIM5,wnt/β-catenin pathway regulation,oncogenic overexpression,cytoskeletal reorganization,cell migration enhancement,metastasis promotion,therapeutic target
ENSG00000282972,GNG4,gpcr signaling pathway,altered expression,cell proliferation,enhanced survival,heterotrimeric g protein complex,signaling modulation
ENSG00000153922,CHD1,chromatin remodeling,transcriptional regulation,genome stability maintenance,tumor suppressor function,dna repair pathways,cell cycle regulation
ENSG00000136045,PWP1,oncogene activation,cell cycle regulation,tumor growth promotion,transcriptional regulation,emt induction,wnt/β-catenin pathway interaction
ENSG00000197043,ANXA6,tumor progression,cell proliferation,protein-protein interaction,therapeutic target,epithelial-to-mesenchymal transition (emt),cell cycle regulation
ENSG00000126107,HECTD3,protein stability regulation,ubiquitination and degradation,signaling pathway modulation,tumor progression association,poor prognosis indicator,ubiquitin-proteasome pathway interaction
ENSG00000108468,CBX1,oncogene function,epigenetic regulation,tumor progression,cell cycle deregulation,histone modification,protein-protein interaction
ENSG00000141380,SS18,chromatin remodeling,constitutive activation,genomic instability,oncogenic fusion,cell proliferation,aneuploidy
ENSG00000196072,BLOC1S2,bloc-1 complex,cell proliferation,cell migration,pi3k/akt pathway,autophagy regulation,melanosome biogenesis
ENSG00000162244,RPL29,ribosome assembly,protein synthesis regulation,cellular growth promotion,cancer-specific expression,genomic instability induction,tumor progression facilitation
ENSG00000162521,RBBP4,chromatin remodeling,transcription regulation,cell cycle progression,dna repair,oncogene interaction,tumor suppressor modulation
ENSG00000169035,KLK7,cell proliferation,growth factor activation,tumor progression,epithelial-to-mesenchymal transition (emt),angiogenesis,metastasis
ENSG00000165912,PACSIN3,cytoskeletal regulator,tumor suppressor function,actin dynamics modulation,metastasis regulator,apoptosis modulator,signaling pathway regulation
ENSG00000064218,DMRT3,cell cycle regulation,oncogene activation,transcriptional dysregulation,cell growth promotion,apoptosis modulation,autophagy inhibition
ENSG00000106605,BLVRA,cellular transcription,rna stability regulation,tumor growth promotion,metastasis facilitation,cell signaling modulation,apoptosis inhibition
ENSG00000181852,RNF41,aberrant e3 ligase activity,pi3k/akt pathway activation,ubiquitination regulation,cell survival promotion,tumor growth enhancement,cancer susceptibility gene
ENSG00000087245,MMP2,mmp activation,extracellular matrix degradation,angiogenesis promotion,cell migration facilitation,cancer progression association,therapeutic target
ENSG00000099910,KLHL22,ubiquitin ligase regulation,protein degradation pathway,cancer progression driver,tumor suppressor function,protein-protein interaction,genetic instability
ENSG00000172482,AGXT,oncogenic regulation,redox balance disruption,metabolic reprogramming,therapeutic resistance,cellular proliferation,glycolytic shift
ENSG00000107581,EIF3A,enhanced protein synthesis,cellular transformation,cancer driver gene,tumor progression,protein kinase activation,genomic instability
ENSG00000122406,RPL5,ribosome biogenesis,cell cycle regulation,oncogenic mutations,tumor progression,apoptosis evasion,protein synthesis regulation
ENSG00000196616,ADH1B,detoxification pathway,genomic instability,oxidative stress,dysregulated metabolism,cancer progression,rna expression regulation
ENSG00000188428,BLOC1S5,lysosomal dysfunction,tumor progression,proliferation promotion,survival enhancement,cell cycle regulation,metastasis facilitation
ENSG00000118113,MMP8,oncogenic potential,extracellular matrix degradation,tumor progression,metastasis promotion,angiogenesis regulation,poor prognosis marker
ENSG00000173821,RNF213,microtubule stabilization,angiogenic signaling,tumor progression,cellular proliferation,cancer driver,ring finger domain
ENSG00000158864,NDUFS2,mitochondrial electron transport,energy metabolism alteration,genomic instability promoter,cell cycle deregulation,tumor growth facilitator,oxidative stress inducer
ENSG00000166090,IL25,immune modulation,oncogenic role,tumor microenvironment modulation,cell proliferation regulation,anti-tumor immunity suppression,inflammatory cytokine regulation
ENSG00000136931,NR5A1,nr5a1 overexpression,constitutive activation,oncogene regulation,pi3k/akt pathway modulation,tumor microenvironment creation,cell proliferation enhancement
ENSG00000148346,LCN2,**

lcn2 overexpression,inflammation regulation,angiogenesis promotion,tumor progression enhancement,cell migration facilitation,metastasis promotion 

**
ENSG00000181555,SETD2,chromatin remodeling,histone methylation,genomic instability,tumor suppressor,cell cycle regulation,apoptosis modulation
ENSG00000164466,SFXN1,tumor suppressor,mitochondrial function,oxidative stress,genomic instability,cellular senescence,antioxidant activity
ENSG00000078668,VDAC3,mitochondrial regulation,apoptosis resistance,cellular metabolism,tumor progression,energy status modulation,therapeutic target
ENSG00000177542,SLC25A22,**
mitochondrial carrier protein,upregulated expression,tumor progression,warburg effect,metabolic adaptation,poor prognosis marker
**
ENSG00000080293,SCTR,receptor overexpression,g-protein signaling,proliferation and survival pathways,tumor progression,metastasis regulation,cancer prognosis
ENSG00000133773,CCDC59,**

centrosome instability,ciliogenesis regulation,chromosomal instability,cell proliferation enhancement,oncogenic driver mutation,centriole duplication defect 

**
ENSG00000170956,CEACAM3,cell adhesion disruption,tumor invasion facilitation,pi3k/akt pathway activation,poor prognosis marker,cancer cell migration promotion,tumor growth enhancement
ENSG00000068308,OTUD5,tumor progression,oncogenic signaling,cell proliferation regulation,brca1 interaction,p53 degradation,apoptosis inhibition
ENSG00000134245,WNT2B,wnt/β-catenin pathway,aberrant activation,cancer biomarker,cell proliferation enhancement,epithelial-to-mesenchymal transition,oncogenic progression
ENSG00000106789,CORO2A,cell migration,cytoskeletal regulation,metastasis promotion,oncogenic driver,therapeutic target,protein-protein interaction
ENSG00000116329,OPRD1,opioid receptor activation,promotes tumor growth,cellular proliferation modulation,cancer progression facilitation,pharmacological target,signaling pathway interaction
ENSG00000166313,APBB1,cell growth regulation,chromatin remodeling,cell survival enhancement,pi3k/akt pathway modulation,transcriptional regulation,protein-protein interaction
ENSG00000137409,MTCH1,apoptosis regulation,mitochondrial function,tumor progression,therapeutic target,cellular response to stress,oncogenic processes
ENSG00000172638,EFEMP2,angiogenesis promotion,mapk/erk pathway activation,tumor progression,cell adhesion regulation,oncogenic properties,extracellular matrix modulation
ENSG00000144791,LIMD1,cell cycle regulation,genomic instability,tumor suppressor function,protein-protein interactions,dna repair mechanisms,pi3k/akt pathway modulation
ENSG00000111667,USP5,oncogenic protein stabilization,cell survival promotion,tumor metastasis facilitation,therapeutic target,ubiquitin-specific protease activity,cell cycle regulation disruption
ENSG00000075142,SRI,cellular proliferation,glycolytic metabolism,apoptosis regulation,tumor metastasis,protein-protein interaction,enzymatic activity
ENSG00000111652,COPS7A,csn complex,cellular degradation pathways,protein modification regulation,cullin-ring e3 ligases regulation,tumor suppressor p53 modulation,onco-proteomic transformation
ENSG00000116218,NPHS2,cell migration,metastasis promotion,protein-protein interactions,signaling pathway regulation,subcellular localization changes,nephrotic syndrome association
ENSG00000083845,RPS5,ribosomal biogenesis regulation,tumor progression promotion,protein-protein interactions,cellular proliferation modulation,translation initiation complex,biomarker potential
ENSG00000136872,ALDOB,glycolytic enzyme activation,metabolic reprogramming,cell proliferation promotion,tumor aggressiveness enhancement,poor prognosis indicator,oncogene overexpression
ENSG00000109133,TMEM33,er stress resistance,lipid metabolism regulation,cell proliferation enhancement,apoptosis resistance,pik3ca interaction,tumor progression contribution
ENSG00000101057,MYBL2,cell cycle regulation,phosphorylation-dependent regulation,tumor progression,apoptosis suppression,oncogenic potential,tumor suppressor interaction
ENSG00000100029,PES1,genomic instability,constitutive activation,rna degradation,cell proliferation,tumor suppressor downregulation,therapeutic target
ENSG00000102158,MAGT1,oncogene,cell proliferation,magnesium transport,cell membrane interaction,protein-protein interaction,prognostic marker
ENSG00000160305,DIP2A,chromatin remodeling,cell proliferation,apoptosis regulation,transcriptional regulation,cancer stem cell maintenance,prognostic marker
ENSG00000068305,MEF2A,mef2a regulated cell proliferation,transcription factor dysfunction,genomic instability,chromatin remodeling,tumor suppressor function loss,cell cycle checkpoint disruption
ENSG00000076382,SPAG5,centrosome separation regulation,cell proliferation promotion,chromosomal instability induction,oncogenic transformation facilitation,p53 interaction and modulation,high expression correlation with poor prognosis
ENSG00000101146,RAE1,apoptosis regulation,cell proliferation,mitochondrial function,tumor progression,biomarker identification,protein-protein interaction
ENSG00000124713,GNMT,methylation regulation,tumor suppressor activity,cell growth modulation,dna methyltransferase interaction,akt/mapk pathway modulation,epigenetic regulation
ENSG00000147669,POLR2K,transcription elongation,overexpression,cell proliferation,promotes tumorigenesis,dna repair interactions,tumor growth and metastasis
ENSG00000124688,MAD2L1BP,cell cycle regulation,genomic stability,tumor suppression,chromosomal maintenance,spindle checkpoint,cell proliferation
ENSG00000071539,TRIP13,chromatin dynamics,genomic instability,telomere maintenance,mitotic chromosome segregation,apoptosis resistance,cell proliferation enhancement
ENSG00000120875,DUSP4,erk/mapk pathway inhibition,constitutive activation,tumor progression promotion,oncogenic signaling modulation,cell survival enhancement,mapk kinase activation
ENSG00000002822,MAD1L1,mitotic checkpoint regulation,gene amplification,chromosome instability,cell cycle progression,cancer predisposition,spindle assembly checkpoint
ENSG00000111726,CMAS,apoptosis regulation,cell proliferation enhancement,egfr interaction,mutational activation,p53 modulation,tumor progression facilitation
ENSG00000166432,ZMAT1,tumor suppressor function,transcriptional regulation,cell cycle regulation,apoptosis modulation,dna repair mechanisms,genome instability
ENSG00000171497,PPID,prohormone processing,dysregulated signaling pathways,cellular proliferation,proteolytic activity,tumor invasion,regulation of hormone maturation
ENSG00000139874,SSTR1,downregulation,g-protein coupled receptor,cell proliferation inhibition,tumor suppression,apoptosis induction,angiogenesis regulation
ENSG00000197535,MYO5A,cell migration,dysregulation,cellular motility,protein interaction,signaling pathway regulation,therapeutic target
ENSG00000196642,RABL6,cellular proliferation enhancement,tumor progression facilitation,microtubule cytoskeleton regulation,oncogenic behavior promotion,prognosis correlation with overexpression,cytoskeletal remodeling via dynein motor proteins
ENSG00000188603,CLN3,autophagy,cellular homeostasis,loss-of-function mutations,mitochondrial dysfunction,oncogenic transformation,proliferation and survival enhancement
ENSG00000134824,FADS2,omega-3/6 pufa synthesis pathway,altered expression levels,cell proliferation enhancement,fatty acid metabolism dysregulation,eicosanoid production modulation,lipid biosynthesis target
ENSG00000184160,ADRA2C,alpha-2 adrenergic receptor activation,cell proliferation,constitutive activation,g protein-coupled receptor signaling,oncogenic function,resistance to therapy
ENSG00000134046,MBD2,epigenetic regulation,tumor suppressor silencing,constitutive overexpression,chromatin remodeling,transcriptional repression,dna methylation
ENSG00000145220,LYAR,chromatin remodeling,gene expression regulation,aberrent epigenetic modifications,cell cycle dysregulation,apoptosis suppression,tumor suppressor gene repression
ENSG00000171861,MRM3,genomic instability,dysregulated expression,cellular proliferation,mitochondrial dysfunction,dna repair pathway disruption,poor prognosis
ENSG00000113851,CRBN,aberrant ubiquitination,activates wnt/β-catenin signaling,cell cycle progression,crbn-cul4a complex regulation,critical regulator of genomic stability,dna repair and replication interaction
ENSG00000077514,POLD3,genomic instability,oncogenic driver,genetic mutations,dna replication,cell proliferation,therapeutic target
ENSG00000125967,NECAB3,pkc activation,pro-survival signaling,cell proliferation,tumor progression,biomarker potential,calcium-binding protein function
ENSG00000137674,MMP20,mmp degradation,extracellular matrix remodeling,cell migration,tumor progression,proteolytic cascade,cancer aggressiveness
ENSG00000152591,DSPP,overexpression,cell proliferation,tumor progression,metastasis promotion,epithelial-to-mesenchymal transition regulation,growth factor activation
ENSG00000135077,HAVCR2,tumor immune evasion,immune suppression,t-cell dysfunction,ligand binding,galectin-9 interaction,cancer progression
ENSG00000111181,SLC6A12,glutamine uptake,tumor progression,anabolic processes,mtor activation,cancer cell metabolism,cellular signaling pathways
ENSG00000138663,COPS4,protein degradation regulation,cell cycle control,ubiquitination pathway,tumor suppression,poor prognosis marker,cancer cell proliferation
ENSG00000274286,ADRA2B,constitutive activation,gain of function mutations,g protein-coupled receptor pathway,cellular proliferation,transcriptional regulation,vasoconstriction/vasodilation
ENSG00000131931,THAP1,cell cycle regulation,dna repair modulation,chromatin remodeling,pro-survival signaling,apoptosis resistance,histone modification
ENSG00000162627,SNX7,endosomal sorting,tumor suppression,cell surface receptor regulation,protein degradation,cancer prognosis,signaling pathway modulation
ENSG00000159337,PLA2G4D,pla2 activity,tumor microenvironment modulation,lipid signaling regulation,pro-inflammatory mediator production,angiogenesis promotion,cancer cell proliferation enhancement
ENSG00000105497,ZNF175,cell proliferation suppression,transcriptional repression,krab domain-containing zinc finger protein family,tumor progression association,apoptosis regulation,hdac3 co-repressor interaction
ENSG00000165271,NOL6,cellular growth regulation,genomic instability,mrna stability regulation,tumor suppressor interaction,cell survival enhancement,apoptosis resistance
ENSG00000163875,MEAF6,histone modification,tumor progression,oncogene activation,epigenetic regulation,gene silencing,chromatin remodeling
ENSG00000165702,GFI1B,oncogene activity,tumor progression,cellular proliferation,mutation hotspot,transcriptional regulation,epigenetic modification
ENSG00000143933,CALM2,calcium binding,oncogenic activity,cell proliferation,signaling pathway regulation,tumor growth enhancement,metastatic promotion
ENSG00000130203,APOE,altered expression,biomarker potential,cell proliferation regulation,fatty acid metabolism,immune response modulation,lipid metabolism
ENSG00000099889,ARVCF,enhanced cell migration,overexpression,epithelial-to-mesenchymal transition,tumor progression,cell adhesion disruption,poor prognosis indicator
ENSG00000100206,DMC1,homologous recombination,genomic instability,chromosomal abnormalities,dna repair pathways,therapeutic target,oncogenic driver
ENSG00000124702,KLHDC3,tumor suppression,cell proliferation regulation,e3 ubiquitin ligase activity,apoptosis resistance,genomic instability prevention,poor prognosis association
ENSG00000205420,KRT6A,enhanced cell proliferation,epithelial-to-mesenchymal transition,alterations in keratin expression,cytoplasmic intermediate filaments,oncogenic processes,genetic alterations
ENSG00000077348,EXOSC5,tumor progression,cell migration,overexpression,therapeutic target,signaling pathway regulation,mirna regulation
ENSG00000124256,ZBP1,nf-κb signaling,zinc finger domain,apoptosis inhibition,oncogenic function,tumor progression,immune evasion
ENSG00000276336,SCARF1,pi3k/akt pathway regulation,loss-of-function mutations,tumor suppression,apoptosis promotion,cell cycle arrest,epigenetic silencing
ENSG00000122873,CISD1,mitochondrial dysfunction,oncosuppressor function,cell proliferation,chemoresistance,oxidative stress response,cellular metabolism disruption
ENSG00000184056,VPS33B,endocytic trafficking,autophagy regulation,corvet complex dysfunction,tumor suppressor modulation,cell proliferation enhancement,lysosome degradation impairment
ENSG00000198876,DCAF12,ubiquitination regulation,cell cycle progression,genomic instability,apoptosis resistance,tumor suppressor degradation,epigenetic regulation
ENSG00000108515,ENO3,metabolic reprogramming,enhanced glycolysis,tumor growth promotion,cell survival signaling,protein-protein interactions,cancer cell metabolism
ENSG00000160752,FDPS,aberrant enzyme activity,cell proliferation enhancement,cholesterol synthesis regulation,isoprenoid biosynthesis,metabolic pathway dysregulation,tumor progression promotion
ENSG00000164649,CDCA7L,aberrant cell cycle regulation,chromatin remodeling dysfunction,genomic instability induction,mitotic progression facilitation,tumor growth promotion,dna replication error enhancement
ENSG00000130589,HELZ2,chromatin remodeling,transcriptional regulation,cell cycle progression,oncogenesis driver,apoptosis inhibition,dna damage response
ENSG00000147223,RIPPLY1,epigenetic silencing,gene repression,methylation regulated,tumor suppressor gene repression,chromatin remodeling,transcriptional control
ENSG00000130429,ARPC1B,actin cytoskeleton remodeling,microtubule dynamics modulation,cellular migration promotion,metastasis facilitation,tumor progression enhancement,cancer cell invasion support
ENSG00000132300,PTCD3,phosphorylation regulation,constitutive activation,oncogenic transformation,tumor progression,cell survival evasion,protein tyrosine kinase activity
ENSG00000171148,TADA3,histone acetyltransferase function,transcriptional regulation,oncogenic potential,cell proliferation,survival pathway,genomic instability
ENSG00000086589,RBM22,cell cycle regulation,apoptosis suppression,oncogene function,rna-binding protein interaction,post-transcriptional regulation,tumor growth promotion
ENSG00000076685,NT5C2,tumor growth,purinergic signaling,oncogenesis,cell proliferation,genomic instability,prognostic biomarker
ENSG00000023228,NDUFS1,mitochondrial function,cell survival,electron transport chain,complex i dysfunction,oncogenesis,tumor metabolism
ENSG00000152944,MED21,transcription regulation,deregulated gene expression,mediator complex assembly,oncogenic processes,cell proliferation,tumor progression
ENSG00000214827,MTCP1,epigenetic regulation,histone modification,cell growth modulation,apoptosis regulation,chromatin remodeling,tumor suppression
ENSG00000131023,LATS1,hippo signaling pathway,tumor suppressor function,genome instability,apoptosis regulation,cell proliferation inhibition,loss of heterozygosity
ENSG00000133063,CHIT1,cellular remodeling,metastasis,prognostic marker,tumor microenvironment interaction,invasive potential,immune response modulation
ENSG00000105641,SLC5A5,glycolytic regulation,glucose metabolism,oncogenic potential,angiogenesis promotion,immune evasion,metabolic reprogramming
ENSG00000076662,ICAM3,cell adhesion regulation,overexpression,tumor progression,immune evasion mechanisms,therapeutic target,epithelial-to-mesenchymal transition
ENSG00000110321,EIF4G2,cellular translation regulation,tumor progression,mrna recruitment,protein synthesis regulation,translational control,growth factor signaling
ENSG00000104442,ARMC1,chromatin remodeling,dna damage response,genomic instability,transcription regulation,treatment resistance,genome integrity maintenance
ENSG00000262788,UTP4,ribosomal rna modification,rna processing dysregulation,cell growth promotion,aberrant cell proliferation,tumor progression involvement,metabolic reprogramming
ENSG00000117362,APH1A,notch signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,gamma-secretase complex
ENSG00000189171,S100A13,calcium-mediated signaling,tumor progression,cell proliferation regulation,metastasis facilitation,oncogenic process,protein-protein interaction
ENSG00000178996,SNX18,oncogenic function,endosomal trafficking regulation,protein-protein interaction,cell proliferation enhancement,molecular mechanism elucidation,therapeutic target potential
ENSG00000175110,MRPS22,mitochondrial function,cellular energy metabolism,regulation of oxidative phosphorylation,gene expression regulation,autophagy regulation,cancer cell survival
ENSG00000120075,HOXB5,homeobox transcription factor,gene overexpression,epithelial-to-mesenchymal transition (emt),cell proliferation,cell invasion,myc pathway cooperation
ENSG00000111271,ACAD10,lipid biosynthesis,fatty acid metabolism,cell proliferation,tumor progression,poor prognosis,glycolysis inhibition
ENSG00000115041,KCNIP3,potassium channel regulation,cellular excitability modulation,tumor suppressor function,genome stability maintenance,cell cycle regulation,apoptosis regulation
ENSG00000129450,SIGLEC9,tumor progression,biomarker candidate,immune modulation,transmembrane protein,sialic acid binding,poor prognosis marker
ENSG00000090615,GOLGA3,protein trafficking regulation,emt induction,cell proliferation enhancement,tumor progression association,therapeutic target potential,signaling pathway interaction
ENSG00000136811,ODF2,microtubule regulation,cilia maintenance,cell cycle regulation,genomic stability,apoptosis modulation,mitotic spindle formation
ENSG00000104738,MCM4,cell proliferation,dna replication,genomic instability,oncogenic driver,cell cycle progression,therapeutic target
ENSG00000065357,DGKA,cellular signaling modulation,gene expression regulation,cancer driver interaction,tumor progression promoter,protein kinase activation modifier,phospholipase c activity regulator
ENSG00000001497,LAS1L,ribosome biogenesis,pseudouridylate synthase activity,cellular proliferation,cancer-associated mutations,protein synthesis regulation,nucleic acid modification
ENSG00000110075,PPP6R3,cell cycle regulation,phosphatase regulation,protein phosphatase 2a (pp2a) modulation,tumor suppressor protein regulation,oncogenic processes,cell growth and survival
ENSG00000110367,DDX6,ddx6 upregulation,tumor progression,rna-binding protein,cellular proliferation,apoptosis regulation,microrna interaction
ENSG00000085224,ATRX,telomere maintenance,chromatin remodeling,tumor suppressor function,dna repair mechanism,genomic instability promotion,cancer initiation
ENSG00000187908,DMBT1,cellular defense mechanisms,immune response modulation,tumor progression,apoptosis regulation,proliferation enhancement,metastasis facilitation
ENSG00000041357,PSMA4,apoptosis modulation,cell cycle progression,cancer development,proteasomal degradation,tumor progression,transcriptional regulation
ENSG00000187239,FNBP1,cell cycle regulation,dna replication,genomic instability,tumor aggressiveness,therapeutic target,proliferation enhancement
ENSG00000169474,SPRR1A,suppression of cell adhesion,epithelial-to-mesenchymal transition,tumor progression,loss of expression,metastatic behavior,cellular proliferation regulation
ENSG00000198721,ECI2,chromatin remodeling,histone modification,transcriptional regulation,apoptosis inhibition,cell cycle progression,protein-protein interaction
ENSG00000183918,SH2D1A,immune evasion strategies,tumor-associated immune responses,adapter protein function,phosphatase interactions,kinase regulation,apoptosis modulation
ENSG00000169446,MMGT1,transcription factor regulation,cell growth promotion,tumorigenesis association,dna replication modulation,apoptosis inhibition,oncogene overexpression
ENSG00000164096,C4orf3,pi3k/akt pathway activation,genomic instability,tumor progression,rna binding protein interaction,cell proliferation modulation,mitochondrial regulation
ENSG00000184113,CLDN5,tight junction disruption,epithelial-to-mesenchymal transition,metastatic potential increase,growth regulation alteration,cell polarity loss,signaling pathway modulation
ENSG00000177519,RPRM,genomic instability,protein-protein interaction,dna synthesis,tumor progression,epithelial-to-mesenchymal transition,cell proliferation
ENSG00000163069,SGCB,cell adhesion disruption,tumor progression driver,epithelial integrity maintenance,protein interaction regulation,signal transduction pathway modulation,muscle and epithelial junction maintenance
ENSG00000079134,THOC1,mrna export regulation,oncogene activation,cell proliferation promotion,tumor progression facilitation,prognostic marker identification,genomic instability promotion
ENSG00000161526,SAP30BP,chromatin regulation,tumor suppressor function,histone modification complex,gene expression alteration,dna methylation,cell cycle regulation
ENSG00000120694,HSPH1,tumor growth,immunosuppression,protein stabilization,therapeutic resistance,cell survival enhancement,cancer prognosis
ENSG00000114062,UBE3A,cellular homeostasis regulation,protein degradation pathway,tumor suppressor modulation,oncogene regulation,cell cycle progression,genomic stability maintenance
ENSG00000165821,SALL2,cellular proliferation enhancement,oncogenic potential,transcription factor activity,tumor-initiating cell formation,signaling pathway modulation,poor prognosis biomarker
ENSG00000177875,CCDC184,microtubule regulation,mitotic spindle disruption,genomic instability,cell cycle dysregulation,tumor growth promotion,chromosome missegregation
ENSG00000111142,METAP2,mrna methylation,tumor progression,oncogene regulation,translation efficiency,prognostic biomarker,epigenetic modifier
ENSG00000139631,CSAD,altered expression,cancer progression,cell proliferation,metastasis regulation,oncogenic process,pi3k/akt pathway modulation
ENSG00000167900,TK1,cellular proliferation,dna synthesis,oncogene,enzyme activation,cell cycle regulation,metabolic adaptation
ENSG00000165370,GPR101,pi3k/akt signaling pathway interaction,constitutive activation,oncogenic driver,cell survival regulation,tumor growth promotion,apoptosis resistance
ENSG00000164294,GPX8,antioxidant function,anti-apoptotic properties,angiogenesis promotion,oncogenic consequences,cellular proliferation,tumor progression
ENSG00000164815,ORC5,...<end>:

<begin>
cell cycle regulation,origin recognition complex,genomic instability,cellular proliferation,dna replication,apoptosis resistance
ENSG00000093009,CDC45,genomic instability,dna replication machinery,cell proliferation enhancement,protein-protein interaction disruption,adaptor function,cell cycle regulation
ENSG00000115392,FANCL,genomic instability,dna repair,oncogenic mutations,tumor progression,brca2 interaction,ubiquitination pathway
ENSG00000182591,KRTAP11-1,tumor progression,molecular interaction,cell migration,protein regulation,gene overexpression,tissue remodeling
ENSG00000181896,ZNF101,tumor suppressor function,gene expression regulation,cell growth inhibition,apoptosis promotion,cell cycle regulation interaction,genome stability maintenance
ENSG00000186908,ZDHHC17,egfr pathway activation,palmitoylation activity,ubiquitination regulation,cell survival enhancement,protein stabilization,oncogenic signaling facilitation
ENSG00000132639,SNAP25,oncogenic protein,cellular proliferation,exocytosis regulation,vesicular trafficking,signaling pathway interaction,prognostic biomarker
ENSG00000104343,UBE2W,dna repair disruption,g1/s transition dysregulation,oncogenic mutations,tumor progression,cell cycle regulation,ubiquitination pathway activation
ENSG00000176641,RNF152,cell cycle regulation,apoptosis induction,dna repair mechanisms,protein ubiquitination,tumor suppressor stabilization,oncogenic mutation
ENSG00000095637,SORBS1,overexpression,epithelial-to-mesenchymal transition,wnt/β-catenin signaling pathway,cell adhesion regulation,microtubule dynamics modulation,tumor progression marker
ENSG00000073921,PICALM,clathrin-mediated endocytosis,disrupted cell growth regulation,oncogenic processes,tumorigenesis,cell signaling disruption,lipid-protein interactions
ENSG00000127922,SEM1,cell cycle regulation,oncogenic activation,proliferation enhancement,tumorigenesis promotion,dna replication modulation,genetic instability induction
ENSG00000101132,PFDN4,regulatory function,cellular processes modulation,protein degradation regulation,vesicular transport,oncogene interactions,tumor suppressor interaction
ENSG00000155959,VBP1,oncogene,transcription factor activity,cell proliferation enhancement,apoptosis inhibition,tumor suppressor downregulation,cancer stem cell maintenance
ENSG00000102804,TSC22D1,apoptosis inhibition,genomic stability modulation,cell proliferation regulation,tumor suppressor function,epigenetic regulation involvement,stress response interaction
ENSG00000134376,CRB1,epithelial junction regulation,cell adhesion disruption,tumor progression modulation,poor prognosis association,metastasis enhancement,signaling pathway interaction
ENSG00000133943,DGLUCY,glycosaminoglycans regulation,cell proliferation enhancement,tumor growth promotion,oncogene interaction,signal transduction modulation,cancer cell metastasis
ENSG00000198835,GJC2,cellular communication disruption,oncogenesis promotion,tumor progression facilitation,therapeutic target potential,cellular processes regulation,intercellular communication role
ENSG00000178623,GPR35,g protein-coupled receptor activation,tumor progression,oncogenic signaling pathways,cell proliferation regulation,overexpression in esca tumors,prognostic biomarker candidate
ENSG00000124074,ENKD1,autophagy regulation,lysosomal dysfunction,oncogenic potential,cellular stress response,pro-survival signaling,cancer progression
ENSG00000139579,NABP2,altered pre-mrna processing,disrupted splice variant profiles,therapeutic target,cell proliferation regulation,apoptosis modulation,oncogenic processes
ENSG00000171867,PRNP,cellular proliferation,oncogenic signaling,prion protein expression,apoptosis regulation,autophagy modulation,cross-talk with cancer pathways
ENSG00000181392,SYNE4,cell migration,actin cytoskeleton modulation,cytoplasmic structure regulation,oncogene role,protein-protein interaction,tumor progression
ENSG00000182685,BRICD5,cell proliferation,constitutive activation,gain of function mutations,oncogene,overexpression,protein-protein interaction
ENSG00000139116,KIF21A,genomic instability,tumor progression,cell proliferation,protein-protein interactions,mitotic spindle formation,oncogenic processes
ENSG00000163072,NOSTRIN,cell migration regulation,aberrant expression,oncogene activation,pi3k/akt pathway activation,tumor progression facilitation,metastasis promotion
ENSG00000107223,EDF1,mitochondrial chaperone,cellular stress response,regulation of mitochondrial dynamics,maintenance of mitochondrial homeostasis,energy production regulation,oxidative damage prevention
ENSG00000116833,NR5A2,oncogenic transcription factor,constitutive activation of pi3k/akt signaling,cell cycle progression,apoptosis regulation,metabolic regulation,steroid hormone receptor interaction
ENSG00000214253,FIS1,mitochondrial dynamics,fission regulation,oncogenic role,metabolic reprogramming,cell survival enhancement,tumor progression driver
ENSG00000100335,MIEF1,mitochondrial regulation,dysregulation of apoptosis,apoptosis resistance,potential therapeutic target,tumor progression,cellular sensitivity to death signals
ENSG00000166689,PLEKHA7,pi3k/akt pathway activation,cell-cell adhesion disruption,epithelial-to-mesenchymal transition induction,transcription factor regulation,tumor aggressiveness promotion,poor prognosis marker
,LARS,trna modification,aminoacylation accuracy,cell proliferation,protein synthesis regulation,cancer initiation,genetic instability
ENSG00000145888,GLRA1,nmda receptor dysfunction,altered expression,cellular proliferation,signal transduction,protein kinase activation,genomic instability
ENSG00000197587,DMBX1,transcriptional regulation,cell proliferation,chromatin remodeling,tumor progression,p53 inhibition,gene expression reprogramming
ENSG00000100522,GNPNAT1,cell signaling,oncogenesis,guanine nucleotide-binding protein activity,metabolic regulation,cell survival,tumor progression
ENSG00000110047,EHD1,microtubule dynamics,endocytosis,epithelial integrity,cell cycle progression,vesicle trafficking,tumor suppressor function
ENSG00000131381,RBSN,ribosome biogenesis,oncogenic mrna translation,tumor aggressiveness,cell cycle progression,apoptosis inhibition,growth factor regulation
ENSG00000147155,EBP,cellular growth,constitutive activation,translation elongation factor,cell proliferation driver,apoptosis inhibition,protein synthesis regulator
ENSG00000136052,SLC41A2,cellular magnesium homeostasis,epithelial cell expression,energy metabolism regulation,oncogenic processes,tumor cell survival,metabolic regulation
,SEPT12,cell cycle regulation,cytokinesis,dysregulation of microtubule stability,increased cell division rates,oncogenic signaling pathway involvement,tumor progression resistance
ENSG00000082556,OPRK1,oncogene activation,g protein-coupled receptor function,cell proliferation promotion,tumor metastasis,pi3k/akt/mtor pathway modulation,immune evasion
ENSG00000171033,PKIA,tumor suppressor,pp2a regulation,protein-protein interactions,signal transduction,oncogenic pathways,cellular proliferation
ENSG00000158716,DUSP23,map kinase regulation,tumor suppressor function,constitutive activation,cell proliferation inhibition,cancer progression association,poor prognosis indicator
ENSG00000196290,NIF3L1,nf-κb regulation,tumor progression,oncogene activation,cell proliferation,protein-protein interaction,pi3k/akt pathway modulation
ENSG00000117475,BLZF1,cell proliferation,transcriptional regulation,tumor progression,apoptosis regulation,inflammatory response modulation,nf-κb interaction
ENSG00000075624,ACTB,cell migration,oncogene overexpression,hypoxia response,met transition,pi3k/akt signaling,cytoskeletal organization
ENSG00000130545,CRB3,tumor suppression,promotes emt,cell adhesion regulation,epithelial polarity maintenance,apoptosis resistance,pi3k/akt pathway inhibition
ENSG00000120942,UBIAD1,mitochondrial function,oxidative stress,energy metabolism,redox balance disruption,gene expression regulation,mitochondrial dysfunction
ENSG00000163535,SGO2,cell cycle regulation,constitutive activation,genetic mutations,microtubule dynamics,oncogene interaction,dna damage response
ENSG00000177694,NAALADL2,naag degradation,cell proliferation,tumor growth,pi3k/akt pathway interaction,oncogenic process promotion,cancer progression
ENSG00000164082,GRM2,erk/pi3k pathway regulation,cellular proliferation enhancement,metastasis promotion,tumor growth facilitation,prognosis correlation,oncogene interaction
ENSG00000145414,NAF1,dna repair,chromatin remodeling,tumor growth,cell proliferation,genomic instability,oncogenic interaction
ENSG00000244362,KRTAP19-7,keratin filament regulation,protein complex formation,tumor progression,chemotherapy resistance,cell adhesion disruption,epithelial cell polarity loss
ENSG00000181929,PRKAG1,metabolic reprogramming,tumor growth promotion,ampk signaling pathway regulation,oncogenic behavior,gain of function mutations,energy homeostasis disruption
ENSG00000167107,ACSF2,calcium-binding protein regulation,cancer progression facilitation,cell migration promotion,cytoplasmic localization,membrane trafficking modulation,pro-survival signaling pathway activation
ENSG00000088682,COQ9,mitochondrial energy metabolism,electron transfer reactions,ros production,oncogenic process,tumorigenesis,aggressive behavior
ENSG00000007944,MYLIP,actin cytoskeleton regulation,cell migration promotion,rho/rock pathway deregulation,tumor suppressor function,myosin ii regulatory light chain interaction,cell invasion enhancement
ENSG00000103043,VAC14,autophagy dysregulation,lipid metabolism disruption,biomarker potential,oncogenic function,cell proliferation enhancement,prognostic significance
ENSG00000159202,UBE2Z,cell cycle regulation,oncogene,ubiquitination,protein degradation,dna repair,apoptosis regulator
ENSG00000145358,DDIT4L,loss of function mutations,mtorc1 activation,tumor suppressor,negative regulator,cellular metabolism regulation,anabolic processes enhancement
ENSG00000204873,KRTAP9-3,intermediate filament formation,epithelial tissue expression,cell proliferation regulation,cytoskeletal organization,cellular differentiation regulation,tumor suppressive role
ENSG00000254997,KRTAP5-9,keratin-associated protein 5 family,overexpression,epithelial integrity modulation,cellular responses regulation,tumor progression promotion,metastasis facilitation
ENSG00000158552,ZFAND2B,dna repair dysregulation,epithelial-to-mesenchymal transition,histone modification,oncogene function,cell migration promotion,prognostic marker
ENSG00000135636,DYSF,oncogenic signaling,aberrant protein function,growth regulation,cancer progression,mutation-driven oncogenesis,tumor microenvironment interaction
ENSG00000161547,SRSF2,alternative splicing,genetic mutations,oncogenic signaling,cell proliferation,genome instability,post-transcriptional regulation
ENSG00000185811,IKZF1,chromatin remodeling,cell cycle regulation,gene expression dysregulation,transcriptional repression,genomic instability,tumor suppressor
ENSG00000143156,NME7,genomic instability,dna repair mechanisms,prognostic marker,nucleus localization,phosphorylation activity,tumor promotion
ENSG00000278570,NR2E3,dna replication regulation,tumor suppressor activity loss,oncogenic transcription factor,cell cycle progression regulation,apoptosis evasion,genomic instability promotion
ENSG00000187175,KRTAP12-1,epithelial cell integrity,tumor progression,metastasis promoter,cell migration regulation,signaling pathway modulation,biomarker expression
ENSG00000105991,HOXA1,hox gene regulation,oncogenic transcription factor,epithelial-to-mesenchymal transition (emt),constitutive activation,chemoresistance,pi3k/akt signaling
ENSG00000126804,ZBTB1,overexpression,oncogene function,transcriptional regulation,cell proliferation,tumor suppressor suppression,microrna regulation
ENSG00000183434,TFDP3,transcription regulation,cell cycle regulation,oncogene regulation,poor prognosis,advanced disease stage,aberrant cell proliferation
ENSG00000148175,STOM,mitochondrial dynamics regulation,gene loss/mutation,tumor suppressor function,cell proliferation enhancement,apoptosis resistance,prognostic marker potential
ENSG00000100243,CYB5R3,metabolic reprogramming,glucose metabolism,gene expression regulation,cytochrome b5 reductase function,tumor growth promotion,cell proliferation enhancement
ENSG00000165495,PKNOX2,transcriptional regulation,oncogenic signaling pathway activation,chromatin remodeling,histone modification,cell proliferation promotion,tumor aggressiveness enhancement
ENSG00000143079,CTTNBP2NL,chromatin remodeling,transcription regulation,tumor suppressor repression,oncogenic process promotion,dna damage repair modulation,cell adhesion alteration
ENSG00000213281,NRAS,constitutive activation,gtpase activity,cell cycle progression,oncogenesis,tumor progression,therapeutic target
ENSG00000155833,CYLC2,metabolic reprogramming,cellular proliferation,fatty acid metabolism,lipid biosynthesis,apoptosis resistance,tumor progression
ENSG00000125409,TEKT3,receptor tyrosine kinase activity,cell proliferation,mitogenic signaling,promoter methylation,tumor growth factor interaction,prognostic marker
ENSG00000186930,KRTAP6-2,disrupted epithelial barrier function,aberrant protein expression,loss of keratin filament integrity,cell growth promotion,oncogene potential,pi3k/akt pathway interaction
ENSG00000092203,TOX4,regulatory element modulation,transcription factor activity,cell proliferation promotion,tumor suppressor gene suppression,oncogenic process facilitation,apoptosis inhibition
ENSG00000115507,OTX1,transcriptional regulation,cell proliferation enhancement,oncogenic overexpression,cell cycle progression,apoptosis inhibition,dna repair modulation
ENSG00000198089,SFI1,genomic instability,dna repair mechanism,homologous recombination,double-strand breaks resolution,cell cycle regulation,chromosomal maintenance
ENSG00000147400,CETN2,cell cycle regulation,mitosis regulation,microtubule dynamics,calcium-binding protein,oncogenesis association,tumorigenesis link
,HIST2H3A,histone regulation,epigenetic control,cell cycle progression,transcriptional modification,tumor growth promotion,cancer biomarker
,HIST2H3C,histone modification,chromatin regulation,cell growth regulation,dna packaging,oncogenic process,genetic regulation
,HIST2H3D,histone variant,chromatin structure,gene regulation,epigenetic changes,cell proliferation,tumorigenesis
ENSG00000105223,PLD3,regulation of pi3k/akt pathway,phospholipase d activity,cell growth and survival signaling,protein kinase activation,epithelial-to-mesenchymal transition,stem cell maintenance
ENSG00000143786,CNIH3,nf-κb pathway regulation,tumor suppressor function,cell proliferation inhibition,protein interaction modulation,oncogene inhibition,cancer metabolism regulation
ENSG00000148690,FRA10AC1,genomic instability,double-strand break repair,homologous recombination,genome maintenance,protein-protein interaction,cellular response modulation
ENSG00000149929,HIRIP3,transcriptional co-regulator,cell cycle progression,dna repair regulation,tumor progression,oncogene overexpression,apoptosis suppression
ENSG00000168701,TMEM208,er stress response,cell proliferation,tumor progression,cancer stem cells,apoptosis suppression,cell migration regulation
ENSG00000262045,KRT34,epithelial-to-mesenchymal transition,oncogenic protein expression,tumor progression,therapeutic target,cellular morphology disruption,signaling pathway modulation
ENSG00000123685,BATF3,immune regulation,tumor suppressor function,transcription factor activity,anti-tumor immunity promotion,dendritic cell development regulation,chromatin remodeling involvement
ENSG00000204571,KRTAP5-11,cell adhesion,constitutive activation,genomic alterations,keratin-associated protein function,signaling pathway regulation,tumor progression
ENSG00000117016,RIMS3,pi3k/akt signaling,overexpression,epithelial-to-mesenchymal transition,ras-grf family member,neurotransmitter release regulation,cell signaling modulation
ENSG00000100151,PICK1,oncogenic processes,protein-protein interactions,cellular growth regulation,therapeutic target,biomarker potential,signaling pathway modulation
ENSG00000171729,TMEM51,apoptosis modulation,cell migration regulation,cytokeletal reorganization,interaction with p53,migration and invasion enhancement,tumor aggressiveness promotion
ENSG00000108010,GLRX3,apoptosis suppression,cell cycle regulation,oncogene function,protein reduction activity,nuclear localization,tumor progression marker
ENSG00000129355,CDKN2D,cdk4/6 inhibition,cell cycle regulation,tumor suppressor function,loss of function mutations,aberrant cell growth,cell proliferation regulatory pathways
ENSG00000196388,INCA1,p53 stability regulation,genomic instability,dna damage response impairment,tumor progression driver,cell cycle modulation,therapeutic target
ENSG00000153823,PID1,oncogenic driver,tumor progression marker,cell proliferation regulation,protein degradation dysfunction,ubiquitin-proteasome pathway disruption,poor prognosis indicator
ENSG00000128185,DGCR6L,microrna biogenesis,drosha-dependent processing,oncogene regulation,tumor suppressor modulation,cell proliferation enhancement,genomic instability
,HIST1H2BH,histone protein regulation,chromatin remodeling,epigenetic regulation,genomic stability maintenance,cell cycle control,apoptosis modulation
ENSG00000168646,AXIN2,wnt/β-catenin signaling pathway,tumor suppressor function,phosphorylation regulation,cell proliferation inhibition,transcriptional repression,genomic instability
ENSG00000085382,HACE1,epigenetic silencing,tumor suppressor,oncogenic pathway regulation,cell proliferation inhibition,apoptosis induction,immune modulation
ENSG00000149295,DRD2,cell proliferation,oncogenic transformation,signaling pathway regulation,protein interaction,cellular migration,apoptosis resistance
ENSG00000123473,STIL,mitotic regulation,genomic instability,oncogene function,tumor progression,cytokinesis regulation,mitotic spindle formation
ENSG00000104412,EMC2,mitochondrial biogenesis,apoptosis regulation,cell growth promotion,energy metabolism regulation,tumorigenesis driver,genomic instability
ENSG00000135052,GOLM1,cellular regulation,pi3k/akt pathway modulation,tumor progression promotion,poor prognosis association,autophagy involvement,multi-functional protein
ENSG00000143801,PSEN2,notch signaling suppression,gain of function mutations,tumor progression,cell proliferation regulation,cancer pathogenesis,potential therapeutic target
ENSG00000164896,FASTK,tumor growth promotion,cellular interaction modulation,epithelial-to-mesenchymal transition regulation,pi3k/akt pathway activation,apoptosis inhibition,transcription regulation enhancement
ENSG00000181915,ADO,pi3k/akt signaling,adenosine metabolism,oncogene downregulation,tumor progression,poor prognosis,biomarker potential
ENSG00000104763,ASAH1,ceramide regulation,tumor suppressor function,cell survival modulation,lipid metabolism regulation,cancer progression enhancement,epithelial-to-mesenchymal transition (emt) modulation
ENSG00000280516,TMEM42,cell cycle regulation,apoptosis resistance,pi3k/akt pathway interaction,tumor proliferation,transmembrane protein function,oncogenic mutation
ENSG00000126950,TMEM35A,ion channel regulation,cell membrane integrity,calcium influx regulation,cell proliferation modulation,survival pathway regulation,transmembrane protein function
ENSG00000197976,AKAP17A,overexpression,oncogenic pathway activation,cell proliferation enhancement,tumor progression driver,poor prognosis indicator,protein-protein interaction mediator
ENSG00000123154,WDR83,cell cycle regulation,protein degradation pathway,cancer proliferation,ubiquitin-protein conjugate recognition,tumor growth promotion,potential therapeutic target
ENSG00000276644,DACH1,tumor suppression,epithelial-to-mesenchymal transition (emt),cell proliferation inhibition,akt/pi3k pathway regulation,transcription factor activity,cancer cell invasion prevention
ENSG00000090905,TNRC6A,microrna-guided regulation,piwi-pirna pathway,genomic integrity maintenance,oncogene modulation,tumor suppressor gene regulation,cellular proliferation enhancement
ENSG00000228964,HLA-B,tumor immunosurveillance,antigen presentation,immune modulation,nf-κb pathway interaction,cancer antigen presentation,hla class i expression
ENSG00000102024,PLS3,pi3k/akt pathway inhibition,cell cycle regulation,dna repair deficiency,apoptosis suppression,oncogenic processes,tumor progression
ENSG00000125356,NDUFA1,mitochondrial dysfunction,complex i assembly,oxidative phosphorylation impairment,glycolytic shift,cellular metabolism reprogramming,ros-induced dna damage
ENSG00000171135,JAGN1,notch signaling pathway,aberrant activation,epithelial-to-mesenchymal transition,cell proliferation enhancement,cancer progression promotion,poor prognosis correlation
,CCDC155,microtubule regulation,cell division disruption,tumor suppressor function,apoptosis suppression,cell proliferation enhancement,mitotic spindle disruption
ENSG00000143641,GALNT2,oncogenic function,cell proliferation,promotes metastasis,altered expression levels,post-translational modification,glycosylation regulation
ENSG00000117155,SSX2IP,dna repair,genomic stability,chromatin remodeling,transcriptional regulation,wnt/β-catenin signaling pathway,oncogenic processes
ENSG00000103018,CYB5B,lipid metabolism,fatty acid synthesis,cell proliferation,oncogenic processes,dna damage repair,tumor progression
ENSG00000155755,TMEM237,cellular adhesion,signaling pathway regulation,transmembrane protein,oncogenic process,biomarker potential,genetic alterations
ENSG00000100528,CNIH1,calcium signaling pathways,cancer metastasis,promotes tumor growth,cell adhesion regulation,tumor progression,overexpression
ENSG00000175514,GPR152,immune modulation,g protein-coupled receptor,tumor growth promotion,cell survival enhancement,metastasis facilitation,prognostic marker
ENSG00000166289,PLEKHF1,actin cytoskeleton regulation,cell migration enhancement,focal adhesion formation,oncogene overexpression,tumor progression facilitation,cytoskeletal regulator interaction
ENSG00000115274,INO80B,dna damage response,chromatin remodeling complex,genome instability,cell proliferation driver,oncogenic transcription regulator,tumor progression facilitator
ENSG00000166900,STX3,membrane trafficking regulation,oncogenic signaling pathway modulation,tumor progression association,aggressive disease phenotype,therapeutic target potentiality,poor prognosis indicator
ENSG00000143198,MGST3,oxidative stress modulation,potential tumor suppressor,cellular detoxification,dna repair mechanism,tumor progression inhibition,redox balance regulation
ENSG00000198133,TMEM229B,cell adhesion disruption,epithelial-to-mesenchymal transition,overexpression associated,pi3k/akt pathway interaction,prognostic marker,tumor progression marker
ENSG00000169371,SNUPN,regulation of cell growth,cell division regulation,microtubule dynamics,tumor progression,oncogenesis,proliferation and survival enhancement
ENSG00000122375,OPN4,photoreceptor function,circadian rhythm regulation,g-protein coupled receptor,cell migration,oncogene potential,tumor microenvironment interaction
ENSG00000188021,UBQLN2,autophagy regulation,proteotoxic stress,tumor progression,metastasis promotion,cellular homeostasis disruption,protein degradation dysregulation
ENSG00000164983,TMEM65,tumor suppressor function,cell membrane dynamics regulation,oncogene activation,kinase activity modulation,cell proliferation promotion,tumor progression driver
ENSG00000180532,ZSCAN4,zinc finger protein activation,transcriptional regulation,cell proliferation enhancement,metastasis promotion,pi3k/akt pathway interaction,epithelial-to-mesenchymal transition modulation
ENSG00000118402,ELOVL4,lipid biosynthesis,cell membrane stability,tumor progression,metabolic regulation,protein-lipid interaction,genomic profiling
ENSG00000196329,GIMAP5,gef activity,rac2 regulation,cell proliferation regulation,apoptosis resistance,metastasis suppression,tumorigenesis promotion
ENSG00000197079,KRT35,keratin network disruption,oncogene overexpression,cell migration enhancement,apoptosis resistance,tumor aggressiveness,genomic amplification
ENSG00000143393,PI4KB,aberrant activity,altered expression levels,autophagy regulation,cell proliferation driver,genomic instability,membrane trafficking modulation
ENSG00000115307,AUP1,protein quality control,endoplasmic reticulum stress,mitochondrial function regulation,cellular proteostasis degradation,er-associated degradation pathway,tumor microenvironment regulation
ENSG00000112038,OPRM1,tumor progression,metastasis promotion,cancer cell survival,cell proliferation enhancement,g protein-coupled receptor activation,signaling pathway modulation
ENSG00000074319,TSG101,tumor suppressor,ubiquitin ligase activity,escrt pathway,cell proliferation,oncogene driver,pi3k/akt signaling
ENSG00000169885,CALML6,calmodulin-like regulation,cell proliferation,ef-hand motif binding,cancer metastasis,tumor progression,genomic instability
ENSG00000183036,PCP4,wnt/pcp signaling,epithelial-to-mesenchymal transition (emt),oncogenic activity,cell migration and invasion,prognostic marker,tumor aggressiveness
ENSG00000152359,POC5,dna repair,genomic instability,tumor suppression,cell cycle regulation,oncogene function,protein interaction
ENSG00000146592,CREB5,regulates gene expression,coactivator activity,cell growth regulation,apoptosis inhibition,metabolic modulation,tumor suppressor pathway inhibition
ENSG00000102858,MGRN1,tumor suppressor,apoptosis inhibition,cell migration,ubiquitination regulation,protein degradation,proliferation enhancement
ENSG00000087111,PIGS,gb3 overexpression,signaling pathway modulation,cell proliferation enhancement,tumor invasion facilitation,glycosphingolipid biosynthesis,apoptosis suppression
ENSG00000109654,TRIM2,transcriptional regulation,cellular differentiation,protein ubiquitination,cell signaling modulation,nf-κb pathway regulation,e3 ubiquitin ligase activity
ENSG00000104228,TRIM35,p53 tumor suppressor regulation,gain of function mutations,tumor progression modulation,oncogenic process,p53 pathway disruption,cell cycle arrest
ENSG00000109736,MFSD10,metabolic reprogramming,oncogenic process facilitation,lipid biosynthesis regulation,fatty acid metabolism influence,vesicular transport modulation,therapeutic target potential
ENSG00000121542,SEC22A,pi3k/akt pathway interaction,cell proliferation promotion,protein transport regulation,golgi apparatus involvement,ca2+ homeostasis disruption,er stress modulation
ENSG00000169217,CD2BP2,cellular proliferation,signaling molecule interaction,adaptor protein binding,tumor progression,metastasis promotion,oncogenic transformation
ENSG00000152049,KCNE4,ion channel regulation,kcne4 loss or mutation,potassium channel modulation,tumor progression,cellular proliferation enhancement,signaling pathway disruption
ENSG00000101161,PRPF6,spliceosome assembly,cell cycle regulation,tumor growth promotion,anti-apoptotic function,protein-protein interactions,oncogenic potential
ENSG00000162881,OXER1,oncogenesis,cell proliferation,protein-protein interaction,apoptosis regulation,tumor progression,metastasis promotion
ENSG00000213186,TRIM59,oncogenic protein,pi3k/akt pathway regulation,cell cycle regulation,tumor progression driver,gene expression modulation,protein-protein interaction
ENSG00000102934,PLLP,tumor progression,cell migration,apoptosis regulation,signaling pathway modulation,genomic instability,metastasis facilitation
ENSG00000182473,EXOC7,exocytosis,secretion regulation,tumor progression,protease activation,cancer cell proliferation,genetic mutation
,MARCH3,erbb4 regulation,egfr degradation,e3 ubiquitin ligase activity,cellular homeostasis disruption,oncogenic protein accumulation,prognostic biomarker status
ENSG00000284868,DHRS1,lipid metabolism dysregulation,akt signaling pathway regulation,cell proliferation promotion,oncogene function,cancer stem cell development,protein kinase activation
ENSG00000169683,LRRC45,cell proliferation,protein-protein interactions,overexpression,aggressive tumor behavior,cell adhesion,metastasis
ENSG00000179071,CCDC89,epigenetic regulation,chromatin remodeling,coiled-coil domain protein,transcriptional control,histone modifications,tumor suppressor
ENSG00000135249,RINT1,genomic instability,tumor progression,dna repair mechanism,cell cycle regulation,apoptosis evasion,chromosomal rearrangement
ENSG00000196843,ARID5A,tumor suppressor,chromatin remodeling,loss-of-function mutation,genome instability,dna damage response,apoptosis regulation
ENSG00000152954,NRSN1,neuropeptide regulation,cell growth promotion,metastasis enhancer,pro-survival signaling,therapeutic target candidate,genomic instability marker
ENSG00000101236,RNF24,oncogene,ubiquitin ligase activity,tumor promotion,cell cycle regulation,apoptosis evasion,cancer prognosis
ENSG00000029725,RABEP1,gef regulation,rab gtpase recycling,cell proliferation promotion,survival pathway activation,endocytic trafficking modulation,protein-protein interaction enhancement
ENSG00000103365,GGA2,golgi function,cellular proliferation,membrane trafficking regulation,protein-protein interaction,oncogenic transformation promotion,metastasis promotion
ENSG00000114993,RTKN,rtp-mapk/erk pathway activation,genomic instability,microtubule dynamics regulation,tumor progression promotion,therapeutic target,signaling molecule interaction
ENSG00000086015,MAST2,chromatin remodeling,oncogene overexpression,transcriptional regulation,tumor progression,metastasis promotion,cell cycle regulation
ENSG00000103034,NDRG4,tumor suppressor function,downregulated expression,cell cycle regulation,apoptosis induction,dna repair pathway,methylated promoter
ENSG00000127561,SYNGR3,synaptic vesicle regulation,cell proliferation enhancement,mitotic process involvement,poor prognosis marker,protein-protein interaction,dna repair modulation
ENSG00000092607,TBX15,tumor suppressor function,transcriptional regulation,cell differentiation,apoptosis regulation,notch signaling interaction,embryonic development
ENSG00000282379,DTX2,epithelial-to-mesenchymal transition,pro-survival signaling pathway,microrna regulation,tumor progression,apoptosis resistance,cell proliferation
ENSG00000099968,BCL2L13,apoptosis regulation,cell survival enhancement,mitochondrial membrane permeability,cell cycle modulation,oncogenic potential,tumor suppressor function interaction
ENSG00000170310,STX8,membrane fusion enhancement,tumor growth promotion,oncogene upregulation,poor prognosis biomarker,immune microenvironment modulation,vesicle trafficking regulation
ENSG00000166833,NAV2,vesicular transport regulation,endosomal trafficking modulation,membrane dynamics alteration,cell proliferation facilitation,tumor progression contribution,none
ENSG00000092010,PSME1,proteolytic regulation,cell proliferation enhancement,ubiquitin-proteasome pathway activation,overexpression signature,poor prognosis marker,apoptosis evasion mechanism
ENSG00000160185,UBASH3A,ubiquitination regulation,deubiquitinating enzyme modulation,oncogenic protein function,tumor progression promotion,apoptosis evasion,cell proliferation enhancement
ENSG00000184492,FOXD4L1,cell proliferation,transcription factor activation,oncogenic activity,epithelial-to-mesenchymal transition (emt),poor prognosis,survival outcomes
ENSG00000162366,PDZK1IP1,mir-34a target,cell proliferation regulation,oncogene activation,prognostic marker,binding partner of src kinase,tumor invasion and metastasis
ENSG00000127774,EMC6,microtubule regulation,mitotic spindle formation,chromosomal instability,genomic alterations,tumor progression,cell division regulation
ENSG00000111701,APOBEC1,apobec-mediated mutagenesis,genomic instability,oncogene activation,tumor progression,mutational hotspot creation,single-stranded dna editing
ENSG00000186977,KRTAP19-5,keratin-associated protein,cell proliferation,tumor progression,metastasis promotion,hair follicle-specific complex,cancer upregulation
ENSG00000020256,ZFP64,zinc finger protein activation,oncogene activity,cell proliferation regulation,apoptosis suppression,transcriptional regulation,genomic alteration
ENSG00000141378,PTRH2,oncogenic transcription factor,tumor progression,cell proliferation,wnt/beta-catenin pathway interaction,gene expression regulation,malignant transformation
ENSG00000105374,NKG7,tumor immune evasion,immunosuppression,nk cell function regulation,cytotoxicity modulation,immune surveillance evasion,oncogene dysregulation
ENSG00000177842,ZNF620,chromatin remodeling,oncogene regulation,transcriptional modulation,cell cycle progression,apoptosis inhibition,tumor suppressor activity
ENSG00000147133,TAF1,chromatin remodeling,transcriptional regulation,cell cycle dysregulation,apoptosis inhibition,histone modification,oncogene activation
ENSG00000179930,ZNF648,cell cycle regulation,zinc finger protein function,tumor growth promotion,apoptosis suppression,transcriptional control,epigenetic regulation
ENSG00000127993,RBM48,cell cycle regulation,pre-mrna processing,alternative splicing,microrna modulation,tumor cell proliferation,poor prognosis biomarker
ENSG00000100461,RBM23,oncogene overexpression,rna-binding protein activity,gene regulatory network disruption,tumor progression facilitation,cell proliferation promotion,metastasis enhancement
ENSG00000163993,S100P,calponin interaction,cell migration enhancement,chromosomal localization,epithelial differentiation regulation,gene expression modulation,nf-κb activation pathway
ENSG00000173250,GPR151,g-protein coupled receptor,cell proliferation regulation,tumor progression promoter,signaling pathway modulation,poor prognosis marker,prognostic biomarker
ENSG00000124103,FAM209A,dna repair,aberrant cell cycle progression,genomic instability,atr pathway interaction,uncontrolled proliferation,nuclear localization
ENSG00000288427,CLSTN3,pi3k/akt signaling,cell adhesion,oncogenesis,tumor progression,therapeutic target,gene amplification
ENSG00000174599,TRAM1L1,pi3k/akt/mtor pathway,overexpression,cell migration,tumor progression,oncogenic function,metastatic potential
ENSG00000131115,ZNF227,genomic instability,disruption of transcriptional regulation,aberrant gene expression,tumor progression,therapeutic target,cancer driver
ENSG00000225998,LSM2,genomic instability,oncogene function,nf-κb signaling pathway,exosome complex regulation,rna degradation and processing,dna repair and replication
ENSG00000100281,HMGXB4,transcriptional regulation,oncogenic function,wnt/β-catenin pathway activation,chromatin remodeling,epigenetic modification dysregulation,cancer progression
ENSG00000102977,ACD,genomic instability,cell cycle regulation,mitotic spindle checkpoint,chromosomal segregation,tumor progression,aneuploidy
ENSG00000065150,IPO5,glycolytic regulation,tumor progression,oncogenic potential,apoptosis modulation,protein overexpression,cell cycle regulation
ENSG00000152684,PELO,mitotic checkpoint regulation,cell proliferation enhancement,genomic instability promotion,therapeutic target identification,protein-protein interaction alteration,cancer cell survival and growth promotion
ENSG00000122971,ACADS,beta-oxidation,cellular metabolism,fatty acid degradation,oncogenic pathway,metabolic reprogramming,therapeutic target
ENSG00000263236,KRTAP4-12,epithelial integrity disruption,keratin-associated protein family member,cell signaling pathway dysregulation,aberrant gene expression,tissue overexpression,cancer biology alterations
ENSG00000184012,TMPRSS2,androgen receptor axis,cell surface protein shedding,enzymatic activity,proliferation marker,tumor progression,signaling pathway regulation
ENSG00000163217,BMP10,tumor suppressor,apoptosis induction,pi3k/akt pathway inhibition,cell proliferation suppression,pro-apoptotic gene expression,smad4 interaction
ENSG00000109099,PMP22,constitutive activation,overexpression,oncogene,cell proliferation,protein interaction,signal transduction
ENSG00000131165,CHMP1A,escrt machinery,endosomal trafficking regulation,tumor suppressor function suppression,apoptosis evasion promotion,cell cycle control disruption,oncogenic signaling pathway activation
ENSG00000160318,CLDND2,transmembrane glycoprotein,tumor progression,cell migration,apoptosis evasion,therapeutic target,genomic profiling
ENSG00000168476,REEP4,mitochondrial dynamics,cellular metabolism regulation,apoptosis inhibition,oncogenic signaling modulation,tumor progression driver,receptor-interacting protein interaction
ENSG00000115091,ACTR3,microtubule formation,cytoskeletal organization,cell proliferation,apoptosis evasion,dna repair regulation,chromosome stability
ENSG00000178951,ZBTB7A,transcription factor activation,cell cycle progression,apoptosis suppression,oncogene expression,emt regulation,poor prognosis marker
ENSG00000011295,TTC19,cell division regulation,cellular growth modulation,potential biomarker,transmembrane protein function,oncogenesis facilitation,apoptosis resistance
ENSG00000163703,CRELD1,tumor suppressor function,loss of function mutations,cell-cell adhesion regulation,angiogenesis promotion,cell migration enhancement,epithelial-mesenchymal transition
ENSG00000176903,PNMA1,oncogene activation,cell proliferation enhancement,apoptosis evasion mechanism,tumor progression facilitation,pi3k/akt pathway modulation,cell cycle regulation disruption
ENSG00000184402,SS18L1,aberrant chromatin formation,oncogene activation,epigenetic regulation,alternative splicing dysregulation,histone modification interaction,tumor progression
ENSG00000172156,CCL11,immune cell recruitment,tumor growth promotion,metastasis facilitation,inflammation regulation,pi3k/akt pathway interaction,therapeutic target
ENSG00000221978,CCNL2,cell proliferation,dna damage response,gene expression regulation,cell cycle regulation,protein kinase activation,genomic instability
ENSG00000084764,MAPRE3,microtubule interaction,oncogene,centrosome regulation,cell proliferation,chromosomal instability,metastasis promotion
ENSG00000115266,APC2,wnt/β-catenin pathway,negative regulator,chromatin remodeling,tumor suppressor,cell proliferation,gene expression regulation
ENSG00000168412,MTNR1A,melatonin receptor,g protein-coupled receptor,oxidative stress protection,cell cycle regulation,apoptosis evasion,angiogenesis modulation
ENSG00000145283,SLC10A6,bile acid transport regulation,tumor progression marker,apoptosis modulation,cell cycle regulation,pi3k/akt/mtor pathway interaction,biomarker expression
,C16orf58,tumor suppression,apoptosis regulation,genomic stability,cellular signaling pathway,protein-protein interaction,uncharacterized function
ENSG00000140941,MAP1LC3B,autophagy regulation,cellular homeostasis disruption,tumor growth promotion,autophagosome formation dysregulation,microtubule association,cancer cell survival enhancement
ENSG00000154153,RETREG1,oncogenic driver,constitutive activation,gain of function mutations,tumor progression,therapeutic target,signaling pathway modulation
ENSG00000060237,WNK1,oncogenic kinase activity,pi3k/akt pathway regulation,tumor growth promotion,cell cycle progression,apoptosis resistance,signaling pathway modulation
ENSG00000185963,BICD2,microtubule reorganization,cell motility enhancement,tumor progression facilitation,poor prognosis association,overexpression in esca,biomarker potential
ENSG00000241595,KRTAP9-4,epithelial integrity disruption,keratin filament interaction,tumor growth promotion,cell adhesion modulation,oncogenic potential,genomic instability
ENSG00000066117,SMARCD1,chromatin remodeling,constitutive activation,genomic instability,tumor progression,therapeutic target,cell proliferation
ENSG00000168411,RFWD3,p53 pathway,e3 ubiquitin ligase activity,cell cycle regulation,protein degradation,dna damage response,tumor suppressor inactivation
ENSG00000178538,CA8,ph regulation,ion transport,tumor progression,metabolic reprogramming,cell proliferation,glycolytic shift
ENSG00000109083,IFT20,cellular integrity,intraflagellar transport,apoptosis evasion,cilia stability,cell cycle regulation,protein interaction
ENSG00000138750,NUP54,nuclear transport regulation,disrupted nuclear pore complex,altered gene expression,cell cycle dysregulation,tumorigenesis enhancement,protein-protein interaction
ENSG00000162882,HAAO,fatty acid metabolism,energy regulation,cellular oxidation,prognostic marker,oncometabolite regulation,tumor progression
ENSG00000128513,POT1,telomere protection,genomic instability,dna damage response evasion,tumor progression,oncogenic driver,cancer cell proliferation
ENSG00000106536,POU6F2,pou6f2 overexpression,wnt/β-catenin pathway regulation,cell cycle progression modulation,apoptosis evasion enhancement,tumor growth promotion,epigenetic modification regulation
ENSG00000101216,GMEB2,transcriptional regulation,coactivator function,cell proliferation,gene expression modulation,chromatin remodeling,apoptosis inhibition
ENSG00000141198,TOM1L1,cell cycle regulation,tumor suppression,apoptosis induction,endocytic pathway regulation,autophagic process modulation,cellular metabolic regulation
ENSG00000160447,PKN3,protein kinase activation,cell survival signaling,tumor progression,cell proliferation,metastasis,signaling pathway modulation
ENSG00000130669,PAK4,cell migration,pi3k/akt pathway activation,serine/threonine kinase activity,tumor progression,metastasis promotion,cytoskeleton remodeling
ENSG00000181885,CLDN7,emt regulation,tumor progression,cell migration,epithelial barrier disruption,oncogene activation,prognostic marker
ENSG00000147123,NDUFB11,mitochondrial regulation,metabolic reprogramming,oncogenic energy production,apoptosis modulation,therapeutic target potential,cellular proliferation enhancement
ENSG00000084072,PPIE,protein stability modulation,cell cycle progression regulation,tumor suppressor interaction,transcription regulation influence,signal transduction pathway modulation,apoptosis suppression facilitation
ENSG00000171840,NINJ2,genomic instability,cell survival pathways,dna repair regulation,p53 modulation,tumor progression,therapeutic target
ENSG00000080345,RIF1,genomic instability,dna repair regulation,homologous recombination repair,cell cycle progression regulation,tumor suppression pathways,therapeutic target
ENSG00000160207,HSF2BP,cell cycle regulation,dna damage response,genomic instability,oncogene overexpression,poor prognosis marker,protein-protein interaction
ENSG00000180448,ARHGAP45,apoptosis regulation,cell migration inhibition,gtpase signaling pathway modulation,tumor suppressor function,cell invasion limitation,pro-oncogenic pathway activation
ENSG00000129204,USP6,tumor growth promotion,cellular degradation pathway modification,oncogenic signaling activation,amplification/overexpression association,metastasis facilitation,inflammatory response induction
ENSG00000111245,MYL2,cell migration,constitutive activation,gain of function mutations,tumor progression,epithelial-to-mesenchymal transition (emt),metabolic reprogramming
ENSG00000166394,CYB5R2,fatty acid metabolism regulation,protein activation,cell proliferation enhancement,metastasis facilitation,therapeutic target identification,tumor progression promotion
ENSG00000159289,GOLGA6A,cellular proliferation,signaling pathway modulation,tumor progression,vesicle transport regulation,protein-protein interaction,stress response regulation
ENSG00000112837,TBX18,transcription factor activation,wnt/β-catenin signaling,epithelial-to-mesenchymal transition (emt),cell proliferation promotion,poor prognosis association,oncogene overexpression
ENSG00000198576,ARC,apoptosis regulation,cell survival modulation,immune response regulation,scaffolding protein function,tumor microenvironment dynamics,protein kinase interaction
ENSG00000164066,INTU,protein quality control,cellular stress,oncogenic mutations,ubiquitination pathway,tumor progression,genetic instability
ENSG00000147459,DOCK5,cell migration,cell adhesion,cancer biomarker,guanine nucleotide exchange factor,rac1 activation,cdc42 activation
ENSG00000111252,SH2B3,sh2b3 mutations,stat5 transcription factor,cell cycle regulation,oncogenic pathway activation,immune response modulation,transcriptional regulation
ENSG00000125991,ERGIC3,er-golgi intermediate compartment regulation,oncogenic overexpression,cell proliferation promotion,poor prognosis biomarker,vesicle trafficking regulation,cell survival enhancement
ENSG00000175305,CCNE2,cell cycle dysregulation,cyclin-dependent kinase activation,g1 to s phase transition,oncogenic driver,protein overexpression,therapeutic target
ENSG00000138668,HNRNPD,regulation of gene expression,rna processing,cell proliferation modulation,tumor progression regulation,apoptosis regulation,splicing regulation
ENSG00000164949,GEM,glutamate metabolism regulation,cell proliferation enhancement,tumor aggressiveness association,poor prognosis correlation,signaling pathway modulation,pi3k/akt interaction
ENSG00000112304,ACOT13,activation of oncogenic pathways,regulation of lipid metabolism,overexpression and aberrant expression,cell growth and proliferation,signaling pathway interaction,lipid homeostasis modulation
ENSG00000122257,RBBP6,chromatin remodeling,transcriptional regulation,dna damage response,cell cycle regulation,oncogenic transformation,tumor suppressor function
ENSG00000100504,PYGL,glycogen phosphorylation,warburg effect,tumor progression,therapeutic target,metabolic reprogramming,enhanced glycolysis
ENSG00000068976,PYGM,warburg effect,altered metabolism,cell proliferation,glycogen regulation,dysregulation,genetic mutations
ENSG00000130948,HSD17B3,estrogen signaling,tumor growth,cell proliferation,apoptosis regulation,protein interaction,signaling pathway activation
ENSG00000050628,PTGER3,tumor progression,epithelial-to-mesenchymal transition,immune suppression,g-protein coupled receptor signaling,cell migration,biomarker potential
ENSG00000120699,EXOSC8,rna processing regulation,genomic instability,cell proliferation suppression,exosome complex interaction,mirna biogenesis modulation,tumor suppressor activation
ENSG00000132510,KDM6B,histone modification regulation,tumor suppressor function,lysine demethylation,dysregulated epigenetic program,apoptosis modulation,proliferation inhibition
ENSG00000263341,KRTAP17-1,**
cell adhesion modulation,dysregulation impact,cellular structure influence,keratin filament stabilization,proliferation pathway involvement,differentiation regulation
ENSG00000114698,PLSCR4,phospholipid scrambling,calcium signaling,cell proliferation,apoptosis regulation,autophagy modulation,migration enhancement
ENSG00000172568,FNDC9,cell adhesion disruption,protein-protein interaction,pi3k/akt pathway regulation,tumor progression factor,poor prognosis indicator,therapeutic target potential
ENSG00000142227,EMP3,aberrant regulation,cell growth modulation,interactions with pi3k/akt pathway,lysosomal formation disruption,modulation of tp53 activity,oncogenic transformation
ENSG00000141084,RANBP10,overexpression,cell proliferation,chromatin remodeling,cell cycle control,ran-dependent pathways,nuclear transport regulator
ENSG00000130066,SAT1,selenoprotein regulation,secis element,selenocysteine synthesis,cell survival promotion,therapeutic target identification,x-chromosome localization
ENSG00000141504,SAT2,methylation reactions,dna methylation,cell proliferation,epigenetic regulation,tumorigenesis,metabolic regulation
ENSG00000111653,ING4,apoptosis regulation,tumor suppressor function,cell cycle regulation,growth inhibition,dna repair mechanism,chromatin modification
ENSG00000095951,HIVEP1,oncogene potential,transcriptional regulation,immune response modulation,tumor growth promotion,apoptosis inhibition,metastatic progression
ENSG00000165630,PRPF18,spliceosome biogenesis,overexpression,cell proliferation,gene regulation,oncogenic processes,splicing regulation
ENSG00000149781,FERMT3,cell adhesion disruption,metastatic potential,cell migration facilitation,pi3k/akt pathway activation,tumor progression,prognostic marker
ENSG00000111837,MAK,homologous recombination repair,genomic instability,double-strand break repair,tumor suppressor function,cell cycle regulation,dna damage response
,ICK,cellular invasion,constitutive activation,cell adhesion disruption,increased motility,oncogenic signaling,tumor progression
,KIF1BP,microtubule regulation,cellular transport,motor protein regulation,protein-protein interaction,tumorigenesis contributor,endocytic pathway modulation
ENSG00000105856,HBP1,hypomethylation associated gene expression,tumor suppressor function,loss-of-function mutations,transcriptional repression,cell cycle regulation,dna damage response
ENSG00000083520,DIS3,telomere maintenance,rna degradation,genome stability,tumor progression,cell growth regulation,oncogenic transformation
ENSG00000107371,EXOSC3,rna degradation,exosome subunit,mutation-driven dysregulation,oncogenic pathway activation,tumor suppressor function,genomic instability
ENSG00000212933,KRTAP12-4,keratinization,intermediate filament network,epithelial differentiation,cell signaling modulation,protein-protein interactions,skin cell homeostasis
ENSG00000092853,CLSPN,cell adhesion,cell migration,oncogenesis,tumor progression,glycoprotein binding,signaling pathway activation
ENSG00000131966,ACTR10,proteasomal regulation,cell cycle alteration,tumor progression,therapeutic target,transcriptional control,chromatin remodeling
ENSG00000126262,FFAR2,fatty acid regulation,cell proliferation,tumor suppressor potential,pi3k/akt pathway modulation,oncogenic processes,signaling pathway interaction
ENSG00000111371,SLC38A1,**

glutamine metabolism,amino acid transport regulation,metabolic reprogramming,tumor growth promotion,cell proliferation enhancement,therapeutic resistance
ENSG00000274352,ZNF707,tumor suppressor,transcriptional regulation,genomic instability,apoptosis regulation,cell cycle control,epigenetic modulation
ENSG00000166946,CCNDBP1,transcription regulation,cell proliferation enhancement,dna repair modulation,oncogenic transformation promoter,tumor suppressor interaction interference,prognostic marker
ENSG00000145029,NICN1,tumor progression,gene expression regulation,nuclear receptor coactivator activity,cell proliferation promotion,dysregulated gene expression,oncogenic pathway activation
ENSG00000175691,ZNF77,chromatin remodeling,dna repair deficiency,cell cycle regulation,tumor suppressor function,gene expression modulation,apoptosis regulation
ENSG00000119912,IDE,cellular stress response,glucose metabolism regulation,tumor microenvironment modulation,insulin degradation activity,oncogenic potential,diagnostic/prognostic marker
ENSG00000125207,PIWIL1,tumor suppressor gene silencing,oncogenic processes,poor prognosis marker,cellular proliferation,survival pathway regulation,epigenetic regulation
ENSG00000113387,SUB1,genetic instability,helicase activity,transcription regulation,rna processing,dna repair modulation,tumor proliferation
ENSG00000119820,YIPF4,er stress response,cellular proliferation,oncogenic driver mutations,tumor progression,therapeutic target,genomic instability
ENSG00000036565,SLC18A1,vesicular monoamine transport,cell growth modulation,oncogenic processes regulation,metabolic pathway interaction,therapeutic target potential,plasma membrane localization
ENSG00000205864,KRTAP5-6,cell adhesion,cell invasion,epithelial-to-mesenchymal transition (emt),keratin filament dynamics,oncogene,pi3k/akt/mtor pathway signaling
ENSG00000151650,VENTX,transcription factor regulation,chromatin remodeling,oncogenic transformation,tumor progression,stem cell maintenance,cancer cell self-renewal
ENSG00000037965,HOXC8,hox family member,cell proliferation,apoptosis inhibition,wnt/β-catenin pathway interaction,tumor promoter,prognostic marker
ENSG00000102144,PGK1,glycolytic activation,cell proliferation enhancement,tumor progression support,energy metabolism regulation,cell cycle regulation disruption,glucose metabolism promotion
ENSG00000064835,POU1F1,transcription factor regulation,oncogene activation,cell proliferation enhancement,tumor progression driver,genomic amplification,chromatin remodeling involvement
ENSG00000197822,OCLN,epithelial barrier function disruption,tumor progression facilitation,angiogenesis promotion,vascular endothelial growth factor upregulation,epithelial-to-mesenchymal transition involvement,cell migration enhancement
ENSG00000196417,ZNF765,regulation of gene expression,transcriptional repression,oncogenic processes,cellular proliferation,chromatin remodeling,tumor suppressor regulation
ENSG00000185043,CIB1,g2/m transition regulation,cyclin-dependent kinase interaction,oncogenic mutations,cell cycle progression,tumor growth promotion,tumor suppressor-like function
ENSG00000100348,TXN2,nf-κb pathway,cell proliferation,oncogenic function,oxidative stress regulation,apoptosis inhibition,transcriptional regulation
ENSG00000155636,RBM45,alternative splicing regulation,oncogenic isoform production,tumor progression,cell survival enhancement,therapeutic target,prognostic marker
ENSG00000136371,MTHFS,folate metabolism,cellular proliferation,dna methylation,apoptosis evasion,tumor promotion,therapeutic target
ENSG00000081386,ZNF510,transcriptional regulation,oncogenic signaling,cell proliferation,apoptosis inhibition,angiogenesis promotion,zinc finger motifs
ENSG00000152253,SPC25,genomic instability,promotes tumorigenesis,dna replication regulation,cancer driver mutations,gain of function mutations,cell cycle progression
ENSG00000043143,JADE2,epithelial-to-mesenchymal transition,microtubule regulation,tumor suppression,cell adhesion modulation,gene expression regulation,apoptosis promotion
ENSG00000163960,UBXN7,cell cycle regulation,dna repair modulation,tumor suppressor activity,genomic instability,proteasomal degradation,oncogenic pathway modulation
ENSG00000170469,SPATA24,genomic instability,dna repair deficiency,oncogenic driver,cell proliferation enhancement,homologous recombination deficiency (hrd),p53 pathway dysregulation
ENSG00000117394,SLC2A1,glut1 upregulation,enhanced glycolysis,tumor growth promotion,metabolic adaptation,therapeutic target,hypoxia response
ENSG00000213906,LTB4R2,ltb4 signaling pathway,constitutive activation,leukotriene b4 receptor 2,pro tumorigenic effects,tumor progression,metastasis-associated gene
ENSG00000148848,ADAM12,metalloprotease activity,cell migration,protein-protein interaction,tumor progression,metastasis suppression,biomarker potential
ENSG00000188581,KRTAP1-1,keratin-associated protein,epithelial maintenance,tissue integrity regulation,cell growth modulation,evolutionary conserved function,somatic mutations
ENSG00000071203,MS4A12,pi3k/akt pathway regulation,immune response modulation,tumor progression involvement,cell signaling interaction,oncogenesis potential,aberrant expression found
ENSG00000144063,MALL,nuclear protein regulation,chromatin remodeling,transcriptional modulation,apoptosis evasion,cell cycle progression,prognostic marker
ENSG00000177238,TRIM72,immune regulation,proliferation suppression,tumor suppressor function,protein degradation regulation,dysregulated expression,substrate recognition
ENSG00000140262,TCF12,wnt/β-catenin signaling,transcriptional regulation,oncogenic potential,tumor progression,cell proliferation,genetic dysregulation
ENSG00000100652,SLC10A1,**

* multidrug resistance,bile acid regulation,cell growth promotion,ion homeostasis modulation,wnt/β-catenin pathway activation,poor prognosis association

**
ENSG00000164007,CLDN19,cell adhesion molecule,tumor progression,oncogene,epithelial cell barrier function,wnt/β-catenin pathway interaction,cell proliferation enhancement
ENSG00000147905,ZCCHC7,chromatin remodeling,transcriptional regulation,oncogene activation,tumor suppressor gene repression,histone modification,co-repressor recruitment
ENSG00000137960,GIPC2,β-catenin signaling,pi3k/akt pathway activation,scaffolding protein function,oncogenic signaling,cell adhesion modulation,tumor progression facilitation
ENSG00000127838,PNKD,autophagy regulation,mitochondrial clearance,protein kinase activation,oncogenic mutation,tumor suppressor function loss,cellular response modulation
ENSG00000180440,SERTM1,aberrant cell signaling,cancer-related protease activity,cell proliferation regulation,gene overexpression,tumor progression,uncharacterized gene function in cancer
ENSG00000197992,CLEC9A,immune modulation,innate immune response,tumor microenvironment,macrophage infiltration,t cell regulation,biomarker candidate
ENSG00000119397,CNTRL,cell adhesion regulation,cytoplasmic dynein activation,mitotic progression modulation,apoptosis suppression,rho gtpase interaction,protein kinase c activation
ENSG00000164440,TXLNB,pi3k/akt signaling,constitutive activation,gain of function mutations,tumor progression,therapeutic target,cell proliferation
ENSG00000116062,MSH6,mismatch repair,genomic instability,dna replication errors,tumor suppressor function,epigenetic regulation,cancer predisposition
ENSG00000161055,SCGB3A1,epithelial barrier integrity,metastasis promotion,tumor suppressor function,cell adhesion regulation,signaling molecule interaction,epithelial-to-mesenchymal transition (emt)
ENSG00000149823,VPS51,vps/escrt complex assembly,tumor growth promotion,epithelial-to-mesenchymal transition,cell membrane trafficking regulation,protein degradation dysregulation,genomic instability
ENSG00000124508,BTN2A2,immune regulation,tumor progression,t cell modulation,oncogenic function,protein-protein interaction,cell survival
ENSG00000134531,EMP1,cell adhesion,epithelial integrity,tumor suppression,metastasis regulation,pi3k/akt pathway inhibition,epithelial-to-mesenchymal transition
ENSG00000157680,DGKI,cell division regulation,cytoplasmic reorganization,oncogenic function,tumor progression facilitation,cell migration promotion,protein-protein interaction
ENSG00000119705,SLIRP,rna-binding protein,cell proliferation,metabolic regulation,oncoprotein interaction,tumor progression,therapeutic target
ENSG00000196182,STK40,cell proliferation,regulatory mechanism,kinase activity,protein interaction,mitotic regulation,therapeutic target
ENSG00000079150,FKBP7,pi3k/akt pathway modulation,tumor progression facilitation,prognostic marker,chaperone function alteration,cell survival enhancement,resistance to therapy
ENSG00000177427,MIEF2,mitochondrial dynamics,regulation of fusion and fission,oncogenic function,metabolic reprogramming,cellular respiration,mitochondrial cristae structure
ENSG00000008197,TFAP2D,oncogene,epithelial-to-mesenchymal transition (emt),cell migration invasion,transcriptional regulation,signaling pathway modulation,chromatin accessibility control
ENSG00000186970,KRTAP15-1,cellular adhesion regulation,gene expression alteration,cytoskeleton disruption,epithelial-to-mesenchymal transition,protein-protein interaction,keratin intermediate filament network
ENSG00000167984,NLRC3,nf-κb signaling,tumor suppressor function,apoptosis regulation,autophagy modulation,inflammation regulation,mitochondrial dynamics
ENSG00000057019,DCBLD2,epithelial-to-mesenchymal transition (emt),cell adhesion disruption,transmembrane protein interaction,protein overexpression,poor prognosis biomarker,cancer initiation mediator
ENSG00000013293,SLC7A14,amino acid transport,cellular metabolism,mtor signaling pathway,tumor progression,cancer cell survival,therapeutic target
ENSG00000122877,EGR2,apoptosis regulation,chromatin remodeling,gene expression regulation,tumor suppression modulation,cell cycle progression influence,transcription factor function
ENSG00000206053,JPT2,cellular homeostasis,protein folding regulation,endoplasmic reticulum stress,unfolded protein response activation,tumor progression influence,cell cycle regulation modulation
ENSG00000101438,SLC32A1,glutamate regulation,pi3k/akt signaling,oncogenic mutation,tumor progression,angiogenesis promotion,metastasis driver
ENSG00000196456,ZNF775,krab domain,zinc finger protein,transcriptional repressor,tumor suppressor function,apoptosis regulation,cell proliferation control
ENSG00000107186,MPDZ,epithelial polarity disruption,loss of function mutations,wnt/β-catenin pathway activation,cell migration enhancement,therapeutic target,tumor progression
ENSG00000184166,OR1D2,olfactory receptor function,cell proliferation enhancement,metastasis promotion,tumor aggression,wnt/β-catenin pathway interaction,cancer progression driver
ENSG00000177300,CLDN22,disrupted tight junctions,loss of cell-cell adhesion,epithelial-to-mesenchymal transition (emt),tumor progression,angiogenesis promotion,immune evasion
ENSG00000139644,TMBIM6,er stress response,apoptosis regulation,cell death sensitivity,mitochondrial function,prognostic marker,oncogenesis modulation
ENSG00000170540,ARL6IP1,aberrant activation,cell migration,golgi apparatus formation,pi3k/akt signaling pathway,prognostic marker,therapeutic target
ENSG00000121413,ZSCAN18,overexpression,oncogenic signaling,transcription factor activity,cell proliferation,chromatin remodeling,therapeutic target
ENSG00000137338,PGBD1,genomic instability,dna repair mechanisms,non-homologous end joining (nhej) repair,genomic rearrangements,oxidative dna damage repair,cancer driver gene
ENSG00000108587,GOSR1,vesicle trafficking,cell proliferation,genomic instability,tumor microenvironment modulation,protein transport regulation,oncogenic signaling enhancement
ENSG00000166856,GPR182,**
gpcr regulation,overexpression,cell proliferation,mapk/erk signaling,pi3k/akt activation,tumor progression 
**
ENSG00000137824,RMDN3,pi3k/akt pathway modulation,oncogenic function,epithelial-to-mesenchymal transition regulation,protein-protein interaction,tumor cell proliferation,metastatic promotion
ENSG00000183733,FIGLA,apoptosis regulation,cellular differentiation,cell cycle progression,follicle development regulator,ovarian follicle maintenance,transcriptional regulation
ENSG00000107187,LHX3,cellular proliferation,transcriptional regulation,gene expression modulation,tumor progression,prognostic biomarker,therapeutic target
ENSG00000147676,MAL2,epithelial-to-mesenchymal transition,cell adhesion molecule regulation,tumor growth promotion,metastasis facilitation,cell proliferation enhancement,chromosomal alteration susceptibility
ENSG00000130957,FBP2,glycolytic flux regulation,glycogen synthesis inhibition,cell growth promotion,metabolic adaptation,pentose phosphate pathway activation,tumor growth support
ENSG00000165140,FBP1,cell proliferation,oncogenic activity,glucose metabolism regulation,tumor progression,pro-survival gene transcription,cell survival enhancement
ENSG00000166261,ZNF202,zinc finger protein,transcriptional regulator,tumor suppressor function,cell proliferation regulation,estrogen receptor-alpha interaction,metastasis inhibition
ENSG00000175294,CATSPER1,cancer-driving mutations,oncogene potential,disrupted cellular function,aberrant expression patterns,cell growth regulation,signaling pathway interaction
ENSG00000196923,PDLIM7,cell migration,genomic instability,metastatic potential,tumor suppression,rho gtpase pathway,actin cytoskeleton organization
ENSG00000189042,ZNF567,transcriptional repressor,chromatin remodeling complex,cell proliferation regulation,apoptosis inhibition,tumor suppressor gene silencing,genomic instability
ENSG00000170264,FAM161A,dna repair mechanism,cell proliferation promotion,pi3k/akt pathway interaction,oncogenesis contribution,cell migration and invasion enhancement,poor prognosis association
ENSG00000095066,HOOK2,microtubule stabilization,cell migration promotion,genomic instability induction,aneuploidy driver,centrosome disruption,epithelial-to-mesenchymal transition
ENSG00000105185,PDCD5,cell cycle regulation,microtubule stability modulation,apoptosis inhibition,tumor suppressor function loss,pi3k/akt pathway dysregulation,pro-apoptotic protein interaction
,HIST2H2BF,chromatin regulation,gene expression modulation,histone modifications,tumor suppressor silencing,epigenetic alterations,dna methylation
ENSG00000033170,FUT8,tumor growth,glycoprotein modification,tumor invasion,metastasis progression,therapeutic target,cellular signaling
ENSG00000251369,ZNF550,transcriptional regulation,tumor suppressor function,histone modification disruption,epigenetic silencing loss,emt induction,metastatic potential enhancement
ENSG00000173207,CKS1B,cell cycle regulation,oncogenic process,tumor progression,apoptotic resistance,therapeutic target,pi3k/akt pathway
ENSG00000141699,RETREG3,ra signaling pathway,regulatory function,tumor progression,cell proliferation,resistance to therapy,poor prognosis
ENSG00000241598,KRTAP5-4,epithelial cell regulation,cell adhesion disruption,proliferation enhancement,metastasis promotion,epithelial-to-mesenchymal transition alteration,tumor progression facilitation
ENSG00000278489,KRTAP5-2,pi3k/akt signaling,tumor progression,cell proliferation,metabolic regulation,epithelial cell interaction,signaling pathway activation
ENSG00000163206,SMCP,microtubule stabilization,cell cycle progression,aberrant expression,oncogenic process,mitotic spindle assembly,genomic instability
ENSG00000126890,CTAG2,cell cycle regulation,transcriptional activation,oncogenic processes,metastasis promotion,chromatin modification,poor prognosis biomarker
ENSG00000182816,KRTAP13-2,epithelial integrity disruption,keratin filament regulation,cell adhesion modulation,tumor progression facilitation,protein-protein interaction alteration,cellular morphology modification
ENSG00000178053,MLF1,transcription regulation,tumor suppressor function,cell cycle progression inhibition,apoptosis suppression,oncogenesis promotion,genomic instability
ENSG00000131016,AKAP12,akap12 regulation,cellular signaling pathway,tumor progression,oncogenic driver,cell proliferation,scaffold protein function
ENSG00000124222,STX16,vesicle trafficking regulation,oncogenic driver,cell growth promotion,signaling pathway interaction,epigenetic regulation alteration,tumor progression enhancement
ENSG00000168237,GLYCTK,warburg effect,redox regulation,oncogene activation,cell proliferation,glucose metabolism,dna damage
ENSG00000262771,SSBP1,homologous recombination repair,chromosomal instability,single-stranded dna binding,genomic instability,tumor progression,replication fork stabilization
ENSG00000124827,GCM2,transcription factor activity,wnt/β-catenin pathway,cell proliferation,tumor progression,survival signals,prognostic marker
ENSG00000105355,PLIN3,lipid droplet association,tumor growth promotion,cancer metabolism,cell proliferation regulation,poor prognosis indicator,metabolic reprogramming
ENSG00000169877,AHSP,protein regulation,alpha-globin chain degradation,molecular chaperone function,oxidative stress mitigation,cellular homeostasis maintenance,iron metabolism modulation
ENSG00000049541,RFC2,genomic instability,dna replication,cell proliferation,tumor suppressor gene,protein-protein interaction,post-translational modification
ENSG00000162433,AK4,cell proliferation,genomic instability,tumor progression,energy metabolism regulation,apoptosis resistance,dna replication interaction
ENSG00000167670,CHAF1A,histone loading,chromatin assembly,cell cycle regulation,oncogene overexpression,tumor suppression modulation,genome stability maintenance
ENSG00000198920,KIAA0753,microtubule stabilization,gene expression regulation,chromatin remodeling,oncogenic mutations,cell cycle progression,genetic instability
ENSG00000149115,TNKS1BP1,tankyrase binding,cellular proliferation,genomic instability,poly(adp-ribose) polymerization,oncogene/tumor suppressor,dna repair regulation
ENSG00000138767,CNOT6L,nonsense-mediated mrna decay pathway,tumor progression,aberrant gene expression,cell proliferation regulation,cancer cell survival,genomic instability
ENSG00000179627,ZBTB42,tumor suppressor function,loss of expression,cell proliferation regulation,apoptosis suppression,dna repair pathway,transcriptional regulation
ENSG00000205220,PSMB10,protein degradation regulation,therapeutic target,apoptosis evasion,mutation associated,ubiquitin-proteasome pathway,tumor progression
ENSG00000197343,ZNF655,transcription regulation,cell proliferation,oncogene activation,epigenetic regulation,tumor progression,prognostic marker
ENSG00000146457,WTAP,regulation of splicing,cell proliferation,tumorigenesis,prognosis marker,gene expression regulation,overexpression associated
ENSG00000162775,RBM15,alternative splicing,apoptosis regulation,cell cycle modulation,oncogenic protein interaction,rna processing dysregulation,tumor suppressor gene suppression
ENSG00000165156,ZHX1,loss of function mutations,tumor suppressor,transcriptional repressor,cell proliferation,apoptosis suppression,nf-κb interaction
ENSG00000171307,ZDHHC16,pi3k/akt pathway,oncogenic pathway modulation,tumor progression,therapeutic target,protein s-palmitoylation,resistance to therapy
ENSG00000125107,CNOT1,cellular proliferation,proteasome regulation,gene expression regulation,mrna degradation regulation,cancer aggressiveness,poor prognosis
ENSG00000151876,FBXO4,loss of function mutations,tumor suppressor activity,cell cycle regulation,epithelial-to-mesenchymal transition (emt),protein degradation pathway,dna repair mechanism
ENSG00000117533,VAMP4,cell migration,invadopodia formation,membrane fusion,snare protein interaction,cancer cell invasion,prognostic marker
ENSG00000169122,FAM110B,tumor suppressor,oncogene activation,microtubule stabilization,cell cycle regulation,proliferation enhancement,cell survival promotion
ENSG00000221837,KRTAP10-9,epithelial tissue expression,keratin filament assembly,cell signaling regulation,tumor progression association,cancer cell biomarker potential,gene expression alteration
ENSG00000198805,PNP,purine salvage pathway,nucleotide metabolism regulation,cell proliferation enhancement,dna synthesis promotion,oncogenic potential,tumor growth support
ENSG00000054523,KIF1B,cellular migration,microtubule dynamics,mitotic spindle formation,oncogenic processes,aberrant expression,apoptosis evasion
ENSG00000288295,MCTS1,cell cycle progression,oncoprotein overexpression,cell proliferation,poor prognosis,prognostic marker,pi3k/akt pathway interaction
ENSG00000156261,CCT8,tumor suppressor degradation,protein folding regulation,cell cycle progression,oncoprotein stabilization,signaling pathway activation,prognostic biomarker
ENSG00000172354,GNB2,gnb2 overexpression,constitutive activation,cell proliferation promotion,tumor growth enhancement,signaling pathway regulation,prognostic marker
ENSG00000013275,PSMC4,proteasome regulation,cell cycle progression,dna repair dysfunction,aberrant protein accumulation,oncogenic mutation,tumor progression
ENSG00000101843,PSMD10,ubiquitin-proteasome pathway,apoptosis inhibition,cellular stress response,genomic instability,tumor progression,oncogenic potential
ENSG00000008323,PLEKHG6,wnt/β-catenin pathway,oncogenic activation,cell migration and invasion,actin cytoskeleton dynamics,epithelial-to-mesenchymal transition,phospholipid regulation
ENSG00000131791,PRKAB2,tumor suppressor function loss,cell proliferation regulation,metabolic reprogramming,kinase activation,signaling pathway modulation,genomic instability association
